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Abstract 
 
Since its discovery 25 years ago, the cyclic di-GMP signalling pathway has been an ever-
expanding area of scientific research.  This pathway, ubiquitous in Bacteria, regulates a 
range of bacterial phenotypes in response to various environmental cues.  Two groups of 
enzymes make and break the secondary messenger c-di-GMP, these being the diguanylate 
cyclase (DGC) and phoshodiesterase (PDE) enzymes respectively.  Both classes of enzymes 
contain a consensus motif of amino acid residues, necessary for the catalytic activity of the 
proteins; specifically a GGDEF motif for DGC proteins and an EAL or HD-GYP motif for PDE 
enzymes.  However proteins exist which contain non-conserved sequences at these sites 
and are therefore deemed likely to be catalytically inactive.  The roles of these so called 
‘degenerate’ proteins are gradually being elucidated and have been found to be regulatory 
proteins, initiating a variety of cellular effects.  This thesis focuses on the degenerate DGC 
and PDE enzymes in E. coli K-12, of which there are four.  At the start of this project, two of 
these (YcgF and YdhA) had been characterised, whilst YdiV and YeaI were largely 
uncharacterised.  
 
Analysis of the YeaI protein confirmed the protein to be a catalytically inactive diguanylate 
cyclase, however the poor solubility of the protein vastly restricted characterisation of the 
protein.  YdiV was shown to be a catalytically inactive phosphodiesterase. Chacterisation of 
the protein showed YdiV to bind to the E. coli transcriptional factor FlhDC, where it acted as 
an anti-FlhDC factor.  The FlhDC factor is the master regulator of flagellar gene 
transcription, shown to bind to DNA and cause gene transcription.  However, upon YdiV 
binding to FlhDC, DNA was shown to be dissociated thereby halting gene expression. 
Kinetic and thermodynamic analysis of the YdiV:FlhDC binding interaction revealed the 
proteins to have a nM binding affinity.  In vitro transcription and EMSA analysis revealed 
the existence of a transitional or intermediate YdiV:FlhDC:DNA species which retains the 
FlhDC transcriptional activation ability.  Phenotypically, overproduction of the ydiV gene 
caused a vast decrease in flagella production and FliC detection.  The regulation of this 
YdiV:FlhDC interaction is currently unknown.  Nucleotide binding assays have revealed a 
possible interaction between YdiV and c-di-GMP, which potentially could regulate the 
activity of YdiV and thereby the YdiV:FlhDC interaction.   Furthermore, in vitro analysis has 
identified a YdiV:FlhDC:FliT species, which if produced in vivo, would add another level of 
regulation and complexity to the flagellar gene expression.  Thus, YdiV has a gene 
regulatory role in E. coli, repressing flagella biosynthesis via its interactions with FlhDC.   
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Chapter 1: Introduction 
 
 
1.1   Mechanisms of signal transduction in Bacteria  
 
The survival of every organism is dependent on cellular signalling mechanisms, to detect 
changes in external and internal conditions and respond accordingly.  There are several 
mechanisms in which bacteria respond to these changes of environment; these being 
certain transcription factors, two component systems and secondary messenger systems.  
 
Transcription factors are the simplest mechanism in which a protein detects a signal and 
causes a direct response intracellularly.  One example in E. coli is arabinose catabolism, 
which is regulated by the AraC protein.  AraC binds to arabinose and responds by inducing 
the expression of five operons encoding proteins for arabinose transport, catabolism and 
autoregulation (Schleif, 2000).  
 
Another frequently used mechanism for signal transduction is the two-component system. 
This involves a histidine kinase (HK) protein (often membrane-bound), which acts as a 
sensory component and a response regulator (RR) protein, which induces a cellular 
response to the signal.  In E. coli 30 HK proteins have been identified alongside a similar 
number of response proteins, indicating the diversity of this system to both detect signals 
and respond.  Often, upon detection of an exogenous signal, the HK domain undergoes 
auto-phosphorylation, which subsquently leads to phosphorylation of the cognate RR.  The 
activated response regulator then induces a cellular change, by mediating changes in gene 
transcription (Yamamoto et al., 2005).  
 
Other systems involve small molecules known as secondary messengers, which work in the 
same basic manner, detecting a stimulus and responding by altering the concentration of 
an intracellular secondary messenger.  The messenger molecule(s) subsequently interacts 
with various effector proteins, resulting in a variety of cellular effects.  In this way, the 
small molecules are responsible for signal transduction, producing a cellular response to a 
signal (Kalia et al., 2013; Botsford & Harman, 1992).  
 
2 
 
One of the best characterised secondary messenger pathways is the cyclic AMP (cAMP) 
pathway, which acts as a four component system and results in changes in gene expression 
(Botsford & Harman, 1992; Borrelli et al., 1992).  
 
In E. coli, the activity of the only adenylate cyclase (CyaA) (responsible for cAMP synthesis) 
is controlled by interaction with the glucose phosphotransferase system (PTS).  
Phosphoenolpyruvate initiates a phosphorelay in which the components of the glucose PTS 
(PtsI, PtsH, Crr and PtsG) are phosphorylated.  PtsG mediates the uptake of glucose across 
the inner membrane with concomitant conversion to glucose-6-phosphate.  Thus, when 
glucose is abundant phosphate flows through the relay and the phosphorylation state of 
the proteins that constitute the glucose PTS is minimal.  When the bacteria are glucose-
starved the PTS is fully phosphorylated and Crr~P interacts with CyaA to promote adenylate 
cyclase activity.  Hence, the bacteria respond to glucose-starvation by increasing the 
intracellular concentration of cAMP.  This is perceived by the cAMP receptor protein (CRP), 
a transcription factor that exhibits enhanced site-specific DNA-binding when in complex 
with cAMP.  Binding of CRP-cAMP to target promoters’ results in the regulation of several 
hundred genes, many of which are associated with the utilization of alternative carbon 
sources.  A single cAMP phosphodiesterase (CpdA) could act to lower the concentration of 
cAMP in E. coli, but its activity with cAMP is low and perhaps a more likely route to lower 
intracellular cAMP concentrations is via TolC-mediated export (Botsford & Harman, 1992; 
Borrelli et al., 1992; Hantke et al., 2011).   
 
Other secondary messengers include (p)ppGpp, which acts in the stringent response to 
enable bacterial adaptation to nutrient starvation conditions (Chatterji & Ojha, 2001). 
Cyclic di-GMP and cyclic di-AMP are cyclic dinucleotides which have been identified as 
important signalling molecules (Hengge, 2009; Corrigan & Gründling, 2013).  A poorly 
understood and recently identified secondary messenger is cyclic GMP (An et al., 2013).   
   
Whilst these signalling pathways regulate very different processes, they operate in a similar 
fashion and represent a significant proportion of the bacterial signalling portfolio (Kalia et 
al., 2013).  The widespread use of nucleotides as secondary messengers opens the 
possibility of other nucleotides being involved in currently unknown/uncharacterised 
regulatory pathways.  
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1.2   Cyclic di-GMP signalling  
 
Bis-(3’-5’)-cyclic dimeric guanosine monophosphate (cyclic di-GMP/ c-di-GMP) was first 
discovered in 1987 to be an activator of a cellulose synthase enzyme in Gluconacetobacter 
xylinus, previously named Acetobacter xylinium (Ross et al., 1987). Since this discovery, 
research activity has increased dramatically and it has been found that c-di-GMP is a 
ubiquitous secondary messenger in bacteria (Hengge, 2009; Römling et al., 2005; Römling 
et al., 2013).  
 
The c-di-GMP pathway is similar to cAMP signalling (Section 1.1) but with a greater level of 
multiplicity, consisting of multiple sensory domains, multiple enzymes responsible for c- di-
GMP turnover and numerous effector proteins activated by c-di-GMP, producing diverse 
cellular effects (Hengge, 2009; Römling et al., 2013).  
 
In the c-di-GMP pathway, external stimuli such as light or the binding of DNA, 
carbohydrates or proteins are stimulants for the activation of c-di-GMP turnover enzymes. 
The formation of c-di-GMP occurs by the activity of diguanylate cyclase (DGC; Section 1.6.1) 
proteins whilst phosphodiesterase (PDE; Section 1.6.2) enzymes break down this secondary 
messenger molecule.  The number of these enzymes varies from species to species, 
however it is common for an organism to contain multiple proteins (10’s-100’s) for both 
enzymatic activities.  The intracellular c-di-GMP acts as a secondary messenger molecule, 
activating various effector proteins which lead to numerous phenotypic responses in the 
cell.  The cellular responses depend on the precise levels of intracellular c-di-GMP, but 
effect major bacterial phenotypes such as cell motility, virulence, biofilm formation and cell 
morphology (Römling et al., 2005; Galperin, 2004; Hengge, 2009).  
 
The widespread presence of this signalling pathway within the bacterial kingdom and the 
diversity of the cellular phenotypes related to c-di-GMP, have cemented the importance of 
this secondary messenger in bacterial adaptation and survival.  Moreover, c-di-GMP is a 
bacterial-specific molecule, providing a whole array of potential targets for novel antibiotic 
design (Hengge, 2009; Römling et al., 2013).  
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1.3   Cellular effects of c-di-GMP signalling  
 
Bis-(3’-5’)-cyclic dimeric guanosine monophosphate signalling pathways result in an array 
of cellular characteristics, achieved by modulating the activities of various effector proteins 
(Hengge, 2009).  These signalling outputs include regulating biofilm formation, 
exopolysaccharide production, gene transcription, flagellum activity and adhesin secretion 
(Newell et al., 2009; Hickman et al., 2005; Kirillina et al., 2004; Tischler & Camilli, 2004; 
Simm et al., 2004; Hickman & Harwood, 2008).  
 
Controlling gene regulation is one of the major cellular effects of c-di-GMP signalling.  One 
example of this comes from the E. coli YddV protein, which upon overexpression, caused 
the up-regulation of 109 genes and repression of 87 genes (Méndez-Ortiz et al., 2006).  In 
conditions of high c-di-GMP (created by over-production of the c-di-GMP producing 
enzyme YddV), genes encoding cell wall proteins were induced, whilst sugar metabolism 
genes were repressed (Méndez-Ortiz et al., 2006).  Another example is VieA (a c-di-GMP 
turnover enzyme) from Vibrio cholerae which represses transcription of the vps genes 
encoding exopolysaccharide proteins (Tischler & Camilli, 2004).  
 
Bis-(3’-5’)-cyclic dimeric guanosine monophosphate is also associated with controlling the 
virulence of pathogens, antibiotic production and regulating cell cycle progression (Tischler 
& Camilli, 2005;  Aldridge et al., 2003; Hengge, 2009; Duerig et al., 2009).  For example, in 
V. cholerae, PilZ domain proteins (Section 1.4.1) have been shown to bind c-di-GMP 
specifically and regulate the expression of virulence genes as well as biofilm and motility 
(Pratt et al., 2007).  
 
However, the major role of c-di-GMP signalling is in regulating the predominant lifestyle 
choice in bacteria; between single motile organisms and biofilm community-based 
lifestyles.  Generally high levels of c-di-GMP cause biofilm formation via the synthesis of 
extracellular polymeric substances (EPS).  A decrease in the intracellular c-di-GMP levels 
supports a more motile phenotype, increasing flagella synthesis and repressing biofilm 
favouring genes (Hengge, 2009; Kirillina et al., 2004; Simm et al., 2004). 
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1.3.1   Bacterial motility and its regulation by c-di-GMP signalling  
 
The motility of bacteria is often dependent on the presence or absence of flagella on the 
bacterial surface (Macnab, 1977 and references within).  A single flagellum consists of a 
basal membrane-bound structure which is attached to a rotating hook, leading to a long 
flagellum filament (Figure 1.1).  The assembly of a flagellum is a sequential process, starting 
with the MS-ring, the C-ring and the type III secretion apparatus.  Next to be formed, is the 
rod which spans the periplasmic space, before the P-ring and L-ring associate.  At the cell 
surface, the hook structure is assembled before finally the filament subunits assemble, 
creating the external appendage (Mcnab, 2003; 1996).  
 
In E. coli there are ~ 50 genes which are involved in flagella production and export, all of 
which need to be tightly regulated in order to produce flagella under the appropriate 
conditions (Figure 1.2) (Chilcott & Hughes, 2000).  These 50 genes are divided into a 
hierarchy of 3 classes, named Class I, II and III or early, middle and late genes (Liu & 
Matsumura, 1994; Chilcott & Hughes, 2000).  The Class I genes consist of the flhDC operon 
only, which encodes the proteins FlhD and FlhC, forming the transcription factor FlhD4C2. 
This protein complex is known as the ‘master regulator’ of flagellum gene transcription, 
binding to the promoter regions of all Class II genes and enhancing their transcription.  The 
Class II genes include basal-body rod proteins proteins such as FlgB, chaperone proteins 
such as FliT and the σ28 factor FliA.  FliA is then necessary to bind upstream of all Class III 
genes and induce their transcription, encoding proteins such as the flagellum filament 
protein FliC (Chilcott & Hughes, 2000; Macnab, 2003; Liu & Matsumura, 1994).  
 
This transcriptional cascade is tightly regulated in a multi-faceted manner.  The 
transcription of flhDC is regulated by systems responding to environmental cues such as 
high osmolarity, quorum sensing and heat shock (Shin & Park, 1995; Sperandio et al., 2002; 
Wei et al., 2001).  The production of FlhDC regulates flagellum synthesis, by up-regulating 
the Class II genes.  Some of the products of Class II transcription then act to both activate 
(FliZ) and repress (FliT) the activity of FlhDC in a feedback loop, to ensure precise control of 
FlhDC activity (Kutsukake et al., 1999; Chilcott & Hughes, 2000).  Furthermore, other Class II 
transcription products (FliA and FlgM) are responsible for the transcription of Class III 
genes, with FliA necessary for the activation of these genes directly and FlgM down-
regulating the activity of FliA (Kutsukake & Iino, 1994; Barembruch & Hengge, 2007). In this 
manner, the production of flagella is tightly regulated.   
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Figure 1.1: Schematic diagram of bacterial flagellar components  
 
Cross-sectional diagram of the flagellar appendage in bacteria, showing the location 
and role of the flagellar proteins. The flagellum is a hollow tube, as clearly shown in 
the diagram, enabling proteins to be secreted from the cell outside, in order to allow 
the formation and growth of the filament.  
 
The assembly of this structure is tightly controlled and sequential.  The MS-ring 
forms first, closely followed by the C-ring and the type III secretion system. 
Following this, the rod structure is assembled, prior to the P-ring and L-ring being 
produced.  The hook is then assembled, before finally the filament subunits are 
added, producing the long tail-like appendage known as a flagellum.  
 
(Macnab, 1996; 2003) 
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Figure 1.2: Schematic diagram of the cascade and regulation of flagellar gene 
synthesis in E. coli 
 
The E. coli flagellar genes are arranged in a three-tier system, named Class I, II and III 
(or early, middle and late) genes.  This system is highly regulated by a number of 
activators and repressors, fine-tuning the expression of the genes.  
 
The regulatory transcription system is shown here, with genes and operons 
indicated by italicised writing, whilst coloured shapes indicate proteins.  Activators 
(or up-regulators) are denoted by + labels and repressors (or down-regulators) 
denoted by – labels.  
 
(Chilcott & Hughes, 2000; Macnab, 2003; Liu & Matsumura, 1994) 
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The link between intracellular c-di-GMP levels and motility was first noted by Simm et al. 
(2004) and since then has been identified in species across the bacterial kingdom.  Low 
intracellular levels of c-di-GMP characteristically produce motile bacteria, by inducing 
flagella synthesis and repressing biofilm production (Simm et al., 2004; Krasteva et al., 
2010; Ryjenkov et al., 2006; Römling et al., 2013).  
 
In V. cholerae, a transcriptional regulator VpsT has been shown to bind to c-di-GMP and 
inversely control extracellular matrix production and motility.  Upon deletion of the vpsT 
gene, cells displayed an increased motility, indicating a direct role of this protein in 
regulating motility.  Upon c-di-GMP binding, VpsT undergoes dimerisation to produce an 
active form which strongly decreases the expression of various flagellum genes. 
Additionally, the transcriptional regulator up-regulates the expression of polysaccharide 
biosynthesis (vsp) genes.  Therefore the protein has a dual role, both inhibiting motility and 
increasing biofilm formation in high c-di-GMP conditions (Krasteva et al., 2010).  
 
FleQ is a c-di-GMP-dependent flagella regulator in Pseudomonas aeruginosa.  FleQ has 
been shown to bind c-di-GMP and upon binding, controls the expression of the pel genes 
(encoding polysaccharide biosynthesis proteins) and the flagella regulon (Hickman & 
Harwood, 2008).  
 
In E. coli, YcgR and YhjH were identified as putative motility-inducing proteins. Both 
proteins were found to restore the motility of a non-motile hns mutant (Ko & Park, 2000). 
YhjH is an active phosphodiesterase and a member of the EAL domain family (Pesavento et 
al., 2008; Section 1.6.2).  YcgR is a PilZ domain protein, which has been shown to bind to    
c-di-GMP (Ryjenkov et al., 2006; Section 1.4.1).   
 
Upon interaction with c-di-GMP, YcgR has been shown to affect motility, causing flagellar 
rotation direction to change (inducing a counterclockwise bias) and the rate of flagellar 
rotation to decrease. Two distinct models have been hypothesised to account for the roles 
of YcgR, however there are distinct differences between models (i.e. whether Yc gR 
interacts with the FliM/FliG proteins, thereby inducing a counterclockwise bias, or the 
MotA protein and thereby reduces the efficiency of energy transfer and slows flagellar 
rotation) which need further investigation before a clarified mechanism of action for YcgR 
is known (Paul et al., 2010; Boehm et al., 2010) These dual roles of YcgR have led to the 
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protein being labelled as having a “brake or clutch” effect on flagellar motility (Römling et 
al., 2013).   
 
1.3.2   Biofilm formation and c-di-GMP regulation of this phenotype 
 
The c-di-GMP signalling pathway has been linked to biofilm production from the initial 
discovery of c-di-GMP in 1987, where the secondary messenger was found to activate the 
cellulose synthase enzyme in G. xylinus (Ross et al., 1987). Since then, this apparent link has 
been confirmed across the bacterial kingdom, identifying many DGC and PDE enzymes that 
regulate cellulose production and biofilm formation (Simm et al., 2004; Tischler & Camilli, 
2004; GarcÍa et al., 2004; Bomchil et al., 2003).  
 
Bacterial biofilms are of great significance, with biofilms present in over 80% of all (acute 
and chronic) human infections.  Common infections such as urinary tract infections, 
catheter infections, chronic wounds, pneumonia and even dental plaque are all produced 
by bacterial biofilms (Costerton et al., 1999; Bjarnsholt, 2013).  
 
The term biofilm refers to a group of microorganisms which adhere to one another on a 
surface, aided by an array of EPS such as DNA, proteins and polysaccharides (O’Toole et al., 
2000; Pratt & Kolter, 1998).  The molecular mechanism of biofilm formation is 
characterised by five distinct steps (Figure 1.3).  Firstly bacteria make an initial contact with 
a surface.  The vast majority of cells are released from the surface and remain motile; 
however some bacterial cells anchor themselves to the surfaces via pili.  Once the cells are 
firmly attached, the biofilm matures by both cell division and recruitment of bacteria to the 
site.  Biofilm matrices are produced, which enclose the cells and forms a protective barrier. 
This matrix is composed of both internal (i.e. polysaccharides synthesised within the cell 
and exported out) and external (i.e. minerals and soil particles) materials.  This biofilm can 
then last for an indefinite time, depending on environmental conditions.  Under certain 
conditions, the biofilm is dispersed, releasing the mass of cells into single motile cells once 
more (Pratt & Kolter, 1998; O’Toole et al., 2000; Stoodley et al., 2002)  
 
In order for biofilms to be produced, cells rely on quorum sensing (QS) methods to 
communicate with other cells and inform the cells about the surrounding environment.  
Quorum sensing is the process in which self-generated signalling molecules called 
autoinducers (AIs), are produced by cells and secreted into the environment.  Bacteria have  
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Figure 1.3: Schematic diagram showing the stages of biofilm formation  
 
Diagram to show how single bacterial cells (shown as blue ovals) aggregate to form a 
biofilm structure with subsequent dispersal into individual cells.  The red dashed lines 
indicate the transition to a new step (of which there are five) and the boxes indicate 
the key processes occurring between each transition.  
 
The cells initially attach to a surface through weak bonds, but can form strong 
irreversible attachments by the production of fimbriae structures which adhere the 
cells to the surface.  The decision to irreversibly attach to a surface is largely due to QS, 
enabling cells to determine whether to remain motile and independent or form an 
aggregated biofilm.  
 
Once bacteria have become firmly attached to a surface, they start producing cellulose 
and other extracellular polymeric substances (EPS) which form the biofilm matrix.  At 
this maturation stage, bacteria stop producing flagellae.  The cells can remain in this 
biofilm for extended periods of time, continuing to divide and produce EPS 
components, all of which give the aggregated cells an increased survival rate.  
 
Once the environmental conditions have changed, and there is no advantage to 
remain in a biofilm, the cells begin to disperse from the biofilm.  To break apart the 
EPS matrix, cells synthesise EPS-degrading enzymes, releasing the aggregated cells.  
Flagella synthesis is re-activated by the cells, enabling swimming to new environments.   
 
(O’Toole et al., 2000; Pratt & Kolter, 1998; Stoodley et al., 2002) 
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a threshold level for AI’s, meaning that the bacteria only detect these molecules when 
multiple nearby bacteria are secreting the molecule.  In this manner, bacteria are informed 
of the surrounding population density and this induces transcriptional changes within the 
cells, such as production of exopolysaccharides or pili formatIon, both of which are crucial 
to biofilm formation (Bassler & Losick, 2006; Hammer & Bassler, 2003; Parsek & Greenberg, 
2005).  
 
Quorum sensing thereby enables bacterial cells to act as a population rather than individual 
cells, which can be advantageous for survival, with biofilms offering protection from UV, 
water-limiting conditions, predation, disinfectants and antibiotics (Chang et al., 2007; Fux 
et al., 2005; Matz et al., 2005; Elasri & Miller, 1999).  The precise environmental conditions 
which cause biofilm formation (by QS) vary from organism to organism.  For example, the 
microaerobic bacterium Campylobacter jejuni forms biofilms in stressful high O2 levels 
(20%) as a survival strategy (Reuter et al., 2010).  Gram-negative bacteria such as E. coli and 
Salmonella survive low nutrient starvation conditions by the formation of biofilms (Kolter et 
al., 1993).  Furthermore, low levels of β-lactam antibiotics induce the production of 
extracellular DNA and biofilm formation in Staphylococcus aureus (Kaplan et al., 2012).  
 
One of the key components necessary for biofilm formation in E. coli and Salmonella strains 
is the synthesis of cellulose, which acts as the major exopolysaccharide in the biofilm 
matrix (Zogaj et al., 2001).  Additionally, bacterial cells require adherence proteins and 
motility appendages, such as curli fibres, flagella and pili, in order to make the initial 
attachment to surfaces for biofilm formation (Pratt & Kolter, 1998; Olsén et al., 1989). 
Cyclic di-GMP signaling proteins have been implicated in biofilm formation by activation of 
these key biofilm-inducing systems, across a range of bacterial species.  
 
In P. aeruginosa, FleQ has been identified as a regulator of bacterial biofilm in a c-di-GMP-
dependent manner.  Under low c-di-GMP conditions, FleQ forms a complex with an 
accessory protein FleN and the complex binds upstream of biofilm associated genes and 
represses transcription by bending the DNA.   However, in high c-di-GMP environments, 
DNA bending does not occur, thereby inducing the expression of biofilm associated genes, 
specifically pel and psl (Baraquet et al., 2012; Hickman & Harwood, 2008).  
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VieA is a V. cholerae EAL domain protein (Section 1.6.2) which hydrolyses intracellular        
c-di-GMP.  Upon activation of the protein (and c-di-GMP hydrolysis), the protein represses 
transcription of exopolysaccharide synthesis (vps) genes, thereby inhibiting biofilm 
formation (Tischler & Camilli, 2004).  
 
In E. coli, the transcription factor CsgD activates transcription of the csgBA operon which 
encodes curli fibre structures (Römling et al., 1998; Prigent-Combaret et al., 2001). The 
transcription of csgDEFG and therefore levels of CsgD in the cell, are regulated by pairs of  
c-di-GMP signalling proteins.  In particular, YdaM and YciR (a DGC and PDE respectively; 
Section 1.6) and YegE and YhjH (a DGC and PDE respectively) are two pairs of proteins 
which regulate CsgD levels (Pesavento et al., 2008; Weber et al., 2006).  These enzymes 
fine-tune the intracellular levels of c-di-GMP, which at high concentrations stimulates the 
transcription of CsgD, thereby controlling the synthesis of curli fibre (Pesavento et al., 
2008; Weber et al., 2006).  
 
Futhermore, CsgD activates the transcription of proteins YaiC and YoaD (DGC and PDE 
activities respectively) which again control the concentration of cellular c-di-GMP 
(Brombacher et al., 2006).  In turn, this c-di-GMP pool regulates the activity of the BcsA 
protein and cellulose formation (Zogaj et al., 2001; Amikam & Galperin, 2006; Ryjenkov et 
al., 2006; Brombacher et al., 2006).  
 
1.4   Cyclic di-GMP effector proteins 
 
Whole arrays of c-di-GMP binding proteins exist in bacterial cells, and it is these effectors 
which convert intracellular fluctuations of c-di-GMP concentrations into phenotypic cellular 
effects.  Whilst a vast number of effector proteins remain unknown, an ever-growing 
number of c-di-GMP binding proteins have been characterised, and can be categorised into 
multiple classes (Römling et al., 2013; Corrigan & Gründling, 2013).  Here four classes; PilZ 
domain proteins, degenerate GGDEF/EAL proteins, riboswitches and unrelated proteins, 
are discussed.  
 
1.4.1   The PilZ domain class of effector proteins  
 
One of the most common effector proteins is the c-di-GMP binding PilZ domain.  This 
domain was first identified in cellulose synthase enzymes from G. xylinus, but was soon 
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revealed as a wide-spread domain (Amikam & Galperin, 2006).  The PilZ domain was 
identified in V. cholerae proteins PlzC and PlzD, shown to regulate motility, biofilm 
formation and virulence of the bacteria in a c-di-GMP-dependent manner (Pratt et al., 
2007).  The E. coli protein YcgR and C. crescentus protein DgrA are just two further 
examples of PilZ proteins, binding c-di-GMP and inducing a downstream signalling cascade 
resulting in the regulation of cell motility (Ryjenkov et al., 2006; Christen et al., 2007).  
 
PilZ domain effectors have been shown to regulate a number of cellular functions, the most 
common of which are motility, exopolysaccharide synthesis and DNA binding functions 
(Ryjenkov et al., 2006; Christen et al., 2007; Merighi et al., 2007; Johnson et al., 2011).  
 
1.4.2   The role of degenerate GGDEF/EAL domain proteins as c-di-
GMP effector proteins 
 
The aforementioned DGC and PDE enzymes are responsible for c-di-GMP turnover in 
bacteria (Section 1.6).  Proteins with these catalytic activities are characterised by a highly 
conserved motif of residues necessary for the enzymatic function.  These motifs are GGDEF 
(for DGC activity) and EAL or HD-GYP (for PDE activity).  The protein domains containing 
these motifs are designated as GGDEF, EAL and HD-GYP domain proteins (Simm et al., 
2004; Paul et al., 2004; Hengge, 2009).  
 
A significant proportion of the GGDEF/EAL domain proteins lack this highly conserved motif 
and are presumed to be catalytically inactive (Section 1.8) (Schmidt et al., 2005; Suzuki et 
al., 2006).  However, several of these proteins have been identified as c-di-GMP receptor-
effector proteins, activated by binding to c-di-GMP and initiating a cellular response 
(Römling et al., 2013; Duerig et al., 2009; Lee et al., 2007; Newell et al., 2009).  At present, 
no degenerate HD-GYP domains have been identified as effector proteins.  
 
In C. crescentus, PopA is a degenerate GGDEF domain protein but binds c-di-GMP at its 
intact I-site (Section 1.8.1).  Upon c-di-GMP binding, PopA is activated and induces a 
downstream cascade of protein recruitment, culminating in the degradation of the 
replication inhibitor protein CtrA.  Ultimately this leads to progression of the C. crescentus 
cell cycle from G1 to S phase (Duerig et al, 2009).  Another example of a degenerate GGDEF 
effector protein is PelD in P. aeruginosa.  PelD is a highly diverged GGDEF domain protein, 
lacking most structural features of DGCs, retaining only an intact I-site.  This protein binds 
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c-di-GMP at its I-site which activates the protein and induces post-translational regulation 
of PEL polysaccharide synthesis (Lee et al., 2007; Christen et al., 2006).  
 
Degenerate EAL domain proteins have also been shown to be c-di-GMP effector proteins. 
In Pseudomonas fluorescens, LapD was identified as a degenerate GGDEF-EAL domain 
protein.  Neither domain is catalytically active, however LapD becomes activated by            
c-di-GMP binding to the EAL domain of the protein.  Upon activation, the protein induces 
cell adhesion and biofilm formation (Newell et al., 2009).  
 
1.4.3   Riboswitches as c-di-GMP effector proteins 
 
Alongside protein effector systems, RNA effector systems have also been identified, named 
as riboswitches.  Riboswitches are non-coding RNA molecules which exist in a characteristic 
secondary structure.  These RNA segments bind c-di-GMP at high affinity and regulate gene 
transcription according to c-di-GMP concentrations.  Virulence genes, flagellum and pilus 
biosynthesis genes have been identified as genes regulated by riboswitches.  Whilst this 
effector class is still relatively uncharacterised, it may represent a highly important class, 
given the already high numbers of riboswitches identified in some species (Sudarsan et al., 
2008; Barrick & Breaker, 2007).  
 
1.4.4   The detection of unrelated proteins as effector proteins  
 
Protein sequence alignments have been useful in identifying effector proteins of class 1 and 
2 (PilZ domain proteins and degenerate GGDEF/EAL domain proteins).  However, several 
proteins have been revealed as c-di-GMP effector proteins which do not fit into these 
classes and appear to have no common motif or domain unifying them.  
 
One example is FleQ which is a transcriptional regulator in P. aeruginosa.  FleQ is a DNA-
binding protein, known to regulate expression of various genes involved in 
exopolysaccharide production and flagellum-based motility.  FleQ acts in a c-di-GMP-
dependent manner, repressing exopolysaccharide synthesis but up-regulating flagellum 
assembly genes in low c-di-GMP environments.  Under high c-di-GMP conditions, FleQ has 
the opposite effect, initiating exopolysaccharide synthesis and repressing motility genes 
(Hickman & Harwood, 2008).  
 
15 
 
Several other transcription factors have been identified as c-di-GMP binding proteins, such 
as Clp from Xanthomonas campestris, a member of the CRP/FNR superfamily, which 
controls virulence gene expression (Chin et al., 2010). In Burkholderia cenocepacia, the 
Bcam1349 protein is a CRP/FNR family transcriptional regulator. This protein regulates 
biofilm formation and virulence genes in a c-di-GMP-dependent manner (Fazli et al., 2011).  
 
1.5   C-di-GMP sensory domains 
 
Further expansion of the c-di-GMP signaling pathway comes from the multitude of sensory 
domains, which detect external stimuli and cause an activation cascade down the c-di-GMP 
pathway.  The vast majority of GGDEF and EAL domains are linked to N-terminal 
transmembrane sensory domains that detect the external signal and activate the coupled 
DGC or PDE activity.  Some GGDEF/EAL domains are coupled to multiple N-terminal sensory 
domains, demonstrating the complex signal integration which occurs (Hengge, 2009; 
Römling et al., 2013).  A small proportion of GGDEF/EAL domains have an attached 
cytosolic domain which acts as a self-contained effector protein, and here the GGDEF/EAL 
domains simply mediate a phosphoryl-transfer reaction between the sensory and effector 
domains (Jenal & Malone, 2006; Schmidt et al., 2005). The most frequently identified 
sensory domains are PAS, GAF and REC domains (Henry & Crosson, 2012; Römling et al., 
2013).  
 
1.5.1   PAS domains as sensory elements 
 
PAS domains, named after the first proteins in which it was recognised (Per, ARNT and Sim) 
are widespread sensory domains, with each of the Per, ARNT and Sim proteins identified as 
regulatory proteins (Ponting & Aravind, 1997; Nambu et al., 1991).  PAS domains have been 
found that detect light, oxygen and other gases and redox potential (Ponting & Aravind, 
1997; Zhulin et al., 1997; Taylor & Zhulin, 1999).  
 
PAS domains have two regions of conserved amino acid residue sequences, but otherwise 
have very high sequence deviation, often only with 20% sequence identity to other PAS 
domains (Zhulin et al.,1997; Taylor & Zhulin, 1999; Henry & Crosson, 2012).  The sensory 
specificity of PAS domains is partly dependent on an associated cofactor, with haem or 
flavin commonly found (Taylor & Zhulin, 1999).   
16 
 
 
In E. coli the dosCP operon encodes the proteins DosC and DosP, both of which control 
intracellular c-di-GMP concentration in an oxygen-dependent manner (Tuckerman et al., 
2009).  The DosP protein is an oxygen-sensing c-di-GMP PDE, with an N-terminal PAS 
domain which acts as a haem-binding oxygen sensor. The DosC protein is a DGC protein 
with an N-terminal GCS (globin-coupled sensor) domain (Tuckerman et al., 2009; Hou et al., 
2001). This GCS domain is a globin domain which binds oxygen at its haem site.  Both of 
these sensory domains thereby enable intracellular oxygen sensing, and maintain 
controlled intracellular c-di-GMP metabolism via the C-terminal coupled DGC and PDE 
activities of DosC and DosP respectively (Tuckerman et al., 2009). 
 
1.5.2   The presence of GAF as a sensory domain 
 
GAF domains are another type of sensory domain found in the c-di-GMP pathway.  Protein 
domains containing strong secondary structure homology were identified in cGMP-specific 
and –stimulated phosphodiesterases, Anabaena adenylate cyclases and E. coli FlhA and 
were named GAF according to these proteins (Aravind & Ponting, 1997).  These domains 
bind to cyclic nucleotides cAMP and cGMP and in doing so cause the activation of DGCs and 
PDEs (Heikaus et al., 2009).  A GAF domain containing a non-haem iron centre has also 
been shown to detect NO (Tucker et al., 2008).  
 
In Myxococcus xanthus, SgmT is crucial for regulating the composition of the extracellular 
matrix.  This protein consists of an N-terminal GAF domain and a C-terminal GGDEF 
domain.  Despite binding to an unknown ligand, the GAF domain is essential for SgmT 
activity, suggesting that ligand binding to GAF induces a conformational change that 
enables c-di-GMP binding to the GGDEF domain and subsequent downstream cellular 
effects (Petters et al., 2012).  
 
1.5.3   REC as a commonly found sensory domain  
 
REC (standing for receiver) domains are so named due to their role as a phosphate acceptor 
or receiver protein, specifically at a conserved Asp residue (Galperin, 2006 and references 
within).  These REC domains, also called CheY domains, are frequently used sensory 
domains in the c-di-GMP pathway, often coupled to GGDEF/EAL/HD-GYP domains. Upon 
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phosphorylation, the REC domains are activated and initiate downstream signalling events, 
activating neighbouring or co-localised proteins (Römling et al., 2013; Paul et al., 2007).  
 
The C. crescentus protein PleD is a REC-containing protein, consisting of 2 N-terminal REC 
domains and a C-terminal GGDEF DGC domain.  Both REC-domains are required for the 
activity of PleD, which is responsible for pole development during the C. crescentus cell 
cycle (Paul et al., 2004).  Upon activation of the REC domains by phosphorylation, the REC 
structure is repackaged, which enables the GGDEF domains to form active DGC dimers 
(Paul et al., 2007).  
 
1.5.4   Less common sensory domains 
 
There is also a multitude of less common sensory domains that have been characterised.  
For example, the E. coli protein YcgF is involved in regulation gene transcription and is 
activated by the detection of blue light.  YcgF consists of an N-terminal BLUF domain and a 
C-terminal EAL domain, with the BLUF domain being activated upon detection of blue light, 
causing a cascade of changes resulting in gene regulation (Tschowri et al., 2009).  MASE1 
and MASE2 domains, have yet to be completely characterised but have been found to 
sense oxygen in Desulfovibrio vulgaris (Nikolskaya et al., 2003).  Additionally the MASE1 
domain from the E. coli protein YfgF has been found to regulate bacterial responses to 
aspartate (Lacey et al., 2013). 
 
Numerous sensory domains have been identified, detecting a multitude of signalling inputs. 
The sheer variety of stimuli gives a clear indication of the breath of environments in which 
the c-di-GMP pathway is responsive to.  Additonally, sensory domains can be both 
cytoplasmic (such as PAS or GAF) or can be periplasmic, again maximising the environments 
and signals which cause c-di-GMP fluctuations (Jenal & Malone, 2006; Römling et al., 2005).  
 
1.6   The biosynthesis and degradation of c-di-GMP 
 
The turnover of the secondary messenger c-di-GMP is dependent on two families of 
enzymes; the diguanylate cyclases (DGCs) and the phosphodiesterases (PDEs).  These two 
families of enzymes control the cellular level of c-di-GMP, with DGCs and PDEs synthesising 
and degrading the molecule respectively (Figure 1.4).  Both enzyme classes have conserved  
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Figure 1.4: The mechanism of cyclic di-GMP turnover 
 
The level of intracellular c-di-GMP is determined by the relative activities of DGC and 
PDE enzymes, characterized by consensus GGDEF and EAL/HD-GYP motifs respectively.  
 
The DGC proteins act to synthesize c-di-GMP from two molecules of GTP and therefore 
the activity of these enzymes increases the cellular c-di-GMP levels.  PDE enzymes 
have an opposing role to the DGC proteins, catalyzing the hydrolysis of c-di-GMP either 
into pGpG or GMP.  The HD-GYP domains degrade c-di-GMP directly into 2 molecules 
of GMP, whilst EAL domain proteins degrade c-di-GMP into pGpG, which is further 
degraded into GMP molecules by a separate enzyme.   
 
The identity of the enzyme which converts pGpG into GMP, often referred to as having 
PDE-B activity, is currently unknown but is believed to be ubiquitous in all c-di-GMP 
signalling bacteria.  
 
(Ryjenkov et al., 2005; Simm et al., 2004; Schmidt et al., 2005; Tamayo et al., 2005; 
Chang et al., 2001; Ryan et al., 2006, Povolotsky & Hengge, 2012) 
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domains, which are named after the amino acid residues located in the active sites.  DGCs 
contain the conserved GGDEF motif and are thereby named GGDEF domains, whilst PDEs 
contain a conserved EAL or HD-GYP domain and are named accordingly (Paul et al., 2004; 
Hengge, 2009).   
 
Initially GGDEF and EAL domains were the only identified c-di-GMP turnover enzymes, 
being the most numerous.  However, several bacterial species contained GGDEF proteins 
but lacked EAL proteins, such as Thermotoga maritima which contains nine GGDEF proteins 
but zero EAL domains (Galperin et al., 2001).  This therefore raised the question whether 
alternative PDEs were present in these species.  Investigations revealed the HD-GYP 
domain as a possible alternative PDE, which was confirmed to be enzymatically active and 
responsible for the hydrolysis of c-di-GMP into GMP molecules (Galperin et al., 1999; 2001; 
Ryan et al., 2006; Povolotsky & Hengge, 2012).  
 
1.6.1   Diguanylate cyclase proteins 
 
Jenal and co-workers made the initial link between GGDEF-motif proteins and the synthesis 
of c-di-GMP and proposed the idea of GGDEF proteins being universal regulatory proteins 
(Paul et al., 2004).  This hypothesis was found to be true, with GGDEF domains found to be 
characteristic of DGC activity and the synthesis of c-di-GMP (Ryjenkov et al., 2005).  These 
domains are characterized by a GGDEF or GG[D/E][D/E]F residue motif, which is a 
consistent feature of all active DGC enzymes in any bacterial species (Galperin et al., 2001; 
Ryjenkov et al., 2005).   
 
Diguanylate cyclase proteins are catalytic proteins which synthesize one molecule of           
c-di-GMP from two molecules of GTP in the cell (Figure 1.4) (Simm et al., 2004; Ryjenkov et 
al., 2005).  These proteins are active as dimers, formed of two GGDEF domains (Figure 1.5) 
(Chan et al., 2004; Paul et al., 2007).  The A-site (active site) is located in the cleft between 
the two GGDEF domains, with each GGDEF motif at this dimerisation interface.  The GGDEF 
motif residues and other conserved residues in the domains make contacts with the two 
GTP molecules and are required for the catalysis of c-di-GMP synthesis (Chan et al., 2004; 
Navarro et al., 2009).  
 
The dimerisation of GGDEF domains is a crucial stage for the activation of DGC activity. The 
majority of GGDEF domains are coupled to N-terminal domains which are thought to  
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Figure 1.5: Characterisation of active and inactive GGDEF and EAL domain proteins  
 
A) Schematic diagrams of active DGC and PDE domains. Active DGCs are produced 
upon the dimerisation of two GGDEF containing subunits, bringing two GGDEF 
motifs together (shown as red boxes) to form an active site at this interface.  
Inhibition sites (shown as green boxes) act to bind c-di-GMP and therefore set 
an upper limit on the activity of DGCs. Active PDEs are characterized as 
monomeric EAL domain proteins, with Mg2+ or Mn2+ (shown as red circles) 
bound at the active site (shown as a blue region), in order to bind c-di-GMP.   
B) Protein sequence alignment of GGDEF domains, with the GGDEF consensus 
sequence boxed in red and the inhibition site shown in blue. PleD is a known 
active GGDEF domain, whilst PopA is a well-characterised ‘degenerate’ GGDEF 
domain (both from C. crescentus). YeaI (from E. coli) was chosen as a putative 
inactive DGC protein.  Clearly, both PopA and YeaI lack retention of the GGDEF 
motif, but have an I-site.  
C) Protein sequence alignment of EAL domains, with the EXL consensus sequence 
boxed in red. Proteins YahA and YhjH from E. coli were chosen to represent 
active PDE enzymes, whilst E. coli YdiV is a putative inactive PDE protein. 
Clearly, both YahA and YhjH contain the EXL motif, whilst this is lost in YdiV.  
For both B and C, protein sequences were obtained from Uniprot and analysed 
by Mega6 software using ClustalW parameters (Section 2.10.2). 
 
(Paul et al., 2004; Ryjenkov et al., 2005; Chan et al., 2004; Paul et al., 2007; Christen et 
al., 2006; Simm et al., 2004; Schmidt et al., 2005; Chang et al., 2001; Tamayo et al., 
2005; Minasov et al., 2009, Sommerfeldt et al., 2009) 
A 
B 
C 
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initiate dimerisation of GGDEF domains.  In the case of PleD, phosphorylation of the REC    
N-terminal domains induces dimerisation of the GGDEF domains, forming a catalytically 
active DGC (Chan et al., 2004; Paul et al., 2007; Sommerfeldt et al., 2009). 
In addition to the catalytic active-site in DGCs, another binding site is present in some 
GGDEF domains which binds c-di-GMP and is responsible for allosteric control of DGC 
activity (Paul et al., 2004; Chan et al., 2004).  This I-site, characterised by a conserved RXXD 
motif is located within the GGDEF domain, upstream from the A-site and is present within 
single- and multi-domain DGCs (Christen et al., 2006).  This non-competitive product 
inhibition is vital for c-di-GMP homeostasis in the cell by setting an upper limit for the levels 
of c-di-GMP in the cell (Christen et al., 2006).  
 
The characterisation of GGDEF domains as an active DGC depends on the conservation of 
the GG[D/E][D/E]F motif as well as the RXXD I-site upstream of this (Ryjenkov et al., 2005; 
Sommerfeldt et al., 2009). 
 
X-ray crystallography of several DGC proteins has revealed a common secondary structure 
between proteins, consisting of a 5 β-strand core surrounded by 5 or 6 α helices, with 2 
short parallel β-strands at one end of the protein (Chan et al., 2004; De et al., 2009; 
Navarro et al., 2009; Forouhar et al., unpublished).  Dimerisation of GGDEF domains occurs 
by the formation of various ionic and hydrophobic interactions between α-helices α4 and 
α5 of each domain, forming the dimerisation interface (Chan et al., 2004). The active sites 
from both GGDEF domains (located at a β-hairpin) are inward facing, towards the other 
GGDEF, whilst both I-sites are on the outer faces of the domains (Chan et al., 2004).  
 
The mechanism of DGC catalytic activity was serendipitously determined by the 
crystallization of PleD in complex with c-di-GMP (Chan et al., 2004).  In the crystal, a c-di-
GMP molecule was found bound to tetrameric PleD.  This GGDEF tetramer was composed 
of two dimers, associated head-to head, with c-di-GMP interacting with two GGDEF active 
sites, one from each of the two dimers (Chan et al., 2004).  This tetrameric species was also 
identified in WspR, which was also crystallized in complex with c-di-GMP (De et al., 2009). 
Therefore it is believed that this transitional tetrameric formation is the general mechanism 
by which DGC proteins catalyse c-di-GMP synthesis.  
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The crystal structure of PleD was also instrumental in determining the manner in which c-
di-GMP feedback inhibition occurs.  PleD consists of two REC domains and a GGDEF 
domain, which then dimerises and produces two interacting GGDEF domains and a stem 
region consisting of four REC domains.  Two intercalated c-di-GMP molecules were 
identified bound to the DGC- stem interface, with each c-di-GMP forming interactions with 
the other c-di-GMP molecule as well as to the REC domain and the GGDEF domain (Chan et 
al., 2004).  This binding explains the mechanism of c-di-GMP inhibition, with domain 
immobilization preventing the continued catalytic activity of PleD (Chan et al., 2004).  This 
domain immobilization mechanism of c-di-GMP feedback was also identified in WspR, 
suggesting a probable DGC-wide mechanism (De et al., 2009).  
 
1.6.2   Cyclic di-GMP-specific phosphodiesterase proteins 
 
Phosphodiesterase enzymes are required for c-di-GMP catabolism and constitute the 
enzymatic activity characteristic of EAL or HD-GYP domain proteins, with E. coli containing 
only EAL proteins (Chang et al., 2001; Galperin, 2004; Simm et al., 2004; Schmidt et al., 
2005).  The EAL domains are characterized by an EAL consensus motif at the active site, 
which is the location of c-di-GMP hydrolysis (Schmidt et al., 2005).  There are 10 consensus 
residues which are necessary for PDE catalytic activity (Tchigvintsev et al., 2010).  These 
conserved residues include the EAL motif (actually consensus EXL) and seven other 
residues, essential for general acid-base catalysis and for c-di-GMP binding (Rao et al., 
2008; Tchigvintsev et al., 2010).  
 
EAL domain proteins are widely distributed amongst Bacteria and are enzymatically specific 
to c-di-GMP.  The EAL domains hydrolyse c-di-GMP into an intermediary pGpG (5’-
phosphoguanylyl-(3’-5’)-guanosine) molecule, which is later broken down to 2 molecules of 
GMP by an unknown PDE-B enzyme (Figure 1.4) (Chang et al., 2001; Simm et al., 2004; 
Schmidt et al., 2005; Ross et al., 1990; Tamayo et al., 2005).  
 
EAL-derived PDE activity functions in a two-metal ion catalytic mechanism, requiring two 
cations, either Mg2+ or Mn2+, to be bound to the EAL domain (Figure 1.5) (Schmidt et al., 
2005;Tamayo et al., 2005; Tchigvintsev et al., 2010).  X-ray crystallography revealed the 
role of the divalent ions in c-di-GMP hydrolysis. The crystal structure of TBD1265 in T. 
denitrificans in complex with c-di-GMP revealed that two metal ions were bound to the 
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active site via six conserved residues.  The metal ions, along with the conserved residues of 
the protein, were responsible for the coordination of c-di-GMP as well as a potentially 
catalytic water molecule (Tchigvintsev et al., 2010).  
 
Whilst Mg2+ and Mn2+ have repeatedly been shown to activate PDE activity, it has been 
found that other cations (Ca2+ and Zn2+) had the opposite effect, inhibiting the PDE activity 
of VieA in V. cholerae (Tamayo et al., 2005).  
 
The oligomeric state of active EAL domains has been investigated following the discovery of 
the dimerisation of GGDEF domains for functional DGC activity.  The E. coli PDE YahA was 
found to be monomeric in solution, indicating the catalytic activity of monomeric EAL 
domains (Schmidt et al., 2005).  However crystallographic studies of EAL proteins revealed 
a dimeric structure. YkuI (from Bacillus subtilis) is an EAL- protein, identified as a 
catalytically inactive monomer in solution, but a dimeric oligomer in a crystal lattice 
(Minasov et al., 2009).  This raises the question whether dimerisation of EAL domains may 
have a regulatory role in controlling their activity.  
 
As with the DGC family, X-ray crystallography has provided the protein structures of EAL 
proteins and revealed structural similarities within the family.  The EAL domains have been 
shown to have a central 8 β-barrel structure surrounded by 9 or 10 α-helices (Navarro et 
al., 2009; 2011).  
 
Whilst the hydrolysis of c-di-GMP into the linear pGpG molecule is well characterised, the 
manner in which pGpG is further degraded into GMP is relatively unknown.  EAL domains 
have been identified to hydrolyse pGpG into GMP, but many orders of magnitude slower 
than the hydrolysis of c-di-GMP into pGpG and thereby have been deemed to be 
physiologically irrelevant (Ross, 1987; Tal et al., 1998).  Therefore, it is widely believed that 
a specific protein, currently of unknown identity, is present in all c-di-GMP signalling 
bacteria, which has PDE-B activity.  
 
1.7   The multiplicity of GGDEF/EAL domains 
 
The GGDEF and EAL domains are almost ubiquitous in Bacteria, however they are absent in 
Archaea and Eukarya, indicating that these domains are specific to the bacterial genomes 
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(Galperin, 2004; Römling et al., 2005).  The number of GGDEF and EAL/HD-GYP domain 
proteins is species dependent, with some bacterial species having 100’s (Vibrio vulnificus) 
whilst others lack any (Helicobacter pylori) (Galperin, 2004).  
 
This multiplicity of GGDEF/EAL proteins was initially puzzling, given that the proteins 
carried out the same two catalytic reactions.  A partial explanation for this multiplicity was 
found by studying the expression conditions of the 29 GGDEF/EAL domain proteins in E. coli 
(Sommerfeldt et al., 2009).  Gene profiling revealed differential expression of the 
GGDEF/EAL domain genes, dependent on growth conditions such as temperature, solid or 
liquid medium and the bacterial growth phase.  Additionally, some genes were under the 
control of the general stress response sigma factor, RpoS (Sommerfeldt et al., 2009).  It was 
therefore clear that the GGDEF/EAL proteins could have independent and specialised 
functions in the cell, presumably able to detect specific stimuli and elicit specific effector 
functions.  
 
Clearly under certain growth conditions, only a limited number of the 29 GGDEF/EAL 
proteins are expressed and therefore present in the cell.  However, the question remains 
how these limited GGDEF/EAL domains produce independent and specific effects and how 
cross-talk is avoided.  Various hypotheses have been proposed, although it is highly 
probable that a variety of these regulatory systems work in parallel to fine-tune this 
network.  
 
Micro-compartmentalisation is one theory in which c-di-GMP is made in various pools in 
the cell and only acts on co-localised effector proteins (Weber et al., 2006).  An example of 
this is in C. crescentus, where various GGDEF/EAL domain proteins are localised to the cell 
poles, thereby regulating c-di-GMP pools directly at the cell poles and thus activating cell 
pole effector proteins.  In this way, GGDEF/EAL proteins in C. crescentus regulate cell cycle 
progression (Duerig et al., 2009).  The co-localisation of DGCs and PDEs with their targets 
has been experimentally demonstrated in several cases.  In G. xylinus, proteins DgcA and 
PdeA co-purify with the cellulose synthase enzyme, indicating their specific function of 
regulating cellulose production (Ross et al., 1987).  
 
Whilst it is known that differential expression of the GGDEF/EAL proteins occurs, the levels 
and activity of the proteins may also be regulated.  For example, the rate of protein 
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proteolysis may be controlled, in order to degrade certain GGDEF/EAL proteins upon a 
change in condition (Hengge, 2009).  Additionally environmental or intracellular stimuli 
may be necessary to regulate the activity of DGCs and PDEs.  This has been shown to be 
true for several proteins, including PleD, in which phosphorylation of the N-terminal REC 
domain is required for PleD enzymatic activity (Paul et al., 2004; Chan et al., 2004; Ryjenkov 
et al., 2005).  
 
An alternative to the micro-compartmentalisation hypothesis is the existence of c-di-GMP 
gradients in the cell, with enzymes only becoming active at a threshold level (Römling et al., 
2013).  
 
1.8   The presence of composite and degenerate domains 
  
Sequence alignments have predicted that both active and inactive classes of GGDEF and 
EAL domain proteins exist (Schmidt et al., 2005; Suzuki et al., 2006). The catalytically active 
classes are predicted to retain the active site motif, whilst inactive domains are identified 
as such by a lack of sequence conservation in the consensus GG[D/E][D/E]F and EAL 
(actually EXL consensus) sites, as well as the supplementary conserved residues discussed 
previously (Sections 1.6.1 and 1.6.2) (Schmidt et al., 2005; Suzuki et al., 2006; Rao et al., 
2008; Ryjenkov et al., 2005).  Over 20% of all known EAL domain proteins lack consensus 
residues, suggesting that a large number of catalytically inactive proteins exist (Rao et al., 
2008).  Accordingly, experimental analysis of these proteins deviating from the consensus 
motifs confirms a much reduced or non-existent enzymatic activity, thereby identifying 
these sets of proteins as catalytically inactive or degenerate (Christen et al., 2005; Tal et al., 
1998; Rao et al., 2008; Suzuki et al., 2006; Kazmierczak et al., 2006).  
 
A significant proportion of GGDEF/EAL domain proteins are in fact coupled to a second 
GGDEF/EAL domain, forming GGDEF-EAL domain fusion proteins.  This dual domain 
composition is counter-intuitive, due to the catalytically opposing roles of these domains. 
However, the vast majority of these dual domain proteins are composed of one 
catalytically active and one inactive domain, with conserved and non-conserved motif 
sequences respectively.   In these cases, the active domain carries out DGC or PDE activity 
whilst the catalytically inactive domain may have a regulatory or secondary function 
(Christen et al., 2005; Lacey et al., 2010).   
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In general, active GGDEF and EAL domains do not exist in the same protein due to their 
opposing roles.  However, one exception exists in the form of protein MSDGC-1 in 
Mycobacterium smegmatis, which contains both GGDEF and EAL domains and exhibits DGC 
and PDE activity in the organism (Kumar & Chatterji, 2008).  This dual enzymatic activity is 
yet to be seen in any other species.  
 
In addition, some proteins exist in which both domains deviate from the consensus motifs, 
producing a catalytically inactive protein consisting of both GGDEF and EAL domains.  An 
example of this is CsrD from E. coli. This protein acts in a GGDEF-EAL dependent manner to 
impart its function as a gene regulatory protein (Suzuki et al., 2006).  
 
Degenerate GGDEF/EAL proteins also exist as singular proteins, either linked to an               
N-terminal sensory or effector domain or present as a single domain protein.  These 
degenerate proteins have been identified to have an ever-expanding number of diverse 
functions in bacteria.  
 
1.8.1   The roles of degenerate GGDEF/EAL domains 
 
Understanding the roles of these degenerate GGDEF/EAL domains is crucial to fully 
comprehending both the individual roles of these proteins and the diversity of these 
GGDEF/EAL domains and the c-di-GMP signaling pathway.  Some of the catalytically 
inactive or ‘degenerate’ GGDEF and EAL domain proteins have been characterized and 
reveal the breath of functions that these proteins impart.  
 
FimX is a GGDEF-EAL domain protein in P. aeruginosa in which the degenerate EAL domain 
is crucial for the function of the protein (Qi et al., 2011). FimX is composed of a two            
N-terminal sensory domains (REC and PAS), a GGDEF domain and a C-terminal EAL domain. 
FimX localizes to a single pole of the bacterial cell, encoded by a localization motif in the 
REC domain, which results in type IV pili formation (Kazmierczak et al., 2006; Qi et al., 
2011).  The EAL domain lacks the consensus EAL motif and lacks efficient c-di-GMP PDE 
activity (Rao et al., 2008).  However, it has been shown that the degenerate EAL domain 
binds to c-di-GMP and as a result causes long-range conformational changes in the REC 
domain of FimX that are necessary for FimX single pole localization (Navarro et al., 2009; Qi 
et al., 2011).  Upon deletion of the EAL domain, or mutation of the EVL sequence, c-di-GMP 
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binding affinity was lost in the EAL domain, resulting in no conformational change in REC 
and a loss of FimX unipolar localization, preventing correct pili assembly (Qi et al., 2011).    
 
PopA is a C. crescentus protein, consisting of two N-terminal REC domains and a GGDEF 
domain. This GGDEF domain lacks the conserved residues and is therefore an inactive DGC. 
Despite this, the GGDEF domain can bind c-di-GMP at its conserved I-site and in this way 
regulates cell cycle progression.  In C. crescentus cells, CtrA acts as the replication initiation 
inhibitor and is responsible for controlling the transition of cells from G1 phase to S phase, 
at which point the DNA will be replicated and cell division can subsequently occur.  At low 
intracellular c-di-GMP concentrations, CtrA is present in the cells and therefore blocks DNA 
replication initiation.  When c-di-GMP levels are elevated, c-di-GMP binds to PopA and in 
doing so, activates the function of this protein.  The activated PopA localizes itself and CtrA 
to the cell poles, where the protease ClpXP is present and degrades CtrA.  Hence, PopA 
initiates the transition of cells from G1 phase into S phase and does so in a c-di-GMP 
dependent manner (Duerig et al, 2009).  
 
In composite proteins, degenerate domains can affect the enzymatic activity of their 
neighbouring GGDEF/EAL domain.  The C. crescentus protein CC3396 consists of a 
degenerate GGDEF domain and an intact and catalytically active EAL domain.  The GGDEF 
domain, whilst lacking DGC activity, is able to bind GTP and in doing so increases the PDE 
activity of its partner EAL domain (Christen et al., 2005). 
 
1.9   The cyclic di-GMP pathway in E. coli  
 
The E. coli K-12 strain was chosen as an experimental model in which to study the cyclic di-
GMP pathway, due to its well characterised genome and loss of pathogenicity in the human 
intestine.   
 
1.9.1   Escherichia coli strain K-12  
 
Escherichia coli strain K-12 was isolated in 1922 from a patient’s stool sample who was 
recovering from diphtheria and since then has become a widely-used prokaryotic model 
(Bachmann, 1972). The E. coli K-12 strain contains a genome of 4.6 million bases encoding 
4288 protein-coding genes (Blattner et al., 1997). Escherichia coli K-12 strain contains many 
copies of DGCs and PDEs (totalling 29), which are largely thought to have been produced by 
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transduction during evolution.  In addition, small scale DNA mutations are often caused by 
UV radiation and certain chemicals and therefore feasibly accounts for some of the DGC 
and PDE sequence variations and even variations in the GGDEF/EAL motif sequence (Serres 
et al., 2009).  
 
The genome size of E. coli K-12 is smaller than the larger genomes of pathogenic E. coli 
strains, such as enteropathogenic Escherichia coli (EPEC), consisting of 4.9 million bases and 
encoding 4703 proteins (Iguchi et al., 2009). Whilst E. coli K-12 encodes 29 cyclic di-GMP 
turnover proteins, pathogenic E. coli strain O104:H4(E. coli EPEC has not been sequenced 
yet) contains 2 extra DGCs, one of which (DgcX) is by far the most strongly expressed DGC 
observed in E. coli (Richter et al., 2014).  
 
1.9.2  Cyclic di-GMP proteins in E. coli K-12 
 
Escherichia coli K-12 has 29 GGDEF/EAL proteins, including the YahA protein present in 
some but not all E. coli strains (Sommerfeldt et al., 2009).  Of these 29 proteins, 12 are 
GGDEF domains, 10 are EAL domain proteins and 7 are composite GGDEF-EAL proteins 
(Figure 1.6).  All of the GGDEF domains are in tandem with various sensory domains such as 
PAS, GAF, HAMP, MASE1 and MASE2 domains.  Equally the majority of EAL domain proteins 
are in tandem with N-terminal domains; however the identity and function of these 
remains largely unknown.  
 
Analysis of the 29 GGDEF/EAL proteins in E. coli K-12 has identified 12 of these to be active 
DGCs, 13 active PDEs and 4 enzymatically inactive proteins, hypothesised to be potentially 
regulatory proteins (Figure 1.6) (Sommerfeldt et al., 2009). These potential regulators (YeaI, 
YdhA, YcgF and YdiV) lack the conserved GGDEF/EAL motifs and therefore were predicted 
to be catalytically inactive (Schmidt et al., 2005, Suzuki et al., 2006).  Due to their unlikely 
catalytic role, the proteins are considered probable regulatory proteins, retained in E. coli 
after years of evolutionary pressures.  YcgF and YdhA have been particularly well 
characterised, and clearly have an important role in E. coli gene regulation.  
 
YcgF is a blue light sensor consisting of an N-terminal BLUF domain and a C-terminal EAL 
domain (with a degenerate EAL motif).  The EAL-domain has been confirmed to lack PDE 
activity but is essential to the role of YcgF.  Following detection of blue light by the BLUF 
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Figure 1.6: Schematic diagram of the 29 GGDEF/EAL domain proteins present in E. 
coli K-12 
 
Each protein is named and its domain structure indicated, with all proteins being 
categorized into one of three categories: active DGCs, active PDEs or potential 
regulatory proteins.  
 
GGDEF domains are shown in blue, with the motif sequence specified. EAL domain 
proteins are shown in red, again with the motif sequence specified.  Black unlabelled 
domains represent N-terminal domains of various types.  
 
(Sommerfeldt et al., 2009; Schmidt et al., 2005; Suzuki et al., 2006) 
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domain, YcgF interacts with the transcription factor YcgE in an EAL-dependent manner.  
This produces an active YcgE protein, which induces the expression of eight genes, 
including acid-resistance genes and production of biofilm-associated substances (Tschowri 
et al., 2009).  
 
 YhdA, more commonly referred to as CsrD (Carbon storage regulator D) is a membrane 
bound protein containing both degenerate GGDEF and EAL motif domains.  This protein is a 
gene expression regulator, working in the CsrA/B/C system. CsrA (Carbon storage regulator 
A) is an RNA-binding protein, responsible for controlling the translation and altering mRNA 
stability of target mRNA’s.  CsrA activity is tightly regulated by CsrB and CsrC non-coding 
RNA molecules, which bind to CsrA and prevent CsrA binding to target RNAs.  These 
regulatory CsrB/C RNA molecules also require tight control and it is CsrD that carries out 
this role by altering rates of CsrB/C RNA degradation.  Whilst the TM domains of CsrD are 
not required, the degenerate GGDEF and EAL domains are essential for this function 
(Suzuki et al., 2006).  
 
YeaI is less well-characterised, identified as a two-domain protein composed of an N-
terminal transmembrane domain and a cytosolic GGDEF domain (Sommerfeldt et al., 2009; 
Daley et al., 2005).  The GGDEF motif deviates from the consensus, indicating a putative 
degenerate DGC (Figure 1.6).  Phenotypic analysis of the protein revealed that YeaI over-
production caused cells to display increased levels of biofilm formation and sedimentation 
under anaerobic conditions at 28⁰C, indicating a possible function of the protein (Lacey, M. 
et al., unpublished). 
 
YdiV is a cytosolic EAL domain protein. Whilst the consensus EXL motif and other conserved 
residues are lacking in YdiV, there have been contradictory classifications of the protein as 
both a catalytically active and inactive PDE (Rao et al., 2008; Hisert et al., 2005; 
Tchigvintsev et al., 2010).  Phenotypic analysis of strains overproducing YdiV indicated a 
possible role of this protein in regulating biofilm production, motility and sedimentation, all 
of which are c-di-GMP related phenotypes.  Upon over-production of YdiV, cells exhibited 
decreased motility under anaerobic and aerobic conditions at 28 and 37⁰C.  YdiV over-
production also caused cells to exhibit decreased biofilm formation at 28⁰C and increased 
sedimentation phenotypes.  Despite these clear phenotypes upon YdiV over-production, 
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ΔydiV exhibited no detectable differences compared to wild type cells (Lacey, M. et al., 
unpublished).  
 
1.10   Aims of the project 
 
The research summarized in this Introduction has shown that c-di-GMP is a crucial second 
messenger in bacteria.  Modulation of c-di-GMP concentrations by the action of multiple 
opposing DGC and PDE enzymes, whose activities respond to a range of environmental 
cues, control fundamental ‘lifestyle choices’.  
 
Diguanylate cyclase activity is associated with GGDEF domains; phosphodiesterase activity 
is associated with EAL domains.  Escherichia coli possess 12 GGDEF proteins, 10 EAL 
proteins and 7 composite GGDEF/EAL proteins.  Intringingly, 4 (YcgR, CsrD, YeaI and YdiV) 
of these 29 proteins are predicted to lack either DGC or PDE activity because of the 
replacement of key active site amino acids.  The predicted lack of catalytic activity 
suggested a regulatory role for these ‘degenerate’ proteins in c-di-GMP signaling pathways. 
Characterisation of YcgR and CsrD provide some support for this view.  Preliminary work 
with E. coli strains over-producing YeaI or YdiV suggested a role in controlling phenotypes 
typically associated with c-di-GMP signaling.  However, at the outset of this project how 
YeaI and YdiV contributed to c-di-GMP signaling in E. coli was unknown.  The hypothesis 
tested was that YeaI and YdiV are catalytically inactive GGDEF and EAL domain protens, 
respectively, that act as effector proteins in c-di-GMP signaling pathways.  Therefore the 
aim of the research described in this thesis was to isolate and characterize the YeaI and 
YdiV proteins.  
 
Due to the likely catalytic inactivity of these proteins as DGCs and PDEs, comprehending 
their roles, potentially as c-di-GMP effector proteins, is crucial to understanding how c-di-
GMP cellular effects are achieved.  Currently, the characterisation of degenerate proteins 
has revealed numerous cellular effects, ranging from pili assembly, targeted protein 
degradation and gene regulation.  In some cases, the activation of degenerate proteins 
correlates to signalling molecules binding to the protein (i.e. c-di-GMP or GTP), however 
some proteins are activated independently of signal molecule binding.  It is hoped that 
understanding these degenerate GGDEF/EAL proteins will increase our knowledge and 
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understanding of both the breadth of c-di-GMP signaling pathways and the contributions 
made by these proteins.   
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Chapter 2: Materials and methods 
 
2.1    Strains and plasmids  
 
Escherichia coli strains and plasmids used are listed in Tables 2.1 and 2.2 respectively.  
 
Table 2.1: Strains of Escherichia coli used in this study 
Strain Relevant characteristics Source of strain  
MG1655 F-,λ- ,ilvG-rfb-50rph-1 Lab collection 
BL21 
λ(DE3) 
Lysogen of λDE3 carrying a copy of T7 
RNA polymerase gene under the control 
of the IPTG-inducible lacUV5 promoter 
Novagen  
DH5α SupE44, lacU169 (ᴓ80 lacZ m15), hsdR17, 
recA1, endA1, gyrA96, thi-1, relA1  
Novagen 
JRG6578 MC1000 ΔfliC, FRT::Km::FRT Dr Graham Stafford, University of 
Sheffield  
JRG6577 MC1000 flhB::lacZ (Gm), flhDC::Km  (KnR) Dr Graham Stafford, University of 
Sheffield  
JRG6097 W3110 ΔlacU169::Tn10, F-, lambda-, 
thyA36, deoC2,    IN(rrnD-rrnE)I, Δ(argF-
lac)U169, ydiV::lacZ   (TcR) 
Prof. R. Hengge, Institut für 
Biologie, Berlin 
JRG6130 MG1000ΔydiV  Lab collection 
JRG6058 MG1655Δfnr pBR322 Lab collection 
JRG6134 MG1655 pBR322:ydiV  Lab collection  
JRG5512 DH5α/pGS2263 Lab collection 
JRG5715 DH5α/pGS2341 This work 
JRG6551 DHSα/pGS2399 This work 
JRG6450 DH5α/pGS2354 This work 
JRG6497 DH5α/pGS2368 This work 
JRG6601 DH5α/pGS2441 This work 
JRG6513 DH5α/pGS2381 This work 
JRG6514 DH5α/pGS2382 This work 
JRG6656 DH5α/pGS2467 This work 
JRG6664 DH5α/pGS2472 This work  
  
 
TcR indicates strains containing tetracycline resistance, KnR indicates kanamycin resistant  
strains.  
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Table 2.2: Plasmids used in this study 
 
 
2.2   Growth of E. coli 
 
2.2.1   Growth media 
 
Escherichia coli was grown in Lennox broth (LB) medium, the constituents of which are 
listed below.  Infrequently, E. coli was grown in motility broth in order to analyse motility of 
any type, the components of this medium are listed below.  The ingredients were placed in 
a beaker and made up to 1 litre with dH2O before transferring to a 1 L Duran bottle and 
then autoclaved  at 121⁰C, 15 psi in order to sterilise.  Media constituents were supplied 
from Oxoid Ltd.  
LB (litre): 10 g NaCl, 10 g Tryptone, 5 g yeast extract 
Motility broth (Iitre): 5 g NaCl, 5 g Tryptone 
LB agar (litre): 10 g NaCl, 10 g Tryptone, 5 g yeast extract, 15 g bacteriological agar 
Motility broth agar (litre): 5 g NaCl, 5 g Tryptone, 3 g bacteriological agar 
Plasmid Relevant characteristics Source 
pET21a Expression vector encoding C-terminal His tag 
(ApR) 
Novagen 
pGEX-KG Expression vector encoding GST tag (ApR) Lab stock 
pCOLD TF Cold-shock expression vector encoding N-
terminal TF chaperone tag (ApR) 
Takara  
pGS2468 pET28a:slyA (KnR) Lab stock 
pGS2263 pET32a: yeaIGGDEF  (Ap
R) Lab stock 
pGS2341 pET21a:yeaIGGDEF (Ap
R) This work 
pGS2399 pCOLD TF: yeaIGGDEF (Ap
R) This work 
pGS2354 pET21a: ydiV (ApR) This work 
pGS2368 pET21a:clp (ApR) This work 
pGS2441 pET21a:flhDC (ApR) This work 
pGS2381 pET21a:FLAG3 (Ap
R) This work 
pGS2382 pET21a:FLAG3:flhDC (Ap
R) This work 
pGS2467 pGEX-KG:fliT(ApR) This work  
pGS2472 pGEX-KG:fliZ (ApR) This work 
ApR indicates plasmids containing ampicillin resistance and KnR indicates kanamycin 
resistance plasmids.  
35 
 
Agar was autoclaved and cooled to 50⁰C before antibiotics were added and pouring into 
petri dishes, approximately 25 ml per dish.  Once the agar plates were set, they were 
stored at 4⁰C.  When antibiotic resistance was present, the relevant antibiotic was added to 
the media at the appropriate concentration (Section 2.2.4). 
 
Chemostat samples of E. coli MG1655 cells were provided by Thomas Curran.  These 
bacteria were grown in Evans minimal medium.  The recipe for Evans minimal medium is 
listed below.  
 
Evans minimal medium (20 litres): 100 ml 2 M NaH2PO4.2H2O, 100 ml 2 M KCl, 100 
ml 0.25 M MgCl2, 500 ml 4 M NH4Cl, 100 ml 0.4 M Na2SO4, 100 ml 0.004 M 
CaCl2.2H2O, 100 ml of trace elements and 7.6 g of nitrilotriacetic acid (C6H6NNa3O6).   
 
Trace elements (2.5 litres):  1.03 g ZnO, 13.5 g FeCl3.6H2O, 5 g MnCl2.4H2O, 0.43 g 
CuCL2.2H2O, 1.19 g CoCl2.6H2O, 0.16 gH3BO3, 0.01 g Na2MoO4.H2O and 20 ml of 
(37%) HCl.  
  
Evans minimal medium was adjusted to pH 6.95 prior to autoclaving, after which the 
medium was supplemented with 20 mM sterile glucose and 30 μg/ml of Na2SeO3.5H2O 
before use. 
    
2.2.2   Escherichia coli growth 
 
Escherichia coli cultures were grown in antibiotic supplemented (Section 2.2.4) growth 
media at 37⁰C with 250 rpm shaking until the required optical density OD600 was reached 
(Section 2.2.3).   
 
Overnight cultures were produced by inoculating 5 ml of antibiotic-supplemented growth 
medium (Section 2.2.4) with a single colony from an agar plate, and were then subjected to 
incubation at 37⁰C and 250 rpm shaking.  
 
When studying bacterial motility, motility broth was used to culture the cells (Section 
2.2.1).  In this thesis, bacteria were grown in motility broth at 37⁰C with 250 rpm shaking in 
conical flasks.  Cells were subsequently cultured by low-speed centrifugation (~4000xg) and 
gentle resuspension of cell pellets in order to reduce flagellar shearing.  
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Samples were provided by Thomas Curran of E. coli MG1655 cells cultured in a glucose-
limited chemostat in Evans minimal medium (Section 2.2.1).  The cells were grown at pH 
6.95 at 37⁰C with 400 rpm stirring.  The bacterial strain was cultured at varying growth 
rates, maintained by altering the dilution rate.  Four dilution rates (0.05, 0.1, 0.2 and 0.5 /h) 
were analysed, producing samples of bacteria grown at four different growth rates.  A 0.05 
/h dilution rate is equivalent to a 13.9 h doubling time, a 0.1 /h dilution rate equivalent to a 
6.9 h doubling time, 0.2 /h dilution rate equivalent to a 3.5 h doubling time and a 0.5 /h 
dilution rate equivalent to a 1.4 h doubling time.  
 
2.2.3   Measurement of bacterial growth 
 
Escherichia coli growth was determined by measuring the OD600 of an aliquot (1 ml) of 
culture against a growth medium blank using a Unicam UV/Vis spectrophotometer.   
 
2.2.4   Supplementation of media  
 
Growth media were supplemented with antibiotics to give final concentrations of 100 
µg/ml ampicillin, 20 µg/ml kanamycin or 10 µg/ml tetracycline, sourced from Melford and 
Sigma respectively.  Isopropyl β-D-1-thiogalactopyranoside (Melford) was added to a final 
concentration between 100 µg/ml and 20 µg/ml (to induce protein over-expression).  
 
2.2.5   Storage of strains 
 
Strains were stored on solid media at 4⁰C for one month. Glycerol stocks of strains were 
maintained for longer storage at -20⁰C.  Glycerol stocks were made from cell pellets of 5 ml 
overnight cultures resuspended in 1.25 ml LB.  To the cell suspension, 1 ml of 80% sterile 
glycerol and the required antibiotics were added.  
 
2.2.6   Making electrically competent cells 
 
A primary culture of E. coli DH5α or BL21 λ(DE3) was made in which 5 ml LB was inoculated 
with the strain and incubated overnight at 37°C (Section 2.2.2).  An aliquot (500 μl) of 
primary culture was used to inoculate 50 ml of LB and this was incubated for 1.5-2 h at 
37°C.  After this time, (OD600 of 0.3-0.6) the bacteria were collected by centrifugation at 
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4500 xg for 10 min using a desk-top microcentrifuge (Sigma 1-15).  The supernatant was 
removed and the cells were washed with 50 ml ice-cold water and re-pelleted.  The cell 
washing was carried out a total of three times.  The final time, the cells were re-suspended 
in the 500 μl water.  Aliquots (100 µl) of cell suspensions were frozen at -80⁰C until 
required.  
 
2.2.7   Transformation of electrically competent cells 
 
Escherichia coli cells were transformed by the addition of 1 µl plasmid DNA (up to 1 µg) to 
100 µl of electrically competent cells (Section 2.2.6).  This mixture was transferred to an ice 
cold 1 mm electroporation cuvette (Gene Flow) and cell-shocked (1800 V, 1 mm path 
length) in an electroporator (Hybaid CS-100). Lennox broth (1 ml) was added to the 
shocked cells and the mixture was incubated at 37⁰C for 1 h.  Cells were then pelleted at 
3500 xg for 5 min before being resuspended in 50 μl LB and plated onto LB agar plates 
containing the relevant antibiotic and incubated at 37°C overnight.  
 
2.3   DNA techniques 
 
2.3.1   Genomic DNA isolation 
 
Genomic DNA of E. coli MG1665 was isolated using a Genomic DNeasy kit (QIAGEN) from 
an aliquot (700 µl) of an overnight culture in LB broth.  By following manufacturer’s 
guidelines, this method produced DNA of approximately 50 ng/ml.  
 
2.3.2   Primer design  
 
Primers were designed to be approximately 15-35 nucleotides long, have a GC content of 
50-60% and a melting temperature of between 55 and 70⁰C.  Restriction sites were 
incorporated as needed and preceeded by the sequence TTTT.  
 
Occasionally primers were designed to contain modifications such as 5’ Biotin tags for DNA 
immobilisation to streptavidin surfaces.  When sequences were required to be inserted into 
vectors, for example a (FLAG)3 tag, oligonucleotides were designed for the entire inserted 
region and therefore were significantly longer than the usual oligonucleotides designed for 
gene amplification. Primers used in this work are listed in Table 2.3.  
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Primer  Description of use Nucleotide sequence 
NSW9 pET21a:ydiV 
forward 
TTTTCATATGAAGATTTTTTTGGAGAATCTTTATC 
NSW10 pET21a:ydiV 
reverse 
TTTTCTCGAGTCGCTGAACCAACGTCGTTAT 
NSW11 pET21a:yeaI 
forward 
TTTTCATATGAAGGACTTCTGTGTCATGCTG 
NSW12 pET21a:yeaI 
reverse 
TTTTCTCGAGAATATGATGAAGAATCACTTTGTT 
NSW13 pET21a:clp forward TTTTCATATGAGCCCAGGAAATACGAC 
NSW14 pET21a:clp reverse TTTTCTCGAGGCGGGTGCCGTACAGCAC 
NSW15 pET21a: FLAG 
forward 
TATGGACTACAAGGACGATGACGACAAGGACTACAAGGA
CGATGACGACAAGGACTACAAGGACGATGACGACAAGG 
NSW16 pET21a: FLAG 
reverse 
GATCCCTTGTCGTCATCGTCCTTGTAGTCCTTGTCGTCATCG
TCCTTGTAGTCCTTGTCGTCATCGTCCTTGTAGTCCA 
NSW17 flhDC into pET21a: 
FLAG forward 
TTTTGGATCCCATACCTCCGAGTTGCTGAAA 
NSW18 flhDC into 
pET21a:FLAG 
reverse 
TTTTAAGCTTTTAAACAGCCTGTACTCTCTGTTC 
NSW19 pCOLD:yeaI 
forward 
TTTTCATATGATTCAGTCAACACGTATTTCCA 
NSW20 pCOLD:yeaI reverse TTTTGGATCCTTAAATATGATGAATAATCACTTTG 
NSW21 pCOLD sequencing 
forward  
GCGAAAGTGACTGAAAAAGAA 
NSW22 pCOLD sequencing 
reverse 
ATCGATTATTTATTTCCTGAAAAC 
NSW24 PydiV reverse TTTTGGTAACCGTCCCTCTCGAA 
NSW27 PfliD forward  TTTTTCTAGAGATTCGTTATCCTATATTGCAAGT 
NSW28 PfliD reverse  TTTTGCGATTTCCTTTTATCTTTCG 
NSW35 pET21a:flhDC 
forward 
TTTTGGATCC ATGCAT ACC TCC GAG TTG CTG  
NSW36 pET21a:flhDC 
reverse 
TTTT CTCGAG AAC AGC CTG TAC TCT CTG TTC 
NSW39 IVT FliD forward TTTTGGATCCGATTCGTTATCCTATATTGCAAGT 
NSW40 IVT FliD reverse TTTTGAATTCGCGCGCTTTTCAGCGTACC 
NSW59 pGEX-KG: fliT 
forward 
TTTTGGATCCAACCATGCACCGCATTTATATTTC 
NSW60 pGEX-KG:fliT 
reverse 
TTTTAAGCTTTCAAAAGAGGTTATCCTGCGGAG    
NSW61 pGEX-KG:fliZ 
forward 
TTTTGGATCCATGGTGCAGCACCTGAAAAGAC     
NSW62 pGEX-KG:fliZ 
reverse 
TTTTAAGCTTTTAATATATATCAGAAGAAGGCAGGC    
NSW65 pGEX-KG 
sequencing forward 
GACCATCCTCCAAAATCGGA 
 
NSW66 pGEX-KG 
sequencing reverse 
GAGGTTTTCACCGTCATCAC 
 
Table 2.3: List of primers used in this study 
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2.3.3   Polymerase Chain Reactions  
 
Polymerase Chain Reactions (PCR’s) were carried out to amplify specific genes or regions of 
DNA from E. coli MG1655 genomic DNA (Section 2.3.1).  Reactions (total volume 20 μl) 
contained 10 μl 2x Extensor long range PCR master mix (Thermo Scientific), 1 μl each of 
forward and reverse primers (100 pmol/µl) (Section 2.3.2), 1 μl of E. coli MG1655 template 
plasmid DNA (~200 ng/µl) (Section 2.3.1) and 7 μl sterile water.  
 
The PCR reactions were run using a cycling programme on a Techne® TC-3000 machine.  A 
typical programme is shown below, which was altered depending on the primer and DNA 
characteristics, following Extensor PCR master mix manufacturer’s guidelines.  
 
Initial denaturation       94°C     5 min 
Denaturing                      94°C     30 s 
Annealing                        50°C     30 s 
Extension                        72°C      1 min 
Final extension               72°C     5 min 
 
Samples were then separated by agarose gel electrophoresis for analysis (Section 2.3.5).  
 
2.3.4   Plasmid purification  
 
Plasmid DNA was purified from an aliquot (5 ml) of E. coli primary culture using a QIAprep® 
Spin Miniprep Kit (QIAGEN) and following manufacturer’s instructions.  
 
2.3.5   Agarose gels 
 
 Agarose gels (1%) were used as standard, consisting of 1 g of agarose (Melford) dissolved 
in 100 ml 1 x TAE buffer.  To visualise smaller DNA fragments, 1.5% agarose gels were used 
(1.5 g agarose per 100 ml).  Gel red (Biotium) was added to the solution at a 1/1000 
NSW84 Blitz target forward Biotin-AGCCATTTTTTGTTAGTCGCCGAAATACTCTTTTCTC
TGCCCCTTATTCCCGCTATTAAAAAAAACAATT 
NSW85 Blitz control 
forward 
Biotin- TGCGTCATCCTTCGCGCTGT    
NSW86 Blitz control reverse TTTTGACTTGCAATATAGGATAACG 
 
x 30 cycles 
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dilution to allow UV detection of DNA, and the gel poured into a sealed tray fitted with a 
comb.  Once the agarose was set, the comb was removed and 1 x TAE buffer added to the 
tank.  DNA samples were mixed with 5 x loading dye (Bioline) and then loaded into the 
wells of the gel, alongside a DNA marker.  Depending on the nature of the DNA to be 
analysed, samples varied between 5-20 µl (including loading dye and water if necessary).  
To check PCR reactions, 2-3 µl volumes of DNA were analysed, whilst gel extraction 
techniques required loading of 15-20 µl DNA.  The gel was then run at 100 V for 60 min (1% 
gels) or 90 min (1.5% gels) using a Power Pac 300 (Bio-Rad) and DNA visualised using a UV 
transilluminator (UVITEC).  
 
The recipe for 50 x TAE buffer (1 litre) was 242 g Tris, 57.1 ml glacial acetic acid, 100 ml 0.5 
M EDTA, pH 8.  Hyperladder I (Bioline) was used as a standard DNA marker, added to each 
agarose gel in order to determine the size of analysed DNA.  
 
2.3.6   Restriction digestion of DNA 
 
Restriction digests were carried out to cleave DNA at specific points and enzymes were 
purchased from MBI Fermentas.  In all cases, 20 µl double digests were carried out using 14 
µl DNA (0.5-1 µg), 1 µl (10 units) of each enzyme, and 2 µl of appropriate 10 x buffer (unless 
stated by manufacturer otherwise).  The buffer was chosen to allow both enzymes to have 
full, or almost full enzymatic activity, according to the manufacturer’s instructions.  
 
Digests were incubated for 90 min at 37⁰C before analysis on an agarose gel to check that 
cleavage had occurred (Section 2.3.5).  
 
2.3.7   DNA isolation and purification from an agarose gel  
 
Aliquots (2 µl) of PCR’s (Section 2.3.3) were separated on an agarose gel (Section 2.3.5) to 
check for correct DNA amplification, before the remainder of the sample was loaded on a 
second agarose gel for purification.  Using the QIAquick Gel Extraction Kit (QIAGEN), the 
amplified DNA was excised from the gel and purified.  
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2.3.8   Quantification of DNA concentration 
 
Purified DNA was quantified using an Eppendorf Biophotometer.  A sample of 100 µl dH2O 
was used as a blank, before measuring the absorbance of a 1/100 dilution of DNA (adding 1 
µl to 99 µl dH2O) at OD260.  This was repeated in triplicate and an average calculated.  
 
2.3.9   DNA Ligation reactions  
 
Ligation reactions were carried out overnight at 4⁰C as 20 µl reactions.  The equation below 
allows the calculation of the appropriate amount of insert and vector for each reaction, 
including 2 µl 10 x T4 DNA Ligase buffer and 1 µl T4 DNA Ligase enzyme (10 units) (Thermo 
scientific). 
 
ng vector x Kb insert              
                                                  Kb vector                  x 3/1 = ng insert 
 
The ligation reaction was used to transform competent E. coli DH5α cells and the 
transformants were selected by plating on antibiotic supplemented LB plates (Section 
2.2.7).  The plates were then incubated overnight at 37°C.  
 
2.3.10   DNA purification  
 
DNA purification was carried out using a “QIAquick PCR Purification Kit” (QIAGEN) and 
following the manufacturer’s instructions.  
 
2.3.11   Screening of transformants  
 
To check whether transformed bacteria (Section 2.2.7) contained the insert or just re-
ligated plasmid, they were screened using PCR reactions.  Transformants were picked from 
relevant agar plates using a sterile tip and stabbed onto another LB plate (supplemented 
with the relevant antibiotic).  Using the same tip, the same transformant was inoculated 
into a 20 µl PCR reaction, consisting of 18 µl 1.1 X ReddyMix PCR master mix (Thermo 
scientific) and 1 µl of each forward and reverse primer (100 pmol/µl).  This was repeated 
for 5-15 colonies per transformation.  
 
 
42 
 
A typical PCR programme used was:  
 
 Initial denaturation      94°C      5 min 
 Denaturing                     94°C     30 s 
 Annealing                       50°C     30 s 
 Extension                       68°C      2 min 
 Final extension              68°C     7 min 
 
PCR products were then separated on agarose gels alongside a control of undigested 
plasmid (Section 2.3.5).  Candidate plasmids were purified using a QIAprep Mini-prep kit 
(QIAGEN) and sent to GeneService for sequencing at Source Bioscience LifeSciences plc 
(Section 2.3.4).  
 
Once confirmed that the ligation was successful, the plasmid was stored and if for protein 
overproduction work, the plasmid was used to transform electrically competent E. coli BL21 
(λDE3) cells (Section 2.2.7).  
 
2.4   Gene expression analysis  
 
2.4.1   β-Galactosidase assays 
 
β-Galactosidase assays were used to analyse ydiV promoter activity in the presence of 
various AHL chemicals.  The strains of interest were grown aerobically overnight in LB 
medium before sub-culturing until mid-log phase was achieved (Sections 2.2.1 and 2.2.2).  
Initially all assays used strain E. coli JRG6097, before a slyA over-production plasmid was 
used to transform this strain for additional studies (JRG6097/pGS2468) (Sections 2.3.4 and 
2.2.7) (Table 2.1 and 2.2).  
 
To carry out the β-galactosidase assays, the OD600 of the cells for each condition was 
recorded using an Unicam UV/Vis spectrometer, using the corresponding medium as a 
blank (Section 2.2.3).  For each overnight/growth condition, a reaction was produced 
consisting of 550 μl Z-buffer, 20 μl chloroform, 10 μl 0.1% SDS and 250 μl cell sample.  The 
composition of Z-buffer was 16.1 g Na2HPO4.7H2O, 5.5 g of NaH2PO4.H2O, 0.75 g of KCl and 
0.246 g MgSO4.7H2O per litre of dH2O, with β-mercaptoethanol added prior to use (2.7 
µl/ml).  
 
x 30 cycles 
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The samples were vortexed for 10 s before incubation at 28⁰C for 5 min.  Following 
equilibration at 28⁰C of both samples and ONPG, the reactions were initiated by the 
addition of 200 µl 4 mg/ml ONPG.  The samples were closely monitored at 28⁰C, recording 
the time taken for each sample to turn a pale yellow colour.  When the colour change 
occurred the reactions were terminated by the addition of 500 µl 1 M Na2CO3.  The samples 
were subsequently centrifuged at 17,000 xg for 5 min and the OD420 measured (Unicam 
UV/Vis spectrometer).  
 
If the solutions failed to change colour within the usual 30 min period, the reactions were 
left for additional incubation and stopped after a suitable time.  
 
For each condition, three biological replicates were made, and the assays were performed 
in triplicate.  From the raw data, the average MU (Miller units) were determined, and the 
standard deviation calculated (shown as error bars on the graph) for each condition.  
Miller Units were calculated by the following equation: 
 
      
    
           
  x 1000 
 
V= volume (µl) of cells used to find OD420 
T= time (min) from reaction initiation to termination 
 
N-(β-ketocaproyl)-L-homoserine lactone and N-hexanoyl-DL-homoserine lactone (Sigma) 
were added at various stages throughout the experiments.  The concentration of AHL used 
also varied, either at a final concentration of 1 µM or 50 µM as indicated.  
 
2.5   Microscopy techniques  
 
2.5.1   Transmission Electron Microscopy (TEM) 
 
Overnight bacterial cultures (5 ml) were grown in motility broth at 37⁰C, before an aliquot 
(2 ml) was added to 50 ml motility broth in 200 ml conical flasks (Sections 2.2.1 and 2.2.2). 
The cells were grown until exponential phase was reached, with an OD600 of ~0.18 (Section 
2.2.3).  At this point, the bacteria were harvested at 4000 xg for 10 min and resuspended in 
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50 µl motility broth.  To preserve the cells, they were added to fixing solution (3% 
glutaraldehyde in 0.1 M sodium cacodylate) in a 1:1 ratio, before visualisation by TEM.  
 
For TEM visualization, the fixed samples were placed onto 400 mesh copper grids (Agar 
Scientific Stansted Essex) coated with a formvar film.  The fixed samples were thoroughly 
mixed by vortexing before a small volume (6-10 µl) was added to the grid and incubated for 
30 s before excess solution was drawn off by blotting paper.  To stain cells, the same 
volume of 1% phosphotungstic acid (6-10 µl) was added for 30 s before excess was drawn 
off again by blotting paper.  
 
The copper grids were then ready to be observed under a FEI G2 Bio-twin tecnai 120 kV 
TEM (Hillsboro) (Mr Chris Hill, University of Sheffield).  
 
2.6   Protein methods  
 
2.6.1   Protein overproduction  
 
Primary cultures were set up by inoculating 5 ml aliquots of growth media (with 
appropriate antibiotic) with a single colony (of the strain of interest) from an agar plate, 
and growing overnight at 37⁰C (Sections 2.2.1; 2.2.2 and 2.2.4).  The overnight cultures 
were then added to 500 ml of antibiotic supplemented LB in 2 L conical flasks for 
incubation at 37⁰C until an OD600 ~0.6 was achieved (Section 2.2.3).  
 
IPTG was added to the cells (in all cases when the plasmid contained an inducible lac 
promoter) at a concentration of between 100 µg/ml to 20 µg/ml (Section 2.2.4) and the 
cells were grown for between 2 or 24 h at either 15 or 25⁰C, depending when maximal 
expression and solubilisation had been shown for that specific protein.  Once cultured, the 
bacterial cells were harvested at 18,500 xg in an ultracentrifuge for 30 min and the pellets 
were stored at -20⁰C.  
 
2.6.2    Cell breakage 
 
Cell pellets were defrosted on ice and resuspended in 1-10 ml of appropriate breakage 
buffer dependent on the specific strain utilised (Table 2.4).  Cells were then lysed by 3 
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rounds of 30 s sonication at 16 microns.  Following this, the cell-free extract was separated 
into soluble and insoluble fractions by centrifugation at 27,000 xg for 15 min.  
 
Table 2.4: Cell breakage buffers  
 
 YdiV-His6, FlhDC-His6, GST-FliT, GST-FliZ, 
FlhDC-(FLAG)3 
(For ITC, BLItz, IVT, EMSA, Antibody 
stimulation, pull-down assays and YdiV 
crosslinking, partial proteolysis and  
nucleotide reactivity) 
20 mM sodium phosphate, 500 mM NaCl, 
5% glycerol, pH 7.5 
Clp-His6, YdiV-His6 (NMR) 20 mM Tris, 500 mM NaCl, 5% glycerol, pH 
7.4  
YeaI-His6 (nucleotide reactivity assays) 25mM HEPES, 500 mM NaCl, 5% glycerol, 
pH 7.5 
YeaI-His6 (partial proteolysis, 
glutaraldehyde) 
20 mM sodium phosphate,  500 mM NaCl, 
5% glycerol, pH 7.5  
TF-YeaI (purification), YeaI-His6 (gel 
filtration) 
20 mM Tris, 500 mM NaCl, 5% glycerol, pH 
7.4 
 
Cell pellets of over-produced proteins were resuspended into one of these various 
breakage buffers (unless otherwise specified).  The breakage buffer chosen was dependent 
on both the protein overproduced and the subsequent assays the protein would be used 
for, as specified.  
 
2.6.3   Affinity purification  
 
All His6-tagged proteins were purified using affinity chromatography methods.  A 1 ml 
HiTrap chelating column (GE healthcare) was attached to the AKTA Prime system and 
initialised according to manufacturer’s instructions.  
 
Bacterial cell pellets were resuspended in the relevant breakage buffer (Table 2.4), the cells 
lysed by sonication and the phases separated (Section 2.6.2).  The soluble fraction was 
filtered using a 0.2 µm filter before applying the fraction to a 10 ml loop attached to the 
AKTA™ Prime equipment.  The His-chelating programme was used, using the relevant 
binding and elution buffers (Table 2.5), which separated the loaded protein sample into a 
number of 1 ml fractions.    
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Table 2.5: Affinity chromatography purification buffers 
 
Binding buffer  (frequently 
used for YdiV and FlhDC, 
YeaI for some assays) 
20 mM sodium phosphate, 0.5 M NaCl, 20 mM imidazole, 
pH 7.5 
Elution buffer  (frequently 
used for YdiV and FlhDC, 
YeaI for some assays) 
20 mM sodium phosphate, 0.5 M NaCl, 0.5 M imidazole, 
pH 7.5 
Binding buffer (NMR- YdiV, 
Clp, YeaI) 
20 mM Tris, 500 mM NaCl, 20 mM imidazole, pH 7.4 
Elution buffer (NMR- YdiV, 
Clp, YeaI) 
20 mM Tris, 500 mM NaCl, 500 mM imidazole, pH 7.4 
Binding buffer (His6-YeaI) 25 mM HEPES, 0.2 M NaCl, pH 7.5 
Elution buffer (His6-YeaI) 25 mM HEPES, 0.125 M NaCl, 0.5 M imidazole, pH 7.5 
Ni-loading buffer 100 mM NiSO4 
 
Three different pairs of binding and elution buffers were used for affinity chromatography, 
depending on the breakage buffer utilised to resolubilise the cell pellet.  Whilst some 
buffers were chosen as optimal purification buffers for specific proteins, others were 
chosen based on the assay in which the protein would be used.  
 
A trace reader showed the A280 levels, thereby indicating the quantity of protein in various 
fractions.  The eluted fractions were electrophoresed on SDS-PAGE gels to identify which 
fractions contained the protein of interest (Section 2.6.9).  
 
2.6.4   Anion exchange chromatography 
 
Anion exchange chromatography was carried out as a secondary purification step for 
YeaIGGDEF.  Following His chelating chromatography (Section 2.6.3), the YeaIGGDEF protein was 
dialysed into binding buffer (Table 2.6) (Section 2.6.7), before anion exchange 
chromatography.  
 
   Table 2.6: Anion exchange buffers 
 
Binding buffer 25 mM HEPES, pH 8.0 
Elution buffer 25 mM HEPES, 1 M NaCl, pH 8.0 
 
The protein was applied using a 10 ml loop to a 1 ml HiTrap Q HP column (GE healthcare) 
which was attached to the AKTA Prime system.  The AKTA system was initialised according 
to manufacturer’s instructions and the Anion Exchange programme used.  The programme 
used buffers recommended in the manufacturer’s instructions (Table 2.6).  The loaded 
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protein was separated into a number of 1 ml fractions, recording the A280 levels of the 
eluted fractions for protein detection.  
 
2.6.5 Resolubilisation of insoluble YeaI protein 
 
In an attempt to re-solubilise the insoluble cell pellet containing YeaIGGDEF protein, a 
denaturing and refolding protocol was undertaken.  The cell pellet was resuspended in 10 
ml of binding buffer (6 M guanidine hydrochloride, 20 mM Tris-HCl, 0.5 M NaCl, 5 mM 
imidazole, 1 mM 2-mercaptoethanol, pH 8.0) and agitated at 4⁰C for several hours.  The 
resulting mixture was separated into soluble and insoluble fractions by centrifugation at 
27,000 xg for 15 min.  The soluble fraction was then filtered through a 0.2 µm filter and 
applied to a 10 ml loop attached to a 1 ml Hi-Trap Chelating column on the AKTA Prime 
system.  The refolding programme was followed, according to the manufacturer’s 
guidelines and recommended buffer compositions.  The protein was separated into a 
number of 1 ml fractions, recording the A280 levels of these eluted fractions.  The eluted 
fractions containing high A280 levels signified the presence of protein in the samples and 
indicated which samples to analyse by SDS-PAGE (Section 2.6.9).  
 
2.6.6 Thrombin cleavage  
 
In some cases, thrombin cleavage was an important purification step, required to cleave 
the protein of interest (YeaIGGDEF) from the large fused tag.  For all variations of this assay, 
samples were taken throughout each protocol, enabling SDS-PAGE analysis to determine 
the level of success (Section 2.6.7).  
 
Optimisation of this protocol utilised Ni-NTA resin for small scale reactions.  Cell pellets of 
the pCOLD TF:YeaIGGDEF overproduction strain (E. coli BL21 λ(DE3)/pGS2399) were 
resuspended in breakage buffer (Table 2.7), the cells broken by sonication, clarified by 
centrifugation and the soluble fraction retained for use (Section 2.6.2).  The Ni-NTA resin 
was prewashed in dH2O and then wash buffer/TCB (Table 2.7) (twice each) in a 1:1 ratio 
before addition of soluble protein to the resin, incubating at 4⁰C for 1 h.  Thrombin (20 
units) was then added to the protein and incubated overnight at either 4 or 20⁰C.  The 
supernatant was removed, the beads washed once again before an imidazole rich elution 
buffer was added.  
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Large scale purifications of YeaIGGDEF, used a 1 ml HiTrap column to purify the fusion TF-
YeaIGGDEF protein from the crude soluble fraction, using the His-chelating programme as 
detailed previously (Section 2.6.3).  Following affinity chromatography, the elution fractions 
were combined and dialysed into TCB buffer (Section 2.6.7).  Following dialysis, thrombin 
(20 units) was added to the protein and incubated for 16 h at 20⁰C to cleave the fusion 
protein into TF and YeaIGGDEF components.  The cleaved mix was applied to a 1 ml HiTrap 
column either manually, or via the AKTA Prime system.  The manual purification step 
involved the application of the protein to the column, manually washing the column with 
TCB and then addition of an elution buffer.  The automatic purification involved protein 
loading to the column and an elution gradient applied using the His-chelating programme, 
as detailed previously (Section 2.6.3).   
 
The buffers used for the thrombin purification step are detailed in Table 2.7.  
 
   Table 2.7: Thrombin cleavage buffers for TF:YeaIGGDEF purifications 
 
Breakage buffer 20 mM Tris, 500 mM NaCl, 5% glycerol, pH 7.4  
Wash buffer   20 mM Tris, 500 mM NaCl, 20 mM imidazole, pH 7.4  
TCB  20 mM Tris, 500 mM NaCl, 2.5 mM Ca2+, pH 7.4  
Elution buffer 20 mM Tris, 500 mM NaCl, 500 mM imidazole, pH 7.4  
  
 
2.6.7 Buffer exchange and concentrating of protein samples 
 
Following purification, the fractions containing the protein of interest were either used 
directly or were buffer exchanged.  Vivaspin 6 ml or 20 ml concentrator columns 
(Vivascience) were used to concentrate the protein and to remove small protein 
contaminants from the sample.  Columns were carefully chosen to elute proteins no more 
than half the size of the desired protein i.e. a 10 KDa cut off was used for a 28 KDa protein. 
Samples were concentrated by centrifugation at 4000 xg for 5 min intervals, with Bradford 
assays (Section 2.6.8) carried out regularly, until the desired concentration of protein was 
achieved.  
 
Vivaspin columns were used for all FlhDC and YdiV fusion proteins, both to buffer exchange 
and to concentrate the proteins.  For buffer exchange purposes, a 20 ml concentrator 
would be used of the appropriate protein retention size, adding 5 ml of protein into the 
column.  The column would be made up to 20 ml by addition of dialysis buffer and the 
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samples buffer exchanged via centrifugation until the column volume reached 5 ml.  This 
buffer exchange was repeated three times, ensuring minimal unwanted buffer remnants 
remained.  
 
The dialysis buffer varied depending on the protein and elution buffer conditions, but the 
dialysis buffer was usually identical to the elution buffer without imidazole.  
 
For ITC and BLItz assays, as well as antibody stimulation, YdiV and FlhDC were dialysed into 
20 mM sodium phosphate, 0.5 M NaCl, pH 7.5.  In addition YdiV was dialysed into the same 
buffer for partial proteolysis, glutaraldehyde and nucleotide reactivity assays.  NMR 
experiments used Clp and YdiV dialysed into 20 mM Tris, 500 mM NaCl, 20 mM arginine, 
pH 7.4.  
 
YeaIGGDEF was buffer exchanged into 20 mM sodium phosphate, 0.5 M NaCl, pH 7.5 for 
partial proteolysis assays and glutaraldehyde assays.  Gel filtration assays took place with 
YeaIGGDEF protein dialysed into 50 mM Tris HCl, 50 mM NaCl, pH 8.0.  HPLC assays were 
carried out following dialysis of YeaIGGDEF into 10 mM HEPES, 0.125 M NaCl, pH 7.5.  
 
All remaining assays did not require this buffer exchange step, utilising protein either in its 
crude soluble form or purified form directly in elution buffer.  
 
2.6.8 Quantification of protein concentration  
 
Protein concentrations were determined using Bradford assays.  A blank of 200 µl Bio-Rad 
reagent (Bradford, 1976) and 800 µl MilliQ water was initially used, before protein samples 
of 1-20 µl were added and the absorbance at A595 determined using a Unicam HEλIOS 
spectrophotometer.  Protein concentration was then calculated by using a standard BSA 
curve.  
 
Additionally, when highly accurate protein concentrations were required, spectroscopic 
techniques were used.  An aliquot (10-20 µl) of purified protein was diluted into the chosen 
protein dialysis buffer to give a 1 ml sample, which was added to a quartz cuvette.  The 
spectrophotometric absorbencies of the protein were recorded at 280 and 320 nm.  The 
absorbance values at these two wavelengths were then used alongside the proteins’ 
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extinction coefficient (ExPaSy ProtParam tool) to calculate the molar concentration using 
the following equation:  
 
Concentration (M) = (A280-A320)/ extinction coefficient  
 
2.6.9 SDS-PAGE 
 
SDS-PAGE gels were used to analyse proteins present throughout the over-expression and 
purification process, with 12% resolving gels used to visualise proteins 20 KDa upwards and 
18% for smaller proteins.  
 
SDS-PAGE was carried out using the Bio-Rad Mini Protean 3 system following the 
manufacturer’s instructions.  Glass plates (Bio-Rad) were cleaned with ethanol and 
clamped into position on a gel casting stand.  The appropriate resolving gel was added to 
the plates until it reached 1 cm from the top and water-saturated isopropanol was layered 
on top of the gel to enable it to set with a level surface.  Once fully set, the isopropanol and 
unpolymerised acrylamide were poured off the resolving gel and the surface of the gel 
washed thoroughly with dH2O.  The stacking gel was then added above the set resolving gel 
and the comb inserted.  Once set, the gel was removed from the stand and clamped into 
the gel running box, where the comb was removed and 1 x running buffer added.  
 
Samples were prepared for SDS-PAGE analysis by mixing the protein sample in a 1:1 ratio 
with SDS-PAGE loading dye and heating at 95⁰C for 5 min.  The samples were then added to 
the wells (5-25 µl), alongside 10 µl of a protein marker and electrophoresis carried out at 
200 V for up to 70 min.  Once complete, the gels were removed from their plates and 
placed into Coomassie stain for 1-2 h, and then into destain until stained polypeptides were 
clearly visible.  Gels were dried using Invitrogen gel-drying kits, using a solution of 30% 
methanol and 5% glycerol.   
 
The SDS-PAGE gel components, running buffer, sample preparation and gel staining buffers 
are listed in Table 2.8. The protein markers used for SDS-PAGE gels are shown in Figure 2.1.  
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Figure 2.1: SDS-PAGE protein markers 
 
Protein markers were used on every SDS-PAGE gel in order to determine the 
molecular weight of the analysed proteins.  Additionally, these markers enabled 
the assessment of successful transfers by Western blot.  
 
A: Precision plus protein marker used as both unstained and prestained (All Blue) 
forms (Bio-Rad). B: Invitrogen Mark 12 unstained marker (Invitrogen).  
 
A B 
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2.6.10   Western blot 
 
Samples to be analysed by Western blot were electrophoresed on the relevant SDS-PAGE 
gels, using Bio-Rad Prestained protein marker (Figure 2.1) as a visible marker (Section 
2.6.9).  The SDS-PAGE gel was transferred to Hybond-C Extra nitrocellulose (Amersham 
Biosciences) membrane using a semi-dry method.  In preparation for the blot, the blotting 
paper and SDS-PAGE gel were soaked in transfer buffer for 20 min.  Meanwhile, a piece of 
membrane was soaked in dH2O for 10 min before being transferred to transfer buffer for 
the remaining 10 min.  Keeping all components submerged in transfer buffer, the blot was 
then assembled, following manufacturer’s instructions and placed into the Transblot 
Electrophoretic Transfer Cell (Bio-Rad).  Once fully assembled, the transfer was carried out 
at 100 mA for 1 h, with gentle buffer stirring.  
 
Once complete, the membrane was removed from the transfer cell and blocked in 50 ml of 
blocking buffer for 30 min.  The blocking buffer was removed and the membrane washed 
several times (3 x) with PBS-Tween.  Subsequently, primary antibody (50 ml) was added to 
the membrane, prepared at a suitable antibody dilution in blocking buffer, which was 
incubated for 1 h.  Following this, the membrane was further washed in PBS-Tween (3 x) 
before the secondary antibody was added (50 ml) for 1 h.  Anti-rabbit labelled with horse 
radish peroxidase (Amersham Biosciences) was the chosen secondary antibody for all 
experiments, used at a 1/10,000 dilution throughout.  The secondary antibody was 
discarded and the membrane washed with PBS-Tween (3 x) prior to a final wash in PBS.  All 
wash and incubation steps were carried out at room temperature with gentle agitation.  
Solution  Constituents  
12% resolving gel 1.28 ml dH2O, 2.5 ml 30% acrylamide (Bio-Rad), 2.35 ml 1.5 M 
Tris pH 8.8, 62.5 μl 10% SDS, 62.5 μl 10% APS and 6.25 μl 
TEMED (N,N,N',N'-tetramethyl-ethane-1,2-diamine) 
18% resolving gel 3.75 ml 30% acrylamide, 2.35 ml 1.5 M Tris pH 8.8, 62.5 μl 10% 
SDS, 62.5 μl 10% APS and 6.25 μl TEMED 
6% stacking gel 2.46 ml dH2O, 0.75 ml 30% acrylamide, 0.47 ml 1 M Tris pH 
6.8, 37.5 μl 10% SDS, 37.5 μl 10% APS, 3.75 μl TEMED 
1X Running buffer 250 mM Tris-base, 0.1 M glycine, 0.1% SDS 
SDS-PAGE loading dye 0.35 ml 1 M Tris HCl pH 6.8, 0.6 ml 50% glycerol, 100 mg SDS, 
93 mg DTT, 50 µl 1% bromophenol blue 
Coomassie stain  10% methanol, 10% acetic acid, 0.05% Coomassie brilliant blue 
Destain  10% acetic acid, 10% methanol 
Table 2.8: Components of SDS-PAGE gels and buffers 
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The membrane was then removed and drip dried before placing protein-side up on 
clingfilm. Western ECL reagents (Pierce) were then made up following manufacturer’s 
instructions (6 ml) and were poured onto the membrane and incubated in the dark for 5 
min.  The ECL reagents were then thoroughly drained off the membrane, before the 
membrane was wrapped in cling film and placed in an X-ray film cassette.  In a dark room, a 
piece of Hyperfilm ECL (GE healthcare) film was placed onto the membrane and sealed in 
the cassette to expose for a suitable time (20 s-10 min) before the film was removed from 
the cassette and developed.  
 
The buffers used for the gel-membrane transfer and for the Western blot are listed in Table 
2.9.  
 
Table 2.9: Western blot buffer components 
 
2.6.11   Antibody production   
 
Polyclonal antibodies were raised against the protein complex FlhD4C2 and the monomeric 
protein YdiV in rabbits, carried out by BioServe, University of Sheffield.  Both proteins were 
purified in their His-tagged fusion form (using strains BL21 λ(DE3)/pGS2354 and BL21 
λ(DE3)/pGS2441), and subsequently dialysed into sodium phosphate buffers (Sections 
2.6.1; 2.6.2; 2.6.3 and 2.6.7).   
 
Each rabbit was injected with up to 1 ml of 1 mg/ml protein by BioServe, taking test bleeds 
after a primary injection, and then after a second round of injections.  After each test 
bleed, the rabbit serum was tested by Western blot analysis (Section 2.6.10) to assess 
antibody production, specificity and potency.  The serum was used at dilutions of 1/100, 
1/500, 1/1000 and 1/5000, with non-immunised rabbit sera being used as a negative 
control.  This was carried out for each protein, for both the first and second round of rabbit 
injections, before the final bleed was tested, to give a starting dilution for Western blots.  
 
10 x PBS (1 litre) 80 g NaCl, 2 g KCl, 14.4 g Na2HPO4, 2.4 g KH2PO4, pH 7.4 
1 x PBS-Tween 10 % 10 X PBS, 0.05 % Tween 20 
Transfer buffer   
(1 litre) 
5.8 g Tris base, 2.9 g glycine, 200 ml methanol, 3.7 ml 10% SDS 
Blocking buffer 5% Marvel, 0.05% Tween 20 in 1 x PBS 
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The final bleed antibody serum was aliquoted into 500 µl tubes, with the majority stored at 
-80⁰C for long-term use, and aliquots for current use kept at 4⁰C.  
2.6.12   Glutaraldehyde crosslinking assays 
 
Glutaraldehye samples (20 µl) were produced, consisting of 16 μl purified protein (0.5 -1 
mg/ml) (Section 2.6.8) and between 0 and 1% glutaraldehyde, making up to the final 
volume with the relevant protein binding buffer, as described in Section 2.6.3.  The 
reactions were incubated at room temperature for 15 min before being quenched by 10 μl 
of 1 M TRIS pH 6.8.  Reactions were frozen until use, when the samples were denatured by 
boiling at 95°C for 5 min with 30 μl SDS-PAGE loading buffer and electrophoresed by SDS-
PAGE analysis (Section 2.6.9).  
 
Crosslinking assays were carried out for both YdiV and YeaI proteins, analysing both as 
purified His-tagged fusion proteins (produced from overproduction strains E. coli BL21 
λ(DE3)/pGS2354 and E.coli BL21 λ(DE3)/pGS2263) (Section 2.6.3).  
  
2.6.13   Gel filtration 
 
A Hi-Load Superdex 200GL column (GE Healthcare) was pre-equilibriated with buffer 
(identical to the protein preparation buffer, Sections 2.6.3 and 2.6.7) prior to the 
application of purified protein to the column.  YeaIGGDEF was added (1 ml of 1.5 mg/ml) in 50 
mM Tris HCl, 50 mM NaCl, pH 8.0 and YdiV was added (100 µl of 3 mg/ml) in 20 mM 
sodium phosphate, 500 mM NaCl, pH 7.5 buffer, with both proteins analysed individually. 
The column was developed at 0.7 ml/min flow rate, using the identical buffer as that used 
to purify the protein.   An attached computer recorded the absorbance at 280 nm of the 
eluant and therefore identified the elution volume of each protein.  The Kav (gel phase 
distribution coefficient) was calculated using the following equation:  
 
    
     
     
 
 
In the equation above, Ve = elution volume of protein, Vo = void volume of column (7.8 ml) 
and Vt = total volume of column (24 ml). 
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The protein molecular weight could then be estimated from the elution times, using a 
standard curve based on proteins of known size.  This calibration curve was produced by 
the application of a four protein mix (Ferritin, Aldolase, Ovalbumin and Ribonuclease) of 
known molecular weight to the Superdex column, and determination of their respective 
elution volumes.  The logMW of these four proteins was plotted against the Kav value for 
each protein and gave a calibration curve for molecular weight calculation of tested 
proteins.  
 
2.6.14   N-terminal sequencing  
 
N-terminal sequencing was used to identify co-purifying proteins produced upon YdiV and 
YeaIGGDEF purifications. YdiV and YeaIGGDEF were over-expressed individually and the proteins 
purified (detailed in Sections 2.6.1-2.6.3).  In each case, the protein mixture (total 
concentration of 0.8 mg/ml) was initially separated on an SDS-PAGE gel (Section 2.6.9) 
before the gel was blotted onto an Immuno-Blot™ PVDF membrane (Bio-Rad).  After a brief 
soaking in methanol, the membrane was transferred to an electroblotting buffer, consisting 
of 10 mM CAPS, 10% (v/v) methanol, pH 11.  The gel was also soaked in this buffer for 5 
min, before the transblotting sandwich was constructed and the electroblotted at room 
temperature for 30 min at 50 V using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-
Rad).  
 
Once electroblotted, the membrane was removed from the transblotting sandwich and 
rinsed with dH2O before a brief soaking in 100% methanol.  The Immuno-Blot PVDF 
membrane was subsequently Coomassie stained (Table 2.10) for 1 min. The membrane was 
destained and thoroughly rinsed in dH2O prior to the membrane being dried at room 
temperature.  The polypeptides of interest were then excised from the membrane and 
amino acid sequences ascertained by Dr A.J.G. Moir (Krebs sequencing and synthesis 
facility) using the Applied Biosystems protein sequencer.  
 
The electroblotting buffers are detailed in Table 2.10.  
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2.6.15   Crystallisation trials 
Crystallisation trials were carried out for proteins using a crystallisation robot (Matrix Hydra 
II PlusOne) and commercially available screens (QIAGEN).  The robot was cleaned and 
utilised following manufacturer’s instructions.  Robotic trials were carried out for YdiV 
protein and for the YdiV:FlhDC complex.  YdiV was purified and dialysed into a 20 mM Tris-
HCl, 500 mM NaCl, 20 mM arginine, pH 7.4 buffer and concentrated to 10-15 mg/ml 
(Sections 2.6.3; 2.6.7).  
 
The YdiV:FlhDC complex was produced by carrying out a pull-down assay (Section 2.8.1) 
using overproduction strains for theYdiV-His6 and (FLAG)3-FlhDC proteins.  The pull-down 
was carried out as described in Section 2.8.1, using the buffers specified in Section 2.8.1.  
The protein complex was analysed by SDS-PAGE (Section 2.6.9) before dialysis of the 
protein into a 20 mM sodium phosphate, 500 mM NaCl, pH 7.5 buffer (Section 2.6.7).  The 
YdiV:FlhDC complex was then concentrated to 9 mg/ml before robotic trials were carried 
out again using the Matrix Hydra II PlusOne robot and commercial screens (QIAGEN).  
 
2.7   Protein:nucleotide interactions 
 
Nucleotides were tested for modulation of protein behaviour in various ways, using the 
following range of nucleotides: GTP, GDP, GMP, cAMP, AMP, ADP, ATP (Sigma), ppGpp 
(TriLink BioTechnologies), c-di-GMP, c-di-AMP, pGpG (BioLog).  
 
2.7.1   Enzymatic reactions  
 
Reactions (15 μl) were composed of 1 μM purified protein, 10 mM Mn2+/Mg2+ and 100 μM 
substrate, made up to 15 μl with dialysis buffer.  The reactions were incubated for 1 h at 
Electroblotting buffer 10 mM CAPS, 10 % (v/v) methanol, pH  11 
Coomassie Stain 0.1% (w/v) Coomassie brilliant blue R25O, 40 % (v/v) 
methanol, 1 % (v/v) acetic acid 
Destain  50 % (v/v) methanol 
Table 2.10: Components of electroblotting buffers 
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37°C before stopping the reaction by heating at 95°C for 5 min.  This assay was carried out 
for both YeaIGGDEF and YdiV proteins, overproduced from strains E. coli BL21 
λ(DE3)/pGS2263 and E. coli BL21 λ(DE3)/pGS2354 (Section 2.6.1) and purified by affinity 
chromatography (Sections 2.6.2; 2.6.3 and 2.6.7) 
 
To prepare samples for HPLC analysis, the reaction samples were made up to 100 μl with 
the addition of dH2O and the samples were transferred to HPLC tubes.  The ELITE La Chrom 
HPLC machine was then initiated following manufacturer’s instructions, and systematically 
took up programmed samples and loaded them onto a C18 LiChroCART 125-3 column.  The 
samples were then subject to a 30 min programme of: 
 
 0  min = 100% buffer A 
20 min = 20% buffer A 
 25 min = 20% buffer A 
 26 min = 100% buffer A 
 30 min = 100% buffer A 
 
The buffers used in the assay were filter sterilized and consisted of: 
Buffer A = 100 mM KH2PO4, 4 mM (butyl)4 NH4HSO4P pH 5.9 
Buffer B= 66% methanol 
 
The flow rate was set at 0.7 ml/min with the sample size being 45 µl for all samples.  To 
standardise the column, a mixture of GTP/GDP/GMP (each at 1 mM) were loaded onto the 
column.  
 
2.7.2   Partial proteolysis 
 
Partial proteolysis methods were carried out using recombinant purified protein, creating a 
characteristic cleavage pattern for each protein by the addition of trypsin to samples.  This 
method was used to analyse nucleotide:protein interaction by incubating proteins with 
various nucleotides and comparing the trypsin cleavage patterns.  Both YeaIGGDEF and YdiV 
were analysed by partial proteolysis, as His-tagged fusion proteins overproduced from 
strains E. coli BL21 λ(DE3)/pGS2263 and E. coli BL21 λ(DE3)/pGS2354 (Section 2.6.1) and 
purified by affinity chromatography (Sections 2.6.2; 2.6.3 and 2.6.7).  
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Optimal conditions for trypsin digests of protein were determined by using various trypsin 
concentrations (stocks of 1 mg/ml and 0.2 mg/ml, made in 0.1 M HCl), incubation 
temperatures (37⁰C or RT) and incubation times (1-10 min).  Trypsin stocks were used, 
adding 3 µl of stock solution into each 30 µl reaction sample, producing samples containing 
trypsin at 100 µg/ml (from 1 mg/ml stock) and 20 µg/ml (from 0.2 mg/ml stock).  Samples 
were set up in tubes, containing 10 µl YeaI (1 mg/ml) or 5 µl YdiV (3 mg/ml) purified 
protein, 3 µl of trypsin at required concentration, and made up to 30 µl with 10 mM Tris-
HCl, pH 8.  These samples were set up, before incubation at the optimal temperature and 
duration, before the reactions were stopped by the addition of 4 µl 10% SDS and heating at 
100⁰C for 10 min.  SDS-loading dye was added to the samples before electrophoresis on a 
high percentage SDS-PAGE gel (Section 2.6.9) along with a control sample lacking any 
trypsin.  
 
Once optimal conditions had been determined, the reactions were repeated with the 
addition of nucleotides (final concentration of 2 mM), ensuring to produce protein and 
nucleotide control sample lacking trypsin, as well as the same reaction mix in the presence 
of trypsin.  Once more these samples were separated by SDS-PAGE methods, enabling 
comparisons between samples.  
 
2.7.3   Nuclear Magnetic Resonance 
 
Proton NMR was carried out for YdiV in the presence of various nucleotides (pGpG, c-di-
GMP, ppGpp, GMP, GDP and GTP) as well as analysing the YdiV protein and the individual 
nucleotides independently.  
 
Conditions for NMR were optimized to get the best signal to noise, with the best detection 
of nucleotides/proteins being achieved when using a Tris buffer (20 mM Tris, 500 mM NaCl, 
20 mM arginine, pH 7.4) with the addition of 1 mM Mg2+and 0.5 mM EDTA.  Samples were 
prepared to give a final concentration of 30 µM protein, nucleotide, or of both protein and 
nucleotide in the optimal conditions.  Purified YdiV-His6 protein was used after dialysing the 
protein into the Tris buffer detailed above (Sections 2.6.3; 2.6.7).  
 
Samples were prepared to give a final volume of 450 µl, before 50 µl D2O was added and 
the solutions mixed.  The samples were then analysed by Dr. Andrea Hounslow, University 
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of Sheffield.  The samples analysed using on a Bruker 800MHz Avance I NMR spectrometer 
and Bruker Topspin2.1 software. 
 
2.7.4   Fluoresence spectroscopy  
  
The fluorescence spectra of proteins in the presence and absence of nucleotides were 
obtained using a Cary Elipse fluorescence spectrophotometer.  An excitation wavelength of 
280 nm was used, scanning the emission between 300 nm and 400 nm.  The excitation slit 
was set to 5 nm, and emission slit set to 20 nm.  
 
For all experiments, a water bath was utilised, enabling the temperature to be controlled 
(26, 30 or 35⁰C) throughout the series of experiments.  
 
For YdiV samples, 0.4 µM purified YdiV-His6 protein (in 20 mM Tris, 500 mM NaCl, pH 7.5) 
(Section 2.6.3 and 2.6.7) and 12 µM Mg2+ (giving a 30-fold excess) were added giving a final 
volume of 3 ml.  Nucleotides were added to the samples to give a 1:1 molar ratio to the 
protein, i.e. at a final concentration of 0.4 µM.  In all cases, the sample buffer was 10 mM 
Tris-HCl, pH 7.4.  The reaction samples were analysed in 3 ml quartz cuvettes, at a specified 
constant temperature.  Reference samples using N-acetyl-L-tryptophanamide (NATA) 
(Sigma) were used as a tryptophan analogue, adding NATA at a concentration to give a 
similar fluorescence intensity as YdiV.  In this case, 3 ml samples were produced consisting 
of 2.3 µM NATA, again with nucleotides at 0.4 µM, Mg2+ at 12 µM, all in a 10 mM Tris-HCl, 
pH 7.4 buffer.  
 
The YdiV:FlhDC fluorescence detection was carried out a similar manner, with each 3 ml 
sample consisting of 50 µM FlhDC:YdiV complex, 1.5 mM Mg 2+ (30-fold excess), with 
nucleotides added in a 1:1 ratio to the protein, again at 50 µM.  The sample buffer in this 
case was 20 mM sodium phosphate, pH 7.5, analysing the samples at a specified constant 
temperature. The FlhDC:YdiV complex used in this assay was formed by a pull-down 
method (Section 2.8.1), using the buffers specified in Section 2.8.1. The complex was eluted 
in 20 mM sodium phosphate, 500 mM NaCl, 500 mM imidazole, pH 7.5.  Complex 
formation and purification was confirmed by SDS-PAGE (Section 2.6.9).  
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2.7.5   Pull-down assays with nucleotides 
 
Ni-NTA beads (QIAGEN) were used as a small-scale protein immobilisation tool, enabling 
immobilization of the YdiV:FlhDC complex for testing the interaction with individual 
nucleotides. 
 
The fusion proteins YdiV-His6 and (FLAG)3-FlhDC (from strains E. coli BL21 λ(DE3)/pGS2354 
and E. coli BL21 λ(DE3)/pGS2382) were produced by overproduction methods (Section 
2.6.1), resuspending the harvested cell pellets in a breakage buffer (Table 2.11).  The cells 
were lysed by sonication and the phases separated by centrifugation (Section 2.6.2). The 
soluble fraction was clarified using a 0.2 µm filter and retained for use, at ~ 1 mg/ml 
(Section 2.6.8).  
 
Table 2.11: Nucleotide:protein pull-down assay buffers  
 
 
Prior to use, the Ni-NTA resin was washed in a 1:1 ratio with dH2O and wash buffer, with 
two washes of each (Table 2.11).  Both solutions were added and mixed with the resin and 
then centrifuged at 100 xg for 1 min.  The supernatant was then removed and the pre-
washed resin aliquoted into reaction tubes.  
 
Each reaction sample contained pre-washed resin (100 µl) and an equal volume of crude 
soluble YdiV-His6.  The mixture was agitated for 30 min at room temperature before the 
sample was separated by centrifugation and unbound protein removed.  The resin was 
washed three times before the addition of crude soluble (FLAG)3-FlhDC (100 µl) and 
incubation and agitation for 10 min at room temperature.  Following centrifugation, the 
supernantant was removed, and three wash steps carried out.  Finally a specified 
nucleotide (30 µl of 50 mM) was added to the samples, again in breakage buffer, incubating 
the samples for 10 min at room temperature.  Each nucleotide was added individually, 
thereby having one reaction sample per nucleotide tested.  The eppendorfs were 
centrifuged again in order to remove the supernatant, before two further wash steps 
occurred.  Finally elution buffer (50 µl) was added to the resin, the samples agitated and 
centrifuged before the final soluble sample was collected (Table 2.11).   
Breakage buffer 20 mM sodium phosphate, 500 mM NaCl, 5% glycerol, pH 8 
Wash buffer 20 mM sodium phosphate, 500 mM NaCl, 20 mM imidazole, pH 8 
Elution buffer 20 mM sodium phosphate, 500 mM NaCl, 500 mM imidazole, pH 8 
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Centrifugation steps always involved 1 min of centrifugation at 100 xg, with wash steps 
always involving the addition of 1 ml of wash buffer, inverting the eppendorfs to fully mix 
the sample, followed by centrifugation.  
 
Supernatant fractions were taken at each stage of the pull-down process for analysis by 
electrophoresis (Section 2.6.9).  
 
2.8   Protein:protein interactions 
 
2.8.1   Pull-down assays 
 
Pull-down assays were used to study the possible interaction between YdiV and FlhDC. 
Following overproduction of the YdiV-His6 and (FLAG)3-FlhDC proteins (from strains E. coli 
BL21 λ(DE3)/pGS2354 and E. coli BL21 λ(DE3)/pGS2382), the cell pellets were resuspended 
in breakage buffer and lysed by sonication (Sections 2.6.1 and 2.6.2).  The cell phases were 
separated by centrifugation and the soluble extracts filtered using a 0.2 µm filter, retaining 
these extracts for use.  
 
A 1 ml Hi-Trap column (GE healthcare) was manually loaded with dH2O (10 ml) before 
charging the column with 100 mM NiSO4 (10 ml).  The column was then loaded once more 
with dH2O (10 ml) prior to column equilibration with the addition of wash buffer (10 ml). 
Soluble YdiV extract was added to the column (7 ml at ~ 1 mg/ml) and the column further 
washed with the addition of wash buffer (10 ml).  The soluble cell-free extract FlhDC was 
added to the column (10 ml at ~ 1 mg/ml) and again the column washed with wash buffer 
(10 ml).  Finally an imidazole rich elution buffer (10 ml) was added to the column, to elute 
all His-tagged proteins.  To clean the Hi-Trap column, dH2O (10 ml) and 25% ethanol (10 ml) 
was passed through the column, prior to storage of the column at 4⁰C.  The buffers utilized 
in this assay are detailed in Table 2.12.  
 
Table 2.12: Protein:protein pull-down assay buffers 
 
Breakage buffer 20 mM sodium phosphate, 500 mM NaCl, 5% glycerol, pH 7.5  
Wash buffer 20 mM sodium phosphate, 500 mM NaCl, 20 mM imidazole, pH 7.5 
Elution buffer 20 mM Sodium phosphate, 500 mM NaCl, 500 mM imidazole, pH 7.5 
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Fractions were collected at each stage of the pull-down assay, for subsequent analysis by 
SDS-PAGE  (Section 2.6.9) or Western blot (Section 2.6.10).  
 
2.8.2  Competition assay pull-down 
 
Pull-down methods were utilized for competition assays, producing soluble extracts of 
YdiV-His6, FlhDC-His6, (FLAG)3-FlhDC, GST-FliT and GST-FliZ proteins, all of which were 
encoded by plasmids (Table 2.2) which were used to transform E. coli BL21 λ(DE3) cells 
(Section 2.2.7) for protein overproduction.  The relevant proteins were overproduced and 
the cells harvested (Section 2.6.1).  The cell pellets were resuspended in breakage buffer, 
prior to sonication, centrifugation and clarification of the soluble extracts (Section 2.6.2).  
 
A 1 ml Hi-Trap column (GE healthcare) was washed with dH2O (10 ml) before charging it 
with 100 mM NiSO4 (5 ml) and then washing the column with dH2O (10 ml) and wash buffer 
(10 ml).  
 
For the control assays, FlhDC was immobilised on the column, by the addition of cell-free 
extract FlhDC-His6 (5 ml of 1.0 mg/ml) following column equilibration.  The column was 
thoroughly washed with wash buffer (10 ml) before addition of GST-FliT or GST-FliZ as cell-
free extracts (5 ml of 1.5 mg/ml).  Unbound proteins were eluted from the column by the 
addition of wash buffer (10 ml) before the elution of His-tagged proteins and any binding 
partners by the addition of elution buffer (10 ml).  
 
The competition assays were a slight variation on the control assays, with three proteins 
(all as cell-free extracts) passaged down the column rather than two.  The column was 
charged and equilibrated as before. Soluble crude YdiV-His6 (5 ml at 1.0 mg/ml) was added 
to the column first, before wash buffer (10 ml) was added.  The second protein loaded onto 
the column was FlhDC-(FLAG)3 (5 ml at 1.0 mg/ml) before another wash buffer step (10 ml). 
Finally GST-FliT or GST-FliZ (5 ml at 1.5 mg/ml) was added, before a final wash step (10 ml) 
and elution step using elution buffer (5 ml).  All proteins were added as cell-free extracts at 
concentrations of ~1.0- 1.5 mg/ml (Section 2.6.8).  
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To clean the Hi-Trap column, dH2O (10 ml) and 25% ethanol (10 ml) was passed through the 
column, prior to storage of the column at 4⁰C.  The buffers utilized in this assay are listed in 
Table 2.12.  
 
Fractions (0.5 ml) were collected at each stage of the pull-down assay, for subsequent 
analysis by SDS-PAGE (Section 2.6.9) or Western blot (Section 2.6.10).  
 
2.8.3  Bio-Layer interferometry for YdiV: FlhDC interaction   
 
 
The BLItz detection system (fortéBIO) was utilised to determine the binding kinetics of the 
YdiV and FlhDC interaction.  This system used amine reactive (AR2G) biosensors (fortéBIO) 
to covalently immobilize one of the proteins to the probe surface.  
 
The probes were hydrated in buffer for 10 min prior to use, before the probes were loaded 
onto the BLItz machine and the reaction programme selected (Table 2.13).  
 
 
These experiments consisted of seven distinct steps, with the biosensor physically moved 
to the appropriate solution vessel at each stage.  Tube steps required 250 µl of solution to 
be present in a black eppendorf, whilst drop stages required 5 µl of a solution to be present 
in a concave drop.  The concave surface was thoroughly washed between samples, to 
ensure no contamination. 
 
Both the YdiV and FlhDC proteins were purified with C-terminal His-tags (Section 2.6.3), 
overproduced using plasmids pGS2354 and pGS2382 respectively (Table 2.2) in E. coli BL21 
λ(DE3) cells and dialysed into sodium phosphate buffer (20 mM sodium phosphate, 500 
mM NaCl, pH 7.5) (Section 2.6.7).  This dialysis buffer was used throughout the experiments 
for baseline and dissociation stages (steps 1, 5 and 7).  The AR2G probes were chemically 
Step Number Step type Duration (s) Position 
1 Initial baseline 60 Tube 
2 Chemical activation 300 Tube 
3 Load sample 600 Tube 
4 Quenching 300 Tube 
5 Baseline 120 Tube 
6 Association 300 Drop 
7 Dissociation 600 Tube 
Table 2.13: BLItz programme details for AR2G biosensor protocols 
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activated (step 2) by addition of the ‘amine coupling second generation reagent kits’ 
following the manufacturer’s guidelines.  Protein immobilisation (step 3) was subsequently 
achieved by a 1/10 dilution of concentrated protein (1-3 mg/ml stock) into 10 mM sodium 
acetate pH 5.  Unbound protein was removed by addition of 1 M ethanolamine pH 8.5 (step 
4) which quenched the reaction.  Following step 5, one of the proteins was immobilised to 
the AR2G probe, with excess chemicals and proteins removed.  Detection of the binding 
interaction was achieved by addition of the partner protein in solution at concentrations 
varying from 9 nM to 10 µM (step 6).  Following experiment completion, the biosensor was 
removed from the BLItz machine, and discarded.  
 
The concentration of the immobilised protein was fixed throughout the series of 
experiments, varying the concentration of soluble protein added in step 6 (Section 2.6.8). 
This produced a series of data which could be analysed using the BLItz Pro software 
(fortéBIO) in order to determine reaction constants for each experiment.   
 
2.8.4 Isothermal titration calorimetry 
 
The binding interaction YdiV:FlhDC was studied in solution, in an ITC detector (TA 
instruments).  Both proteins were purified (Section 2.6.3) as His-tagged fusion proteins 
(using plasmids pGS2382 and pGS2354) and were dialysed into sodium phosphate dialysis 
buffer (20 mM sodium phosphate, 500 mM NaCl, pH 7.5) (Section 2.6.7) and degassed 
before use.  
 
System cleaning and equilibration was carried out following manufacturer’s instructions. 
The FlhDC protein complex (44 µM) (Section 2.6.8) was loaded into the sample chamber 
and YdiV (235 µM) loaded into the syringe.  The syringe was loaded into the chamber, and 
the system equilibrated to 25⁰C with 250 rpm agitation in the chamber.  Once the system 
was fully equilibrated and the heat changes in the chamber minimal, the titrations were 
initiated.  YdiV was injected into the reaction chamber from the loaded syringe, with 25 
injections taking place every 180 s, each of volume 2 µl.  
 
Analysis of the detected heat changes was carried out using the NanoAnalyse software (TA 
instruments).  Following manufacturer’s instructions, the baseline heat changes were 
determined and subtracted from the detected changes to produce a corrected heat change 
trace.  The molar ratio of the chamber protein (FlhDC) and syringe protein (YdiV) were 
65 
 
determined by the NanoAnalyse software (TA instruments), calculating the ratio after each 
injection.  These molar ratios could then be plotted against the corrected heat changes for 
the duration of the experiment.  At this point, various binding models could be added to 
the graphs and the model optimally fitted to the data.  Several binding models were tested 
against the data and variables altered to produce the best-fit curve.  Once the binding 
model was determined, the thermodynamic parameters of the interaction were calculated 
by the software, giving interaction stoichiometry and binding constants values.  
 
The binding interaction was repeated in triplicate, yielding multiple data sets to fit binding 
models to, thereby increasing confidence in the binding data.  Between each analysis, the 
reaction chamber and syringe were cleaned following manufacturer’s instructions.  
 
2.9   Protein:DNA interactions 
 
2.9.1   Radioactive labelling of DNA 
 
DNA fragments were amplified by PCR reactions (Section 2.3.3) and checked for 
appropriate amplification on agarose gels (Section 2.3.5).  Following this, DNA was purified 
by a Qiagen PCR purification kit (Section 2.3.10), and then was digested with appropriate 
restriction enzyme (XbaI) (Section 2.3.6) before repeating the Qiagen PCR purification step 
(Section 2.3.10).  The DNA was then quantified to find the appropriate amount to 
radioactively label (Section 2.3.8).  
 
A 30 µl reaction mixture was then made, including a suitable volume of DNA to give 150 ng 
DNA, 3 µl Klenow buffer, 0.5 µl Klenow (5 units) (Fermentas) and 0.5 µl [α-32P] - dCTP (10 
mCi/ml) (Perkin Elmer), making up the volume with dH2O.  The reaction was then left for 1 
h on the radiation bench before a final PCR purification was carried out (Section 2.3.10) and 
the labelled DNA solution was frozen.  
  
2.9.2   Electromobility shift assays (EMSA) 
 
EMSA gels were made, using Bio-Rad plates and tanks, as described for SDS-PAGE gels.  The 
gels were made using the components listed in Table 2.14, and the gels clamped into the 
Bio-Rad tanks before adding 0.5 x TBE buffer to the tank (Table 2.14).  
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Table 2.14: EMSA gel and buffer components 
10 x TBE buffer (1 litre) 108 g Tris, 55 g boric acid, 40 ml EDTA (0.5 M, pH 8) 
Gel shift gels 5.63 ml dH2O, 1.5 ml 30% acrylamide (37:5:1), 0.38 ml    10 
x TBE, 75 µl APS, 7.5 µl TEMED 
EMSA binding buffer (10 x) 400 mM Tris pH 8, 10 mM EDTA, 10 mM MgCl2, 5% glycerol 
EMSA binding buffer (1 x) 
(20µl) 
17.5 µl 10 x EMSA binding buffer, 2 µl 100 mM DTT, 0.5 µl 
100 mg/ml BSA 
EMSA loading dye 50 % glycerol, bromophenol blue  
 
After removing the comb from the gel, each well was scraped using a needle to ensure all 
the wells were clean and free of polymerized acrylamide, before pre-running the gel.  
 
Samples were prepared, containing 1 µl of 1 x EMSA binding buffer, 1 µl of radio-labelled 
DNA (at 5 ng/µl), 1 µl of 2 mg/ml Calf Thymus DNA, 2 µl of 500 mM NaCl, making up to 10 
µl with dH2O (Table 2.14).  In samples containing protein, the volume of 500 mM NaCl was 
reduced to compensate for protein addition (in 500 mM NaCl), ensuring a final volume of 
10 µl in all cases.  All samples had a final salt concentration of 100 mM.  The samples were 
prepared and mixed, before being transferred to a radiation area where the radiolabelled 
DNA was added (Section 2.9.1).  From here the samples were incubated for 30 min at 37⁰C, 
before 2 µl of EMSA loading dye was added to each sample, mixed and 10 µl loaded to the 
gel (Table 2.14).  
 
In cases where antibodies were added (Section 2.6.11), the antibodies were diluted 1/10 
into salt buffer, and 1 µl added after the incubation period just prior to EMSA loading dye. 
For nucleotide addition (Section 2.7), nucleotides were diluted into dH2O and added prior 
to DNA addition and incubation, to give a final concentration of 100 µM in the samples.  
 
The EMSA gel was pre-run at 30 mA per gel for 30 min using a power pac 300 (Bio-Rad) 
before it was slowed to 10 mA per gel, whilst loading of samples occurred.  Once loaded, 
the gel was run at 30 mA per gel for approximately 25 min, or until the dye front had run 
off the gel.  
 
Once complete, the tank was drained and the gel was dried and visualized by 
autoradiography (Section 2.9.4).  
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2.9.3   In vitro transcription (IVT) assays 
 
Large sequencing gel plates were cleaned with 70% ethanol, before the “ears” plate was 
prepared further by rubbing in 500 µl Gel Slick Solution (Lonza) to ease gel separation later. 
The plates were assembled with spacers between the back and ear plates, before being 
sealed tightly with tape.  
 
The gel mix was then made and added using a syringe, ensuring no air bubbles formed 
(Table 2.15). A comb was then added and the gel was left to set.  
 
Table 2.15: List of constituents in IVT gels, dyes, markers and buffers 
 
IVT gel  60 ml of 6% sequencing gel (19:1 acrylamide, 1 x TBE, 
7 M urea), 600 µl 10% APS, 60 µl TEMED 
10 x TBE buffer (1 litre) 108 g Tris, 55 g boric acid, 40 ml EDTA (0.5 M, pH 8) 
Perfect RNA Marker  (0.1-1 Kb) 0.75 µg RNA template mix, 80 mM HEPES pH 7.5, 12 
mM MgCl2, 10 mM NaCl, 10 mM DTT, 2 mM ATP, 2 
mM GTP, 2 mM CTP, 0.1 mM UTP, 50 U T7 RNAP 
(Novagen), 20 units RiboLock RNase inhibitor 
(Fermentas),  5 µCi [α-32P]- UTP (800 Ci mmol-1) 
(Perkin Elmer) 
Stop/Loading dye  95% formamide, 20 mM EDTA, pH 8, 0.05% 
bromophenol blue, 0.05% xylene cyanol 
 
 
The prepared IVT gel was clamped into position into a Flowgen gel running tank, and 1 x 
TBE buffer added at the top and bottom of the gel (Table 2.15).  Urea and acrylamide were 
removed from the gel wells using a syringe, prior to pre-running the gel at 55 W for 
approximately 1 h using a Pharmica power supply.  During this time the samples were 
prepared to run on the gel.  Once ready, the samples were loaded into the wells, ensuring a 
lane on either side of the samples contained just stop/loading dye and the gel was run at 
50 W for approximately 2 h, or until the first tracking dye had run off the gel.  Once 
complete, buffer was drained from the tank, and the gel was dried and visualized by 
autoradiography (Section 2.9.4).  
 
Reactions for IVT analysis (10.5 µl) contained 1 pmole E. coli RNA polymerase, 0.1 pmole 
linear DNA, 40 mM Tris-HCl, pH 8, 10 mM MgCl2, 1 mM DTT, 75 mM KCl, 0.1 mM EDTA, 5% 
glycerol, 250 µg/ml bovine serum albumin (BSA) and relevant concentrations of the chosen 
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transcriptional regulators.  In cases of ligand addition, the nucleotides (Section 2.7) were 
added to give a final concentration of 1 mM at the same point as the protein regulators.   
 
These reactions were incubated at 37⁰C for 15 min before transcription was initiated by the 
addition of 2 µl of NTP mix to the tubes.  The NTP mix contained 50 µM UTP, 1 mM of each 
ATP, CTP and GTP and 1 µCi [α-32P]- UTP (Perkin Elmer).  Transcription was terminated after 
a 15 min 37⁰C incubation by the addition of 12.5 µl stop/loading dye, before the samples 
and marker were analysed on an IVT gel (Table 2.15).  
 
A 0.1-1 Kb marker was made using Perfect RNA Marker Template Mix (Novagen).  The 
reaction mixture was made and was incubated for 1 h at 37⁰C, before the reaction was 
terminated by a 1:20 addition of Stop/Loading dye (Table 2.15). The marker was then 
stored at -20⁰C before being used at ~2 ng for gel calibration.  
 
2.9.4   Autoradiography 
 
Following electrophoresis, EMSA and IVT gels were transferred onto Whatman 3MM filter 
paper and the gels were dried in a Scie-Plas vacuum drier at 80⁰C.  Once dry, the gels were 
exposed to Kodak medical X-ray film at -70⁰C for a required period of time.  Once complete, 
the films were developed in Kodak Industrex developer and then Kodak Industrex fixer 
before being washed in water and air-dried.  
 
2.9.5   DNA:protein kinetics  
 
The BLItz (fortéBIO) system was utilised to measure the kinetics of DNA: protein 
interactions.  This system utilized streptavidin (SA) biosensors (fortéBIO), enabling 
immobilization of biotinylated DNA.  
 
Double-stranded DNA was produced for the region of interest (PfliD) and a control region, 
using primer pairs NSW84 and 28 and NSW85 and 86 respectively, with both forward 
primers containing a 5’ Biotin tag (Table 2.3).  Following amplification of these regions 
(Section 2.3.3) the DNA was purified by gel extraction from an agarose gel (Section 2.3.7) 
and concentrated in a spin-vac to give concentrated samples.  For all BLItz assays, both the 
target and control DNA were used at a concentration of 35 µg/ml (Section 2.3.8).  
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The biosensors were first hydrated in buffer for 10 min before being loaded onto the BLItz 
machine. These experiments consisted of 5 distinct steps (Table 2.16).  
 
Table 2.16: BLItz programme details for SA biosensor protocols 
 
All stages in which the biosensor was submerged into a tube required 250 µl of solution to 
be present in the tube, whilst drop stages required 5 µl of a solution to be present in a 
concave drop.  The concave surface was thoroughly washed between samples, to ensure 
no contamination.  
 
Both the YdiV and FlhDC proteins were purified in their His-tagged fusion forms (produced 
from plasmids pGS2354 and pGS2441 in E. coli BL21 λ(DE3) cells) (Section 2.6.3) and 
dialysed into sodium phosphate buffer (20 mM sodium phosphate, 500 mM NaCl, pH 7.5), 
the same buffer used throughout the experiments for baseline and dissociation stages 
(steps 1,3 and 5).  DNA was immobilized in step 2, with proteins added in the association 
step 4.  For each interaction, the experiments were repeated several times, with a fixed 
DNA concentration and a range of protein concentrations (between 5000 nM and 10 nM) 
(Section 2.6.8).   
 
Following completion of an experiment, the biosensor was removed from the BLItz 
machine, and discarded.  Analysis of the experiment was carried out using the BLItz Pro 
software (fortéBIO), fitting a curve to the detected biosensor thickness changes.  Using this 
fitted line, the reaction constants could be determined as well as the level of error and 
average values across several experiments.    
 
 
 
 
 
 
Step number Step type Duration (s) Biosensor position 
1 Initial baseline 60 Tube 
2 Loading 300 Drop 
3 Baseline 60 Tube 
4 Association 300 Drop 
5 Dissociation 600 Tube  
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2. 10   Analysis software 
 
2.10.1   Image J  
 
Image J software (http://imagej.nih.gov/ij/) was used to quantify the intensity of proteins 
or DNA from qualitative assays such as SDS-PAGE gels (Section 2.6.9) and Western blot 
analysis (Section 2.6.10).  This software was used following manufacturer’s instructions.  
 
2.10.2   DNA and protein alignments 
 
Promoter alignment was carried out for the ydiV promoter region in a range of E. coli and S. 
enterica strains.  The DNA sequences were retrieved from xBASE 
(http://www.xbase.ac.uk/) and aligned computationally using the Mega6 software 
(http://www.megasoftware.net) and the ClustalW parameters.  The promoter motifs were 
detected using Softberry promoter prediction software (www.softberry.com) which were 
subsequently transferred manually to the ydiV alignment.  
 
Protein alignments were carried out to highlight the degeneracy of the YeaI and YdiV 
proteins alongside known active DGC’s and PDE’s respectively. The protein sequences were 
retrieved from UniProt (http://www.uniprot.org/) and aligned computationally using the 
Mega6 software and ClustalW parameters (http://www.megasoftware.net).  
 
2.10.3   Phylogenetic analysis 
 
Phylogenetic analysis of the ydiV promoter regions was carried out by Mega6 software 
(http://www.megasoftware.net) which produced phylogenetic trees of the strains based 
purely on the degree of nucleotide similarity.  
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Chapter 3: Characterisation of the ‘degenerate’ Escherichia coli 
diguanylate cyclase protein YeaI 
 
3.1   Introduction 
 
The diguanylate cyclase (DGC) family of bacterial proteins are involved in cyclic di-GMP 
signalling by synthesising the secondary messenger molecule c-di-GMP (Simm et al., 2004). 
These DGCs have a conserved active site motif, composed of the residues GG[D/E]EF and 
an sporadic inhibitory (I) site for c-di-GMP feedback.  The conserved GG[D/E]EF motif is 
necessary for the catalytic activity of DGCs to convert GTP molecules into c-di-GMP (Simm 
et al., 2004; Chan et al., 2004).  
 
YeaI is a two domain protein found in E. coli, composed of an N-terminal membrane-bound 
domain and a C-terminal cytosolic GGDEF domain.  The N-terminal of the protein consists 
of multiple predicted transmembrane regions, of unknown function (Sommerfeldt et al., 
2009; Daley et al., 2005).  The C-terminal domain is a member of the GGDEF family, having 
sequence similarities to the family, and a conserved I-site, but lacking the consensus GGDEF 
motif, with an EGEVF sequence found instead (Sommerfeldt et al., 2009; Figure 1.6).  
There have been conflicting views on YeaI and its role as a DGC. Whilst Sommerfeldt et al. 
(2009) hypothesized that the protein was catalytically inactive, Sanchez-Torres et al. (2011) 
found evidence that YeaI was an active DGC despite its altered active site motif.  Whilst 
functional roles of the protein have been determined, deleting the yeaI gene resulted in no 
change in the intracellular c-di-GMP levels.  However this has been interpreted to be 
insignificant, with any changes in c-di-GMP only acting at the YeaI protein locality (Sanchez-
Torres et al., 2011). 
  
The phenotypic roles of YeaI have been characterised, and show that the protein is 
involved in regulating both motility and biofilm lifestyles of bacteria (Sanchez-Torres et al., 
2011).  Analysis of a yeaI deletion strain revealed a 4-fold increase in cell motility and a 30-
fold increase in biofilm formation.  This indicated a phenotypic role of YeaI in repressing 
both biofilm formation and motility to some extent, having functional roles in the cell 
despite possessing an EGEVF rather than GGDEF motif (Sanchez-Torres et al., 2011).  Active 
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DGC proteins synthesize c-di-GMP in the cell, high levels of which characteristically cause 
biofilm formation and repress motility (Simm et al., 2004). The phenotypic analysis of YeaI 
therefore contradicts to some extent the characteristic roles of an active DGC, with YeaI 
repressing rather than inducing biofilm synthesis (Sanchez-Torres et al., 2011).  
Work in this chapter has determined the following:  
- The YeaI GGDEF domain is an inactive DGC protein (Section 3.6) 
- The YeaI GGDEF domain has no clear nucleotide binding capabilities (Section 3. 7) 
- There is support to suggest that the YeaI GGDEF domain has, like active DGCs, 
retained the ability to form dimers (Section 3.8) 
- Overproduction of the protein is especially poor, producing low levels and poor 
purity samples (Section 3.3) 
- Cloning DNA encoding the YeaI GGDEF domain into a pCOLD TF vector has largely 
overcome the overproduction problem, however purification still remains 
problematic and the main priority for future work (Section 3. 9) 
 
3.2   Production of YeaI GGDEF domain overproduction plasmids 
 
As previously stated the YeaI protein consists of an N-terminal membrane bound domain 
and a cytosolic GGDEF domain (Figure 3.1) (Daley et al., 2005).  The N-terminal region of 
the protein consists of several transmembrane helices, with linker regions separating these 
helices.  Nine possible transmembrane regions have been identified computationally by 
UniProtKB (www.uniprot.org) using various prediction tools, with each transmembrane 
helix of ~20 amino acid residues in length (Figure 3.1).  The precise location of the cytosolic 
GGDEF domain was determined by the domain annotations found again at UniProtKB, 
identifying residues 356-491 of YeaI to be homologous to other proteins belonging to the 
DGC family.  The secondary structure of this DGC domain in YeaI is unknown, however X-
ray crystallography of other proteins in the DGC family have shown a common structure 
between DGC proteins, consisting of a 5 β-strand core surrounded by 5 or 6 α-helices (De et 
al., 2009; Navarro et al., 2009). 
 
Membrane bound proteins are notoriously difficult to study and purification of such 
proteins is very complex.  It was therefore decided to study only the C-terminal GGDEF 
domain of YeaI (referred to from here on in as YeaIGGDEF), anticipating that this would 
simplify purification and still provide useful information on the function of the protein.  The  
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Figure 3.1: Structure and degeneracy of the YeaI protein  
A) Schematic of YeaI protein, indicating two clear domains; an N-terminal 
transmembrane (TM) region and a C-terminal cytoplasmic domain.  
Computational prediction tools have identified nine possible TM helices 
(UniProtKB), the identity of which is indicated by the amino acid residue 
numbers at either end of the helices. The cytoplasmic C-terminal domain of the 
protein shows amino acid residue homology to the DGC family of proteins. 
B) Alignment of GGDEF domains of YeaI (from E. coli) alongside the active DGC 
protein PleD (from C. crescentus) and the degenerate GGDEF domain protein 
PopA (from C. crescentus) (Section 1.8.1).  The sequences were retrieved from 
Uniprot and the alignment carried out by Mega6 software (Section 2.10.2).  
The final residues of the N-terminal domains of the proteins are shown in grey, 
to highlight the start of the GGDEF domains of each protein. The GGDEF active 
site region is boxed in red, highlighting the degenerate nature of YeaI. The I-site 
of the proteins is boxed in blue, showing the lack of an I-site for PleD, but the 
presence of an I-site in both the PopA and YeaI proteins.  
A 
B 
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DNA corresponding to YeaI residues 356-491 was therefore used for production of YeaIGGDEF 
overproduction plasmids.  
 
A pET32a:yeaIGGDEF plasmid (pGS2263) had previously been made, producing an N-terminal 
His6-YeaIGGDEF fusion protein.  To investigate whether the position of the His6 tag affected 
the solubility of the protein, the yeaIGGDEF gene was also cloned into a pET21a vector, to 
give a C-terminal tagged fusion protein rather than an N-terminal tag (Figure 3.2).  The    
yeaIGGDEF gene was amplified from genomic E. coli MG1655 DNA by PCR using primers 
NSW11 and NSW12, giving NdeI and XhoI restriction sites at either end of the PCR product 
(Table 3.1) (Section 2.3.3).  
 
Table 3.1: Primers used in amplification of the yeaIGGDEF gene for insertion into the 
plasmid pET21a 
 
The grey shaded sequence indicates an NdeI restriction site and the boxed sequence shows 
an XhoI restriction site.  No stop codon was encoded by the reverse primer, in order to 
allow transcription to continue into the vector and transcribe the C-terminal His6 tag, 
encoding a fusion protein.  
 
The purified PCR product and pET21a vector (Novagen) were digested with NdeI and XhoI 
enzymes, prior to ligation (Sections 2.3.4; 2.3.6; 2.3.9 and 2.3.10).  The ligated DNA was 
then used to transform electrically competent E. coli DH5α cells and transformants were 
selected for on ampicillin supplemented agar (Sections 2.2.4 and 2.2.7).  Following colony 
PCR screening, DNA sequencing confirmed the identity of the insert, using T7 promoter and 
T7 terminator primers (Table 3.2) (Section 2.3.11).  
 
Table 3.2: Sequencing primers used for the plasmid pET21a 
 
Primer Sequence Function 
NSW11 TTTTCATATGAAGGACTTCTGTGTCATG
CTG 
Forward primer for yeaIGGDEF into 
pET21a   vector 
NSW12 TTTTCTCGAGAATATGATGAAGAATCAC
TTTGTT 
Reverse primer for  yeaIGGDEF into 
pET21a  vector 
Primer Sequence Function  
T7 promoter 
primer 
TAATACGACTCACTATAGGG Forward primer for pET21a 
sequencing 
T7 terminator 
primer 
GCTAGTTATTGCTCAGCGG Reverse primer for pET21a 
sequencing 
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Figure 3.2: Schematic plasmid maps for the insertion of yeaIGGDEF into pET32a and 
pET21a 
Maps for the pGS2263 and pGS2341 plasmids, derived from pET32a and pET21a 
vectors respectively.  The positions of the various tags, antibiotic resistance cassette 
and yeaIGGDEF insertion site are indicated, as well as the fusion proteins produced in 
each case.   
In both cases, the origin of replication is indicated, labelled as ori.  The differing sizes of 
the fusion proteins are accounted for by the various tags used, with His6 tag (0.8 KDa), 
S tag (1.7 KDa) and TrxA (11.8 KDa) fused to the yeaIGGDEF (15.3 KDa).  Alongside the 
defined tags, linker regions exist between the tags and insert and thereby contribute 
to the fusion protein molecular weight.  
The pGS2263 construct encodes an N-terminal TrxA, His6 and S tag, each of which is 
linked together by up to 11 amino acid residues.  This entire N-terminal region 
contributes 16.8 KDa, giving a total molecular weight of 32.2 KDa.  
The pGS2341 construct gives a C-terminal His6 fusion protein, with 2 amino acid 
residues linking yeaIGGDEF and the His6 tag, giving a total molecular weight of 16.4 KDa.  
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Plasmids containing no mutations in the yeaIGGDEF sequence were named pGS2341 
(pET21a::yeaIGGDEF).  
 
3.3   Optimisation of YeaIGGDEF overproduction 
 
Both plasmids pGS2341 (pET21a::yeaIGGDEF) and pGS2263 (pET32a:yeaIGGDEF) were used to 
transform electrically competent E. coli BL21 λ(DE3) cells (Section 2.2.7) for overproduction 
trials, altering variables such as IPTG concentration and induction time.  Trials were carried 
out using 100 ml cultures, growing the cells at 37⁰C before inducing the cells at lower 
temperatures, where the cells remained for subsequent growth.  An aliquot (1 ml) of an 
overnight culture was added to 100 ml of LB containing ampicillin, and the cells were grown 
at 37⁰C with shaking at 250 rpm until an OD600 of ~0.6 was achieved (Section 2.6.1).  IPTG 
was added, to a final concentration of either 100 µg/ml or 20 µg/ml and the cultures 
incubated at 25⁰C or 4⁰C (to reduce production of inclusion bodies) with shaking.  Cell 
samples were taken before induction (0 h), and at regular hourly intervals.  The samples 
were prepared and analysed by SDS-PAGE (Section 2.6.9).  
 
 A clear overproduced polypeptide was present in the post-induction fractions, which was 
believed to correspond to YeaIGGDEF, at ~13 KDa in the pET21a construct (migrating slightly 
faster than its expected molecular weight of 16 KDa) and at ~30 KDa in the pET32a 
construct (of expected molecular weight 32 KDa) (Figure 3.3 and 3.4).  This significant size 
variation of YeaIGGDEF in the two constructs can be explained by the contrasting nature of 
the tags, with a <1 KDa His6 tag fusion to YeaIGGDEF in the pET21a construct, but >16 KDa 
fused to the protein in the pET32a construct (Figure 3.2).  
 
Analysing the pET21a construct first, the YeaIGGDEF-His6 protein was overproduced to a 
similar extent when using either IPTG concentration (Figure 3.3A and B).  Induction 
duration appeared to have a more significant effect on overproduction, with 4 h or more 
producing the highest yield of YeaIGGDEF-His6 (Figure 3.3).  The pET32a construct, in which 
the tag was N-terminal, again yielded high levels of overproduced His6-YeaIGGDEF, especially 
at conditions of 25⁰C, either with 100 or 20 µg/ml IPTG for 3 or more h induction (Figure 
3.4A).  Whilst induction temperatures of 4⁰C produced lower levels of overproduced 
protein, reasonable yields were seen using 100 µg/ml IPTG for 5 or 6 h (Figure 3.4B).  
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Figure 3.3: Optimisation of overproduction conditions for the YeaIGGDEF-His6 fusion 
protein in the E. coli BL21 (λDE3)/pGS2341 strain  
Coomassie-stained SDS-PAGE gel of samples taken pre- and post-induction of 
yeaIGGDEF expression in the pET21a vector.  
M: Precision plus protein standards (molecular weights indicated in KDa), 0-24 
indicate induction times in h, with YeaIGGDEF production being induced using either a 
final concentration of 100 µg/ml (A) or 20 µg/ml (B) IPTG, as specified.  
The position of YeaIGGDEF-His6 is indicated (expected size 16 KDa).  
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Figure 3.4: Optimisation of overproduction conditions for the His6-YeaIGGDEF fusion 
protein in the E. coli BL21 (λDE3)/ pGS2263 strain 
Coomassie-stained SDS-PAGE gel of samples taken pre- and post-induction of yeaIGGDEF 
expression in the pET32a vector.  
M: Precision plus protein standards (molecular weights indicated in KDa), 0-24 
indicate induction times in h, with YeaIGGDEF production being induced using either a 
final concentration of 100 µg/ml or 20 µg/ml IPTG, as specified. Induction 
temperatures were either 25⁰C (A) or 4⁰C (B).  
The position of His6- YeaIGGDEF is indicated (expected size 32 KDa), in reality indicating 
the larger fusion protein TrxA-His6-S tag-YeaIGGDEF. 
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For ease of differentiation between both fusion proteins, theTrxA-His6-S tag-YeaIGGDEF 
fusion protein produced by overproduction from plasmid pGS2263 is labelled as His6-
YeaIGGDEF throughout this chapter, to clearly differentiate between this protein and the C-
terminally tagged YeaIGGDEF-His6 protein.  
 
3.4   Solubility trials of YeaI  
 
Whilst the overproduction trials gave an indication of the optimal conditions for YeaIGGDEF 
production, conditions that would give the highest level of soluble YeaIGGDEF needed to be 
established.  Solubility trials were therefore carried out for both the pET32a:YeaIGGDEF strain 
(giving the His6-YeaIGGDEF protein) and the pET21a:YeaIGGDEF strain (producing YeaIGGDEF-His6 
protein) at the various overproduction conditions.  Cell pellets of both YeaIGGDEF 
overproduction strains (E. coli BL21 λ(DE3)/pGS2262 and E. coli BL21 λ(DE3)/pGS2341), 
grown under the various conditions, were prepared for solubility trials (Tables 2.1 and 2.2). 
The cell pellets were resuspended in breakage buffer, the cells broken by sonication, prior 
to clarification into distinct soluble and insoluble phases (Section 2.6.2).  The insoluble 
fractions were resuspended in breakage buffer, and both components analysed by SDS-
PAGE (Section 2.6.9).  This showed that the proteins were mostly insoluble, with generally 
>90% of the protein existing in the insoluble fraction (Figures 3.5 and 3.6).  Small but 
potentially useable levels of YeaIGGDEF were however found in the soluble fractions in some 
conditions, for example, when using the pET21a construct with 2 or 3 h induction with 20 
µg/ml IPTG (Figure 3.5B).  Equally although faint, the same induction conditions were 
optimal for the solubility of YeaIGGDEF in the pET32a construct, with cell growth at either 25 
or 4⁰C (Figure 3.6B and 3.6D).  
 
It was concluded that the optimal conditions for maximum protein solubility were obtained 
using the pET32a construct (His6-YeaIGGDEF) with induction at 25⁰C for 3 h by 20 µg/ml IPTG. 
These conditions were then used for all future culturing of the His6-YeaIGGDEF strain.   
 
Given the low solubility levels of YeaIGGDEF even after optimisation, attempts to solubilise 
the insoluble pellet were carried out.  The insoluble cell pellet resulting from the 
overproduction protocol was resuspended in 6 M guanidine hydrochloride and refolding 
was attempted on a 1 ml HiTrap chelating column using the refolding programme on the   
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Figure 3.5: Optimisation of solubility conditions for the YeaIGGDEF-His6 fusion protein 
in the E. coli BL21 (λDE3)/pGS2341 strain 
Coomassie-stained SDS-PAGE gel of insoluble and soluble cell samples, analysing  
YeaIGGDEF solubility in the pET21a vector.  
M: Precision plus protein standards (molecular weights indicated in KDa), 0-6 indicate 
induction times in h, with “i” indicative of insoluble fractions and “s” indicative of 
soluble fractions. YeaIGGDEF solubility was analysed for overproduction using either a 
final concentration of 100 µg/ml (A) or 20 µg/ml (B) IPTG.  
The position of YeaIGGDEF-His6 is indicated (expected size 16 KDa).  
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Figure 3.6: Optimisation of solubility conditions for the His6-YeaIGGDEF fusion 
protein in the E. coli BL21 (λDE3)/ pGS2263 strain  
Coomassie-stained SDS-PAGE gels analysing the composition of soluble and 
insoluble cell fractions, identifying YeaIGGDEF solubility in the pET32a vector.  
Different IPTG concentrations and growth temperature combinations were used 
to induce gene expression, with A) 100 µg/ml IPTG at 25⁰C, B) 20 µg/ml IPTG at 
25⁰C, C) 100 µg/ml IPTG at 4⁰C and D) 20 µg/ml IPTG at 4⁰C.   
For all gels M: Mark 12 protein marker (molecular weights in KDa).  Numbers 0-6 
indicate induction times in h, with “i” indicative of insoluble fractions and “s” 
indicative of soluble fractions.  The position of His6-YeaIGGDEF is indicated 
(expected size 32 KDa).   
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AKTA prime (Section 2.6.5). However this was unsuccessful, producing no improved protein 
levels, and was therefore not further investigated.  
 
3.5   Purification of His6-YeaIGGDEF  
 
Despite solubility levels of YeaIGGDEF being poor, purification of the protein was undertaken, 
using the N-terminal His-tagged construct (pET32a: YeaIGGDEF).  Frozen cell pellets of the 
YeaIGGDEF overproduction strain (1-5 litres of BL21 λ(DE3)/pGS2263) were thawed and 
resuspended in 25 mM HEPES breakage buffer, before the cells were broken by sonication 
and clarified by centrifugation (Section 2.6.2).  The soluble fraction was retained and 
filtered before application onto a 1 ml HiTrap column for affinity chromatography (Section 
2.6.3).  The His-chelating programme was run on an ATKA prime, following manufacturer’s 
instructions, and gave a multi-peak trace, indicating various stages of protein elution 
(Figure 3.7A).  The initial peak is characteristic of non-specific protein elution, whilst the 
later peak usually indicates elution of the stronger binding His-tagged protein.  Elution 
fractions spanning this later peak were analysed by SDS-PAGE and showed relatively pure 
protein at approximately 32 KDa, the expected molecular weight for the His6-YeaIGGDEF 
protein (Figure 3.7B).  The fractions containing the most pure His6-YeaIGGDEFwere then 
combined and concentrated using a 10 KDa cut-off Vivaspin column, using HEPES or sodium 
phosphate dialysis buffer to buffer exchange the protein (Section 2.6.7).  The protein 
concentration was assessed by Bio-Rad assays and if necessary, further concentrating the 
protein until a sufficiently high concentration was achieved (Section 2.6.8).  
 
Anion exchange was investigated as a second purification step, hoping to remove some 
contaminating proteins (Section 2.6.4).  However, whilst some contaminating polypeptides 
were lost, the yield of YeaIGGDEF was compromised (data not shown); hence this step was 
omitted in subsequent purification procedures.  
 
3.6   Analysis of YeaIGGDEF enzymatic activity  
 
To assess whether YeaIGGDEF was an active or inactive DGC protein, enzymatic assays were 
carried out with GTP (the substrate for DGCs) as well as various other nucleotides.  The 
assays consisted of 1 µM purified protein (Section 3.5) and 10 mM Mg2+ or Mn2+ incubated 
with various nucleotides (100 µM) at 37⁰C for 1 h.  Following incubation, reactions were 
heat inactivated at 95⁰C for 5 min, and then analysed by HPLC analysis, with absorption at                                         
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Figure 3.7: HiTrap chelating chromatography to purify His6-YeaIGGDEF 
A) Elution profile of His6-YeaIGGDEF from HiTrap chelating chromatography. 
 Cell-free extract containing His6-YeaIGGDEF was applied to a 1 ml HiTrap 
chelating column and fractionated by an imidazole gradient (linear gradient 
from 0-0.5 M).  The blue trace shows the detected A280 levels, indicative of 
protein levels, with the red trace showing the imidazole gradient.  The 
expected His6-YeaIGGDEF location is indicated.   
B) Coomassie-stained SDS-PAGE gel of His6-YeaIGGDEF purification.  
M= Mark 12 protein marker (molecular weights indicated in KDa), lanes 1-8 are 
elution fractions from the HiTrap column spanning the His6-YeaIGGDEF peak seen 
in the elution profile (A).  
 
The position of His6-YeaIGGDEF is indicated (of expected molecular weight 32 
KDa).  
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254 nm (Section 2.7.1).   
 
Control reactions were carried out, using catalytically active DGC and PDE proteins. Purified 
protein samples of PleD (a known DGC) and YfgF (a known PDE) were kindly donated by Dr. 
Melissa Lacey (University of Sheffield) and incubated with known substrates (GTP and c-di-
GMP respectively), before separating these samples by HPLC (Figure 3.8).  For both 
proteins, a distinct profile shift was detected when the nucleotides alone and when the 
nucleotide and relevant protein were mixed, showing that the assay was able to detect the 
enzymatic activity of the proteins by the ability to differentiate between nucleotides.  
 
The assay was then used to study YeaIGGDEF enzymatic activity.  This showed identical 
profiles when the black (nucleotide only) and pink (nucleotide and protein) traces were 
overlayed (Figure 3.9).   Identical traces were seen when using Mg2+ or Mn2+ (data not 
shown for Mn2+ series).  This confirms that YeaIGGDEF does not act under any of the tested 
nucleotides.  Of particular importance is of course GTP, the substrate regularly converted 
by DGCs into c-di-GMP.  This too, had an identical elution trace when GTP individually was 
loaded, as when the GTP and YeaI mix was analysed, showing that GTP remained in the 
sample.  The elution times for GTP, c-di-GMP and pGpG were 12.0, 13.3 and 11.6 min 
respectively, with control reaction carried out at a later date, with minor elution 
differences here being accounted for by buffer pH fluctuations.  
 
This experiment therefore confirmed that the TrxA-His6-S tag-YeaIGGDEF fusion protein lacks 
DGC activity, with no reactivity with GTP, or the other tested nucleotides.  This supports the 
‘degenerate’ nature of YeaIGGDEF reported by Sommerfeldt et al. (2009) and contradicts the 
conclusion of Sanchez-Torres et al. (2011).  
 
3.7   Nucleotide binding by YeaIGGDEF 
 
After confirming that YeaIGGDEF was an inactive DGC, we considered the possibility that 
YeaIGGDEF might bind a nucleotide, such as GTP or c-di-GMP.  It is known that the GGDEF 
catalytic motif is altered to EGEVF in YeaI, however that did not necessarily imply that the 
binding cleft was lost entirely (Sommerfeldt et al., 2009).  In addition, GGDEF domains are 
known to have I-sites, which act by binding c-di-GMP to produce a negative feedback loop, 
slowing the catalytic activity of the DGCs.  These I-sites are characterised by an RXXD motif, 
which is maintained in YeaI (Sommerfeldt et al., 2009).  To investigate the nucleotide  
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Figure 3.8: DGC/PDE assay controls, using active DGC and PDE enzymes 
HPLC elution traces, plotting retention time (min) against intensity (mAU).  
On the left hand side is the overlayed trace for YfgF, an active PDE.  This protein is 
therefore expected to convert c-di-GMP into pGpG, which was tested by analysing a    
c-di-GMP only sample with a c-di-GMP and YfgF sample.  The black trace (c-di-GMP 
only) gives a peak corresponding to c-di-GMP, whilst the pink trace (YfgF and c-di-
GMP) indicates the presence of a major new peak, confirming the activity of the 
protein.  
On the right hand side, is the overlayed trace for PleD, an active DGC.  DGCs are known 
to convert GTP into c-di-GMP, so this activity was tested by analysing GTP both in the 
presence and absence of PleD and comparing the elution traces.  Here the black (GTP 
only) trace is completely separate from the pink (PleD and GTP) trace, confirming 
turnover of GTP by the protein.  
 
                              pGpG      c-di-GMP                                                                        GTP       c-di-GMP 
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binding ability of YeaIGGDEF, partial proteolysis assays were carried out.  
 
Partial proteolysis was used to identify nucleotide binding by analysing trypsin cleavage 
profiles of the protein in the presence of various nucleotides.  The highly specific enzyme 
trypsin cleaves at the C-terminal of Lys and Arg residues in a protein, but only cleaving at 
the accessible surface residues rather than buried ones.  For each cleavage the enzyme 
makes, an additional polypeptide fragment is produced, appearing as a new species on an 
SDS-PAGE gel.  Theoretically ligand binding can conceal or reveal (by inducing a 
conformational change) cleavage sites, either reducing or decreasing the number of 
fragments seen on a gel.  Of course, nucleotide binding may occur without affecting the 
environment of Lys or Arg residues, which would be undetectable and is therefore one of 
the major limitations of the assay.  
 
Optimisation of trypsin cleavage was achieved using 10 µg purified YeaIGGDEF (Section 3.5), 
adding trypsin enzyme at different stock concentrations (1 mg/ml or 0.2 mg/ml), different 
times (1, 5 or 10 min) and incubating at different temperatures (RT or 37⁰C) (Section 2.7.2). 
The samples were then analysed by SDS-PAGE (Section 2.6.9) which identified the optimal 
trypsin cleavage conditions to be 100 µg/ml trypsin (using a 1 mg/ml trypsin stock) 
incubated for 5 min with YeaIGGDEF at room temperature (Figure 3.10).  Under these 
conditions the YeaIGGDEF was clearly cleaved into smaller fragments with some intact protein 
remaining, and the contaminating polypeptide(s) remaining mainly intact. 
 
Following optimisation, partial proteolysis was carried out, incubating purified YeaIGGDEF, 
trypsin and excess nucleotide (Section 2.7) (2 mM final concentration) under the optimised 
cleavage conditions, before stopping the reactions and electrophoresing the samples on an 
SDS-PAGE gel (Sections 2.7.2 and 2.6.9).   The ligand free samples acted as control 
reactions, to compare the nucleotide addition reactions with, and indicated production of 
two cleavage polypeptides upon trypsin addition (Figure 3.11- indicated by arrows).  
Nucleotide addition produced only minor profile differences, specifically upon ppGpp, GDP 
and ATP addition.  The presence of these three nucleotides caused the major cleavage 
product of ~ 15 KDa (as seen in the no ligand sample) to become much more prominent.  
However, whilst these differences might be indicative of ligand binding, any slight gel 
loading inaccuracies could cause the same intensity variations seen.  The major 15 KDa 
cleavage product could possibly correspond to the TrxA protein of the TrxA-His6-S tag-  
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Figure 3.10: Trypsin cleavage optimisation assay for the cleavage of YeaIGGDEF 
Coomassie- stained SDS-PAGE gel showing trypsin cleavage optimisation for YeaI.  
M: Precision plus protein standards, with molecular weights shown in KDa. C: 
Concentrated YeaI at 1 mg/ml (15 µg loaded) with no trypsin addition.  
The remaining samples contain 10 µg YeaI with trypsin addition under the conditions 
indicated.  Trypsin concentrations (1 mg/ml or 0.2 mg/ml stocks giving 100 µg/ml and 
20 µg/ml trypsin per sample respectively), incubation temperatures (room 
temperature or 37⁰C) and times (1, 5 and 10 min) were varied, using all possible 
combinations.  
 
Position of the intact YeaI (expected molecular weight 32 KDa) is indicated, along with 
the major contaminating protein, and the cleavage products produced by trypsin 
digestion.   
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Figure 3.11: Partial proteolysis of YeaIGGDEF in the presence of nucleotides  
Coomassie-stained SDS-PAGE gel showing partial proteolysis assays of YeaI and 
various nucleotides.  
M: Precision plus protein standards marker (with molecular weights shown in KDa). 
For each lane, P indicates a protein only lane, with YeaI protein (10 µg) and no trypsin 
addition.  Lanes labelled P+T indicates the same amount of YeaI with the addition of 
trypsin, using the 1 mg/ml stock as determined by optimisation trials.  Ligands were 
added to the reaction mix as indicated at 2 mM final concentration, and incubated 
with the protein and trypsin mix.  
The position of the intact YeaIGGDEF (of expected molecular weight 32 KDa) is indicated, 
along with the major contaminating protein and the visible cleavage products 
(identified by the unlabelled arrows).  
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YeaIGGDEF fusion.  TrxA has an expected molecular weight of 12 KDa, with the linker region 
between TrxA and YeaIGGDEF providing a likely relatively unfolded region, which dependent 
on the nature of the residues, may well provide sites for trypsin cleavage.  
 
To account for gel loading variations, quantification of the protein levels visible on the SDS-
PAGE gels (Figure 3.11) were carried out using Image-J software, enabling comparisons 
between samples (Section 2.10.1).  The levels of protein following trypsin cleavage were 
analysed; specifically the levels of intact protein and the predominant cleavage product (~ 
15 KDa), to analyse the effect of nucleotide addition on the extent of protein cleavage 
(Figure 3.12).  There are clear fluctuations in the levels of intact protein (blue) for the 
various samples, averaging at 4500 ±500 arbitrary units.  This variation is likely to be 
predominately caused by gel loading inaccuracies.  However, the more drastic variation is 
in the levels of the major cleavage product (red).  For most samples this averages at ~ 841 
arbitrary units, approximately 1/5th of the level of intact protein.  However, the ppGpp, 
GDP and ATP supplemented samples have much higher levels of this cleavage product, with 
ppGpp addition producing the 15 KDa protein fragment at a level of 2500 arbitrary units, 
altering the previous ratio between intact protein and cleavage product from 1:5 to a 1:2 
ratio.  The addition of GDP and ATP to protein samples also increased the level of this 
cleavage product, quantified at levels of ~ 2000 and ~1500 arbitrary units respectively 
(giving a 1:2 or 1:3 ratio of intact protein: cleavage product).  Of importance, for all three 
nucleotides (ppGpp, GDP and ATP), the levels of intact protein were approximately the 
average level (quantified to 4500 arbitrary units), and therefore the increase in cleavage 
fragment levels cannot be accounted for by SDS-PAGE gel overloading.   
 
The presence of these three nucleotides appears to have altered the profile of YeaIGGDEF 
protein cleavage, suggesting a possible interaction with YeaIGGDEF.  One explanation is that 
nucleotide binding to the protein has induced a conformational change to the protein 
which has increased the exposure of a trypsin cleavage site, thereby causing a higher level 
of cleavage at this site.  However, whilst this is a feasible hypothesis, the low purity protein 
sample casts doubts to this explanation, with a contaminated and smeary image seen in 
the SDS-PAGE gels (Figure 3.11).  Not only does the smeary image make quantification 
difficult, and more error-prone, but the presence of the contaminating protein also raises 
the possibility that this protein is being digested by trypsin too, and therefore contributing 
to the cleavage pattern.  Whilst there is some indication of nucleotide binding to YeaIGGDEF, 
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Figure 3.12: Quantification of YeaIGGDEF partial proteolysis products upon nucleotide 
addition 
Image-J quantification of protein levels following trypsin partial proteolysis for 
YeaIGGDEF protein samples containing various nucleotides.  
The levels of intact YeaIGGDEF protein (blue) and levels of the major cleavage product at 
~ 15 KDa (red) following trypsin cleavage of YeaIGGDEF were quantified from the SDS-
PAGE gels in Figure 3.11.  The protein levels were analysed in the presence of various 
nucleotides (as specified).  
Values on the y-axis show arbitrary units referring to the intensities of the protein 
species.  
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a more concentrated and purer protein sample is essential to enable further assays to be 
carried out, such as NMR, fluorescence spectroscopy and to repeat the partial proteolysis 
assays.  Combining the results from various interaction-probing techniques and simply 
using a cleaner protein sample, would clarify these possible protein and nucleotide 
interactions, giving a more conclusive result.   
 
Of note, the identity of the major contaminating species at approximately 25 KDa was 
investigated, as it could be an interaction partner of YeaIGGDEF.  The contaminating protein 
was isolated from an SDS-PAGE gel in which the YeaIGGDEF protein preparation was 
electrophoresed (Section 2.6.9).  This contaminating protein was then analysed by N-
terminal sequencing (Dr. Arthur Moir- University of Sheffield) (Section 2.6.14).  N-terminal 
sequencing identified this protein to have the amino acid residue sequence SRVCQVT, 
belonging to the N-terminus of the protein.  This protein sequence was submitted to the 
FASTA database (http://www.ebi.ac.uk/Tools/sss/fasta/) and identified the sequence to 
certainly belong to the 50S ribosomal protein RpmB (synonym L28).  RpmB is a component 
of the 50S ribosome subunit and is required for ribosomal assembly (Maguire & Wild, 
1997).  However, RpmB has an expected molecular weight of only 9 KDa, compared to the 
~ 25 KDa seen by protein electrophoresis, indicating the possibility of a protein complex 
involving RpmB to account for this higher molecular weight species.  Several 50S ribosomal 
subunits have been identified to artificially crosslink with other 50S ribosomal subunits, 
including RpmB (L28) with Rpl1 (L9) (Walleczek et al., 1989; Redl et al., 1989).  Together this 
RpmB-Rpl1 complex gives a molecular weight of 25 KDa, however this complex has only 
been identified in artificial crosslinking conditions rather than in vivo (Walleczek et al., 
1989; Redl et al., 1989).  Therefore, the visible contaminating species can reasonably 
confidently be identified as the ribosomal subunit RpmB in complex with an additionally 
protein, possibly L9, but equally possibly another cellular protein.  Further investigations 
are thereby crucial here in order to determine the exact identity of the co-purifying 25 KDa 
species.  
 
 Despite identification, there is no obvious reason why RpmB would be co-purifying with 
YeaIGGDEF, with no reported involvement of YeaIGGDEF in ribosomal assembly or function.  To 
investigate further, pull-down assays could be carried out, using either purified proteins or 
overproduced soluble extracts, immobilizing YeaIGGDEF to a HiTrap column via its His6 tag, 
and adding untagged RpmB to the column.  Following wash and elution steps, analysis of 
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the protein fractions collected throughout the experiment would identify whether or not 
an interaction was occurring between RpmB and YeaIGGDEF or whether the appearance of 
RpmB in the gels was purely an artefact from the protein preparation.   
 
3.8   Oligomeric analysis of YeaIGGDEF 
 
The oligomeric state of YeaIGGDEF was investigated with glutaraldehyde crosslinking assays 
and gel filtration analysis.  DGC proteins are characteristically active as dimers, with an 
active site formed in the cleft between two GGDEF units (Chan et al., 2004).  We therefore 
wished to determine whether YeaIGGDEF maintained this characteristic, or whether this was 
lost upon motif degeneration.  Of note, TrxA is a monomer, meaning that any 
oligomerisation detected for the TrxA-His6-S-tag-YeaIGGDEF protein would be dependent on 
YeaIGGDEF interactions only.    
 
Cross-linking assays were carried out, adding glutaraldehyde to protein samples, which 
acted as a low-specificity crosslinker for any two amino groups.  Samples were made 
consisting of purified YeaIGGDEF (Section 3.5) and varying quantities of glutaraldehyde (0-
1%), which were incubated at room temperature before quenching the reactions with 1M 
Tris pH 6.8 (Section 2.6.12).  Samples were then analysed by SDS-PAGE gel (Section 2.6.9).   
 
The Coomassie-stained SDS-PAGE gel clearly showed the monomeric protein (of expected 
molecular weight 32 KDa) in the low glutaraldehyde samples, the proportion of which 
decreases as the % of glutaraldehyde increases (Figure 3.13).  At 0.01 and 0.02% 
glutaraldehyde, two additional species are present; one between 50 and 100 KDa, and also 
an extremely large species at >250 KDa (Figure 3.13).  The large >250 KDa species is most 
logically explained as being a product of non-specific glutaraldehyde crosslinking, simply 
forming a very large artificial aggregate.  Using the monomeric size of 32 KDa, a dimer 
should theoretically be 64 KDa and a trimer 96 KDa, meaning that the species between 50-
100 KDa is either a dimer or a trimer with aberrant motility.  Since active DGCs form dimers 
(Chan et al., 2004), it is more likely that this oligomeric form is a YeaIGGDEF dimer rather than 
a trimer.  
 
Gel filtration analysis was carried out by loading a purified sample of YeaIGGDEF protein (20 
mM sodium phosphate, 100 mM NaCl pH 7.5) (Section 3.5) onto an equilibrated Superdex  
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Figure 3.13: Oligomerisation analysis of YeaIGGDEF 
Coomassie-stained SDS-PAGE gel of YeaIGGDEF in the presence of various % 
glutaraldehyde.      
M: Precision plus protein standards (molecular weights shown in KDa).  The remaining 
lanes show YeaI samples, with varying % of glutaraldehyde added, as specified.  
Monomeric YeaIGGDEF of expected size 32 KDa, is indicated.  
Of note, a contaminating species at ~ 25 KDa is faint but present, as previously seen in 
partial proteolysis (Figures 3.8 and 3.9).   
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200 gel filtration column (Section 2.6.13).  Gel filtration acts to separate proteins based 
purely on size, eluting larger proteins early, retaining smaller proteins in the column for 
longer.  The A280 value (indicative of protein levels) was recorded as the sample passed 
through the gel filtration column, quantifying the level of protein eluted at various points.  
The gel filtration trace showed multiple protein peaks (Figure 3.14).  Standard traces, using 
reference proteins of known molecular weight enabled conversion of the retention 
volumes into molecular weights.  The predominant peak eluted at a retention volume of 
14.52 ml is indicative of an 82 KDa species, which is similar to the dimeric or trimeric 
oligomer detected by crosslinking assays (Figure 3.13, 3.14).  Of note, a monomeric peak is 
absent in this trace, with the only other significant peaks at retention volumes of 15.49 ml 
(equivalent to 44 KDa) and 16.45 ml (equivalent to 22 KDa).  The smaller 22 KDa is a 
contaminating species, apparent in the aforementioned crosslinking and partial proteolysis 
assays and identified by N-terminal sequencing as being a complex containing L28 (Section 
3.7).  The 44 KDa species can therefore be accounted for in two ways; as a contaminating 
protein (meaning that all the YeaIGGDEF is present as this 82 KDa species), or as a YeaIGGDEF 
monomer bound to cellular cofactors that have been co-purified.  Either way, there is a 
limit to the certainty of the conclusions, given the poor purification and yield of the protein.  
In this case, it was only possible to produce 0.18 mg of low purity protein to analyse by gel 
filtration, making analysis difficult.  Ideally, cleaner protein sample at a much higher purity 
would be used for both gel filtration and cross-linking assays in order to achieve more 
definitive results. 
 
3.9   Optimising the yield of soluble YeaIGGDEF 
 
One of the recurring problems experienced throughout the work with YeaIGGDEF was the 
high level of protein insolubility, with only a very small proportion of the overproduced 
protein being soluble and available for future use.   
 
Attempts to alleviate this problem, by cloning YeaIGGDEF into different vectors, altering the 
fused tag position, by additional purification steps and by attempting to solubilise the 
insoluble pellet, did not significantly alter the solubility and yield of purified protein.  Whilst 
some assays were possible with the limited protein produced, many demanded more 
protein than it was possible to produce.  This meant that further binding assays such as 
NMR or fluorescence and structure solving techniques such as X-ray crystallography were 
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Figure 3.14: Gel filtration trace for YeaIGGDEF 
Elution profile of His6-YeaIGGDEF from gel filtration chromatography.  
Purified YeaIGGDEF (concentration 0.18 mg/ml in 20 mM sodium phosphate, 100 
mM NaCl, pH 7.5 buffer) was applied to an equilibrated Superdex 200 gel 
filtration column.  
The absorbance of eluant at 280 nm (blue trace) was plotted against retention 
volume, with the numbers at the crest of each peak specifying the retention 
volume of each eluted protein.  The conductivity applied to the column (red line) 
and the point at which the protein was added to the gel filtration column (pink 
dotted line) are shown.  
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 simply impossible.  Therefore, increasing the solubility of the protein was a major hurdle 
and demanded an alternative method for YeaIGGDEF production before further experiments 
could be undertaken.  
 
3.9.1   Ligation of YeaIGGDEF into pCOLD TF vector 
 
In an attempt to increase solubility of the overproduced YeaI protein, the yeaI GGDEF sub-
gene was cloned into a pCOLD TF vector (Takara), to form a fusion protein with an               
N-terminal trigger factor (TF) soluble chaperone, a His6 tag and a cleavage site between 
these N-terminal tags and our protein of interest YeaIGGDEF (Figure 3.15).  The TF protein is a 
chaperone, anticipated to assist protein folding and to reduce insoluble protein production 
(Hoffmann et al., 2010).  Moreover, the vector is a cold-shock expression vector, inducing 
protein expression at lower temperatures.  This is dually beneficial, suppressing the 
expression of other cellular proteins with the decreasing growth temperature and 
theoretically increasing protein solubility too, reducing inclusion body formation (Takara 
Bio manufacturer’s instructions).  
 
The yeaI GGDEF sub-gene was amplified from genomic E. coli MG1655 DNA and ligated into 
pCOLD TF by use of primers NSW11 and NSW20.  These primers were designed to contain 
an NdeI and a BamHI restriction site at either end of the PCR fragment respectively (Table 
3.3).  
 
Table 3.3: Primers used in amplification of the yeaIGGDEF gene for insertion into the 
plasmid pCOLD TF 
 
The grey shaded sequence indicates an NdeI restriction site and the boxed sequence shows 
a BamHI restriction site.  A stop codon was included in the reverse primer (NSW20) to 
terminate transcription at the end of the yeaIGGDEF gene.  
 
PCR reactions were carried out using high fidelity polymerase, E. coli MG1655 genomic DNA 
and primers NSW 11 and NSW20 to amplify yeaIGGDEF (Section 2.3.1; 2.3.3).  The resultant  
Primer Sequence Function 
NSW11 TTTTCATATGAAGGACTTCTGTGTCAT
GCTG 
Forward primer for yeaIGGDEF into 
pCOLD TF vector 
NSW20 TTTTGGATCCTTAAATATGATGAATAA
TCACTTTG 
Reverse primer for  yeaIGGDEF into 
pCOLD TF vector 
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Figure 3.15: Schematic plasmid maps for the insertion of yeaIGGDEF into the pCOLD 
TF vector 
Map for the pGS2399 plasmid, derived from pCOLD TF vector, indicating locations of 
the tags, antibiotic resistance cassette and yeaIGGDEF insertion site, and the fusion 
protein produced.  
The origin of replication is indicated and labelled as ori.  
This N-terminal region consists of a translation enhancing element (TEE), a His6 tag 
and trigger factor (TF) tag adjacent to a thrombin cleavage site which separates the 
N-terminal region to the yeaIGGDEF insertion site.  Alongside the defined tags, linker 
regions exist between the various tags and insert and therefore contribute to the 
fusion protein molecular weight.  
The fusion protein (expected molecular weight 69 KDa) is cleavable at three sites, 
one of which is the chosen thrombin site.  Cleavage at this site should produce two 
fragments: YeaIGGDEF (expected molecular weight 16 KDa) and the TF tag (expected 
molecular weight 53 KDa).  
 
99 
 
PCR product was cleaned by PCR purification (Section 2.3.10) and digested using the NdeI 
and BamHI restriction enzymes (Sections 2.3.6).  The purified pCOLD TF plasmid (Takara) 
was digested with the same restriction enzymes (NdeI and BamHI) (Sections 2.3.4 and 
2.3.6).  The ligated product consisting of the yeaIGGDEF fragment and pCOLD TF vector were 
used to transform electrically competent E. coli DH5α cells with selection on ampicillin 
supplemented agar (Sections 2.3.9 and 2.2.7).  The resultant colonies were selected and 
screened using colony PCR with the sequencing primers NSW21 and NSW22 to assess 
which plasmids contained the correctly sized insert (Table 3.4) (Section 2.3.11).  
Table 3.4: Sequencing primers for pCOLD TF vector  
 
 
Plasmids containing an appropriate insert were checked by DNA sequencing (Source 
Bioscience) using the same sequencing primers (Table 3.4).  
 
Plasmids containing no mutations in the yeaIGGDEF sequence were named pGS2399 (pCOLD 
TF:yeaIGGDEF).  The plasmid was then used to transform electrically competent E. coli BL21 
λ(DE3) cells (Sections 2.2.7).  
 
3.9.2   Overproduction and solubility trials 
 
Trials were carried out to determine the optimal overproduction conditions for the TF-
YeaIGGDEF fusion protein using 500 ml cultures of the E. coli BL21 (λDE3)/pGS2399 strain and 
inducing the cells at 15⁰C (specified in the Takara manufacturer’s instructions) by adding 
either 100 µg/ml or 20 µg/ml final concentrations of IPTG inducer (Section 2.2.4).  In 
practise an aliquot (5 ml) of overnight culture was added to 500 ml of ampicillin 
supplemented LB.  The cells were then grown at 37⁰C with shaking at 250 rpm until an 
OD600 of ~-0.6 was reached (Sections 2.2.2, 2.2.3 and 2.6.1).  Following this IPTG was added, 
at the two different concentrations, and cultures grown at 15⁰C with shaking at 250 rpm 
for induction.  Samples were taken pre-induction (0 h), and then at 2, 4, 6 and 24 h after 
induction and were analysed by SDS-PAGE (Section 2.6.9).  
Primer Sequence Function 
NSW21 GCGAAAGTGACTGAAAAAGAA Forward sequencing primer for pCOLD 
TF vector 
NSW22 ATCGATTATTTATTTCCTGAAAAC Reverse sequencing primer for pCOLD 
TF vector  
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The SDS-PAGE gel showed overproduction of the fusion protein at the expected size of 69 
KDa in all of the induction samples, confirming successful overproduction of the protein 
(Figure 3.16).  Regarding optimal induction conditions, all four induction times produced a 
similar level of protein.  Following this, all eight conditions were analysed to assess the 
optimal conditions for soluble protein production.  
 
3.9.3   Solubility trials to optimise overproduction of TF-YeaIGGDEF 
 
Following the overproduction trials, solubility trials were carried out to determine which 
induction conditions produced the highest proportion of soluble TF-YeaIGGDEF protein.  
 
The cultures used for overproduction trials were also used for solubility trials (E. coli BL21 
λ(DE3)/ pGS2399), simply taking a 20 ml sample at the various induction times (2, 4, 6 and 
24 h) and pelleting the samples (Section 2.6.1).  The cell pellets were resuspended in Tris 
breakage buffer (pH 7.4) before breaking the cells open by sonication and clarification of 
the sample (Section 2.6.2).  The clarified samples were then separated into soluble and 
insoluble fractions, resuspending the insoluble fractions in breakage buffer, prior to 
analysis of both fractions by SDS-PAGE (Sections 2.6.2 and 2.6.9).  
 
The solubility gels demonstrated more fluctuations in protein levels, with the highest 
proportion of soluble TF-YeaIGGDEF appearing to be after 24 h of induction, using a final 
concentration of 20 µg/ml IPTG, which was therefore chosen as the optimal 
overproduction condition (Figure 3.17).  
 
3.9.4   Optimisation of YeaIGGDEF purification 
 
In order to purify YeaIGGDEF, the large chaperone trigger factor (TF) tag was cleaved using 
the thrombin cleavage site in the pCOLD TF vector adjacent to the inserted YeaIGGDEF site 
(Figure 3.15).  
 
Prior to large scale purification of YeaIGGDEF, the conditions for small scale preparation were 
optimised.  Cell pellets of the pCOLD TF:YeaIGGDEF overproduction strain (E. coli BL21 
λ(DE3)/pGS2399) were resuspended in 20 mM Tris breakage buffer (pH 7.4), the cells were 
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Figure 3.16: Optimisation of overproduction conditions for the TF-YeaIGGDEf fusion 
protein in E. coli BL21 (λDE3) cells 
M: Precision plus protein standards (molecular weights shown in KDa). 
P: Pre-induction samples, with all other samples showing overproduction samples. 
The numbers 2, 4, 6 and 24 refer to the time (in h) of induction, with IPTG final 
concentrations added as specified.  
The fusion protein is present at its expected size (69 KDa) as indicated.  
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Figure 3.17: Solubility optimisation for TF-YeaIGGDEF  
Coomassie-stained SDS-PAGE gels, analysing the soluble and insoluble fractions for 
cells induced with a final concentration of IPTG at (A) 100 µg/ml and (B) 20 µg/ml.  
 
In both cases, M: Precision plus protein standards (molecular weights indicated in 
KDa).  P: Pre-induction cellular sample.  All other lanes are soluble and insoluble 
fractions, with the numbers 2, 4, 6 and 24 referring to induction duration in h.  The 
insoluble and soluble fractions are indicated by “i” and “s” respectively.  
 
In both cases, the location of TF-YeaI GGDEF (expected molecular weight of 69 KDa) is 
indicated.  
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broken by sonication, clarified by centrifugation and the soluble fraction retained for use 
(Section 2.6.2).  The soluble fraction was purified by affinity chromatography, adding a 
small volume to pre-washed Ni-NTA beads, incubating at 4⁰C for 1 h to immobilise the 
fusion protein via the His6-tag.  The beads were then thoroughly washed in 20 mM Tris 
buffer, before thrombin (20 units) was added to the beads and incubated overnight at 4⁰C 
(Section 2.6.6).  Following this, the supernatant was removed, which should contain the 
released YeaIGGDEF protein, before washing the beads once more, and eluting the bound 
His6-TF protein by an imidazole Tris buffer.   
 
Samples were taken at various stages throughout the purification, enabling analysis by SDS-
PAGE (Figure 3.18) (Section 2.6.9).  The initial purification appeared not hugely successful, 
with a significant quantity of the fusion protein present in the unbound sample (lane 3) 
indicating the Ni-NTA beads were saturated.  The thrombin cleavage step was successful to 
an extent, cleaving the 69 KDa fusion protein into two components: TF and YeaIGGDEF (lane 
6).  However thrombin cleavage (lane 6) was expected to release YeaIGGDEF, whilst retaining 
the His6-TF on the resin until the imidazole addition step.  However, this was not the case, 
with both the His6-TF and YeaIGGDEF being released after addition of thrombin (lane 6) and 
predominately uncleaved protein being eluted with imidazole addition (lane 9).  
Whilst, separation of TF and YeaIGGDEF was a problem which needed to be addressed, the 
efficiency of thrombin cleavage also required optimisation.  The purification was therefore 
repeated incubating the thrombin at 20⁰C rather than 4⁰C, and analysing samples once 
more by SDS-PAGE gel (Section 2.6.9).  Thrombin cleavage was improved at 20⁰C (Figure 
3.19), increasing the proportion of protein cleaved by the enzyme, compared to that at 4⁰C 
(Figure 3.18).  However, once again, both the YeaIGGDEF and TF proteins were released from 
the resin directly following thrombin addition (Figure 3.19- lane 4) with no significant 
quantities of TF remaining bound to the resin until imidazole addition (lane 7).   
 
Further optimisation was achieved by the addition of calcium (at a final concentration of 
2.5 mM) and removal of imidazole (previously at 20 mM) to the wash buffers.  The assay 
was carried out using the adjusted buffers and upon SDS-PAGE analysis of the assay 
samples, showed an increased efficiency of thrombin cleavage, with ~ 1:1 ratio of un-
cleaved and cleaved protein (Figure 3.20).  In addition, the intact fusion protein 
(TF:YeaIGGDEF) remained bound upon thrombin addition whilst previously being released at 
this point (Figure 3.18 and Figure 3.19).  
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Figure 3.18: Purification of TF-YeaIGGDEF, with thrombin incubation at 4⁰C 
Coomassie-stained SDS-PAGE gel showing the initial attempt to purify YeaIGGDEF.  
M: Precision plus protein standards marker (molecular weights shown in KDa), Lane 1: 
Insoluble fraction, 2: Soluble fraction, 3: Unbound proteins, 4: Wash steps 1+2, 5: Wash 
steps 3 + 4, 6: Thrombin step, 7: Wash 5+6, 8: Wash 7+8, 9: Imidazole addition.  
The fusion protein (expected MW: 69 KDa), TF tag (expected MW: 53 KDa) and 
YeaIGGDEF (expected MW: 16 KDa) components are indicated by their respective arrows.  
Figure 3.19: Purification of TF-YeaIGGDEF, with thrombin incubation at 20⁰C 
Coomassie-stained SDS-PAGE gel, analysing samples in the purification procedure.  
 M: Precision plus protein standards marker (molecular weights shown in KDa), Lane 1: 
Unbound proteins, 2: Wash steps 1+2, 3: Wash steps 3 + 4, 4: Thrombin addition, 5: 
Wash 5+6, 6: Wash 7+8, 7: Imidazole addition.  
The fusion protein (expected MW: 69 KDa), TF tag (expected MW: 53 KDa) and YeaIGGDEF 
(expected MW: 16 KDa) components are indicated by arrows.  
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Figure 3.20: Purification of TF-YeaIGGDEF, with calcium addition to buffers 
Coomassie-stained SDS-PAGE gel, analysing samples throughout the purification 
steps.  
M: Precision plus protein standards marker (molecular weights shown in KDa), Lane 
1: Soluble YeaI, 2: Unbound proteins, 3: Wash steps 1+2, 4: Wash steps 3 + 4, 5: 
Thrombin step, 6: Wash 5+6, 7: Wash 7+8, 8: Imidazole addition.  
The fusion protein (expected MW: 69 KDa), TF tag (expected MW: 53 KDa) and 
YeaIGGDEF (expected MW: 16 KDa) components are indicated by arrows.  
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The major hurdle to be overcome which became apparent in these trials was the lack of 
protein (TF and YeaIGGDEF) separation.  This appears to be due to insufficient TF-His6 
immobilisation to the resin, which may suggest the formation of a potential interaction 
between YeaIGGDEF and TF.  In an attempt to enhance the immobilisation of TF-His6, a 1 ml 
HiTrap column was used for the large-scale purification, to provide a larger surface area for 
immobilisation compared to the low volume Ni-NTA resin used for optimisation trials.  
  
3.9.5   Large scale purification  
 
The purification was then scaled up, using a 1 ml HiTrap column for purification rather than 
Ni-NTA resin beads.  The use of a HiTrap column was dual purpose, firstly to limit the resin 
reaching saturation for the fusion protein TF:YeaIGGDEF in order to maximise the yield of 
YeaIGGDEF.  Secondly, the column was used in an attempt to maximise the immobilisation of 
TF-His6 with the column (due to its increased surface area for interactions), ideally releasing 
only YeaIGGDEF upon thrombin addition.   
 
Cell pellets of the pCOLD TF:YeaI overproduction strain were prepared once more (Section 
3.9.2), retaining the soluble fraction for use (Sections 2.6.1 and 2.6.2).  The filtered soluble 
fraction was then applied to a 1 ml HiTrap column for affinity chromatography, mirroring 
the small-scale purification.  The His-chelating programme was run on the ATKA prime, 
giving a single peak absorbance trace for the eluted fractions (Figure 3.21A) (Section 2.6.3).  
Elution fractions spanning this peak from the trace were then analysed by SDS-PAGE, and 
identified the fractions containing TF-YeaIGGDEF (Figure 3.21B).  
 
The TF-YeaIGGDEF fractions were dialysed into TCB buffer (Table 2.7), acting to remove 
imidazole and to add Ca2+ to the buffer, which improved thrombin cleavage in the initial 
trials (Figure 3.20) (Section 2.6.6).  Thrombin (20 units) was then added to these dialysed 
protein samples and left for 16 h at 20⁰C, again using the preferential incubation 
temperature determined previously.  Following successful thrombin cleavage, cleaving the 
vast majority of the fusion TF-YeaIGGDEF into the two consistuent protein components 
(Figure 3.22A-lane 2), the mixture was manually applied to a 1 ml HiTrap column.  Once 
again, it was proposed that the TF tag would bind to the HiTrap column via the His6 tag, 
whilst untagged YeaIGGDEF would flow through the column.  Following this, upon imidazole 
addition (at a single concentration) the bound TF tag and any uncleaved fusion protein 
would theoretically be eluted.  Despite a lack of success in optimisation trials, it was hoped  
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Figure 3.21: HiTrap chelating chromatography as an initial step to purify TF-YeaIGGDEF 
A) Elution profile of TF-YeaIGGDEF from HiTrap chelating chromatography. 
 Cell-free extract containing TF-YeaIGGDEF was applied to a 1 ml HiTrap chelating 
column and fractionated by an imidazole gradient (linear gradient from 0-0.5 
M).  The blue trace shows the detected OD280 levels, indicative of protein levels, 
with the red trace showing the imidazole gradient.  The expected TF-YeaIGGDEF 
location is indicated.   
B) Coomassie-stained SDS-PAGE gel of TF-YeaIGGDEF purification.  
 M= Precision plus protein standards (molecular weights indicated in KDa), 
lanes 1 shows the crude soluble fraction, lanes 2-9 show elution fractions 7-14 
collected after imidazole gradient application, and represent fractions 
corresponding to the labelled peak in A.  
 
The position of TF-YeaIGGDEF is indicated (of expected molecular weight 69 KDa).  
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Figure 3.22: Thrombin cleavage as a secondary step for YeaIGGDEF purification from TF-
YeaIGGDEF 
Coomassie-stained SDS-PAGE gels for large scale cleavage and purification of YeaIGGDEF 
from the TF-YeaIGGDEF fusion protein.   
Thrombin was used to cleave the TF-YeaIGGDEF fusion protein into the two components. 
Isolating YeaIGGDEF was then attempted by applying the cleaved mixture to a HiTrap 
chelating column and eluting bound protein with imidazole buffer in (A) a single step, 
(B) an elution gradient by running the His-chelating programme.  
In both cases, M: Precision plus protein standards marker (molecular weights shown in 
KDa).  
A) Lane 1: Soluble TF-YeaIGGDEF following initial HiTrap, 2: Post thrombin cleavage, 
3: Flow-through following application of mixture to second HiTrap column, 4-6 
Wash steps, 7-10: elution fractions following imidazole addition to the column.  
B) Lane 1-14: Elution fractions following application of a linear imidazole gradient 
(0- 0.5 M), using the His-chelating programme on the AKTA.   
The fusion protein (expected MW: 69 KDa), TF tag (expected MW: 53 KDa) and YeaIGGDEF 
(expected MW: 16 KDa) components are indicated by arrows.  
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that the protocol would be improved on a larger scale, with a much increased accessibility 
for TF to bind to the resin in the 1 ml HiTrap column than in the small volume of beads used 
in optimisation.  However, as was the case for the optimisation assays, this did not occur, 
with both the TF tag and YeaIGGDEF present at a low level in the wash steps following 
addition to the column (Figure 3.22- lane 3) and at a greater level in the imidazole elution 
fractions (Figure 3.22A- lanes 7-9).   
 
Endeavouring to solve the problem of co-elution, the cleaved protein mix was also applied 
to a HiTrap column and the His-chelating programme run on the AKTA (following 
manufacturer’s instructions) (Section 2.6.3).  This provided a linear imidazole gradient of 0-
0.5 M to the column, enabling sequential elution of proteins dependant on the protein’s 
affinity.  Elution fractions were analysed by SDS-PAGE (Section 2.6.9) but again failed to 
produce isolate YeaIGGDEF, with very faint quantities of YeaIGGDEF visible in lanes 8-10, in the 
same elution fractions as the TF fragment (Figure 3.22B).  
 
Clearly, a vast improvement in the overproduction and solubility of YeaIGGDEF was achieved 
upon fusion with the TF chaperone, compared to the previous overproduction systems 
used.   Whilst this is significant progress, there is still difficulty isolating the YeaIGGDEF 
protein.  The consistent co-elution of YeaIGGDEF and TF suggests that an interaction is 
occurring between them.  This interaction hypothesis would explain why YeaIGGDEF was 
present in imidazole elution fractions, with the TF bound being immobilized to the HiTrap 
column, and therefore retaining YeaIGGDEF in the column until imidazole addition.  
Futhermore, a TF:YeaIGGDEF interaction may cause the His6 tag to be buried within the 
protein, explaining why the affinity of TF for the HiTrap column was weaker than expected, 
present in pre-imidazole wash steps rather than being entirely immobilised (Figures 3.18, 
3.19, 3.20 and 3.22).   
 
In some cases, a tag is not of great concern, such as a small His6 tag which would be 
unlikely to cause much disruption to the native structure and function of the protein.  
However, the TF tag is more than three times the size of the protein of interest YeaIGGDEF, 
and therefore may be having a dramatic effect on the protein characteristics.  It was 
therefore essential to remove the TF tag.  Given more time, gel filtration or Vivaspin size 
exclusion columns could be used to solve this problem, theoretically separating the TF and 
YeaIGGDEF proteins on size.  Equally, the pCOLD TF vector contains three cleavage sites 
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between the TF and the cloned YeaIGGDEF, enabling the efficiency of other enzymes to be 
investigated.  However, if an interaction between TF and YeaIGGDEF has been formed, these 
methods may not alleviate the problem, potentially requiring denaturing conditions such as 
guanidine hydrochloride addition to unfold the proteins.  Assuming this treatment 
disrupted the TF:YeaIGGDEF interaction, YeaIGGDEF could be isolated by gel filtration but would 
subsequently require refolding prior to use in assays.  
 
Searching the literature, it appears that the inability to separate TF with the fused protein 
of interest may be a common phenomenon.  The Zhou et al. (2014) group reported 
successful purification of the recombinant protein pCOLD TF-SsSAD (Sapium sebiferum roxb 
stearoyl-acyl carrier protein desaturase).  Whilst this group do not report unsuccessful 
cleavage of the TF from the SsSAD, it is interesting that this group used only the 
recombinant protein for further work (Zhou et al., 2014).  Another group used the same 
pCOLD TF vector to overproduce silicatein protein (Schröder et al., 2012).  In this case, the 
purified fusion protein was cleaved by thrombin into the TF and the pro-silicatein protein, 
which was subsequently cleaved from pro-silicatein into the mature silicatein.  Therefore, 
whilst silicatein was successfully isolated from the TF protein, there was no report that the 
N-terminal pro-peptide region (present in the pro-silicatein but not mature silicatein 
protein) was itself separated from the TF (Schröder et al., 2012).  
      
The TF protein is a protein folding chaperone, existing at the surface of ribosomes or in the 
cytosol.  Whilst the mechanism of action is well-characterised for ribosomally-associated 
TF, the activity of cytosolic TF is less known.  The crystal structure of an interaction 
between TF and a ribosomal protein S7 (from Thermotoga maritima) has been solved and 
shows two S7 molecules encapsulated in a cage of two TF molecules.   The two TF proteins 
in this structure were aligned and formed a hydrophilic cage, suggested to have a cellular 
role to promote folding of the S7 protein.  Whilst this encapsulation has only been detected 
for T7 in complex with S7, this interaction is predicted to be non-specific due to a very large 
interaction interface between TF and S7 and S7 being poorly packed in the TF cage 
(Martinez-Hackert & Hendrickson, 2009).  
 
Therefore, the hypothesis of an interaction between TF and YeaIGGDEF appears a likely 
explanation for the poor cleavage (Figure 3.22), with YeaIGGDEF feasibly being trapped inside 
TF.   
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3.10   Discussion 
Work described in this chapter aimed to characterise the E. coli protein YeaI, and has 
yielded a system to improve the solubility of the protein and thereby aid future work.  
 
It was previously suspected that the YeaIGGDEF was fairly insoluble, with low yields reported 
using the plasmid pGS2263, producing an N-terminal TrxA-His6-S tag-YeaIGGDEF fusion 
protein.  We therefore changed the location and nature of the fused tag, to determine 
whether this improved protein solubility.  Successful cloning of YeaIGGDEF into a pET21a 
vector yielded a minimal fusion protein of YeaIGGDEF-His6, with a C-terminal tag (Figure 3.2).  
Both plasmids (pGS2263 and pGS2341) were used to transform electrically competent        
E. coli BL21 (λDE3) cells and overproduction and solubility optimisation trials were carried 
out.  In both cases, successful overproduction of the fusion proteins occurred.  However 
upon fractionation, both strains yielded extremely low (<5%) soluble protein, with varied 
induction times, temperatures and IPTG concentrations having little effect on solubility. 
The optimal conditions for solubility were chosen, and the protein purified by a one-step 
affinity chromatography method, which produced low but sufficient levels of TrxA-His6-S 
tag-YeaIGGDEF protein for use in a limited range of assays.  
 
Contradictory views on the enzymatic activity of YeaI have been reported in the literature. 
The GGDEF motif is known to deviate in YeaI, which in itself indicates a possible lack of 
catalytic function.  However there have been opposing views on YeaI’s enzymatic activity, 
with Sommerfeldt et al. (2009) finding the protein to be catalytically inactive, whilst 
Sanchez-Torres et al. (2011) deduced that YeaI is enzymatically active.  Nucleotide 
reactivity assays were carried out in this work, and identified that YeaIGGDEF did not react 
with GTP (the substrate of DGC domains) or various other nucleotides (Figure 3.9).  This 
identified YeaIGGDEF as an inactive DGC and supported the findings of Sommerfeldt et al. 
(2009).  
 
Resulting from the assignment of YeaI as a degenerate DGC, the ability to interact with 
nucleotides and the oligomeric state of the protein were investigated.   
 
Despite the lack of reactivity, it was suggested that the protein may have retained the 
ability to bind to nucleotides.  Other degenerate DGC proteins have been found to bind 
nucleotides and were functionally regulated by this binding.  Whether the same was true 
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for YeaI was investigated by partial proteolysis, allowing visual identification of any 
contaminating protein, and thereby reducing the risk of producing false positive results.  
Minor variations in the digestion profiles were seen, with species intensity altering as 
nucleotides were added to the reaction mix (Figure 3.11). However at no point did the 
profile change dramatically, with no polypeptide fragment being lost or emerging in the 
samples upon nucleotide addition.  The major polypeptide cleavage fragment appeared at 
an increased intensity upon addition of the nucleotides ppGpp, GDP and ATP, which could 
indicate enhanced exposure of a cleavage site when these nucleotides bind to the protein. 
Quantification of the proteolysis protein species revealed that the intensity changes of the 
predominant cleavage fragment (upon ppGpp, GDP and ATP) were not an artefact of 
sample loading errors, with no change in the levels of intact protein in these samples 
(Figure 3.12).  Of note, GTP addition did not alter the proteolysis profile at all, suggesting 
no binding of GTP to YeaIGGDEF.  
 
Despite three nucleotides causing an apparent change in protein cleavage profiles, 
interpretation of these results was difficult due to poor protein purity, with no certainty 
that the contaminating proteins did not contribute to these changes (Figure 3.11).  In 
addition, nucleotide binding is only detectable by this technique if the binding alters the 
exposure of trypsin cleavage sites in the protein.  Therefore, whilst this technique suggests 
no binding of YeaIGGDEF to GTP, other techniques such as NMR or fluorescence could be used 
to supplement this data, and confirm this lack of binding.  The same techniques could also 
support or disprove the possible binding to ppGpp, GDP and ATP.  Both NMR and 
fluorescence assays required increased protein purity, thereby increasing the necessity for 
an improved protein overproduction method.  
 
The DGC protein family form catalytically active dimers, in which an active site is formed in 
the cleft between two GGDEF units (Chan et al., 2004).  Gel filtration and glutaraldehyde 
assays were carried out to determine the oligomeric structure of YeaIGGDEF.  In both cases, a 
potential dimeric species was formed, indicating that the protein may have retained this 
feature of active DGC proteins (Figures 3.13 and 3.14).  However, the low levels of protein 
purity made interpretation difficult, as the oligomeric species formed is of a molecular 
weight between that expected of a dimer and a trimer.  One hypothesis for the aberrant 
migration of the protein is from non-linear crosslinking in the glutaraldehyde assays, which 
is likely to alter the mass/charge ratio of proteins and therefore could explain the 
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inconclusive results, producing a species between the expected dimeric and trimeric sizes. 
Thus, it is suggested that the oligomeric species produced is more likely to represent a 
dimer, with perhaps additional contaminating or co-purified proteins becoming attached to 
the dimeric GGDEF increasing the molecular weight in gel filtration and with non-linear 
crosslinking affecting the migration of proteins in glutaraldehyde assays.  To increase 
confidence in these results, purer protein samples would be used for these assays, with a 
much reduced level of contaminating species, thereby giving the oligomeric state formed 
by YeaIGGDEF only.  Nevertheless, it appears that TrxA-His6-S tag-YeaIGGDEF is not a monomer.  
 
Following on from these assays, increasing the yield of YeaIGGDEF became a priority, because 
the amount and poor quality of the protein limited the range of experiments that could be 
carried out, and impaired our confidence in those we could carry out.  At this point, the 
gene was cloned into the cold shock expression vector pCOLD TF.  Successful cloning and 
overproduction of the YeaIGGDEF protein was confirmed.  The major success though, was the 
hugely increased solubility levels of the fusion protein, with more than 50% of the protein 
being present in the soluble fraction of the cell extract (Figure 3.17).  However purification 
of this TF-YeaIGGDEF was challenging, with problems in cleaving the TF-YeaIGGDEF protein with 
thrombin.  Once overcome, separating the TF chaperone and YeaIGGDEF was problematic, 
with both proteins eluting from HiTrap chelating columns at the same imidazole gradient 
suggesting the occurrence of a possible TF:YeaIGGDEF interaction (Figure 3.22).  Whilst the 
fusion protein TF-YeaIGGDEF could be purified to a high concentration and purity, it was 
decided not to carry out assays with the fusion protein.  This was due to the large size 
difference between the 53 KDa TF and 16 KDa YeaIGGDEF and the possible interactions 
between TF and YeaIGGDEF.  These YeaIGGDEF:TF interactions could potentially shield binding 
sites or cleavage sites of YeaIGGDEF, or cause conformational changes to YeaIGGDEF, all of 
which could alter the results from any assays carried out.  Future work to purify YeaIGGDEF 
could investigate the use of detergents, urea or guanidine hydrochloride to disrupt the 
YeaIGGDEF:TF interaction, in an attempt to isolate YeaIGGDEF for use in subsequent assays.  
 
To conclude, this work supports the notion that YeaI is an inactive DGC protein, as reported 
by Sommerfeldt et al. (2009).  In addition, YeaIGGDEF exists as an oligomer (probably dimeric 
species), and there is no evidence of nucleotide binding.  The most significant progress has 
been increasing the solubility of YeaIGGDEF, with the TF-YeaIGGDEF protein having a much 
improved level of solubility than the previously used His-tagged constructs.  In addition, a 
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very high level of purification of the fusion protein was achieved.  Once the issue of 
separating the TF and YeaIGGDEF components has been overcome, the high yield and purity 
of the YeaIGGDEF will enable a much broader repertoire of assays to be carried out, with 
increased confidence in all results.   
 
One possible focus for future work could be analysing the contaminating L28 species, seen 
in the glutaralahyde and partial proteolysis assays, to determine the exact identity of the 
L28 species (whether it is L28-L9) and whether an interaction between YeaIGGDEF and L28 is 
produced.  If a genuine interaction was formed, studying the function of this interaction 
would be of paramount importance.  
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Chapter 4: Characterisation of the Escherichia coli ‘degenerate’ 
phosphodiesterase protein YdiV 
 
4.1   Introduction 
 
The secondary messenger molecule cyclic di-GMP (c-di-GMP) is controlled by two groups of 
enzymes in E. coli; the diguanylate cyclases and phosphodiesterases, which are responsible 
for the anabolism and catabolism of c-di-GMP respectively (Simm et al., 2004).  The 
phosphodiesterase (PDE) family of bacterial proteins have a conserved motif in the active 
site, consisting of the amino acid residues EAL.  This site is required for the catalytic activity 
of these proteins, converting cyclic di-GMP molecules into linear pGpG molecules, prior to 
the breakdown of pGpG into 2 GMP (Simm et al., 2004; Schmidt et al., 2005). 
 
YdiV is a cytosolic protein, composed of a single PDE domain.  However unlike the majority 
of PDEs, YdiV deviates from the consensus motif EAL, possessing instead an ELI motif and 
also lacking 7 out of 10 other conserved catalytic residues  (Figure 4.1)(Sections 1.6.2 and 
1.9) (Tchigvintsev et al., 2010).  Despite this lack of conservation, there has been some 
controversy regarding it’s catalytically activity, with Hisert et al. (2005) finding YdiV to be 
catalytically active (and renaming the protein CdgR for c-di-GMP regulator) whilst other 
groups have found the protein to be inactive (Tchigvintsev et al., 2010; Wada et al. 2011).  
 
An X-ray crystallography structure has been obtained to 1.9 Å for the YdiV protein.  Whilst 
the sequence similarities to other EAL domains is low, with <20% amino acid identity, the 
3D structure shows the characteristic EAL topology of a TIM-like barrel fold (Figure 4.1).  Of 
note, a groove is present in the YdiV structure, which acts to bind c-di-GMP in other EAL 
domain proteins (Li et al., 2012).  One of the focal points of this investigation was the 
nucleotide binding potential of the protein.  Various other ‘degenerate’ c-di-GMP signalling 
proteins have been shown to be regulated by nucleotide interactions.  For example, PopA 
in Caulobacter crescentus and PelD in Pseudomoas aeruginosa are both degenerate GGDEF 
proteins whose functions are activated by c-di-GMP binding (Duerig et al., 2009; Lee et al., 
2007).  Of particular note is FimX from P. aeruginosa, which consists of degenerate GGDEF 
and EAL domains and is responsible for twitching motility.  This protein is activated by high-
affinity binding of c-di-GMP to its degenerate EAL domain (Navarro et al., 2009). Therefore  
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Figure 4.1: Primary and secondary structure of YdiV  
A) Topology of YdiV, as determined by X-ray crystallography (Li et al.,2012) YdiV 
consists of 10 α-helices and 8 β-strands, forming a modified TIM-like barrel structure 
consistent with other EAL domain proteins (Li et al., 2012).  
B) Protein sequence alignment of EAL domains of YdiV, YahA and YhjH (all from E. coli).  
The sequences were retrieved from Uniprot and the alignment carried out by Mega6 
software (Section 2.10.2).  
The EAL domain active site region, of consensus sequence EXL is boxed in red, 
highlighting the degenerate nature of YdiV.  Tchigvintev et al. (2010) identified 10 
conserved residues that were required for the catalytic activity of EAL domains. These 
10 residues are boxed in blue, with YahA having all 10 of the conserved residues. YhjH 
has a conserved EXL motif and retains 9/10 conserved residues. On the other hand, the 
predicted ‘degenerate’ protein YdiV both lacks the EXL consensus motif and lacks 7/10 
conserved residues (Tchigvintsev et al., 2010).  
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it was hypothesised that the degenerate EAL protein YdiV, interacts with c-di-GMP or other 
nucleotides.   
 
When this study began, the role of YdiV was still largely unknown, with phenotypic analysis 
suggesting that YdiV affected biofilm, sedimentation and motility levels in E. coli cells, with 
ydiV overexpression causing a decrease in cell motility (Dr Melissa Lacey, unpublished 
work).  During the project, the role of YdiV was determined, revealing that the protein 
bound to a transcription factor FlhD4C2 to inhibit activation of flagella genes (Wada et al., 
2012).  
 
Whilst functional roles of YdiV have been elucidated, the mechanism of modulating YdiV 
activity is not understood, with no known trigger of protein activity.  An inducer of ydiV 
gene expression has been reported: SdiA causes the upregulation of ydiV in the presence of 
extracellular autoinducer 1 (AI-1).  This is a quorum sensing mechanism in which 
extracellular AI-1 produced by other microbial species causes the activation of SdiA and 
subsequent expression of ydiV in E. coli (Zhou et al., 2008).  Equally inhibition of ydiV 
expression is thought to occur under high glucose conditions (Zhou et al., 2008).  Part of 
this investigation therefore included studies of ydiV expression, aimed at finding conditions 
in which the gene was expressed, analysing potential quorum-sensing signalling molecules, 
and different growth rates of bacteria.  
 
The investigations carried out in this chapter determined the following:  
 
- YdiV is a catalytically inactive EAL domain (PDE) protein (Section 4.4) 
- Preliminary evidence of c-di-GMP binding to YdiV (Section 4.5) 
- YdiV is a monomer in solution, unable to retain the PDE dimeric form (Section 4.3) 
- Upon overproduction of ydiV, there was a significant reduction in the number of 
flagella per cell accompanied by the absence of FliC (Section 4.6) 
- Conditions for YdiV overproduction from its own promoter could not be 
determined,  indicating very low levels in vivo (Section 4.7) 
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4.2   Cloning, over-expression and purification of YdiV 
 
4.2.1   Cloning of the ydiV gene into an over-expression plasmid 
 
To enable over-expression of the YdiV protein, the ydiV gene was ligated into the over-
expression plasmid pET21a to create a C-terminal His6-tag fusion with ydiV (Figure 4.2).  
The ydiV gene was amplified from genomic E. coli MG1655 DNA by PCR using primers 
NSW9 and NSW10 (Section 2.3.2).  These primers were designed to contain NdeI and XhoI 
restriction sites at either end of the PCR fragment (Table 4.1).  The stop codon of the ydiV 
gene was not included in the reverse primer, in order to allow a C-terminal His6 tag to be 
fused to the gene, creating a fusion protein for easy purification.  
Table 4.1: Primers used in amplification of the ydiV gene for ligation into the plasmid 
pET21a 
 
 
 
PCR reactions were carried out using high fidelity polymerase, E. coli MG1655 genomic DNA 
and primers NSW9 and NSW10 to amplify the ydiV gene (Sections 2.3.1 and 2.3.3).  The 
resultant PCR product was isolated by PCR purification (Section 2.3.10) and digested using 
the NdeI and XhoI restriction enzymes (Sections 2.3.6).  The pET21a plasmid (Novagen) was 
purified and digested with the same restriction enzymes (NdeI and XhoI) (Sections 2.3.4 
and 2.3.6).  The ydiV fragment and linearised pET21a vector were ligated via their sticky 
ends and used to transform electrically competent E. coli DH5α cells (Sections 2.3.9 and 
2.2.7).  Transformants were selected on ampicillin supplemented agar (Section 2.2.4).  The 
resultant colonies were screened using colony PCR methods with the appropriate T7 
promoter and terminator primers to assess which plasmids contained the correctly sized 
insert (Table 4.2) (Section 2.3.11).  Plasmids containing an appropriately sized insert were 
checked by DNA sequencing (Source Bioscience) using the same sequencing primers (Table 
4.2).  
Primer Sequence Function 
NSW9 TTTTCATATGAAGATTTTTTTGGAGA
ATCTTTATC 
Forward primer for ydiV gene 
NSW10 TTTTCTCGAGTCGCTGAACCAACGTC
GTTAT 
Reverse primer for ydiV gene (no stop 
codon in order to form YdiV-His6 fusion) 
The grey shaded sequence indicates an NdeI restriction site (including the start codon ATG) and 
the boxed sequence shows an XhoI restriction site.  
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Figure 4.2: Schematic plasmid map for the insertion of ydiV into pET21a 
Plasmid map for the pGS2354 vector, indicating the position of the His6-tag, antibiotic 
resistance cassette and the fusion protein produced.  
The origin of replication is indicated and labelled as ori.  
The construct encodes a C-terminal His6 fusion protein, with two amino acid residues 
linking ydiV and the His6 tag, giving a total molecular weight of 28.1 KDa.  
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Table 4.2: Sequencing primers used for the plasmid pET21a 
Primer Sequence Function  
T7 promoter 
primer 
TAATACGACTCACTATAGGG Forward primer for pET21a sequencing 
T7 terminator 
primer 
GCTAGTTATTGCTCAGCGG Reverse primer for pET21a sequencing 
  
Plasmids containing no mutations in the ydiV sequence were named pGS2354 
(pET21a::ydiV). The plasmid was then used to transform electrically competent E. coli BL21 
λ(DE3) cells (Section 2.2.7).  
 
4.2.2   Optimisation of YdiV overproduction  
 
Trials were carried out in order to determine the optimal conditions for YdiV-His6 
overproduction, altering variables such as IPTG concentration and induction time, using 
100 ml cultures and growing the cells at 37⁰C before induction at 25⁰C, where the cells 
remained for subsequent growth.  An aliquot (1 ml) of an overnight culture (of strain E. coli 
BL21 λ(DE3)/pGS2354) was added to 100 ml of LB containing ampicillin, and the cells were 
grown at 37⁰C with shaking at 250 rpm until an OD600 of ~0.6 was achieved.  IPTG was 
added, to a final concentration of either 100 µg/ml or 20 µg/ml and the cultures incubated 
at 25⁰C with shaking (Sections 2.2.2, 2.2.3 and 2.6.1).  Samples were taken before induction 
(0 h), and every hour after induction until 5 h was reached.  The samples were prepared 
and analysed by SDS-PAGE, as described in Section 2.6.9 (Figure 4.3).  
 
A polypeptide at ~25 KDa was present in the post-induction fractions, which was believed 
to correspond to YdiV, although it migrated slightly further than the expected 28.12 KDa 
molecular mass (including His6 tag and linker).  The protein abundance appeared much 
greater in the lower IPTG samples (20 µg/ml compared to 100 µg/ml), so the optimal IPTG 
concentration deemed to be 20 µg/ml.  Induction duration also had some impact on 
protein overproduction level, with a 2 h induction period chosen as the optimal duration 
for maximum protein levels.  Following optimisation of YdiV overproduction, the protein 
was purified in a one-step affinity chromatography method.  
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Figure 4.3: Optimisation of overproduction conditions for the YdiV protein in E. coli 
BL21 λ(DE3)/pGS2354 cells 
Coomassie-stained SDS-PAGE gel of samples taken pre- and post-induction of ydiV 
expression.  
M: Precision plus protein standards (molecular weights indicated in KDa), 0-5 
indicate induction times in h, with YdiV production being induced using either a final 
concentration of 100 µg/ml or 20 µg/ml IPTG, as specified.  
The position of YdiV is indicated.  
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4.2.3   Purification of YdiV–His6 fusion protein 
 
Purification of His-tagged YdiV was achieved by a single-step Ni-NTA affinity 
chromatography method.  Frozen cell pellets of the YdiV overproduction strain (E. coli BL21 
λ(DE3)/ pGS2354) from 1-5 litres of culture (Section 4.2.2) were thawed and resuspended 
in breakage buffer, the cells were then broken by sonication, clarified by centrifugation and 
the soluble fraction retained for future use (Section 2.6.2).  Following separation of the 
insoluble and soluble cell fractions, the location of YdiV was determined by analysing the 
insoluble and soluble fractions on an SDS-PAGE gel (Section 2.6.9) and showed the 
presence of YdiV in the soluble fraction (Figure 4.4).  The filtered soluble fraction was 
applied to a 1ml HiTrap column for affinity chromatography (Section 2.6.3).  The His-
chelating programme was run on an ATKA, following the manufacturer’s instructions, and 
gave a multi-peak A280 trace (Figure 4.5A).  The initial peaks in the elution trace are 
characteristic of the elution of weakly-bound proteins; i.e. those with multiple histidine 
residues which make some level of interaction with the Ni-NTA column, whilst the larger 
later eluting peak represented the His6-tagged protein.  The fractions spanning this major 
peak were separated on an SDS-PAGE gel (Figure 4.5B).  From the SDS-PAGE gel it is clear 
that YdiV was purified to a high level using this single purification step, with lanes 5-8 
(fractions 13-16) showing very clean and pure protein, with all major contaminating bands 
removed. These fractions were therefore used for all further assays and experiments, 
calculating the protein concentration of YdiV prior to use (Section 2.6.8).  The protein 
migrated further than its expected molecular weight of 28.12 KDa, at ~25 KDa, however N-
terminal amino acid sequencing (Dr Arthur Moir, University of Sheffield) gave a protein 
amino acid sequence of N’ MKIF thereby confirmed the identity of the protein to be YdiV 
(Section 2.6.14).  
 
In some cases, the protein was dialysed into a different buffer in order to remove 
imidazole, whilst other times the protein was used as prepared, depending on the nature of 
the assay (Section 2.6.7).  
 
Crystallisation trials were carried out for YdiV in an attempt to elucidate the structure of 
the protein (Section 2.6.15).  YdiV was purified and dialysed into 20 mM Tris-HCl, 500 mM 
NaCl, 20 mM arginine, pH 7.4 buffer (Sections 2.6.3; 2.6.7).  The protein was concentrated 
to 10-15 mg/ml and tested for crystallisation with a variety of commercial screens 
(specifically pH clear, PEG, PACT, JCSG+, Classics and MPD) (QIAGEN) (Section 2.6.15).  No  
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Figure 4.4: Identification of soluble YdiV following overproduction 
 SDS-PAGE gel of the insoluble and soluble cell fractions following protein 
overproduction.  The cell pellet from cultures of the YdiV overproduction strain 
was resuspended in breakage buffer, broken by sonication and the debris was 
pelleted.  Samples of the insoluble and soluble fractions were analysed on an SDS-
PAGE gel to identify the location of YdiV. 
M: Precision Plus protein standards (molecular weights shown in KDa). Lane 1: 
Insoluble cell sample, 2: Soluble cell sample.  The position of YdiV is indicated, 
showing that some of the protein does remain in the insoluble fraction, but is also 
present in the soluble fraction.   
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Figure 4.5: HiTrap chelating chromatography as a one-step purification of YdiV-
His6 fusion protein 
A) Elution profile of YdiV-His6 from HiTrap chelating chromatography. 
 Cell-free extract containing YdiV-His6 was applied to a 1 ml HiTrap chelating 
column and fractionated by application of an imidazole gradient (linear 
gradient from 0-0.5 M).  The blue trace shows the A280 values, indicative of 
protein levels, with the red trace representing the imidazole gradient.  The 
expected YdiV-His6 location is indicated.   
B) Coomassie-stained SDS-PAGE gel of YdiV-His6 purification.  
HiTrap elution fractions spanning the major peak from the Ni-NTA trace. M= 
Precision plus protein standards (molecular weights indicated in KDa), lanes 
1-9 show elution fractions 9-17 collected during the imidazole gradient 
application, and represent fractions corresponding to the labelled peak in A.  
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protein crystals were identified using these screens and therefore this was not further 
investigation.  
 
4.3   Oligomeric analysis of YdiV  
 
To investigate the oligomeric state of the YdiV protein, both glutaraldehyde crosslinking 
assays and gel filtration techniques were carried out.  
 
Glutaraldehyde acts as a low-specificity crosslinker between amino groups in proteins, 
enabling oligomeric states of a protein to be fixed and therefore identified.  Samples 
consisting of purified YdiV protein (Section 4.2.3) and various quantities of glutaraldehyde 
were incubated at room temperature before quenching the reactions with 1 M Tris-HCl pH 
6.8 (Section 2.6.12).  The samples were then analysed on an SDS-PAGE gel (Section 2.6.9). 
The SDS-PAGE gels showed the monomeric protein at ~25 KDa (expected size of 28 KDa) in 
the 0% glutaraldehyde sample, with a weak contaminating species at ~50 KDa (Figure 4.6). 
Upon addition of 0.01% or 0.02% glutaraldehyde, the pattern of polypeptides was similar to 
that without glutaraldehyde, with YdiV at 25 KDa and a contaminating species at 50 KDa. 
The main difference was the presence of protein at higher molecular weights with a 
possible species at ~100 KDa and smearing at the very top of the PAGE gel.  The 100 KDa is 
most likely to be an artefact, resulting from the non-specific nature of the glutaraldehyde 
rather than the formation of a tetrameric YdiV species.  Therefore, crosslinking assays do 
not give any indication of YdiV oligomer formation.  
 
Gel filtration was used as a size-exclusion method in which to study the native oligomeric 
state of YdiV.  The Superdex 200 column was calibrated by applying a mixture of four 
reference proteins of known MW (Ferritin, Aldolase, Ovalbumin and Ribonuclease A) 
(Section 2.6.13). A plot of the Kav (dependent on elution volume of the protein) and 
logMW was produced (Figure 4.7A). This plot provided a method to determine the MW of a 
protein simply from its elution volume from the column.   
 
To analyse the molecular weight of YdiV, a purified sample (3 mg/ml in 20 mM sodium 
phosphate, 500 mM NaCl, pH 7.5) (Section 4.2.3) was applied to a pre-equilibrated 
Superdex200 gel filtration column (Section 2.6.3 and 2.6.13).  The A280 value (indicative of 
protein quantity) was recorded as the sample passed down the column, and showed a clear 
peak at an elution volume of 16.76 ml (Figure 4.7B).  The minor peaks seen following the  
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Figure 4.6: Oligomeric analysis of YdiV  
SDS-PAGE gel of YdiV treated with gluataraldehyde assays.  
M: Precision Plus protein standards (molecular weights indicated in 
KDa). Lanes 1: YdiV with 0% gluataraldehyde, 2: YdiV with 0.01% 
glutaraldehyde 3: YdiV with 0.02% glutaraldehyde.  
The monomeric YdiV and contaminating species positions are indicated.  
127 
 
 
  
Figure 4.7: Gel filtration analysis of YdiV  
A) Calibration plot for Superdex 200 gel filtration column 
B) Elution profile of YdiV from gel filtration chromatography 
A calibration plot (A) was carried out using a mixture of four proteins of known MW 
which were applied to the column.  A plot of the Kav (dependent on elution volume of 
the protein) and logMW was produced.  This enabled calculation of the MW of YdiV, 
based on the elution volume detected in B. 
Purified YdiV (concentration 3 mg/ml in 20 mM sodium phosphate, 500 mM NaCl pH 
7.5) was applied to an equilibrated Superdex200 gel filtration column.  
The elution profile (B) shows the absorbance of eluant at 280 nm (blue trace) against 
elution volume, with the numbers at the crest of each peak specifying the retention 
volume of each eluted protein.  The conductivity applied to the column (brown line) and 
the point at which the protein was added to the gel filtration column (pink dotted line) 
are shown.  
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predominant peak were eluted from the column by a change in the applied conductivity to 
the column (brown trace) and are smaller MW proteins (Figure 4.7B).  
 
To calculate the MW of YdiV, the elution volume of 16.76 ml was used to determine the 
proteins Kav (gel phase distribution coefficient) value, using the equation below.   
 
    
     
     
 
 
In the equation above, Ve = elution volume (ml) of protein, Vo =void volume of column (7.8 
ml) and Vt= total volume of column (24 ml).  Using this equation, the major peak in the 
elution profile (Figure 4.6B) gave a Kav value of 0.553, which was then applied to the 
calibration curve (red line on Figure 4.6A).  The corresponding logMW determined by the 
best-fit line was between 4.35 and 4.40 which when converted to a MW gave a value of 
22.38 to 25.12 KDa.   
 
Therefore taken together, cross-linking and gel filtration indicate that YdiV exists as a 
monomer.  Whilst unknown at the time of undertaking this study, the X-ray crystallography 
structure of YdiV was resolved consisting of two YdiV molecules per asymmetric unit (Li et 
al., 2012).  This was analysed to consist of two YdiV monomers packed tightly together 
rather than an YdiV dimer.  The crystal structure revealed key differences between the two 
YdiV molecules compared to other dimerised EAL domains.  The dimerization helices of the 
YdiV monomers were much further apart from one another than in other EAL domains and 
the interaction interface between monomers was much smaller than expected for EAL 
domain proteins (Li et al., 2012). It was therefore suggested that YdiV could not form stable 
dimers in solution, which was confirmed by gel-filtration analysis which detected YdiV as a 
monomeric species (Li et al., 2012).  The independent data provided here confirms this.  
 
4.4   Confirmation of the ‘degenerate nature’ of the YdiV EAL domain 
 
To investigate whether YdiV was an active or inactive PDE, enzymatic assays were carried 
out for YdiV with c-di-GMP (the substrate for EAL domain proteins) as well as various other 
nucleotides.  The assays consisted of 1 µM protein and 10 mM Mg2+ or Mn2+ being 
incubated with various nucleotides at 37⁰C for 1 h before the reactions were halted by  
rapid heating to 95⁰C for 5 min.  The samples were then analyzed by HPLC (Section 2.7.1).  
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Control reactions were carried out using known DGC and PDE proteins, to confirm the 
ability of the assay to differentiate between nucleotides, as detailed in Section 3.6 (Figure 
4.8).  After demonstrating the effectiveness of the technique, it was used to study YdiV 
enzymatic activity, using purified YdiV-His6 protein (Section 4.2.3).  The YdiV traces show 
identical traces for all pairs of samples, with the black (nucleotide only) and pink (protein 
and nucleotide) traces overlaying in all cases (Figure 4.9).  This indicated that YdiV did not 
have enzymatic activity for any of the tested nucleotides.  Identical traces were produced 
when using Mn2+ or Mg2+ (data not shown for Mn2+ series).  Of particular importance was  
c-di-GMP, the substrate regularly converted by EAL domains into linear pGpG.  This too, 
had an identical elution trace when c-di-GMP alone was loaded and when the c-di-GMP 
and YdiV mix was analysed, confirming that c-di-GMP remained unaltered in the sample 
and was not degraded by YdiV.  
 
The elution times for GTP, c-di-GMP and pGpG were 22.8, 8.6 and 6.8 min respectively.  
The control reactions were carried out at an earlier date, with elution differences here 
being accounted for by buffer pH fluctuations and a well-preserved column which had 
undergone less use.    
 
This experiment therefore confirmed the hypothesis that YdiV is an inactive PDE lacking 
activity with c-di-GMP or other nucleotides, in agreement with the data from Tchigvintsev 
et al. (2010) and Wada et al. (2011), but in contrast to Hisert et al. (2005).  
 
4.5   Determination of YdiV ‘ligand’ binding 
 
After showing that YdiV was an inactive or ‘degenerate’ PDE the possibility that YdiV may 
bind a nucleotide, such as c-di-GMP was investigated (Section 2.7).  It was known that the 
EAL catalytic motif was lost in the YdiV protein, however that did not imply that the 
substrate binding cleft was lost entirely.  To investigate this, several assays were used 
including partial proteolysis and intrinsic fluorescence before a subset of nucleotides, 
deemed most likely for binding, were analysed by proton NMR.  
 
4.5.1   Partial proteolysis analysis 
 
Partial proteolysis was used as a technique to potentially identify nucleotide binding to   
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Figure 4.8: Control reactions for determining YdiV PDE activity, using known active 
DGC and PDE enzymes 
HPLC elution traces, with retention time (min) on the x axis and intensity on the y 
axis.  
On the left hand side is the overlayed trace for YfgF, an active PDE.  This protein is 
able to convert c-di-GMP into pGpG, and this was established by comparing a c-di-
GMP only trace with a c-di-GMP plus YfgF sample.  The black trace shows the 
nucleotide only sample, corresponding to c-di-GMP.  The pink trace is the nucleotide 
and protein trace, in this case YfgF and c-di-GMP.  The trace indicates the absence of 
c-di-GMP and the presence of a new peak, confirming the catalytic activity of the 
protein.  
On the right hand side, is the overlayed trace for PleD, an active DGC. DGCs are 
known to convert GTP into c-di-GMP, so this activity was tested by analysing GTP 
both in the presence and absence of PleD and comparing the elution traces.  The 
pink trace shows nucleotide and protein, whilst the black trace is the nucleotide 
only.  Here the black GTP trace is completely lost and a new profile (pink) trace 
emerged upon PleD addition, confirming catalytic activity.  
These control assays confirmed the suitability of these experiments as a means to 
differentiate nucleotides.  
                              pGpG      c-di-GMP                                                                        GTP       c-di-GMP 
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YdiV as indicated by different patterns of trypsin cleavage (Section 3.7).  Optimisation of 
trypsin cleavage was initially achieved using 15 µg purified YdiV (Section 4.2.3), adding 
trypsin enzyme at different stock concentrations (1 mg/ml or 0.2 mg/ml), for different 
times (1, 5 or 10 min) and incubating at different temperatures (RT or 37⁰C).  Following the 
optimisation assays, 1 mg/ml stock trypsin (producing samples containing 100 µg/ml 
trypsin) and a reaction time of 10 min at RT was chosen for the partial proteolysis assays 
(Figure 4.10).  This condition produced clear protein cleavage, with the intact YdiV being 
cleaved into three products, whilst some uncleaved protein was still visible.  
 
Partial proteolysis was carried out, as indicated in Section 2.7.2, incubating purified YdiV, 
trypsin and excess nucleotide (2 mM final concentration) under the optimised cleavage 
conditions, before stopping the reactions and separating the samples by SDS-PAGE (Figure 
4.11).         
    
The resulting SDS-PAGE gels revealed some minor changes upon nucleotide addition 
(Figure 4.11).  Firstly, the no nucleotide control samples of protein and trypsin yielded the 
same polypeptide profile as observed in the optimisation reactions, with some intact 
protein remaining and the three breakdown products appearing.  Of note, cleavage 
product 1 actually consisted of two distinct species, a more intense major species which 
was noted previously, and a smaller product, which had previously been missed.  This 
provided a profile to compare all the other samples to.  When c-di-GMP was present, 
cleavage product 1 (highlighted by a black box) appeared to migrate more slowly and was 
weaker and less well-defined than the no nucleotide sample, despite the track appearing to 
be equally loaded compared to the control.  This could potentially mean a binding 
interaction had occurred and was altering the ability of trypsin to cleave YdiV.  Equally 
when ppGpp was present, cleavage product 1 appeared to be more defined, apparently 
lacking the smaller MW species seen in the no nucleotide sample and instead having one 
single species at this site.  This could be significant, as it could mean that the ppGpp was 
binding to YdiV and shielding a cleavage site.  In the presence of cAMP, a similar situation 
was seen to c-di-GMP with a weak polypeptide species at cleavage site 1.  The remaining 
nucleotides do not appear to alter the trypsin cleavage pattern in any obvious manner, 
with very similar fragment patterns seen for all other nucleotides.  
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Figure 4.10: Trypsin cleavage optimisation assay for the cleavage of YdiV protein 
Coomassie-stained SDS-PAGE gel showing trypsin cleavage optimisation for the YdiV 
protein.  
 
M: Precision plus protein standards marker, with molecular weights shown in KDa.  
C: YdiV (5 µl of 3 mg/ml) with no trypsin addition.  
The remaining samples had the same quantity of YdiV (5 µl of 3mg/ml) but with the 
addition of trypsin at the various concentrations and incubation temperatures and 
times.  The numbers 1, 5, 10 refer to the time (min) over which the incubation 
occurred prior to stopping the reactions.  Trypsin stocks of 1 mg/ml and 0.2 mg/ml 
were used, adding 3 µl of stock solution to final sample volumes of 30 µl (generating 
samples containing trypsin at 100 µg/ml and 20 µg/ml respectively).  The reaction 
incubation temperatures were either at room temperature or 37⁰C, as stated.  
  
Position of the intact YdiV (of expected molecular weight 28 KDa) is indicated, along 
with the three cleavage products.  
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Figure 4.11: Partial proteolysis of YdiV in the presence of nucleotides  
Coomassie-stained SDS-PAGE gel showing partial proteolysis assays with YdiV and 
various nucleotides.  
M: Precision plus protein standards marker, with molecular weights shown in KDa. For 
each lane, P indicates a protein only lane, with YdiV protein (5 µl of 3mg/ml) and no 
trypsin addition.  Lanes labelled P+T indicate the same amount of YdiV with the 
addition of trypsin, using the 1 mg/ml stock as determined by optimisation trials. 
Ligands were added to the reaction mix as indicated at 2 mM final concentration, and 
incubated with the protein and trypsin mix.  
Position of the intact YdiV (of expected molecular weight 28 KDa) is indicated, along 
with the previously identified well-defined cleavage products from optimisation.  
 
Black boxes are used to highlight regions of interest.   
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The major limitation with this assay is in determining how significant these digest 
differences are, which is why other experimental techniques have been used.  From these 
assays, it was tentatively suggested that there were reasons to investigate nucleotide 
binding further, especially YdiV binding to ppGpp and c-di-GMP.  
 
4.5.2   Fluorescence spectroscopy of YdiV  
 
To test the rather ambiguous results obtained from the partial proteolysis assays, intrinsic 
fluorescence spectroscopy was carried out, to assess the potential binding of nucleotides 
by YdiV.  
 
Intrinsic tryptophan fluorescence was measured for YdiV before and after nucleotide 
addition, to determine whether any enhancement or quenching of fluorescence occurred. 
Intrinsic fluorescence comes from the proteins fluorescent residues; tryptophan, and to a 
lesser extent phenylalanine and tyrosine residues, of which YdiV has 3W, 6Y and 15F 
residues.  Theoretically, the technique can therefore detect nucleotide binding to a protein, 
if the binding results in changes in conformation that alter the fluorescent properties of 
these residues.  This method again has limitations, with only 24 residues in YdiV 
(accounting for 10% of the protein) having significant effect on fluorescence, potentially 
limiting its ability to report on nucleotide interactions.  
 
Samples were made, consisting of 0.4 µM of purified YdiV (Section 4.2.3) dialysed into Tris-
HCl buffer pH 7.4, 30-fold excess Mg2+ (final concentration of 12 µM) in a 10 mM Tris-HCl 
pH 7.4 buffer (Section 2.7.4).  Nucleotides were added such that a 1:1 ratio to the protein 
was achieved, i.e. 0.4 µM.  
 
Reference samples using N-acetyl-L-tryptophanamide (NATA) were used as a tryptophan 
analogue, adding the various nucleotides to the NATA samples to determine any changes 
when no interaction was occurring.  The level of variation in the NATA samples could be 
used to assess whether any variation seen in the YdiV samples was real or simply an 
artefact.  For NATA samples, NATA was added to give similar fluorescence intensities as 
YdiV (at 2.3 µM) and ligands were again added at 0.4 µM, Mg2+ at 12 µM in a 10 mM Tris-
HCl pH 7.4 buffer.  
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Samples were made, mixed thoroughly in a 3 ml cuvette.  Fluorescence readings were 
taken at 26⁰C, with an excitation wavelength of 280 nm, and emission readings recorded 
between 300-400 nm (Figure 4.12).  The most obvious difference in the resultant spectra 
was that the YdiV emission peak was at ~330 nm, compared to the NATA emission peak at 
~360 nm.  This is simply due to the contrasting nature of the fluorescence emitters, with 
NATA having a purely Trp emission, which exists freely in solution, whilst the YdiV emission 
is due to the protein tryptophan residues, which are therefore influenced by the protein 
environment.   
 
When comparing the YdiV traces in the presence of nucleotides to the NATA and 
nucleotide traces, a few minor differences were seen (Figure 4.12).  In the presence of 
pGpG and c-di-GMP, the minor variations observed for YdiV with and without these 
nucleotides was approximately the same as the NATA variation, indicating no apparent 
binding to YdiV.  The remaining nucleotides caused a slight decrease in YdiV fluorescence 
(red traces compared to the protein only blue traces in Figure 4.12), which in many cases 
(GTP, GMP, cAMP) was a larger change than the reference NATA samples with and without 
these nucleotides.   However, even the biggest change observed, for YdiV with and without 
GTP addition, resulted in a less than a 10% decrease in fluorescence intensity, which is a 
relatively small change.  Of note, there was no significant red/blue shift in the wavelength 
of maximum fluorescence of the samples upon nucleotide addition (Figure 4.12).  Any 
changes in the wavelength maxima were of ~ 1 nm difference, within the same variation 
range as for the multiple YdiV only samples and therefore irrelevant.   
 
To investigate how reliable these changes were, the c-di-GMP assays were repeated at 
various constant temperatures (26, 30 and 35⁰C) using both YdiV and the reference NATA 
compound.  The traces obtained showed quite a significant variation in response to 
temperature (Figure 4.13).  At 26⁰C and 35⁰C, both YdiV and NATA underwent a similar 
fluorescence quenching upon c-di-GMP addition, suggesting that no interaction had taken 
place between YdiV and c-di-GMP.  However at 30⁰C, the result was different, with the YdiV 
sample undergoing a significantly larger quench when c-di-GMP was present compared to 
the NATA sample.  Taken on its own, this 30⁰C assay might suggest that binding was 
occurring between c-di-GMP and YdiV, however it is unlikely that the binding would be so 
temperature specific, and therefore this experiment is more likely to show the level of 
error and variability in this technique.  Since the quenching seen at 30⁰C for YdiV and  
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Figure 4.13: Fluorescence spectroscopic analysis of YdiV and c-di-GMP binding at 
various constant temperatures 
The c-di-GMP series of assays were carried out at different temperatures (26, 30 
and 35⁰C), with YdiV and NATA as specified.  In all cases, blue traces show YdiV (0.4 
µM) or NATA only, with red traces showing YdiV or NATA in the presence of c-di-
GMP (0.4 µM) 
The emission intensity (y-axis) is shown against emission wavelength (x-axis) for all 
graphs.  
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c-di-GMP is a similar decrease (~10%) to several of the YdiV-nucleotide differences in Figure 
4.12, this questions the validity of these changes, and the likelihood is that they are simply 
variations within experimental error.  
 
This technique therefore did not rule out nucleotide binding by YdiV, but equally it did not 
suggest that ligand binding occurred or provide any information on the identity of the 
potential ligand.  
 
4.5.3   Nuclear Magnetic Resonance analysis of YdiV in the presence of 
nucleotides 
 
Following the initial two techniques used to analyse nucleotide binding, proton NMR was 
carried out for a smaller subset of nucleotides, as a final attempt to reach a conclusion on 
this matter.  Proton NMR studies the environment of H nuclei in a protein or nucleotide 
with proton nuclei having characteristic chemical shifts depending on the molecular 
structure and environment in which the proton resides.  
 
The technique of NMR exploits the natural magnetic field associated with all atoms, placing 
samples into a large magnet and thereby lining up the nuclear spin with the NMR magnet, 
resulting in net magnetisation in the direction of B0 (the static magnetic field).  The spin is 
then perturbed by applying rf (radio-frequency) energy to the sample, causing the 
magnetisation to flip 90⁰, no longer aligned with the applied magnetic field.  The 
magnetisation precesses in the magnetic field, inducing an electric current in a detection 
coil, at a resonance frequency of each nucleus.  The excited nuclei decay with time back to 
the equilibrium position, resulting in an FID (free-induction decay) which is recorded.  The 
recorded signal has a low signal-to-noise ratio, therefore signal averaging is applied, 
enabling lots of individual decay curves to be added together and thereby increasing this 
ratio.  This is then Fourier transformed into a spectrum showing the chemical shift of the 
sample, and indicating the environments of all hydrogen nuclei.  From these spectra, the 
environments of simple molecules can be analysed and protein and ligand binding detected 
(Wüthrich, 1986) 
 
Proton NMR was carried out for YdiV with and without the addition of various nucleotides 
(Section 2.7.3).  A smaller subset of nucleotides was chosen for this analysis, due to the 
increased workload of this technique, choosing c-di-GMP and ppGpp, which had shown 
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potential as ligands in the partial proteolysis analysis in Section 4.5.1.  Alongside these, 
pGpG was chosen, simply due to its similarity to ppGpp, and the GXP group chosen (GMP, 
GDP and GTP) due to GTP and GMP being the enzymatic substrates and breakdown 
products in the c-di-GMP signalling pathway.  Samples were made consisting of 30 µM 
purified YdiV (Sections 2.6.3 and 2.6.7), 30 µM nucleotide, or 30 µM of both protein and 
nucleotide, all of which were analysed in a Tris-HCl buffer (20 mM Tris, 500 mM NaCl, 20 
mM arginine, pH 7.4) with the addition of 1 mM Mg2+ and 0.5 mM EDTA (Section 2.7.3) . 
The samples were then analysed by proton NMR (Dr. Andrea Hounslow, University of 
Sheffield) and spectra recorded for samples from 1-11 ppm.   
 
Samples of nucleotides individually and the nucleotides in mixtures with the YdiV protein, 
as well as an YdiV only sample, were analysed, enabling the nucleotide peaks to be 
compared when YdiV was both absent and present.  Additionally the protein (amide) region 
of the spectra could be compared between an YdiV only sample and the YdiV plus 
nucleotides sample.  
 
A representative nucleotide chemical shift was found to be in the ~6 ppm range, which was 
not overlapping with protein spectra and therefore could be compared for each set of 
nucleotides, tested singularly and when mixed with YdiV.  The spectra were stacked in 
order to enable comparison between each pair of samples (Figure 4.14).  Theoretically if a 
protein and nucleotide were to interact, the nucleotide would make binding contacts with 
the protein, therefore changing the environment of the hydrogen nuclei in the nucleotide.  
This would be detected by NMR as a change in linewidth of the peaks as well as a change in 
the chemical shifts.  The MW of a complex is directly related to the relaxation decay rate of 
the NMR signal, which is detectable as a change in linewidth.  Therefore the small MW 
nucleotides would have a sharp peak, as the rate of decay of the magnetisation is slow, 
whilst large proteins which have fast NMR decay rate would produce a broad peak.  If a 
nucleotide were to bind to a protein, it would be enveloped in this protein to some extent 
and therefore take on the MW of the protein, detectable as a broadened peak in the NMR 
spectra.  In addition, if a nucleotide and protein were to bind, the protein would alter the 
environment of the nucleotide hydrogen nuclei and therefore cause a change in the 
chemical shift.  
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Figure 4.14: Proton NMR spectra focused on the nucleotide chemical shift in the 
presence and absence of YdiV 
Stacked proton NMR spectra, showing the nucleotide chemical shift region of the 
spectra for each sample.  
Samples contained 30 µM nucleotide, or 30 µM of both nucleotide and YdiV in a Tris-HCl 
buffer (20 mM Tris-HCl, 500 mM NaCl, 20 mM arginine, pH 7.4) with the addition of 1 
mM Mg2+ and 0.5 mM EDTA. In all cases, nucleotides are indicated with +/- referring to 
presence or absence of YdiV protein. 
The spectrum for each sample was recorded between 1-11 ppm chemical shift, and the 
region shown here between 5.8-6.15 ppm covers the nucleotide-derived portion of the 
spectra only.  
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From the spectra obtained, at 5.8-6.15 ppm the stacked pairs of nucleotide and nucleotide 
plus protein peaks do not seem to change upon protein addition (Figure 4.14).  For all six 
nucleotides the pairs of peaks appear similar with little change in width or in chemical shift.  
The only minor change is upon pGpG addition when the doublet dips appear smaller than 
when pGpG alone was present; however this was regarded as a minor change and one that 
did not unequivocally indicate binding.  
 
Additionally, the protein amide regions of the spectra could be compared, to determine 
whether the protein spectrum was changing.  This amide region of a protein has a 
characteristic chemical shift of 5-9 ppm; here the focus was on 6.5-9 ppm to avoid the 
presence of nucleotide derived peaks seen at 5-6 ppm.  Theoretically, if a nucleotide were 
to bind to a protein, this would influence the environment of the protein nuclei, in at least 
the region of binding and the surrounding nuclei.  This change in environment would affect 
the resonance frequency of the nuclei, detectable by a change in the chemical shift.  Whilst 
it is almost impossible to detect a change in specific nuclei in the amide region, analysis of 
this region as a whole can be sufficient to detect binding.  
 
Samples of the YdiV protein and the protein mixed with each nucleotide were analysed, 
stacking the spectra for ease of analysis (Figure 4.15).  The complicated series of spectra 
shown represent each NH group of every one of YdiV’s 237 residues.  Of note are the two 
large peaks seen in all samples at 7.3 ppm and 8.2 ppm, which are due to the nuclei in the 
buffer used to prepare each sample.  Upon comparing the stacked spectra, the bottom five 
spectra (GMP, GDP, GTP, pGpG and ppGpp nucleotide and protein samples) appeared 
essentially identical, with the only minor change being the appearance of a small peak at 
~8.25 ppm for the GMP and YdiV sample.  Therefore these five spectra were taken as a 
baseline for comparison with the other two spectra.  
 
Upon addition of c-di-GMP to the protein, a distinct spectrum was produced, differing in 
several places to the bottom five spectra.  Changes at 8.1, 7.8, 7.4, 7.2 and 6.9 ppm were 
identified (highlighted by blue boxes), all of which are indicative of a change in 
environment of YdiV upon c-di-GMP addition (Figure 4.15).  
 
Unexpectedly, the YdiV only spectrum also showed differences compared to the baseline 
spectra, specifically at 8.0, 7.9, 7.4, 7.2 and 6.9 ppm, indicated by red boxes (Figure 4.15).  
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Figure 4.15:  Proton NMR spectra in the 6.3-9.1 ppm region, for YdiV in the presence 
and absence of nucleotides 
Stacked proton NMR spectra, showing the chemical shift between 6.3 and 9.1 ppm, 
with the protein (YdiV) only trace at the top, as labelled, and all other traces being of 
the protein in the presence of various ligands, again as specified.  
Samples contained 30 µM YdiV, or 30 µM of both YdiV and nucleotide (as indicated) in 
a Tris-HCl buffer (20 mM Tris-HCl, 500 mM NaCl, 20 mM arginine, pH 7.4) with the 
addition of 1 mM Mg2+ and 0.5 mM EDTA.  
Boxed regions of the traces indicate particular regions of interest, which differ to the 
baseline (GMP/GDP/GTP/pGpG/ppGpp) traces.  
Red boxes highlight areas of interest in YdiV (at 8.0, 7.9, 7.4, 7.2 and 6.9 ppm) whilst 
blue boxes highlight areas of interest in the YdiV + c-di-GMP sample (notably at 8.1, 
7.8, 7.4, 7.2 and 6.9 ppm).   
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These spectral disparities indicate changes in the protein nuclei environments when the 
protein was present alone compared to when the protein was in the presence of 
nucleotides (GMP/GDP/GTP/pGpG/ppGpp).  Three of the spectral changes (at locations 6.9, 
7.2 and 7.4 ppm) were present in both the YdiV and YdiV + c-di-GMP sample, and therefore 
are c-di-GMP independent.  Crucially though, the YdiV only trace lacks the peaks at 8.1 and 
7.8 ppm which were present in the c-di-GMP sample, revealing that these spectral changes 
were c-di-GMP dependent.  The peaks at 8.1 and 7.8 ppm present in the YdiV and c-di-GMP 
sample refer to changes in the environment of the protein amide backbone residues; 
however, the identity of these residues cannot be determined by ID proton NMR. 
 
Interpreting the data was complicated by the fact that the YdiV only sample differed from 
all the remaining nucleotide samples, rather than being identical to some of those traces, 
which would then confirm the validity of any changing spectra.  This therefore raises 
questions as to whether the observed differences are due to genuine binding interactions 
or weak artefacts of interactions between the sample components affecting the spectra.  
To clarify this Clp, a known c-di-GMP binding protein, was isolated, and the NMR spectra 
after c-di-GMP binding was determined for this system (Chin et al., 2010).  
 
4.5.4   Cloning and over-production of the fusion protein Clp-His6 
 
The transcriptional regulator Clp from Xanthomonas campestris was used as a positive 
control, as this protein is known to bind c-di-GMP (Chin et al., 2010). 
 
The gene clp was amplified from X. campestris pv. vesicatoria using primers NSW13 and 
NSW14 (Table 4.3), as described in Section 2.3.2.  These primers were designed to contain 
an NdeI and an XhoI restriction site at either end of the PCR fragment (Section 2.3.2).  The 
clp stop codon was not included in the primer sequence, in order to allow fusion with the 
C-terminal His6 tag encoded by the pET21a vector (Figure 4.16).  
 
Table 4.3: Primers used in amplification of clp gene for insertion into pET21a vector 
Primer Sequence Function 
NSW13 TTTTCATATGAGCCCAGGAAATAC
GAC 
Forward primer for clp gene 
NSW14 TTTTCTCGAGGCGGGTGCCGTACA
GCAC 
Reverse primer for clp gene (no stop 
codon to enable Clp:His fusion) 
 The grey shaded sequence indicates an NdeI restriction site (which includes the start codon 
ATG) and the boxed sequence shows an XhoI restriction site.  
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Figure 4.16: Schematic plasmid map for the insertion of clp into pET21a 
Plasmid map for the pGS2368 constructed vector, indicating position of the His6 tag 
and clp insertion site, and the fusion protein produced.  
 The direction of transcription is indicated.  
The vector encodes a C-terminal His6 fusion protein, with two amino acid residues 
linking clp and the His6 tag, giving a total molecular weight of 26 KDa.  
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PCR reactions were carried out using high fidelity polymerase, E. coli MG1655 genomic DNA 
and primers NSW13 and NSW14, to amplify the clp gene (Section 2.3.3).  The PCR product 
was purified and digested with the restriction enzymes NdeI and XhoI (Sections 2.3.10 and 
2.3.6).  The pET21a vector was purified and digested with these same restriction enzymes 
to create a linearised plasmid (Sections 2.3.4 and 2.3.6).  The PCR product and plasmid 
were then ligated and used to transform electrically competent E. coli DH5α (Sections 2.3.9 
and 2.2.7).  Colonies containing the plasmid were selected using ampicillin resistance and 
then the size of the plasmid insert was analysed by colony PCR and T7 promoter and T7 
terminator primers (Table 4.2) (Sections 2.3.11).  The sequence of the insert was then 
confirmed by DNA sequencing using the T7 sequencing primers (Table 4.2) and plasmids 
containing no mutation were named pGS2368 (pET21a::clp).  The plasmid was then used to 
transform electrically competent E. coli BL21 (λDE3) cells, ready for protein overproduction 
(Section 2.2.7).  
 
Overproduction of the protein construct, Clp-His6 was carried out in E. coli BL21 λ(DE3) 
pGS2368.  The optimal overproduction conditions were not investigated, instead the Chin 
et al. protocol in which overproduction occurred for 8 h with 100 µg/ml IPTG inducer was 
adopted (Chin et al., 2010).  Overnight cultures were grown in LB, supplemented with 
ampicillin, which were then used to inoculate larger 500 ml cultures for overproduction. 
The cultures were incubated at 37⁰C until an OD600 of ~0.6 was reached, at which point 
IPTG was added and the cultures incubated for another 8 h.  Following this, the cultures 
were harvested and cell pellets stored at -20⁰C until required (Sections 2.2.2, 2.2.3 and 
2.6.1)  
 
To purify the Clp-His fusion protein, the cell pellets (of strain E. coli BL21 λ(DE3)/pGS2368) 
were re-suspended in breakage buffer, prior to sonication and fractionation of the soluble 
and insoluble fractions (Section 2.6.2).  The soluble fraction was purified by HiTrap His-
chelating chromatography on an AKTA Prime protein system (Section 2.6.3).  The His-
chelating programme was run on the system and the elution profile recorded (Figure 
4.17A).  The elution profile showed two distinct peaks, of which the first usually indicates 
the elution of non-specifically bound protein.  To confirm the presence of Clp in the second 
peak, eluted fractions were analysed on an SDS-PAGE gel (Section 2.6.9) and showed 
purified Clp-His6 at the expected size of 26 KDa (Figure 4.17B).  The purest and most 
concentrated fractions were then chosen for future use.  
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Figure 4.17: HiTrap chelating chromatography as a one-step purification of Clp-His6 
fusion protein 
A) Elution profile of Clp-His6 from HiTrap chelating chromatography.  
Cell-free extract containing Clp-His6 was applied to a 1 ml HiTrap chelating 
column and fractionated by an imidazole gradient (linear gradient from 0-0.5 
M).  The blue trace shows the detected A280nm levels, indicative of the presence 
of protein, with the red trace representing the imidazole gradient.  The 
expected Clp-His6 location is indicated.   
B) Coomassie- stained SDS-PAGE gel of Clp-His6 purification.  
HiTrap elution fractions spanning the second peak from the Ni-NTA trace in (A). 
 M= Precision plus protein standard marker (molecular weights indicated in 
KDa), 2: soluble crude extract, 3-7: fractions 12-16 eluted from the HiTrap 
column.  
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4.5.5   Nuclear Magnetic Resonance analysis of Clp in the presence of 
c-di-GMP  
 
In order to study the proton NMR spectrum of Clp, the chosen purified fractions (Figure 
4.16B) were dialysed into the same Tris-HCl buffer used for the YdiV assays (20 mM Tris-
HCl, 500 mM NaCl, 20 mM arginine, pH 7.4) (Section 2.6.7).  Samples were then prepared 
of 30 µM Clp, 30 µM c-di-GMP and 30 µM of both Clp and c-di-GMP in the same buffer 
conditions as previously used to test YdiV samples.  The samples were then analysed by 
NMR, focusing again on the nucleotide peak and the amide regions of the spectra (Figure 
4.18 and 4.19 respectively) (Section 2.7.3).  
 
Given the knowledge that Clp bound to c-di-GMP (Chin et al., 2010), it was surprising that 
the nucleotide peak corresponding to the nuclei in the c-di-GMP molecules did not alter 
upon protein addition (Figure 4.18).  It was expected that the nucleotide peak would 
broaden or shift if bound to a protein, however that did not occur, with both traces being 
essentially identical in the presence or absence of protein.  
 
More differences were noted in the protein amide region of the spectra, with some of the 
protein peaks (identified by green boxes) altering quite significantly in the presence of       
c-di-GMP, specifically at regions 6.6, 6.75, 7.0, 7.8, 7.9 and 8.1 ppm (Figure 4.19).  Whilst 
this was reassuring, it is also known that a large conformational change occurs upon Clp 
and c-di-GMP binding, which questions whether any interaction lacking this large 
conformational change, would be detectable from the NMR spectra using this method.  
Interestingly, the chemical shifts produced at 7.8 and 8.1 ppm upon c-di-GMP interaction 
with Clp were similar to those in the YdiV and c-di-GMP sample (Figure 4.15).   
 
The relatively minor changes in the Clp amide spectra upon c-di-GMP binding (Figure 4.19), 
supports a hypothesis of nucleotide binding in YdiV, given that there was a similar level of 
chemical shifts observed (Figure 4.15).  
 
Whilst no firm conclusion can be made, it was tentatively proposed that YdiV interacts with 
c-di-GMP.  Both partial proteolysis and proton NMR have revealed changes in the trypsin 
profile and proton chemical shifts respectively upon addition of c-di-GMP.  To support this 
hypothesis, further experimentation would be necessary, such as analysis by Isothermal 
Titration Calorimetry.  
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Figure 4.18: Proton NMR spectrum in the 5.71-6.15 ppm region for c-di-GMP, in the 
presence and absence of Clp 
Stacked proton NMR trace, showing the nucleotide chemical shift region of the specta, 
at 5.7-6.15 (indicated here in ppm).  
Samples contained 30 µM c-di-GMP, or 30 µM of both c-di-GMP and Clp in a Tris-HCl 
buffer (20 mM Tris-HCl, 500 mM NaCl, 20 mM arginine, pH 7.4) with the addition of 1 
mM Mg2+ and 0.5 mM EDTA.  
The annotations +/- refers to presence or absence of Clp protein. 
 
 
Figure 4.19:  Proton NMR spectrum in the 6.3-9.1 ppm region, for Clp in the presence 
and absence of c-di-GMP  
Stacked proton NMR spectra, showing the chemical shift between 6.3-9.1 ppm, for the 
red (Clp only) and blue (Clp and c-di-GMP) samples.  
Samples contained 30 µM Clp, or 30 µM of both c-di-GMP and Clp in a Tris-HCl buffer 
(20 mM Tris-HCl, 500 mM NaCl, 20 mM arginine, pH 7.4) with the addition of 1 mM 
Mg2+ and 0.5 mM EDTA.  
Green boxed regions highlight regions of spectral differences between the Clp only and 
Clp + c-di-GMP samples.  
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4.6   Characterisation of the effects of ydiV over-expression and 
mutations on bacterial motility 
 
Following Dr Melissa Lacey’s work, in which phenotyping studies showed a decrease in 
motility upon ydiV over-expression (unpublished), investigations were carried out, to 
determine whether YdiV was affecting the flagella levels directly, or whether some other 
mechanism was acting.  
 
The strains studied were E. coli MG1655 (wild-type cells), JRG6058 (MG1655 pBR322), 
JRG6134 (MG1655 pBR322:ydiV), JRG6130 (MG1655ΔydiV) and JRG6578 (MC1000ΔfliC) 
(Table 2.1).  This represented a wild-type strain, two positive control strains (vector and 
ydiV mutant), the strain of interest (ydiV over-expression in strain JRG6134) and a negative 
control strain (fliC mutant).  
 
To analyse the motility phenotypes of these strains, two approaches were taken, detection 
of FliC by Western blot analysis and flagella visualisation by EM.  
 
4.6.1   Determination of FliC expression levels according to ydiV 
expression  
 
Since FliC is the basic subunit forming E. coli flagellar filament, the levels of this protein 
were analysed by Western blot assays, probing with a FliC antibody (Kuwajima et al., 1986).  
 
The E. coli strains of interest were grown in motility broth as overnight cultures and then 
sub-cultured until OD600 ~0.2 reached (Sections 2.2.1, 2.2.2 and 2.2.3).  The cells were 
harvested by centrifugation at 4000 xg for 10 min and the pellets resuspended carefully in 
dH2O to reduce flagellar shearing, before samples were mixed with SDS-loading dye (Table 
2.8).  The samples were then analysed by SDS-PAGE and Western blot as described in 
Sections 2.6.9 and 2.6.10 respectively.  Western blot analysis used a primary antibody of 
FliC (1/3000 dilution) with the anti-rabbit secondary antibody (diluted at 1/10,000).  
 
The Coomassie-stained SDS-PAGE gel showed equal loading of samples of the various 
strains indicating comparable cell densities and components (Figure 4.20).  The FliC protein, 
of expected size 51.3 KDa, was not identifiable from the SDS-PAGE gel. The Western blot  
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Figure 4.20: Detection of FliC production in various strains, including ΔydiV 
and ydiV over-expression strains 
Coomassie-stained SDS-PAGE gel (top) and Western blot probed with FliC 
antibody (bottom).  
The SDS-PAGE gel shows equal loading of the five strains (as specified), 
which were then probed with the FliC antibody.  
The expected size of FliC was 51.3 KDa, and is not clearly visibly from the 
SDS-PAGE gel, however it can clearly be identified by Western blot analysis.  
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however clearly showed a species indicating the FliC protein, which appeared to be present 
in only some of the strains.  The wild-type (E. coli MG1655), empty vector control (MG1655 
pBR322) and YdiV mutant (MG1655 ΔydiV) possessed detectable FliC, at a seemingly similar 
level.  As expected the negative control fliC mutant (MC1000 ΔfliC) lacked FliC.  Of note, the 
strain of interest; the ydiV over-expression strain (MG1655 pBR322:ydiV) also lacked FliC in 
the Western blot, indicating that ydiV over-expression in some manner prevents FliC 
production.  
 
4.6.2  Flagella number per cell changes as a result of ydiV over-
expression or mutations 
 
To confirm this FliC change upon ydiV over-expression, the E. coli flagella were visualised by 
transmission electron microscopy.  Strains were once again grown in motility broth (Section 
4.6.1) until comparable optical densities were achieved. The cultures were harvested at low 
speeds (4000xg) and resuspended slowly and very gently in order to reduce flagellar 
shearing.  Once the cultures had been resuspended, the cell samples were fixed in a 50/50 
mix of fixing solution, preserving the growth state of cells (Section 2.5.1).  When ready to 
observe the cells, samples were placed on a formvar coated copper grid, stained with 
phosphotungstic acid and observed by EM as detailed in Section 2.5.1 (Mr Chris Hill, 
University of Sheffield).  Ideally, for future work, the same batch of cell samples would be 
used for both of the flagellar detection techniques used (Western blots and EM) rather 
than separate cell cultures which were used in this work.  
 
Representative images were recorded for each strain (Figure 4.21).  Upon visualisation, it 
could be seen that there was a marked change in flagella number for the various strains. 
There were flagella protruding from almost every cell in the wild-type strain (E. coli 
MG1655), the ydiV mutant (MG1655ΔydiV), and although less clear, the vector control 
strain (MG1655 pBR322).  As expected there was a complete lack of flagella in the fliC 
mutant strain (MC1000 ΔfliC) but of interest there was a clear decrease in flagella in the 
ydiV over-expressing strain (MG1655 pBR322:ydiV).  Quantifying the number of flagella 
present in a sample of 25 cells of each strain (highlighted the lack in flagella in ydiV 
overproduction strains.  The samples of 25 cells showed 93 flagella (E. coli MG1655), 59 
flagella (pBR322), 69 flagella (ΔydiV) and 1 flagellum for the negative control strain (ΔfliC).  
The same sized cell sample of ydiV overproduction (pBR322:ydiV) cells showed only 9  
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flagella, noticeably less that the empty vector control or wild-type strains.  Therefore, there 
is an ~80% decrease in flagella numbers in the ydiV overproduction strain compared to the 
vector control or wild-type strains.  This supports the theory that elevated levels of YdiV (as 
seen in the pBR322:ydiV strain) inhibit FliC production.  As FliC is the basic unit which forms 
the visible bacterial flagella filament, this results in a lower number of flagella produced.  
 
In hindsight, these motility assays (both Western blot and TEM visualisation) should have 
been carried out at 30⁰C rather than 37⁰C, as flagellar-based motility is inhibited above 
37⁰C (Adler & Templeton, 1967). Whilst clearly FliC was detected in the Western blot assays 
and flagella are detected in the TEM, abundant numbers are not apparent, which could be 
resolved by repetition of the assays at a lower temperature.  
 
4.7   Identification of ydiV induction conditions   
 
Following the observation that over-expression of ydiV caused motility changes, attempts 
were made to determine under which growth conditions the ydiV gene was highly 
expressed.  This was carried out both by studying the protein levels and gene expression 
levels under various growth conditions. 
 
4.7.1   YdiV protein production analysis  
 
The effect of E.coli growth rates on YdiV protein levels was analysed by Western blot 
analysis.  Chemostat samples were provided by Thomas Curran, in which E. coli MG1655 
cells were cultured in Evans minimal medium (Section 2.2.1) at pH 6.95, 37⁰C and with 400 
rpm stirring.  The chemostat cultures were grown at different growth rates, by controlling 
the medium dilution rate.  Bacterial growth rates between 13.9 h (0.05 /h dilution rate) and 
1.4 h (0.5 /h dilution rate) were analysed, as described in Section 2.2.2 
 
The chemostat samples analysed came from cultures grown at four different dilution rates 
(0.05, 0.1, 0.2 and 0.5 /h) each with two biological replicates.  These samples were analysed 
alongside the E. coli strains MG1655 (wild-type), JRG6130 (MG1655 ΔydiV acting as a ydiV 
mutant) and JRG6134 (MG1655 pBR322:ydiV acting as a YdiV overproduction strain) all 
grown in LB medium at 37⁰C (Sections 2.2.1 and 2.2.2) with these and the chemostat 
samples diluted to give comparable cell densities (Table 2.1).  These whole-cell samples 
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were separated by SDS-PAGE electrophoresis (Section 2.6.9) and analysed by Western 
blotting (Section 2.6.10) alongside a reference sample of purified YdiV protein at 0.01 
mg/ml concentration (Figure 4.22) (Section 4.2.3).  Polyclonal antibodies raised against YdiV 
(Section 5.5), were used in the Western blot analysis, initially at 1/5000 dilution before 
lowering to 1/10,000 to decrease the non-specific background.  
 
The resultant Western blots indicated that the expression levels of YdiV are below the 
detection limit (Figure 4.22).  The 0.01 mg/ml purified sample (which was too dilute for  
Coomassie detection), was easily detected by Western blotting.  Other than this sample, 
the only other sample containing detectable levels of YdiV was the YdiV overproduction 
strain in lane 3 (Figure 4.22).  All other samples did not show the presence of YdiV.   This 
indicates a very low level of YdiV was present at all the dilution rates tested, and gave no 
indication of ydiV induction conditions. 
 
4.7.2   Gene expression analysis of ydiV in the presence of quorum 
sensing molecules 
 
The expression levels of ydiV were further analysed in the presence of quorum sensing (QS) 
molecules, using β-galactosidase assays to quantify expression levels (Section 2.4.1).  
 
It has been reported that an up-regulator of ydiV expression is SdiA (Suppressor of cell 
division inhibitor) which is part of the QS system 1.  SdiA is a quorum-sensing protein, and 
is activated by extracellular autoinducer 1 (AI-1) which is presumably produced by other 
microbial species because E. coli does not produce AI-1 (Zhou et al., 2008).  The primary 
autoinducers produced by many gram-negative bacteria are acyl-homoserine lactone (AHL) 
molecules, which are lipid molecules consisting of a lactone ring and an acyl chain (Watson 
et al., 2002; Zhou et al., 2008).  
 
Theoretically then, the levels of flagella gene expression can be altered to some extent 
simply by altering the autoinducer 1 (AHL) levels via a cascade of activation and inhibition 
(Figure 4.23).  
 
β-Galactosidase assays (Section 2.4.1), using strain JRG6097 (a ydiV::lacZ fusion strain) were 
used to attempt to identify conditions in which ydiV was induced (Table 2.1).  These assays 
156 
 
 
 
                             
                         
                                   
                                  
                         
 
 
 
 
  
Figure 4.22: Comparison of YdiV protein expression levels at various growth rates 
A) Coomassie-stained SDS-PAGE gel, B) Western blot probed with YdiV antibody.  
For ease of labelling, dilution rates (/h) are denoted simply by numbers, i.e. 0.05 to 0.5, 
as explained previously, and the two biological replicates denoted by #1 or #2.  
M:BioRad prestained marker, molecular weights indicated in KDa.  Lanes 1: E. coli 
MG1655, 2: ΔydiV, 3: pBR322:ydiV, 4: 0.01 mg/ml purified YdiV protein, 5: MG1655 
0.05 #1, 6: MG1655 0.05 #2, 7: MG1655 0.1 #1, 8: MG1655 0.1 #2, 9: MG1655 0.2 #1, 
10: MG1655 0.2 #2, 11: MG1655 0.5 #1, 12: MG1655 0.5 #2. 
The position of YdiV is indicated by the arrow, and boxed in B.  
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Figure 4.23: Schematic of SdiA induced YdiV expression 
Schematic diagram of the series of events that result in YdiV production and the 
inhibition of the transcription factor FlhDC.  
N-acyl-homoserine lactone molecules (AHL) are produced and activate SdiA, which 
upregulates the transcription of ydiV, causing an increased level of YdiV protein in the 
cell.  The YdiV in turn then causes FlhDC to be dissociated from DNA, causing 
downregulation of flagellar genes.  
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were carried out in the presence of two types of AHL; N-(β-Ketocaproyl)-L-homoserine 
lactone and N-Hexanoyl-DL-homoserine lactone, which for ease are henceforth referred to 
as K and H respectively.  
 
The ydiV-lacZ strain (JRG6097) of E. coli was cultured overnight and then sub-cultured at 
28⁰C until mid-log phase was reached (Section 2.2.2).  The β-galactosidase assays were 
prepared, using 250 µl cells and initially 1 µM AHL at the sub-culturing stage, and assays 
carried out at 28⁰C under aerobic conditions (Section 2.4.1).  The concentration of AHL and 
stage of its addition were altered throughout the experiments, dependent on previous 
results.  
 
For each condition, three biological replicates were made, and the assays performed in 
triplicate.  From the raw data, the average MU (Miller unit) was determined, and the 
standard deviation calculated (shown as error bars on the graph) for each condition.  
 
Initially a final concentration of 1 µM AHL was added at the sub-culture stage and β-
galactosidase assays carried out after 3 h of incubation (Figure 4.24A).  The MU values for 
all cultures were low and similar.  There was no difference between the samples, with the 
error bars overlapping for all four conditions.  Following this, AHL was added for the 
duration of cell growth, at a concentration of 1 µM AHL (Figure 4.24B).  Again, very low 
expression of ydiV was detected.  Despite the AHL samples having a higher MU (Figure 
4.24B), there were no significant differences between conditions.  
 
Following a lack of any ydiV induction, the concentration of AHL was increased to a 
concentration of 50 µM to determine if the concentration was simply too low previously.  
Assays were carried out, this time just adding either K or H to the samples (Figure 4.24C). 
Once again no difference was seen, providing no indication of how ydiV expression is 
activated. 
 
At this point, it was concluded that ydiV was not being induced to a detectable level, even 
with the addition of high concentrations of AHLs.  SlyA is known to be a transcriptional 
regulator and an inducer of cell motility and potentially an up-regulator of ydiV expression 
(Simms & Mobley, 2008).  We therefore transformed the JRG6097 strain with a SlyA 
overproduction plasmid (pGS2468) (Section 2.2.7) (Table 2.2).  The plasmid contained the  
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Figure 4.24: β-Galactosidase assay results using the E. coli ydiV-lacZ strain 
Bar graphs plotted from β-galactosidase assays carried out in the presence of varying 
concentrations of AHL.  In all cases, a negative control ‘No addition’ culture was used as 
a baseline, alongside ‘K’, ‘H’ and ‘K/H’ mixes, simply indicating the presence of the K (N-
(β-Ketocaproyl)-L-homoserine lactone) or H (N-Hexanoyl-DL-homoserine lactone) or a 
mixture of both.  
A: A final concentration of 1 µM AHL was added at the sub-culture stage, absent in the 
overnight stage.  B: A final concentration of 1 µM AHL was added for duration of E. coli 
ydiV-lacZ cell growth.  C: A final concentration of 50 µM AHL was added for the duration 
of E. coli ydiV-lacZ cell growth. 
For A, B and C, the bars show the average MU (Miller Units) for each condition.  Each 
condition was tested using three biological replicates, with assays done in triplicate. 
Average MU values are plotted, with variation shown as error bars.   
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slyA gene under the control of its own promoter, requiring no IPTG induction.  Further β-
galactosidase assays (Section 2.4.1) were carried out using this E. coli JRG6097/pGS2468 
strain, again adding 50 µM AHL to the cells for the duration of growth (Figure 4.25). 
The data (Figure 4.25), showed K addition gave a higher average MU value, however these 
were not significantly different from the other cultures.  Therefore SlyA overproduction did 
not appear to affect ydiV expression.  
 
4.7.3   Promoter alignment  
 
In a final attempt to understand the regulation of ydiV transcription, the promoter regions 
upstream of the ydiV gene in various E. coli and Salmonella strains were analysed (Section 
2.10.2).  All sequenced strains of E. coli and S. enterica were analysed, retrieving the 
sequences from xBASE (http://www.xbase.ac.uk/).  The intergenic 247 bases between ydiV 
and the upstream nlpC gene from E. coli strain K-12 MG1655 was chosen as a sufficient 
promoter region and the same length upstream sequence was obtained for other strains 
containing the ydiV gene.  These DNA sequences were then analysed and aligned using 
Mega6 (http://www.megasoftware.net ) and the ClustalW parameters.  In addition, 
Softberry promoter prediction software (www.softberry.com) was used to detect 
regulatory promoter motifs in the alignment (Figure 4.26).  
 
Analysing the degree of similarity first, the E. coli strains (except B-strains) showed a high 
degree of sequence identity to one another, with almost completely identical promoter 
sequences.  The two E. coli B-strains (B str. REL606 and BL21(DE3)) were noticeably 
different to the remaining E. coli sequences.  However, the promoter regions for the E. coli 
B-strains were identical to each other, showing conservation within this subgroup. Finally, 
six S. enterica strains were also analysed, and were almost completely alike, showing 
promoter conservation within the species.  Of importance however, whilst the S. enterica 
strains showed clear differences to the E. coli sequences, there were regions of identity. 
Indeed there was higher sequence similarity detected between the E. coli K-12 derived 
strains and S. enterica sequences compared to the E. coli K-12 derived strains and E. coli B-
strains, implying an unexpected evolutionary order.  
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Figure 4.25: β-Galactosidase assay results using the E. coli ydiV- lacZ/pET28a:slyA 
strain 
Bar graphs plotted from β-galactosidase assays carried out in the presence of 50 µM 
AHL.  Control assays with no AHL are shown as ‘No addition’ samples, plus N-( β-
Ketocaproyl)-L-homoserine lactone  and N-Hexanoyl-DL-homoserine lactone were 
added, labelled as ‘K’ and ‘H’ addition respectively.  
Here the AHL addition was carried out at the initial over-night stage, meaning presence 
of AHL for the duration of cell growth.  
Each condition was tested using three biological replicates, and the assays done in 
triplicate.  Average values are shown in Miller Units (MU), with error bars indicating 
the level of variation in the samples.  
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E. coli  55989  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  APEC O1  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  B str. REL606  - - - - - - - - - T C T G T A A T T G T T A T G T C T T A T G G C C T - C A T C - - C C T T T T A G
E. coli  BL21(DE3)  - - - - - - - - - T C T G T A A T T G T T A T G T C T T A T G G C C T - C A T C - - C C T T T T A G
E. coli  BW2952  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli CFT073  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  ED1a  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  IAI1  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  IAI39  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C T C C G T C C A T T T A C
E. coli  K-12 MG1655  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  NCTC86  - - - - - - - - - - - - - - - - A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  O103:H2 str. 12009  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  O111:H- str. 11128  - - - A G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  O127:H6 str. E2348/69  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli O157:H7 str. TW14359  - - - - G T A T G T C G A A A A T T G G A C G T C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  O26:H11 str. 11368  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli S88  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli  str. K-12 substr. DH10B  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli str. K-12 substr. W3110  - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - A T T T A C
E. coli UMN026  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
E. coli UTI89  - - - - G T A T G T C G A A A A A T G G A C G G C G A T G A T A C A T - C G C C G T C C A T T T A C
S. enterica subsp. enterica serovar Choleraesuis  str. SC-B67  T T G T C A T C A T A T A T A A T G A T A T A A C C G T A G C A T T T A C A A A C G T A C T T T T A
S. enterica subsp. enterica serovar Enteritidis  str. P125109  T T G T C A T C A T A T A T A A T G A T A T A A C C G T A G C A T T T A C A A A C G T A C T T T T A
S. enterica subsp. enterica serovar Gallinarum  str. 287/91  T T G T C A T C A T A T A T A A T G A T A T A A C C G T A G C A T T T A C A A A C G T A C T T T T A
S. enterica subsp. enterica serovar Paratyphi  A str. ATCC 9150  T T G T C A T C A T A T A T A A T G A T A T A A C C G T A G C A T T T A C A A A C G T A C T T T T A
S. enterica subsp. enterica serovar Typhimurium str. 14028S  T T G T C A T C A T A T A T A A T G A T A T A A C C G T A G C A T T T A C A A A C G T A C T T T T A
S. enterica subsp. enterica serovar Typhimurium  str. LT2  T T G T C A T C A T A T A T A A T G A T A T A A C C G T A G C A T T T A C A A A C G T A C T T T T A
E. coli  55989  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli APEC O1  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T C T
E. coli  B str. REL606  C C G G A T A C T G A A A A A C A T C C T T C G A G A G G G A C G G T T A C C A T G A A G A T T T T
E. coli  BL21(DE3)  C C G G A T A C T G A A A A A C A T C C T T C G A G A G G G A C G G T T A C C A T G A A G A T T T T
E. coli BW2952  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli  CFT073  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli  ED1a  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T C T
E. coli  IAI1  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli  IAI39  T C C T G A A T A C A G T A G T A T T T T A C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli  K-12 MG1655  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli  NCTC86  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli  O103:H2 str. 12009  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli O111:H- str. 11128  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli O127:H6 str. E2348/69  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T C T
E. coli  O157:H7 str. TW14359  T C C A G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli  O26:H11 str. 11368  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli S88  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T C T
E. coli  str. K-12 substr. DH10B  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli str. K-12 substr. W3110  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli UMN026  T C C A G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T A T
E. coli UTI89  T C C T G A A T A C A G T A G T A T T T T G C - A G A C A A A A A T T C C G T A A A T G G A T T C T
S. enterica subsp. enterica serovar Choleraesuis  str. SC-B67  T T A A A A A C G G G C G T G T T C A C G C C C T G T T A A A A G - - T A C A A G A T T G A A T A T
S. enterica subsp. enterica serovar Enteritidis  str. P125109  T T A A A A A C G G G C G T G T T C A C G C C C T G T G A A A A G - - T A C A A C A T T G G A T A T
S. enterica subsp. enterica serovar Gallinarum  str. 287/91  T T A A A A A C G G G C G T G T T C A C G C C C T G T G A A A A G - - T A C A A C A T T G G A T A T
S. enterica subsp. enterica serovar Paratyphi A str. ATCC 9150  T T A A A A A C G G G C G T G T T C A C G C C C T G T T A A A A G - - T A C A A G A T T G A A T A T
S. enterica subsp. enterica serovar Typhimurium str. 14028S  T T A A A A A C G G G C G T G T T C A C G C C C T G T G A A A A G - - T A C A A G A T T G A A T A T
S. enterica subsp. enterica serovar Typhimurium  str. LT2  T T A A A A A C G G G C G T G T T C A C G C C C T G T G A A A A G - - T A C A A G A T T G A A T A T
E. coli 55989  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli APEC O1  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G C C C C C T G - - - - - A A A A A G T
E. coli  B str. REL606  T T - T G G A G A A T C T T T A T C A T T C T G A T T G C T A T T T C C T G C C G A T A A G A G A C
E. coli  BL21(DE3)  T T - T G G A G A A T C T T T A T C A T T C T G A T T G C T A T T T C C T G C C G A T A A G A G A C
E. coli  BW2952  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli CFT073  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli  ED1a  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli IAI1  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli  IAI39  T C G T T T A T A A T C A G G A T A A T C T A A T A A A A G G C C C C C T G - - - - - A A A A A G T
E. coli  K-12 MG1655  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli NCTC86  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli O103:H2 str. 12009  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli  O111:H- str. 11128  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G - A C C C C T G - - - - - A A A A A G T
E. coli O127:H6 str. E2348/69  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli O157:H7 str. TW14359  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli O26:H11 str. 11368  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli  S88  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G C C C C C T G - - - - - A A A A A G T
E. coli str. K-12 substr. DH10B  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli  str. K-12 substr. W3110  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli  UMN026  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
E. coli  UTI89  T C G T T T A T A A T C A G G A T A A T C T A A A A A A A G G A C C C C T G - - - - - A A A A A G T
S. enterica subsp. enterica serovar Choleraesuis  str. SC-B67  T G G T T T A T A A T C A G A G T A A G T T A A A A A A A G G A A C C G G T T C A C C G G T A A A C
S. enterica subsp. enterica serovar Enteritidis  str. P125109  T G G T T T A T A A T C A G A G T A A G T T A A A A A A A G G A A C C G G T T C A C C G G T A A A C
S. enterica subsp. enterica serovar Gallinarum str. 287/91  T G G T T T A T A A T C A G A G T A A G T T A A A A A A A G G A A C C G G T T C A C C G G T A A A C
S. enterica subsp. enterica serovar Paratyphi A str. ATCC 9150  T G G T T T A T A A T C A G A G T A A G T T A A A A A A A G G A A C C G G T T C A C C G G T A A A C
S. enterica subsp. enterica serovar Typhimurium  str. 14028S  T G G T T T A T A A T C A G A G T A A G T T A A A A A A A G G A A C C G G T T C A C C G G T A A A C
S. enterica subsp. enterica serovar Typhimurium  str. LT2  T G G T T T A T A A T C A G A G T A A G T T A A A A A A A G G A A C C G G T T C A C C G G T A A A C
1 20 40 
60 80 
100 120 140 
Figure 4.26: Promoter alignments for the ydiV upstream sequences in E. coli and       
S. enterica strains 
Figure details on pXX.  
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E. coli 55989  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T A T G T A A T T G
E. coli  APEC O1  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  B str. REL606  A A C C A G C A A G T C C T T G T C G G C G T T G A G T T A A T T A C C C A T T T C T C C A G T G A
E. coli BL21(DE3)  A A C C A G C A A G T C C T T G T C G G C G T T G A G T T A A T T A C C C A T T T C T C C A G T G A
E. coli  BW2952  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli CFT073  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli ED1a  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  IAI1  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T A T G T A A T T G
E. coli IAI39  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  K-12 MG1655  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli NCTC86  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli O103:H2 str. 12009  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  O111:H- str. 11128  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T A T G T A A T T G
E. coli O127:H6 str. E2348/69  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  O157:H7 str. TW14359  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  O26:H11 str. 11368  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T A T G T A A T T G
E. coli  S88  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli str. K-12 substr. DH10B  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  str. K-12 substr. W3110  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  UMN026  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
E. coli  UTI89  G G T T A A C A - - - - - - T G G A A C A A A T G A A - - A G T T A C T C - C T T C T G T A A T T G
S. enterica subsp. enterica serovar Choleraesuis  str. SC-B67  A A G A A A A A - - - - - - T G A T G A C G C T T C A - - - A T T A G T A - - - T C T G A A G T T A
S. enterica subsp. enterica serovar Enteritidis  str. P125109  A A G A A A A A - - - - - - T G A T G A C G C T T C A - - - A T T A G T A - - - T C T G A A G T T A
S. enterica subsp. enterica serovar Gallinarum  str. 287/91  A A G A A A A A - - - - - - T G A T G A C G C T T C A - - - A T T A G T A - - - T C T G A A G T T A
S. enterica subsp. enterica serovar Paratyphi  A str. ATCC 9150  A A G A A A A A - - - - - - T G A T G A C G C T T C A - - - A T T A G T A - - - T C T G A A G T T A
S. enterica subsp. enterica serovar Typhimurium  str. 14028S  A A G A A A A A - - - - - - T G A T G A C G C T T C A - - - A T T A G T A - - - T C T G A A G T T A
S. enterica subsp. enterica serovar Typhimurium  str. LT2  A A G A A A A A - - - - - - T G A T G A C G C T T C A - - - A T T A G T A - - - T C T G A A G T T A
E. coli  55989  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  APEC O1  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  B str. REL606  A G A - T G G C A C G G T G C G T - A T C C C G A C G A G T C G G G T T A T A G C G C A A C T T A C
E. coli  BL21(DE3)  A G A - T G G C A C G G T G C G T - A T C C C G A C G A G T C G G G T T A T A G C G C A A C T T A C
E. coli BW2952  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  CFT073  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli ED1a  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli IAI1  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  IAI39  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  K-12 MG1655  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli NCTC86  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  O103:H2 str. 12009  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli O111:H- str. 11128  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  O127:H6 str. E2348/69  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  O157:H7 str. TW14359  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  O26:H11 str. 11368  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  S88  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  str. K-12 substr. DH10B  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli str. K-12 substr. W3110  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli UMN026  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
E. coli  UTI89  T T A - T G T C T T A T G G C C T C A T C C C T T T T A G C C G G A T A C T G A A A A A C A T C C T
S. enterica subsp. enterica serovar Choleraesuis str. SC-B67  C G T C T G T T T C C G T C C G T A G T - - - G A C T G G A T G G C G A A T A G C G C C C T A A C C
S. enterica subsp. enterica serovar Enteritidis  str. P125109  C G T C T G T T T C C G T C C G T A G T - - - G A C T G G A T G G C G A A T A G C G C C C T A A C C
S. enterica subsp. enterica serovar Gallinarum  str. 287/91  C G T C T G T T T C C G T C C G T A G T - - - G A C T G G A T G G C G A A T A G C G C C C T A A C C
S. enterica subsp. enterica serovar Paratyphi  A str. ATCC 9150  C G T C T G T T T C C G T C C G T A G T - - - G A C T G G A T G G C G A A T A G C G C C C T A A C C
S. enterica subsp. enterica serovar Typhimurium  str. 14028S  C G T C T G T T T C C G T C C G T A G T - - - G A C T G G A T G G C G A A T A G C G C C C T A A C C
S. enterica subsp. enterica serovar Typhimurium  str. LT2  C G T C T G T T T C C G T C C G T A G T - - - G A C T G G A T G G C G A A T A G C G C C C T A A C C
E. coli 55989  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  APEC O1  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  B str. REL606  C G A G G A G C A A C A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli BL21(DE3)  C G A G G A G C A A C A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  BW2952  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli CFT073  T C G A G A G G G A A G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli ED1a  T C G A G A G G G A A G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  IAI1  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  IAI39  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  K-12 MG1655  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli NCTC86  T C G A G A G G G A C G G T T A C C A T G A A G A T T T T T - - - - - - - - - - - - - - - - - - - -
E. coli O103:H2 str. 12009  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli O111:H- str. 11128  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  O127:H6 str. E2348/69  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli O157:H7 str. TW14359  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  O26:H11 str. 11368  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  S88  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  str. K-12 substr. DH10B  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli  str. K-12 substr. W3110  T C G A G A G G G A C G G T T A C C A T G A A G A T T T T T T T G G A G A A T C T T T A T C A T T C
E. coli UMN026  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
E. coli UTI89  T C G A G A G G G A C G G T T A C C - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
S. enterica subsp. enterica serovar Choleraesuis str. SC-B67  A T G G G A C T G G C G T A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
S. enterica subsp. enterica serovar Enteritidis  str. P125109  A T G G G A C T G G C G T A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
S. enterica subsp. enterica serovar Gallinarum  str. 287/91  A T G G G A C T G G C G T A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
S. enterica subsp. enterica serovar Paratyphi A str. ATCC 9150  A T G G G A C T G G C G T A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
S. enterica subsp. enterica serovar Typhimurium  str. 14028S  A T G G G A C T G G C G T A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
S. enterica subsp. enterica serovar Typhimurium  str. LT2  A T G G G A C T G G C G T A - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Figure 4.26: Promoter alignments for the ydiV upstream sequences in E. coli and       
S. enterica strains 
Figure details on pXX.  
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Figure 4.26: Promoter alignments for the ydiV upstream sequences in E. coli and S. 
enterica strains 
DNA sequence alignment of the upstream +247 bases for the ydiV gene, from various 
sequenced bacterial genomes.   
The numbers indicate the base number of the alignment for reference, with 1 being the 
start of the intergenic gene region between nlpC and ydiV genes in E. coli K-12 MG1655, 
and base 247 being adjacent to the ydiV sequencing start codon. The sequence of E. coli 
K-12 MG1655 is in bold and underlined, as this is the strain studied throughout this 
work and thereby used for comparison with the other strains.  
The highlighted regions indicate predicted regulatory promoter motifs. The yellow 
region at 10 bases is a -10 (TATAAT box), present only in the Salmonella strains. The 
blue region (at 80 bases) highlights the -35 box and an additional yellow region (at 100 
bases) is indicative of another -10 box, both of which are involved in the recruitment of 
RNA polymerase (σ70 and σ24).  The red region shows the UP region (-60 to -40) which 
can increase σ24-dependent transcription by up to 30-fold when it is particularly A/T 
rich. 
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More significant than just the DNA sequence however, was the presence or absence of 
promoter motifs in this DNA.  These DNA motifs are required for RNA polymerase and 
sigma factors, as well as transcription factors, to attach to the DNA and regulate gene 
transcription.  The ydiV gene is thought to be regulated by the RpoE (σ24) which is a second 
heat stress sigma factor in E. coli, alongside the housekeeping RpoD (σ70) transcription 
factor (Rouvière et al., 1995; Gama-Castro et al., 2008; Wada et al., 2012). RpoE is known  
to be activated by cellular stresses, such as heat shock, the misfolding of outer membrane 
proteins, presence of the starvation signal ppGpp and metal ion exposure (Mecsas et al., 
1993; Ades et al., 2003; Egler et al., 2005; Costanzo & Ades, 2006).  The expression of rpoE 
has been identified to be positively regulated by σ24 itself, and is predicted to be repressed 
by phosphorylated CpxR (Raina et al., 1995; De et al., 2002). RpoD is the major sigma factor 
during normal growth conditions, known to be repressed by the anti-sigma factor σD 
(Jishage et al., 1996; Jishage & Ishihama, 1998).  
 
The presence of strongly conserved motifs for these sigma factors (RpoE and RpoD) would 
therefore enable a high rate of gene transcription, whilst a less well conserved motif would 
reduce the level of transcription.  The key motifs required for RNA polymerase (σ70 
holoenzyme) addition are the -10 element (consensus sequence of TATAAT) and the -35 
element (consensus sequence of TTGACA) (Reznikofl et al.,1985).  Additional UP-regions 
have also been identified, which can increase transcription 30-fold.  These UP-regions are 
located between -60 and -40, immediately upstream of the -35 box, and are A/T rich (Ross 
et al., 1993).  The RpoE (σ24) factor recognises the same -35 and -10 DNA motifs, but the 
combined -35/-10 score is significant here, requiring the presence of both motifs to be fully 
functional (Mutalik et al., 2009; Rhodius & Mutalik, 2010).  In addition, the presence of a 
conserved ‘AAC’ motif in the -35 region is a good indication of gene expression, as well as 
A/T rich UP-regions (Mutalik et al., 2009).  
 
Using Softberry promoter prediction software, the -35 and -10 regions were identified in 
the alignment (Figure 4.26) and UP A/T regions were identified based on the -35 location. 
The E. coli K-12 derived strains all yielded a predicted -35 site (highlighted blue, with the 
identical sequence TTCCGT).  Therefore, whilst relatively low identity is retained in this -35 
site (compared to the consensus sequence), all the E. coli K-12 strains exhibit the identical 
motif, predicting identical σ70 affinity to this site for all strains.  The -10 site (highlighted 
yellow) was then identified for all the E. coli K-12 derived strains (with the sequence 
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TATAAT) showing full sequence identity with the consensus motif, and therefore indicating 
strong recruitment of RNA polymerase to this site (Figure 4.26).  Of significance here is the 
low conservation of the -35 site for all E. coli K-12 strains, highly important for the 
transcription by σ24, the transcriptional activation of which is determined by the combined -
35/-10 score (Rhodius & Mutalik, 2010).  In addition, the -35 site lacks a conserved ‘AAC’ 
region, which is again important for σ24 activity.  However, whilst the -10 and -35 sites are 
not particularly well conserved, another factor is the UP region, which can increase σ24-
dependent transcription by up to 30-fold.  This UP-region (highlighted in red) consists of 14 
A/T bases for the E. coli K-12 strains, indicating reasonably strong gene promotion at this 
site. Therefore, the E. coli K-12 strains have identical promoter motifs suggesting equal, but 
not particularly strong activation by RNA polymerases.  
 
The E. coli B-strains lack the -35 and -10 site entirely and have a weaker A/T rich UP-region, 
questioning how RNA polymerase would be recruited in these bacterial strains.  The S. 
enterica strains lack a predicted -35 site, and correspondingly lack an A/T region upstream 
of this.  However these strains do contain two TATAAT boxes, one of which is at the very 
start of the analysed DNA sequence, and the other aligned to the E. coli -10 site. The first 
TATAAT box is of unknown function, with the upstream gene (nlpC) discrete from ydiV, and 
the promoter regions not overlapping at all.  The second TATAAT box is the -10 site, 
perfectly conserved to the consensus; however the -35 region is poorly conserved, not 
identified by the promoter detection software at all.  In addition to the poor -35 region, the 
UP-region is weak, with only 9/20 bases being A/T.  
 
Whilst computational analysis has identified ydiV transcription to be σ24-dependent (Gama-
Castro et al., 2008), the promoter alignment reveals reasonably weak conservation in the 
promoter DNA to the consensus motifs of σ24 transcription.  For example, the -35/-10 score 
for the E. coli K-12 strains is not particularly high, with weak conservation of the -35 site.  In 
addition, the ‘AAC’ motif characteristically found in σ24-regulated genes is absent, indicating 
that any σ24-dependant transcription of ydiV is likely to be weak.  Alongside the poor 
conservation amongst the E. coli K-12 strains, the S. enterica and E. coli B-strains have even 
weaker promoter motifs.  This poor promoter region may explain the difficulty in 
determining the expression conditions for ydiV transcription, possibly with poor 
transcription even under optimal conditions.  
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To investigate this further, artificially increasing the cellular σ24 levels could enable ydiV 
expression conditions to be identified, with significant levels of σ24 overriding the 
problematic weak ydiV promoter regions.   To increase the σ24 levels, either addition of the 
starvation signal ppGpp, or deletion of the σ24 repressor proteins (RseA and RseB) would 
produce high levels in the cell.  In this way, it could be shown whether ydiV transcription is 
really σ24-dependent or whether σ70 is responsible for its transcription.  For completion, 
overproduction of σ70, and analysis of ydiV transcription would determine which σ factor 
was being used, and also determine whether the ydiV transcription rate was low 
irrespective of which σ factor was used.  
 
4.7.4   Phylogenetic analysis  
Using the promoter alignments for E. coli and S. enterica strains, a phylogenetic tree was 
produced based on maximum parsimony (Section 2.10.3), using Mega6 software 
(http://www.megasoftware.net ), analysing just the ydiV promoter region from each strain 
(Figures 4.27, 4.28).   
 
The phylogram visually shows the DNA differences between the various strains, with the 
scale bar indicating 0.2 substitutions per nucleotide site (Figure 4.27). This phylogram 
shows the high sequence similarity across the E. coli K-12 derived strains, with very short 
branches interlinking these species, indicative of a very small number of DNA changes 
across this group.  The S. enterica group again show small DNA differences amongst the     
S. enterica strains, revealing the high level of DNA conservation amongst this group.  
However, the branch linking the S. enterica group and the E. coli K-12 strains is relatively 
long, indicative of the vast number of DNA substitutions between the two groups.  The       
S. enterica strains have diverged less from the ancestor, with a probability of ~0.4 
substitutions per nucleotide site, meaning approximately every other base is different in 
the S. enterica strains compared to the ancestor.  Comparing this with the E. coli K-12 
strains and the common ancestor, a much greater proportion of the DNA sequence has 
altered over evolution, with a probability of ~1 substitution per nucleotide, meaning almost 
all the DNA sequence is different in the E. coli K-12 compared to the common ancestor.  
However, the distance between the S. enterica and E. coli K-12 strains reveals fewer DNA 
changes between these two groups,  with a probability of ~ 0.6 substitutions per nucleotide 
or a DNA change for 2/3 nucleotides.  Therefore approximately 1/3rd of the DNA sequence  
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Figure 4.27: Phylogram of E. coli and S. enterica strains based on similarities in ydiV 
promoter sequences 
Based on the ydiV promoter sequences, the strains were aligned phylogenetically based 
on a method of maximum parsimony. The phylogram thereby indicated the strains of 
greatest evolutionary similarities and differences.  The length of the branches between 
each strain is indicative of the time between each strain, with small branches signifying 
highly similar strains.  
The scale 0.2 refers to 0.2 substitutions per nucleotide site, and therefore enables the 
level of DNA similarities and differences between strains to be identified.  
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 E. coli APEC O1
 E. coli S88
 E. coli IAI39
 E. coli O127:H6 str. E2348/69
 E. coli UTI89
 E. coli CFT073
 E. coli ED1a
 E. coli 55989
 E. coli IAI1
 E. coli O111:H- str. 11128
 E. coli O26:H11 str. 11368
 E. coli O157:H7 str. TW14359
 E. coli UMN026
 E. coli BW2952
 E. coli K-12 MG1655
 E. coli NCTC86
 E. coli O103:H2 str. 12009
 E. coli str. K-12 substr. DH10B
 E. coli str. K-12 substr. W3110
 S. enterica subsp. enterica serovar Typhimurium str. 14028S
 S. enterica subsp. enterica serovar Typhimurium str. LT2
 S. enterica subsp. enterica serovar Choleraesuis str. SC-B67
 S. enterica subsp. enterica serovar Paratyphi A str. ATCC 9150
 S. enterica subsp. enterica serovar Enteritidis str. P125109
 S. enterica subsp. enterica serovar Gallinarum str. 287/91
 E. coli B str. REL606
 E. coli BL21(DE3)
Figure 4.28: Cladogram to reveal the relatedness of E. coli and S. enterica strains 
based on similarities in ydiV promoter sequences 
Based on the ydiV promoter sequences, the strains were aligned phylogenetically, 
which indicated the strains of greatest similarities and differences.   
Each branch point identifies that the descending branches are produced of a common 
ancestor, with many strains being closely related.  Whilst the relatedness of strains can 
be visualised here, the branches are not to scale, so no evolutionary time or divergence 
can be determined.  
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is conserved amongst the E. coli K-12 and S. enterica strains, showing the level of 
divergence between the groups.  
 
Moving on to study the E. coli B-strains, based on the ydiV promoter sequences, these 
strains appear to be produced from an ancestor, which subsequently diverged into the E. 
coli K-12 and S. enterica strains (Figure 4.27). However, this is an ydiV promoter specific 
discovery, which is not supported by genome-wide studies of E. coli and S. enterica 
ancestory (Elena et al., 2005). Based on the ydiV promoter phylogram, it appears that the 
DNA sequences in the three groups has diverged quite substantially, to account for the 
large branches between the three groups (Figure 4.27).  Using the branch lengths, it can be 
seen that the E. coli B-strains are more similar in DNA sequence to the S. enterica strains 
than the E. coli K-12 strains.  Using the scale, the E. coli B-strains have a 0.6 probability of 
nucleotide substitutions compared to the S. enterica strains, indicating only 40% sequence 
homology between the two groups.  However, this is a greater sequence homology than 
that between the E. coli B-strains and the K-12 strains, which ranges between 0-40% 
sequence homology on a species-species basis.  
 
The most apparent conclusion from this phylogram is the high level of sequence similarities 
within the three groups, but the relatively high levels of divergence between the groups, 
with the E. coli B-strains being more similar to the S. enterica strains than the E. coli K-12 
strains.  
 
In order to identify the strains of highest similarities, a cladogram was also produced, which 
revealed only the branching patterns between strains rather than the amount of DNA 
changes amongst strains (Figure 4.28). This revealed five pairs of highly similar E. coli K-12 
strains, as well as two pairs of very similar S. enterica strains.  In addition, E. coli K-12 
MG1655, which was used throughout this work as a wild-type model, was the ancestor for 
14 identified strains, including the pathogenic avian APEC strain and the O157:H7 strain.  
 
Taking all into account, the induction conditions of ydiV are still unknown. Whilst 
experimental data has failed to reveal any conditions in which ydiV up-regulation occurs, 
promoter alignment has revealed that this may be due to weak promoter motifs, meaning 
that ydiV transcription may always be at a low level.  Further analysis to improve the 
conservation of promoter consensus sites (by site-directed mutagenesis) could reveal 
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whether the low levels of ydiV transcription are due to simply poor RNA polymerase 
transcription.  Equally, exploring more extreme growth conditions would presumably 
activate σ24 at a higher level, and therefore may identify ydiV growth conditions. 
 
4.8   Discussion  
 
Work carried out in this chapter has characterised the E. coli protein YdiV. Successful 
cloning and overproduction of the YdiV protein fused to a C-terminal His6 tag was 
undertaken, enabling a simple one-step purification which yielded pure and concentrated 
protein. YdiV has been reported to be an active PDE by Hisert et al. (2005), but an inactive 
PDE by Tchigvintsev et al. (2010) and Wada et al. (2011).  The data reported here supports 
the inactive or ‘degenerate’ view of YdiV.  Through nucleotide reactivity assays, it was 
shown that YdiV did not react with c-di-GMP (the substrate of active EAL domains) nor with 
several other tested nucleotides, identifying YdiV as one of the four ‘degenerate’ 
GGDEF/EAL domain proteins in E. coli (Figure 4.9).  This supported the conclusions of 
Tchigvintsev et al. (2010) and Wada et al. (2011).   
 
Following the assigment of YdiV as an inactive PDE, studies were undertaken to investigate 
nucleotide binding to the protein, which might regulate YdiV protein function.  Previous 
studies had shown the possibility of degenerate GGDEF/EAL proteins becoming activated 
by nucleotide binding (Duerig et al., 2009; Lee et al., 2007), and structural analysis of FimX 
had provided information specific to EAL domain proteins (Navarro et al., 2009). 
Futhermore, the X-ray crystallography structure of YdiV indicates a groove similar to that 
seen in other EAL domain proteins to enable c-di-GMP coordination at the active site (Li et 
al., 2012).  Therefore, it seemed quite plausible for YdiV to be regulated by a nucleotide of 
some type. 
  
The intrinsic fluorescence results were largely inconclusive, given that all the fluorescence 
changes upon nucleotide addition were quantitatively small, and of equal size to the 
control variations.  Therefore the results of interest are those from the partial proteolysis 
and proton NMR.  Partial proteolysis (Figure 4.11) showed a slightly varied protein 
fragmentation pattern upon c-di-GMP, ppGpp and cAMP additions compared to the 
protein alone or the protein mixed with the other nucleotides.  Clear variations in the 
profiles were seen; however in no case did the cleavage pattern dramatically alter 
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suggesting no large conformational changes.  There are 14 cleavage sites (K and R residues) 
in YdiV, resulting in 120 possible protein fragments.  From the SDS-PAGE gels of the partial 
proteolysis assays (Figure 4.11) there appear to be two fragments between 15-20 KDa, one 
fragment between 10-15 KDa and one fragment smaller than 10 KDa.  The identity of these 
fragments (in terms of residue components) is unknown, and with 120 possible fragments 
is difficult to predict.  To identify the location of these fragments in the whole protein,       
N-terminal sequencing could be carried out on these SDS-PAGE gel fragments, to decipher 
the trypsin sites cleaved and give further insight into nucleotide-dependent changes in 
protein structure.  
 
The major difficulty is determining the significance of these trypsin cleavage changes. 
Whilst clear differences are seen upon specific nucleotide addition, the overall fragment 
pattern is very similar, confirming that a major conformational change has not occurred. 
Since nucleotide binding is likely to occur, if at all, at a small binding pocket of the protein, 
this is not necessarily surprising.  Therefore the differences seen in cleavage fragment 
number 1 and its smaller halo partner species could be very significant, indicating binding 
of a nucleotide and therefore concealing a trypsin cleavage site forming the more intense 
single band at cleavage site 1 with ppGpp present.  Equally, in the case of c-di-GMP and 
cAMP, nucleotide binding may have revealed a trypsin cleavage site and therefore 
produced weaker bands at cleavage fragment 1.  
 
Proton NMR revealed spectral changes in the amide region for all tested nucleotides in 
comparison with the YdiV only sample (Figure 4.15).  However, 5 out of 6 tested 
nucleotides produced near identical spectra and therefore these were used as baseline 
spectra.  The addition of c-di-GMP to the protein produced distinct chemical shifts, which 
were not present in the YdiV protein sample or for the remaining nucleotide and protein 
samples.  This therefore highlighted c-di-GMP as a possible binding molecule, inducing 
chemical shifts at 7.8 and 8.1 ppm.  Of note, the known c-di-GMP binder, Clp produced 
chemical shifts at the same spectral region upon c-di-GMP addition (Figure 4.19).  This 
suggests the possibility that c-di-GMP is binding to YdiV.  
 
Taken together, the partial proteolysis and proton NMR data tentatively suggest c-di-GMP 
binding to YdiV.  The partial proteolysis assays highlighted c-di-GMP as one of a few 
nucleotides to subtly alter the cleavage pattern of the pattern.  Proton NMR reinforced this 
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suggestion, with c-di-GMP producing a distinctly different spectrum to the other tested 
nucleotide samples, mirroring some of the changes seen for Clp:c-di-GMP binding.  Whilst a 
firm conclusion cannot be made, the data provides the foundations for further 
investigations.  To further investigate this binding, a wider range of experiments could be 
carried out, such as crosslinking methods (to capture any transient interactions) and high 
sensitivity techniques such as Isothermal Titration Calorimetry.   
 
The oligomerisation state of YdiV was also investigated to determine whether YdiV retained 
the ability to form dimers, as is the case for other EAL domains (Tchigvintsev et al., 2010). 
Oligomeric analysis revealed YdiV to be a monomeric protein (Figures 4.6 and 4.7).  Whilst 
undertaking this investigation, the same conclusions were found by Li et al. (2012), both by 
X-ray crystallography and gel filtration techniques (Li et al., 2012). The YdiV structure 
revealed a decreased ‘dimerisation interface’ between the YdiV monomers compared to 
other catalytically active EAL domains (Li et al., 2012).  Additionally, YdiV was identified to 
lack three of seven conserved residues required for EAL domain protein dimerisation 
(Tchigvintsev et al., 2010).  Therefore it is not at all surprising that YdiV cannot form dimeric 
species, existing solely as a monomeric protein.  
 
Of interest then, if a nucleotide was found to bind to the protein, would be to analyse 
whether any conformational change was induced by binding, causing the dimerisation 
interface to open and enabling dimerisation to become more stable.  To investigate this 
further, a modified 2-hybrid system could be used, for example tagging YdiV with two 
domains of adenylate cyclase (Karimova et al. 1998).  If YdiV was to dimerise, the two 
domains of adenylate cyclase would come together, creating the active enzyme and 
increasing the cAMP levels in the cells.  The cAMP would then activate CRP, and a reporter 
promoter-lacZ fusion would be induced.  The expression of lacZ could be detected by β-
galactosidase assays, and therefore the level of dimerisation assessed.  Various possible 
nucleotides could then be added to the bacteria, assessing the affect the nucleotides have 
on YdiV dimer stability, and determining both if a nucleotide binds and whether it alters 
YdiV stability.  Alternatively site-directed mutagenesis of the dimerisation motif to the 
conserved motif would be an interesting experiment, analysing whether this did restore the 
ability of YdiV to form dimers, and analysing the nucleotide binding capacity of this 
mutated protein.  
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Functional characterisation of YdiV revealed the importance of the protein in flagella 
production, supporting the motility phenotypes seen by Dr Melissa Lacey (unpublished).  Dr 
Lacey found over-expression of ydiV resulted in a marked decrease in cell motility, which 
was confirmed here by detection of FliC levels and visualisation of flagella.  Western blot 
analysis identified a complete lack of FliC in an ydiV overexpression strain (MG1655 
pBR322:ydiV), which resulted in a marked decrease in flagella numbers visible by electron 
microscopy (Figures 4.20 and 4.21).  Therefore, the data supports the phenotypic analysis, 
showing that upon ydiV over-expression, flagellin protein (FliC) is repressed, resulting in a 
decrease of flagella numbers of ~80% and hence causing the bacteria to be less motile.  
This is consistent with the motility inhibitory effects of YdiV overproduction seen by other 
groups during the course of this work (Li et al., 2012; Wada, et al. 2012).   
 
Whilst work in this chapter has begun to characterise the function of YdiV, the conditions of 
ydiV expression are still largely unknown.  Western blot analysis of cells grown at different 
growth rates failed to show an optimal growth rate for high ydiV induction, with the YdiV 
levels being below the detection limit (Figure 4.22).  Whilst this does not necessarily mean 
that ydiV is not induced here, it does suggest that the quantities of YdiV protein in the cell 
are extremely low.  Equally, while this does not disregard the functional phenotypes we 
have determined for YdiV, it puts into question how artificial these situations are.  It is 
obvious that experimentation using overproduced protein is not an ideal comparison with 
the situation in vivo, however the majority of the effects seen with YdiV (motility inhibition, 
possible nucleotide binding) are seen with overproduced levels of YdiV.  Clearly this 
questions whether these effects would occur, at least to the same extent, if YdiV was at a 
much lower concentration.  The lack of progress to determine ydiV upregulation conditions 
was illustrated by β-galactosidase assays (Figure 4.24) in which quorum sensing molecules 
AHL were added to induce ydiV expression.  Again these experiments did not identify any 
growth condition under which ydiV was upregulated, leaving open the environmental 
conditions needed for up-regulation.  The addition of AHL molecules did not seem to affect 
the level of ydiV expression, however despite previous evidence that SdiA upregulated ydiV 
(Zhou et al., 2008), it has recently been contradicted by Spurbeck et al. (2013), who claim 
SdiA has no effect on ydiV expression, a conclusion also reached from the experiments 
carried out here (Figure 4.24).  
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Promoter alignments were made, to determine the degree of sequence similarities of the 
ydiV promoter regions across the E. coli and S. enterica genomes (Figure 4.26).  This 
revealed three distinct groups; the E. coli K-12 strains; the E. coli B-strains and the                 
S. enterica strains, each of which had high sequence identity within the group, but differed 
from the other groups.  The transcription of ydiV is predicted to be σ70- and σ24-dependent. 
Promoter prediction software revealed a highly conserved -10 region for all the S. enterica 
and E. coli K-12 derived strains, but a weak or absent -35 region; a characteristic often 
associated with promoters that require a positively acting transcription factor.  The activity 
of σ24- is dependent on the overall strength of both the -35 and -10 boxes, plus an 
additional ‘AAC’ motif at the -35 site, which was lacking throughout.  Therefore the level of 
RNA-polymerase recognition of the promoter motifs is likely to be reasonably weak, 
possibly explaining the low level of ydiV transcription via poor promoter recognition.   
Additionally, genome wide transcriptional analysis has been carried out for E. coli, and 
provided an insight into ydiV induction.  Transcription of ydiV in E. coli K-12 is down 
regulated by carbon monoxide (Nobre et al., 2009), hyperosmotic conditions (Gunasekera 
et al., 2008) and acidic pH stress (King et al., 2010), and up-regulated slightly by DNA 
damage (by Norfloxacin) and biofilm formation (Faith et al., 2007; May et al., 2009). 
However, the pathogenic strain E. coli 0157:H7 has shown significant ydiV up-regulation in 
the presence of cinnamaldehyde (Visvalingam et al., 2013), with N-acyl homoserine 
lactones actually down-regulating the gene expression (Hughes et al., 2010).  Clearly 
therefore the ydiV gene expression can be altered, but possibly the growth conditions 
required for up or down-regulation are simply more extreme than typical laboratory 
growth conditions for E. coli, suggesting the possibility of a basal level of gene-expression 
which is only altered in stress conditions.  This is consistent with ydiV expression being σ24-
dependent, as this factor is a heat-shock stress factor, or dependent on an unknown 
transcription factor.  However this yields no explanation how YdiV imparts its functional 
roles, in motility and as an anti-FlhDC factor in non-extreme conditions.  
 
To conclude, the E. coli protein YdiV has been found to be a catalytically inactive PDE, part 
of the ‘degenerate’ group of GGDEF/EAL proteins in bacteria.  The protein has been 
successfully purified, enabling investigation of potential activation triggers for the protein, 
in the form of nucleotides.  Nucleotide binding assays have suggested a possible nucleotide 
interaction with c-di-GMP, but require further investigation to increase the confidence of 
this result.  Functional investigations have shown YdiV to regulate bacterial motility by 
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regulation of flagella synthesis in some manner, cementing the importance of the protein 
in cell function.  However the induction conditions of ydiV have not been elucidated, but 
analysis of the promoter regions revealed weak conservation of consensus motifs, 
suggesting that transcription is generally low due to a lack of RNA polymerase recruitment 
at these sites.  
 
Further work in this thesis will investigate the mechanism in which YdiV regulates flagella 
synthesis and impacts motility, and it’s interactions with the transcriptional regulator 
FlhD4C2 and the effect this has on the DNA-binding capacity of FlhD4C2.  
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Chapter 5: Characterisation and functional investigation of the 
Escherichia coli YdiV and FlhDC interaction 
 
5.1   Introduction 
 
As discussed previously, the E. coli flagellar biosynthesis genes are arranged in a three tier 
system, named Class I, II and III, or early, middle and late genes (Figure 1.2).  The Class I 
genes consist of the flhDC operon, Class II includes operons flgAMN, flhBAE, fliAZY and 
fliDST, and Class III includes fliC and motAB (Liu & Matsumura, 1994; Chilcott & Hughes, 
2000).  
 
The flhDC operon is responsible for flagellar gene expression.  The flhD and flhC genes 
encode proteins which form the heterotetrameric complex FlhD4C2 (Wang et al., 2006).  
The FlhD4C2 complex is a DNA-binding protein, that up-regulates Class II genes (Liu & 
Matsumura, 1994).  These Class II genes encode proteins such as the σ factor FliA, basal 
body proteins such as FlgB, chaperones such as FliT and export machinery proteins such as 
FlhB (Figure 1.2) (Chilcott & Hughes, 2000; Macnab, 2003).  FliA activates the expression of 
all Class III genes, producing proteins such as the flagella filament protein FliC and 
chemotaxis proteins CheR and CheB (Chilcott & Hughes, 2000; Macnab, 2003).  
 
Due to the impact of FlhDC on this system, the complex is regarded as the ‘master 
regulator’ of flagella gene transcription.  The two proteins FlhD and FlhC, which can form 
homodimers (FlhD2 and FlhC2) are functional as a complex, initially thought to be FlhD2C2, 
before being shown to be the hexameric form FlhD4C2 (Liu & Matsumura, 1994; Claret & 
Hughes, 2002; Wang et al., 2006).  This FlhD4C2 complex binds upstream of class II flagellar 
genes, at an ~50 bp region, which overlaps the -35 element of the promoters (Liu & 
Matsumura, 1994; Claret & Hughes, 2002).  Sequence comparisons identified these binding 
regions as two inverted repeats of the consensus sequence 
AA(C/T)G(C/G)N2/3AAATA(A/G)CG, separated by a 10-12 base pair spacer (Claret & Hughes, 
2002; Stafford et al., 2005).  These two repeats were named as ‘FlhDC binding boxes’, with 
a single FlhD4C2 complex binding to the entire 50 bp region, interacting with both FlhDC 
binding boxes (Claret & Hughes, 2002). Binding of FlhD4C2 to the promoter DNA induces a 
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bend of 111⁰ in the DNA, causing DNA to wrap itself around the protein complex and gene 
transcription to be promoted (Wang et al., 2006).  
 
Due to the extensive influence of FlhD4C2, regulation of its expression and activity is critical. 
The expression of flhDC is regulated by several systems, such as quorum sensing, heat 
shock and high osmolarity responses and by several regulatory proteins such as CsrA and 
LrhA (Sperandio et al., 2002; Shin & Park, 1995; Lehnen et al., 2002; Wei et al., 2001; Shi et 
al., 1992).  Flagellar synthesis is further regulated by the induced transcriptional cascade 
produced following flhDC transcription (Figure 1.2).  FlhDC itself regulates flagellar 
synthesis by up-regulating class II genes.  Protein products of this class II transcription then 
act to activate (FliZ) and repress (FliT) the activity of FlhDC in a feedback loop, to ensure 
tight regulation of FlhDC activity.  Furthermore, other class II transcription products (FliA 
and FlgM) are responsible for the transcription of class III genes, with FliA (σ28) activating 
transcription and FlgM down-regulating the activity of FliA.  These many levels of regulation 
ensure fine-tuning of the extent and timing of flagella production.  
 
In Salmonella enterica, it has been found that FlhD4C2 binds to the STM1344 protein.  This 
protein:protein interaction affects DNA expression, with STM1344 inhibiting FlhD4C2 
binding to Class II promoter DNA, thereby repressing gene transcription (Wada et al., 
2011).  The activity of STM1344 therefore has a huge downstream impact, affecting the 
production of flagella and therefore motility in S. enterica.  
 
The E. coli YdiV and S. enterica STM1344 proteins have significant similarities; both being 
catalytically inactive PDEs with high sequence identity (52%) (Simm et al., 2009).  In 
addition STM1344 has been found to affect the c-di-GMP pool, despite neither synthesising 
nor degrading the molecule.  Moreover, STM1344 has been found to affect the transition 
between biofilm formation and motility in Salmonella, mirroring the functions of YdiV in    
E. coli (Simm et al., 2009).  However, there are also noteable differences.  Deletion of 
STM1344 prevented efficient flagellin production, which did not occur upon YdiV deletion 
(Wada et al., 2011).  Additionally, 52% amino acid sequence identity, whilst high, is 
considerably lower than the average protein homology between S. enterica and E. coli (of ~ 
80-90%) indicating possible functional differences between the proteins (McClelland et al., 
2000).  
 
 
179 
 
 
Work in this chapter provides information on:  
- Kinetic analysis of the YdiV: FlhDC interaction, revealing a high affinity interaction 
(Section 5.4) 
- Identification of in vivo growth conditions in which this complex is likely to be 
formed (Section 5.6) 
- Determination of YdiV to act as an anti-FlhDC factor, causing dissociation of DNA 
above certain concentration ratios (Section 5.7) 
- Investigation of nucleotide binding to the YdiV:FlhDC complex, yielding no 
conclusive results (Section 5.10) 
- Analysis of the FlhDC:YdiV complex in competition with other FlhDC binding 
proteins, discovering the formation of a FliT:FlhDC:YdiV complex (Section 5.11) 
 
5.2   Construction and over-production of the YdiV and FlhDC proteins  
 
Overproduction plasmids were constructed to produce various fusion proteins: YdiV-His6, 
FlhDC-His6 and (FLAG)3-FlhDC, which were used in several assays in this chapter.  The 
cloning and overproduction of YdiV-His6 was as described in Section 4.2.  
 
5.2.1   Cloning of FlhDC to create over-expression plasmids 
 
The E. coli flhDC operon was amplified from E. coli MG1655 genomic DNA and inserted into 
the pET21a plasmid.  This was achieved in two ways, simply utilising the plasmids His6-tag 
to create a His6-tagged construct, and engineering a triple FLAG-tag into the plasmid, 
creating a (FLAG)3-tagged FlhDC (Figure 5.1).  
 
To enable formation of a His6-tagged protein, the flhDC operon was amplified by PCR from 
genomic E. coli MG1655 DNA using primers NSW35 and NSW36 (Section 2.3.3).  These 
primers contained BamHI and XhoI restriction sites, with no stop codon included in NSW36 
to enable a C-terminal His6-tag fusion (Table 5.1).  
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Figure 5.1: Schematic plasmid maps for the insertion of flhDC into pET21a constructs  
Plasmid maps for the pET21a vector, indicating the position of the tags in the vector, 
the antibiotic resistance cassette and the fusion constructs produced.  Two DNA 
constructs were made, encoding a C-terminal His6 fusion, and an N-terminal (FLAG)3 
construct and named pGS2441 and pGS2382 respectively.  
The origin of replication is indicated and labelled as ori.  
The C-terminal tag produces FlhC-His6 and FlhD of expected molecular weights of 22 
and 13 KDa respectively.  The N-terminal tag produces the proteins (FLAG)3-FlhD and 
FlhC of expected molecular weights 16 and 22 KDa respectively.  
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Table 5.1: Primers for the production of two overproduction plasmids producing the 
fusion proteins FlhDC-His6 and (FLAG)3-FlhDC 
 
 
 
 
The PCR product was isolated by PCR purification and digested with BamHI and XhoI 
restriction enzymes (Sections 2.3.10 and 2.3.6).  The pET21a plasmid (Novagen) was 
purified (Section 2.3.4) and digested with the same restriction enzymes (Section 2.3.6) 
before ligation of the flhDC fragment and the linearised pET21a vector (Section 2.3.9).  This 
ligated DNA was used to transform electrically competent E. coli DH5α cells and 
transformants were selected on ampicillin supplemented agar (Section 2.3.11).  Following 
this, the colonies were screened by colony PCR, before plasmids were checked by DNA 
sequencing (Source Bioscience) using the T7 promoter and T7 terminator primers (Table 
4.2).  The resulting plasmid containing no mutations in the flhDC sequence was named 
pGS2441 (pET21a:flhDC). 
 
To create the (FLAG)3-tagged protein construct, a two-step process was carried out, initially 
creating a FLAG3-tag in the pET21a vector, before amplifying the flhDC operon for insertion 
into this modified vector.  Oligonucleotides NSW15 and NSW16 were designed to encode a 
3x-FLAG tag and were annealed at 68⁰C to produce a dsDNA fragment (Table 5.1).  Of note, 
Primer Sequence Function 
NSW35 TTTTGGATCCATGCATACCTCCGAGTTG
CTG  
Forward primer for flhDC 
amplification to insert into pET21a 
NSW36 TTTTCTCGAGAACAGCCTGTACTCTCTG 
TTC  
Reverse primer for flhDC 
amplification to insert into pET21a 
NSW15 TATGGACTACAAGGACGATGACGACAA
GGACTACAAGGACGATGACGACAAGGA
CTACAAGGACGATGACGACAAGG 
Forward primer encoding (FLAG)3 to 
insert into pET21a 
NSW16 GATCCCTTGTCGTCATCGTCCTTGTAGTC
CTTGTCGTCATCGTCCTTGTAGTCCTTGT
CGTCATCGTCCTTGTAGTCCA 
Reverse primer encoding (FLAG)3 to 
insert into pET21a  
NSW17 TTTTGGATCCCATACCTCCGAGTTGCTG
AAA 
Forward primer for flhDC 
amplification to insert into 
pET21a:FLAG3 
NSW18 TTTTAAGCTTTTAAACAGCCTGTACTCTC
TGTTC 
Reverse primer for flhDC 
amplification to insert into 
pET21a:FLAG3 
The sequences shaded grey indicate BamHI restriction sites, with the boxed sequence 
indicating a HindIII restriction site, cyan specifying an NdeI site, and green indicating an 
XhoI site.  
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NSW15 contained a start codon, designed to enable transcription of the FLAG-tag in the 
vector.  The FLAG3 fragment and the pET21a vector were then digested with NdeI and 
BamHI restriction enzymes (Section 2.3.6) before ligation of the (FLAG)3 fragment into the 
linearised vector (Section 2.3.9).  This ligated DNA was then used to transform electrically 
competent E. coli DH5α.  Transformants were selected and screened as previously 
described for pET21a plasmids (Section 2.3.11).  The resultant plasmid was named pGS2381 
(pET21a:FLAG3) and was used to generate a (FLAG)3-FlhDC plasmid.  The flhDC operon was 
amplified from genomic E. coli MG1655 DNA (Section 2.3.3) using primers NSW17 and 
NSW18, introducing BamHI and HindIII restriction sites at either end of the PCR product 
(Table 5.1).  A stop codon was included in primer NSW18, to terminate transcription at the 
3’ end of the flhDC operon, but no start codon was required, initiating transcription in the 
N-terminal (FLAG)3 tag instead.  Following amplification, the purified product (Section 
2.3.10) and pET21a:FLAG3 vector (Section 2.3.4) were digested with BamHI and HindIII 
restriction enzymes (Section 2.3.6) before ligation of the DNA (Section 2.3.9).  Once again 
the ligated DNA was used to transform electrically competent E. coli DH5α cells (Section 
2.3.11) and transformants were selected and screened before DNA sequencing (Source 
Bioscience) using the T7 promoter and T7 terminator primers (Table 4.2).   The resultant 
plasmid was named pGS2382 (pET21a:FLAG3:flhDC).  
 
5.2.2   Over production of the FlhDC protein 
 
Plasmids pGS2382 and pGS2441 were used to transform electrically competent E. coli BL21 
λ(DE3) (Section 2.3.7).  The transformants were used to overproduce the (FLAG)3-FlhDC and 
FlhDC-His6 fusion proteins respectively.  In each case an aliquot (1 ml) of overnight culture 
was added to 100 ml of ampicillin supplemented LB, and the cells were grown at 37⁰C with 
250 rpm agitation, until an OD600 of ~0.6 was reached (Section 2.6.1).  IPTG was added to a 
final concentration of 100 µg/ml and the cultures were incubated at 25⁰C for the remainder 
of cell growth.  Samples were taken at hourly intervals and the cellular protein composition 
analysed by SDS-PAGE (Section 2.6.9) to determine the optimal growth conditions for 
protein overproduction.  
 
The (FLAG)3-FlhDC protein was clearly visible in the overproduction samples, with a 3 h or 
more induction period giving satisfactory overproduction levels (Figure 5.2).  Equally, the 
FlhDC-His6 fusion protein was successfully overproduced, yielding rather modest 
overproduction levels after 2 or more h induction (Figure 5.3).  For production of both  
183 
 
                          
 
 
 
 
 
 
 
                      
 
 
 
 
 
Figure 5.2: Optimisation of overproduction conditions for the (FLAG)3-FlhDC protein in 
E. coli BL21 (λDE3)/ pGS2382 cells 
Coomassie-stained SDS-PAGE gel of whole cell samples taken pre- and post-induction of 
FlhDC expression.  
M: Precision plus protein standards (molecular weights indicated in KDa), 0-5 indicate 
induction times in h, with FlhDC production being induced using a final concentration of 
100 µg/ml IPTG, as specified.   The position of FlhC and (FLAG)3-FlhD are indicated, at 
approximately the expected sizes (FlhC: 22 KDa, (FLAG)3-FlhD: 16 KDa).  
 
Figure 5.3: Optimisation of overproduction conditions for the FlhDC-His6 protein in E. 
coli BL21 (λDE3)/ pGS2441 cells 
Coomassie-stained SDS-PAGE gel of whole cell samples taken pre- and post-induction of 
FlhDC expression.  
M: Precision plus protein standards (molecular weights indicated in KDa), 0-6 indicate 
induction times in h, with FlhDC production being induced using a final concentration of 
100 µg/ml IPTG, as specified.  The position of FlhC and FlhD-His6 are indicated, at 
approximately the expected sizes (FlhC-His6: 22 KDa, FlhD: 13 KDa). 
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proteins a 3 h induction period was chosen for future cell culture.  The differing molecular 
weights of the FlhD and FlhC proteins, encoded by the two plasmids used for 
overproduction, was due to the differing nature and locations of the affinity tags in each 
case (Figure 5.1). 
 
5.2.3   Purification of His-tagged proteins 
 
Both YdiV-His6 and FlhDC-His6 were purified in a single-step affinity chromatography 
method, whilst the (FLAG)3-FlhDC was used in its soluble crude state.  
 
For all three strains (E. coli BL21 λ(DE3)/pGS2354, E. coli BL21 λ(DE3)/pGS2441 and E. coli 
BL21 λ(DE3)/pGS2382), the cell pellets (from 1-5 litres of culture) were resuspended in 
breakage buffer, sonicated and the phases separated by centrifugation (Section 
2.6.2)(Table 2.2).  The soluble fractions were then used directly in assays, or applied to 
chromatography columns to produce pure protein (Section 2.6.3).  
 
YdiV purification was achieved with a one-step affinity chromatography method, which 
yielded >90% pure protein, as described in Section 4.2.3.  
 
FlhDC-His6 purification was carried out in the same manner as YdiV-His6 purification, 
applying the soluble protein fraction produced (from E. coli BL21 λ(DE3)/pGS2441 cells) to a 
1 ml HiTrap column, for affinity chromatography.  The His-chelating programme was run on 
an AKTA, following manufacturer’s instructions (Section 2.6.3).  The resultant trace was 
multi-peaked, with non- specifically bound protein eluting initially, prior to the larger peak, 
representing the His6-tagged protein (Figure 5.4A).  The elution fractions corresponding to 
the major peak were then analysed by SDS-PAGE as described in Section 2.6.9 (Figure 5.4B) 
and showed the presence of the protein of interest, FlhDC, composed of two defined 
species (corresponding to separated FlhD and FlhC, due to the denaturing conditions of the 
gel).   From the gel, fractions corresponding to lanes 4, 5 and 6 were chosen for future use, 
as these were the most pure and concentrated protein samples.  
 
In some cases, eluted fractions containing the FlhDC-His6 fusion protein were used directly, 
or they were transferred into an imidazole-free buffer using a Vivaspin 20 column for other 
assays (Section 2.6.7).  
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Figure 5.4: HiTrap chelating chromatography as a one-step purification of FlhDC-His6 
protein 
A) Elution profile of FlhDC-His6 from HiTrap chelating chromatography. 
 Cell-free extract containing FlhDC-His6 was applied to a 1 ml HiTrap chelating 
column and fractionated by an imidazole gradient (linear gradient from 0-0.5 
M).  The blue trace shows the A280 values, indicative of protein levels, with the 
red trace representing the imidazole gradient.  The expected FlhDC-His6 location 
is indicated.   
B) Coomassie-stained SDS-PAGE gel of FlhDC-His6 purification.  
HiTrap elution fractions spanning the major peak from the Ni-NTA trace.  M= 
Precision plus protein standards (molecular weights indicated in KDa), lanes 1-9 
show elution fractions collected during the imidazole gradient application, and 
represent fractions corresponding to the labelled peak in (A).  
The positions of FlhD (expected molecular weight 13 KDa) and FlhC-His6 
(expected molecular weight 22 KDa) are indicated.  
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The denaturing conditions of SDS-PAGE gels yielded FlhD and FlhC monomers only (Figure 
5.4B).  However, it is known that these proteins form various oligomeric species, such as 
homodimers of FlhD or FlhC, as well as the reported multimers FlhD2C2 and FlhD4C2 (Liu & 
Matsumura, 1994, Wang et al., 2006).  The hexameric FlhD4C2 structure is believed to be 
the functional form of the transcription factor, and therefore the molecular weight of this 
species was used throughout for molarity calculations.  Gel filtration of purified FlhDC 
showed a complex consisting of 2:1 ratio of FlhD and FlhC proteins, supporting the FlhD4C2 
oligomeric species (data not shown).  Production of FlhDC from overproduction constructs 
however produced a mixture of oligomeric forms; therefore the complex is referred to as 
FlhDC rather than specifying a potentially misleading oligomer.  When necessary the 
stoichiometry of FlhD and FlhC is specified.  
 
5.3   Determination of YdiV:FlhDC binding 
 
Knowing that S. enterica STM1344 (ydiV) and FlhDC interacted (Wada et al., 2011), it was 
important to determine whether the same was true in E. coli.  Pull-down assays were 
chosen to analyse this possible interaction, immobilising one protein to a column and 
adding a second protein to the column.  The point of elution of the second protein was 
carefully analysed, with immediate elution indicative of no interaction, but retention by the 
column indicating a protein interaction.   
 
Pull-down assays were carried out (Section 2.8.1) immobilising soluble overproduced YdiV-
His6 (Section 4.2.2) onto a HiTrap column, before soluble overproduced (FLAG)3-tagged 
FlhDC was added (Section 5.2.3).  Following washing, an imidazole rich elution buffer was 
added to the column, to elute all His-tagged proteins.  Fractions collected at each stage of 
the pull-down were separated by SDS-PAGE (Section 2.6.9), one of which was Coomassie-
stained and the other probed with a FLAG antibody in a Western blot analysis (Section 
2.6.10).  
 
The Coomassie-stained SDS-PAGE gel showed the presence of all proteins at their expected 
sizes, YdiV-His6 (lane 1) and the FlhDC components (lane 4) in their respective crude 
extracts (Figure 5.5A).  Subsequent wash steps (lane 6) following FlhDC addition lacked high 
levels of FlhDC, suggesting a possible interaction between FlhDC and YdiV.  This interaction 
was confirmed by the co-elution of YdiV and FlhDC in the imidazole elution fractions (Figure 
5.5A, lanes 7-11). 
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Figure 5.5: Binding interaction between the E. coli proteins FlhDC and YdiV 
A) Coomassie-stained SDS-PAGE gel of pull-down assay fractions 
B) Western blot, probed with a FLAG  antibody 
The method used is described in Section 2.8.1. 
In both cases lanes M: BioRad All blue pre-stained marker (molecular weights shown in 
KDa), 1: crude soluble YdiV, 2: unbound protein from column, 3: wash step, 4: crude 
soluble FlhDC, 5: unbound protein, 6: wash step, lanes 7-11: elution fractions.  
The YdiV-His6 (lane 1) and (FLAG)3-FlhDC proteins (lane 4) are present in the crude cell 
extracts and in the elution fractions (lanes 7-11), as indicated.  The expected molecular 
weights of the proteins are: YdiV-His6 (28 KDa), FlhC (22 KDa), (FLAG)3-FlhD (16 KDa).  
The Western blot with FLAG antibody, shows the presence of (FLAG)3-FlhDC, appearing 
as multiple species in the elution fractions, as indicated.  
 
 
Imidazole elution 
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Western blot techniques analysed the same pull-down samples, probing with a FLAG 
antibody to specifically detect (FLAG)3 –FlhD.  The Western blot confirmed the FlhDC:YdiV 
interaction, clearly identifying (FLAG)3 –FlhD in the elution fractions (Figure 5.5B).  The 
(FLAG)3-FlhD protein was detected as multiple species, indicating the formation of different 
oligomers of FlhD (Figure 5.5B).  This is in agreement with the known ability of FlhD to form 
dimers as well as multimers with FlhC of FlhD2C2 and FlhD4C2, in addition to the many 
oligomeric states of the FlhDC:YdiV complex (Liu & Matsumura, 1992; Wang et al., 2006; Li 
et al., 2012). As the antibody detects FlhD and given the low levels of eluted FlhC, a 
possibility and minor concern would be that YdiV is binding to FlhD, rather than the FlhDC 
complex.  Given that some FlhC was detected, we were reasonably confident of the YdiV 
and FlhDC interaction, mirroring the situation reported for FlhDC and STM1344 in S. 
enterica (Wada et al., 2011). Whilst unknown at the point of this investigation, the 
YdiV:FlhDC interaction was reported independently by Wada et al. (2012).  
 
Crystallisation trials (Section 2.6.15) were carried out for the YdiV:FlhDC complex, in an 
attempt to elucidate the structure of the protein, as only the YdiV2-FlhD2 structure has 
currently been solved (Li et al., 2012).  The YdiV:FlhDC complex was purified by pull-down 
assays (Section 2.8.1), the purification confirmed by SDS-PAGE (Section 2.6.9) before 
dialysis of the complex into a 20 mM sodium phosphate, 500 mM NaCl, pH 7.5 buffer 
(Section 2.6.7).  The protein complex was then concentrated to ~9 mg/ml (Section 2.6.7) 
and tested for crystallisation with commercial screens (PACT, PEG, MPD, Classics, pH clear 
and JCSG+) (QIAGEN) (Section 2.6.15).  No protein crystals were identified using these 
screens and therefore this was not further investigation. 
 
5.4   Characterisation of the YdiV and FlhDC binding interaction  
 
The binding interaction between FlhDC and YdiV was characterised kinetically using a BLItz 
(fortebio) detector and thermodynamically by Isothermal Titration Calorimetry (TA 
instruments).  
 
The BLItz system detects binding interactions by measuring biosensor thickness (nm) as a 
reaction proceeds, detecting protein as a physical increase in sensor thickness. 
Immobilisation of one protein to the biosensor is therefore required, enabling a detectable 
biosensor change upon protein:protein interactions. Isothermal Titration Calorimetry (ITC) 
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measures binding interactions by detecting the heat change upon titration of one species 
into a vessel containing its binding partner. 
 
To study the FlhDC and YdiV protein interaction, both proteins were purified as His6-tagged 
constructs (Sections 4.2.3 and 5.2.3) and dialysed in sodium phosphate buffers (Section 
2.6.7).  Absorbencies were recorded at 280 and 320 nm for both proteins and were used 
with calculated extinction coefficient values (ExPASy ProtParam tool) to determine molar 
concentrations (Section 2.6.8).  The protein purity was crucial to accurate kinetic and 
thermodynamic calculations and therefore proteins were analysed by SDS-PAGE (Section 
2.6.9) to check for protein purity.  The SDS-PAGE gels showed high levels of protein purity 
for both the YdiV and FlhDC protein, with very little contaminating proteins (Figure 5.6). 
These results gave confidence in the calculated protein concentrations, thereby allowing 
kinetic and thermodynamic assays to be pursued.   
 
For the BLItz assay (Section 2.8.3), chemical immobilisation of one protein to an AR2G 
biosensor was carried out by forming covalent amide bonds between primary amine 
groups of the protein and the carboxy-terminated biosensor surface.  A second protein was 
subsequently added in solution and the protein interactions studied.  Protein 
immobilisation is a major limitation of this technique, potentially shielding interaction 
interfaces.  To reduce any experimental errors caused by this, both proteins were 
immobilised to the biosensor in turn and tested with the other partner in solution.  To 
supplement these experiments, ITC analysed the protein interaction in solution.  
 
5.4.1   Characterisation of YdiV binding to the immobilised FlhDC 
protein 
 
The FlhDC complex was immobilised to an AR2G biosensor at a fixed concentration of 13.2 
µM and YdiV protein was added at five different concentrations ranging from 16 µM to 16 
nM (1000-fold range).  
 
The biosensor thickness was recorded, identifying the points at which proteins were 
associating and dissociating with/from the biosensor (Figure 5.7).  Five differently coloured 
traces are present on the figure, indicative of the five different YdiV concentrations added 
to the immobilised FlhDC.  
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Figure 5.6: Assessment of FlhDC and YdiV protein purity for kinetic and 
thermodynamic interaction analysis  
SDS-PAGE gel of purified protein samples. M: Precision plus protein standard 
(molecular weights shown in KDa), 1 + 2: purified FlhDC-His6 (44 µM), 3 + 4: purified 
YdiV-His6 (235 µM).  Lanes 1 and 3 contain 10 µl of each purified protein, whilst lanes 2 
and 4 contain 8 µl of protein.  The concentrations stated above are those determined 
by using extinction coefficient values (Section 2.6.8).  
The locations of proteins are indicated, at the expected molecular weights: YdiV-His6 
(28 KDa), FlhC-His6 (22 KDa), FlhD (13 KDa).  
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Figure 5.7: BLItz binding spectra for YdiV binding to immobilized FlhDC 
Binding spectra for a series of experiments in which a fixed concentration of FlhDC was 
immobilised to a biosensor and soluble YdiV was added to the system.  The binding 
reaction was composed of 7 discrete steps; 1: initial baseline, 2: chemical activation, 3: 
loading, 4: quenching, 5: baseline, 6: association and 7: dissociation.  
A) Biosensor binding (nm) traces recorded for the entire duration of each 
experiment, as the reactions proceeded (sec).  
B) Biosensor binding (nm) trace for the final three steps, enlarging the association 
and dissociation curve data.  
 
For both traces, the steps are specified, with each vertical line indicating the start of a 
new step.  
The concentration of FlhDC was 13.2 µM, with YdiV concentrations varying for each of 
the five runs, identified by different coloured traces.  The concentrations of YdiV tested 
were; run 1: 1.6 µM, run 2: 3.2 µM, run 3: 16 µM, run 4: 0.16 µM and run 5: 0.016 µM.  
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All five traces show biosensor thickening (step 3) indicative of FlhDC immobilisation to the 
biosensor (Figure 5.7A).  Whilst excess protein was released in the quenching stage (step 
4), the thickness of the biosensor remained above baseline, confirming that protein was 
bound to the sensor.  Upon YdiV addition (step 6), association curves were seen (of varying 
gradients due to the varying YdiV concentrations) showing a distinct increase in binding 
(Figure 5.7B).  The dissociation step (step 7) caused the binding thickness’ to decrease, but 
gradually rather than instantaneously, indicating that the proteins are slowly dissociating.  
As can be seen, the higher YdiV concentrations (i.e. runs 2 and 3) elicited the largest change 
in amplitude of the association curve, indicative of thicker biosensors being formed, whilst 
lower YdiV concentrations (runs 4 and 5) produced numerically fewer YdiV and FlhDC 
interactions and therefore produced a smaller amplitude change in the association curve 
(Figure 5.7B). 
 
Using the association and dissociation data, binding kinetics were calculated using the BLItz 
fortebio system.  Global kinetic analysis gave an average set of kinetics, taking into account 
the values from all five experiments (as none were obviously outliers).  The KD value was 
286 nM, with an association rate (ka) of 1.539x10
3 ± 4.9x101 1/Ms and a dissociation rate 
(kd) of 4.41x10
-4 ± 3.1x10-5 1/s.  The KD value indicates strong affinity binding between the 
proteins, generated by a high association and a low dissociation rate.  To give a sense of 
scale, affinity constants for weak non-specific protein interactions are usually mM, 
antibody-antigen KD values are in the region of 10-100 nM, whilst the highly specific 
streptavidin-biotin interactions have KD values in the pM or even fM range (Green, 1975).  
 
5.4.2   Characterisation of FlhDC binding to the immobilised YdiV 
protein 
 
The analysis was then repeated using the two proteins in opposite roles.  YdiV was 
immobilised to the biosensor at a concentration of 6.9 µM, adding FlhDC at concentrations 
ranging between 41 µM and 41 nM, again a 1000-fold range.  
 
 YdiV immobilisation was confirmed by the association curve (step 3) and raised baseline 
(step 5) following loading of YdiV to the AR2G surfaces (Figure 5.8A).  Upon FlhDC addition 
(step 6), association curves were produced (again of varying gradients due to the varying 
FlhDC concentrations) showing a distinct increase in biosensor thickness (Figure 5.8B).  The  
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Figure 5.8: BLItz binding spectra for FlhDC binding to immobilized YdiV  
Binding spectra for a series of experiments in which a fixed concentration of YdiV was 
immobilised to a biosensor and soluble FlhDC was added to the system.  The binding 
reaction was composed of 7 discrete steps; 1: initial baseline, 2: chemical activation, 3: 
loading, 4: quenching, 5: baseline, 6: association and 7: dissociation.  
A) Biosensor binding (nm) trace recorded for the entire duration of each 
experiment, as the reactions proceeded (sec).  
B) Biosensor binding (nm) trace for the final three steps, enlarging the association 
and dissociation curve data.  
 
For both traces, the steps are specified, with each vertical line indicating the start of a 
new step.  
YdiV was used at 6.9 µM, with FlhDC concentrations varying for each of the six runs, 
identified by differently coloured traces.  The concentrations of FlhDC tested were; run 
1: 4.1 µM, run 2: 8.2 µM, run 3:  41.3 µM, run 4: 412 nM,  run 5: 41 nM and run 6: 206 
nM.  
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dissociation step (step 7) again showed a gradual decrease in binding thickness, indicating 
protein dissociation (FlhDC) from the biosensor but a significant proportion remained 
bound to the YdiV coated biosensor (Figure 5.8B).  
 
Once again, individual kinetic values were computed by the BLItz fortebio system, 
disregarding run 6 when calculating an average value, due to its poorly fitted analysis 
curve.  The affinity constant KD was calculated at 395 nM, once again a nM affinity, 
indicative of a strong specific binding interaction.  The association constant (ka) was 
measured at 3.17x103 ± 1.15x102 1/Ms and the dissociation constant (kd) calculated at 
1.25x10-3 ± 2.77x10-5 1/s.  Therefore the rate of protein association was high and the 
dissociation rate was low.  
 
Taken together, the two global KD values of 286 nM and 395 nM indicate high affinity 
binding between YdiV and FlhDC.  The calculated ka and kd errors are relatively low, at 
between 2-7%, providing confidence in the global KD values.  The variation between the KD 
values could be due to the artificial nature of protein immobilisation, potentially shielding 
binding interfaces and altering affinities.  
 
 5.4.3   Characterisation of YdiV and FlhDC interactions in solution 
 
The binding interactions between YdiV and FlhDC complex were also studied in solution, by 
Isothermal Titration Calorimetry (Section 2.8.4).  Both proteins were purified with a             
C-terminal His6-tag (Sections 4.2.3 and 5.2.3) before dialysis of proteins into sodium 
phosphate dialysis buffer and determination of protein concentrations, as detailed in 
Section 5.4. 
 
Following system cleaning and equilibration, FlhDC (44 µM) was loaded into the sample 
chamber and YdiV (235 µM) into the syringe.  Titrations were then carried out at 25⁰C with 
250 rpm stirring in the sample chamber.  There were 25 injections of YdiV into the 
chamber, each of 2 µl volume, spacing the injections 180 s apart to enable restoration of 
constant temperature between injections.  Following completion of the experiment, and 
repetition in triplicate, thermodynamic analysis was undertaken.  Throughout the duration 
of the experiment, the fluctuations in the chamber temperature were recorded, and could 
be corrected to a baseline. These corrected heat changes revealed an exothermic reaction 
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between FlhDC and YdiV, with temperature increases produced upon YdiV injection (Figure 
5.9).  These heat changes were then related to the protein concentrations, calculating exact 
concentrations of each protein as the reaction proceeded, and plotted to give a graph of 
final heat changes Q (µJ) against protein molar ratios.  In order to calculate the 
thermodynamic values of the reaction, the heat changes detected were inputted into a 
model fitting program (Figure 5.9). 
 
The FlhDC and YdiV titration heat changes were applied to a range of models, but the 
independent model gave the closest fit and was therefore deemed the most likely binding 
model.   A single binding curve was observed, with an n value of 0.8, indicating that a 1:1 
stoichiometry of FlhD4C2 and YdiV.  This suggests that only one YdiV binds to the FlhD4C2 
complex under these conditions, potentially requiring a trigger for additional binding of 
YdiV to the FlhD4C2 complex.  The KD value of 158 nM was similar to the 286-395 nM values 
calculated from BLItz analysis.  The binding of YdiV to FlhDC was enthalpy and entropy 
driven (ΔH = -34.1 KJ/mol; ΔS = 24.9 J/mol).  The ΔG for the reaction was -41.5 KJ/mol. 
These measurements do not support a recently proposed model in which four YdiV 
molecules bind sequentially to FlhD4C2, with addition of the 1st or 2nd YdiV units having no 
disruptive effect on the FlhD4C2-DNA interactions (Figure 5.10).  However, further addition 
of the 3rd or 4th YdiV subunits were speculated to disrupt the conformation of the FlhD4C2 
ring structure and trigger DNA dissociation (Li et al., 2012).  
 
5.5   Production of YdiV and FlhDC antibodies 
 
Following characterisation of the YdiV:FlhDC complex, it was of interest to determine the 
conditions under which these proteins were expressed in E. coli and therefore when the 
complex would be likely to form.  Antibodies against these proteins were raised, foreseeing 
the usefulness of these to analyse protein levels.  
 
Polyclonal antibodies were raised against YdiV and FlhDC proteins, by Bioserve (University 
of Sheffield).  Purified and dialysed His-tagged proteins were produced for each protein 
(Sections 4.2.3; 5.2.3 and 2.6.7), and used to stimulate antibody production in rabbits 
(Section 2.6.11).  
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Figure 5.9: Isothermal Titration Calorimetry curve for the FlhDC YdiV titration 
The top graph shows the corrected heat changes (µ/Js) for the FlhDC YdiV titration, with 
addition of YdiV clearly producing an exothermic reaction, denoted by an increase in 
chamber temperature.   
Using the known concentrations of the proteins, the molar ratio of proteins interacting 
throughout the experiment was determined (lower graph).  These points were then 
fitted to an independent binding site model, with the fitted curve shown.  Using this 
fitted curve, the FlhDC and YdiV binding kinetics and molar stoichiometries were 
determined, shown in the figure.  
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Figure 5.10: Schematic of the proposed Li et al. (2012) model for YdiV:FlhD4C2 
interaction 
Diagram to show the model of YdiV binding to the FlhD4C2 complex, as proposed by Li 
et al. (2012).  This model shows a ring-structure of FlhD4C2 with DNA binding to the 
FlhC subunits via specific DNA-binding regions (shown in light blue).  This model 
proposes a sequential binding interaction with YdiV, suggesting that two YdiV 
molecules can bind to FlhD4C2 via the outer-most FlhD units.  Addition of the initial 
two YdiV molecules is suggested to be undisruptive to the ring structure of FlhD4C2, 
thereby retaining the DNA-binding ability of the complex.  However, upon binding of 
further YdiV molecules to the inner FlhD subunits (totalling three or four), the ring-like 
FlhD4C2 structure is broken due to spatial restrictions.  The FlhC units rotate inwards, 
essentially concealing the DNA-binding regions and therefore the complex is no longer 
able to bind DNA.  
Modified from Li et al. (2012). 
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5.5.1   Bleed specificity tests  
 
The proteins were injected into separate rabbits, producing a primary immune response 
against the proteins, before a second round of injections was carried out to give a 
heightened secondary response.  Small test bleeds were taken at both stages, and Western 
blot analyses (Section 2.6.10) were carried out to detect the presence of FlhDC and YdiV 
antibodies.  Samples of rabbit serum which had not been subject to antigen challenge were 
used as control samples.   
 
Following the first round of antigen exposure, the rabbit antisera were used to probe for 
the relevant target protein (YdiV or FlhDC) using purified YdiV and crude soluble FlhDC as 
the target proteins.  Equally loaded protein samples (Figure 5.11A) were probed by various 
dilutions of the rabbit sera in Western blot analyses (Figure 5.11B).  Importantly, the rabbit 
sera contained the relevant antibodies, detecting YdiV protein (left) and FlhDC as the FlhD 
and FlhC proteins individually (right).  This specificity was confirmed by an additional 
Western blot, consisting of YdiV and FlhDC proteins probed with non-stimuated rabbit sera, 
which failed to detect these proteins (Figure 5.11C).  
 
Following a second round of antigen exposure, rabbit serum samples were taken once 
more, hoping to detect a heightened response to the protein.  The anti-YdiV and anti-FlhDC 
sera were probed against purified protein samples (0.05 mg/ml of YdiV or FlhDC 
respectively) at four different dilution levels (1/100, 1/500, 1/1000 and 1/5000). For both 
proteins, the respective antibody clearly detected the protein of interest, with the Western 
blot detection becoming cleaner and better defined when using more dilute antibody 
(Figure 5.12).  Significantly, the sera show stronger detection and therefore affinity for the 
proteins, compared to the first injection sera.  Once more, the purified protein samples 
were probed with rabbit control serum and the resulting Western blots (Figure 5.12C) 
lacked detection of either protein, showing that the response in Figure 5.12B was a 
targeted and specific response.  
 
Due to the required level of specificity being reached after the second injection, the rabbits 
were not further challenged, but left for blood levels to be restored, before terminal bleeds 
were taken, which were used for all future antibody work.  
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Figure 5.11: Primary immune response antibody specificity test  
Following addition of the initial injection of YdiV or FlhDC antigens into rabbits, small 
samples of rabbit antisera were removed.  These antisera were tested for specificity 
against YdiV and FlhDC.  
A) Coomassie-stained SDS-PAGE gel of protein (either purified YdiV or crude 
soluble FlhDC) with All blue marker on the far left hand sides of the gel 
(molecular weights shown in KDa).  
B) Western blot using rabbit second bleed serum at various dilutions.  
C) Western blot using rabbit control serum (from non-injected rabbits) at various 
dilutions.  
In all cases, the antibody dilution was as specified and the locations of YdiV and 
FlhDC are as indicated.  
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Figure 5.12:  Secondary immune response antibody specificity test  
Following a second antigen exposure, the rabbits were expected to produce a 
heightened secondary response.  A sample of antiserum was removed and tested 
against purified YdiV and FlhDC (antigen) samples, to determine the specificity of the 
antibodies.  
A) Coomassie-stained SDS-PAGE gel of 0.05 mg/ml purified protein (YdiV or FlhDC 
as specified) with the All-blue marker on the far left hand side of each gel 
(molecular weights indicated in KDa).  
B) Western blot using rabbit second bleed serum at various dilutions. 
C) Western blot using rabbit control serum (from non-injected rabbits) at various 
dilutions.  
In all cases, the antibody dilution was as specified and the protein positions are as 
indicated.  
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5.5.2   Terminal bleed antibody sensitivity tests 
 
To test the sensitivity of the final bleed antisera, the sera were used at dilutions of 1/5000 
to probe antigen samples at 0.05 mg/ml and 0.01 mg/ml via Western blot.  Strong 
detection was seen for both antigens, with the antisera identifying even the weakest 0.01 
mg/ml protein levels (Figures 5.13 and 5.14).  In the case of YdiV, the detection was very 
clean giving a single species (Figure 5.13).  However, the FlhDC antiserum detected multiple 
species, which were consistent with the monomeric proteins FlhD and FlhC, as well as 
homo- and hetero-oligomers of these proteins (Figure 5.14), which are known to be formed 
(Liu & Matsumura, 1992; Wang et al., 2006).  Therefore, for future work, a 1/5000 dilution 
of both antisera was adopted as to be a suitable starting concentration.  
 
5.6   Determination of YdiV and FlhDC concentrations at different 
growth rates 
 
The effect of E. coli growth rates on ydiV and flhDC expression levels were analysed in an 
attempt to identify conditions in which FlhDC and YdiV protein levels were at their highest. 
Chemostat samples were provided by Thomas Curran, in which E. coli MG1655 cells were 
cultured in Evans minimal medium at pH 6.95, 37⁰C and with 400 rpm stirring at different 
dilution rates (Sections 2.2.1 and 2.2.2).  Four dilution rates were analysed (0.05, 0.1, 0.2 
and 0.5 /h), creating approximately a 10-fold range of bacterial doubling times.  
 
5.6.1   Analysis of YdiV expression levels 
 
YdiV protein levels were analysed using rabbit polyclonal antibodies to probe the E. coli cell 
samples specified above.  The resultant SDS-PAGE (Section 2.6.9) and Western blot (Section 
2.6.10) showed no detection of YdiV in the samples, and as a consequence, indicate that 
the protein must be present at very low levels in the cell (Figure 4.21).  
 
5.6.2   Analysis of FlhDC expression levels  
 
To detect the FlhDC expression levels, the chemostat growth rate samples were again 
analysed, alongside the E. coli strains MG1655 (wild-type) and JRG6577 (an flhDC mutant) 
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Figure 5.13: Anti-YdiV terminal bleed sensitivity test  
Coomassie-stained SDS-PAGE gel (left) and Western blot (right) assessing the sensitivity 
of the rabbit antiserum against the YdiV antigen.  
In both cases, M: BioRad all blue prestained marker (molecular weights indicated in 
KDa). Lane 1: Concentrated YdiV (0.05 mg/ml) 2: Diluted YdiV (0.01 mg/ml).  The 
Western blot (R) analyses the same SDS-PAGE gel lanes, but is probed with the YdiV 
rabbit antiserum (at a dilution of 1/5000). The YdiV protein (of expected molecular 
weight 28 KDa) was clearly detected by Western blot as indicated.  
 
 
Figure 5.14: Anti-FlhDC terminal bleed sensitivity test  
Coomassie-stained SDS-PAGE gels (left) and Western blot (right) assessing the sensitivity 
of the rabbit antiserum against the FlhDC antigen.  
In both cases, M: BioRad all blue prestained marker (molecular weights indicated in 
KDa). Lane 1: Concentrated FlhDC (0.05 mg/ml) 2: Diluted FlhDC (0.01 mg/ml).  The 
Western blots (R) analyses the same SDS-PAGE gel lanes but is probed with the FlhDC 
rabbit antiserum (at a dilution of 1/5000). The location of FlhC and FlhD are indicated at 
the expected molecular weights of 22 and 13 KDa respectively, as well as predicted FlhC2 
and FlhD2C2 species (expected molecular weight of 44 and 68 KDa respectively).  
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which were grown in LB medium at 37⁰C (Section 2.2.2) (Table 2.1).  Of importance, strain 
JRG6577 was grown in the absence of kanamycin, in order to lose the complementation 
plasmid containing flhDC (Table 2.1).  The chemostat and control cell samples were then 
diluted to give comparable cell density, and were analysed on an SDS-PAGE gel  (Section 
2.6.9) and by Western blot (Section 2.6.10), alongside a reference sample of purified FlhDC 
protein at 0.01 mg/ml concentration (Section 5.2.3).  Polyclonal antibodies raised against 
FlhDC (Section 5.5.2), were used in the Western blot analysis, initially at 1/5000 dilution 
before increasing the dilution to 1/10,000 to reduce the non-specific background.  
Equal loading of the samples was confirmed by SDS-PAGE analysis (Figure 5.15A).  Unlike 
YdiV, Western blot analysis showed expression of FlhDC (Figure 5.15B).  The purified FlhDC 
sample which is barely detectable in the PAGE gel, was clearly detected by the Western 
blot and enabled identification of the protein in the test samples.  The wild-type sample 
(lane 1) gave a weak species of the expected size, which was absent in the ΔflhDC sample 
(lane 2).  In the chemostat samples, a clear species is present in all cases, the intensity of 
which appears to peak at a dilution rate of 0.2 /h before decreasing slightly at 0.5 /h.  
 
The purified FlhDC sample yielded a faint species at 13 KDa (indicative of FlhD) in the 
Coomassie-blue stained SDS-PAGE gel (Figure 5.15A).  The Western blot, however, 
identifies multiple species in lane 3, signifying the presence of both monomeric 
components of the FlhDC protein sample, as well as several of the expected oligomeric 
states of the complex (Figure 5.15B).  For ease of analysis, only the FlhD component was 
quantified but is directly representative of the FlhDC complex levels.  
 
The intensity of the species seen by Western blot, was quantified by Image-J (Section 
2.10.1) to show the relative expression levels of FlhDC (Figure 5.16).  Of interest, the wild-
type levels of FlhDC are much lower than all the chemostat samples, presumably as a result 
of differing strain and growth conditions.  Whilst the wild-type strain was grown in LB 
medium at exponential phase, the chemostat samples were grown continuously in minimal 
medium and samples taken at steady state.  
 
Comparing the E. coli growth rate samples, the levels of FlhDC increased almost 2-fold 
between the 0.05 and 0.1 /h dilution rates, indicating that an increased bacterial growth  
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B 
Figure 5.15: FlhDC expression changes at various growth rates 
Samples of E. coli MG1655 chemostat cultures maintained at different dilution rates 
were analysed to identify whether FlhDC was up and down-regulated.  
Cell samples were analysed by A) Coomassie-stained SDS-PAGE and B) Western blot 
analysis, probed with FlhDC antiserum.  
For each sample, the dilution rates (1/h) are denoted simply by numbers, i.e. 0.05 to 
0.5, as explained previously, and the two biological replicates denoted by #1 or #2.  
M:BioRad Prestained marker (molecular weights shown in KDa),  1: E. coli MG1655, 2: 
E. coli JRG6577 (an flhDC mutant) 3: 0.01 mg/ml purified FlhDC protein, 4: MG1655 
0.05 #1, 5: MG1655 0.05 #2, 6: MG1655 0.1 #1, 7: MG1655 0.1 #2, 8: MG1655 0.2 #1, 
9: MG1655 0.2 #2, 10: MG1655 0.5 #1, 11: MG1655 0.5 #2. 
The location of FlhDC (specifically FlhD) is indicated.  
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Figure 5.16: Relative intensities of FlhDC expression, as quantified by Image-J 
software 
The relative intensities of FlhDC expression, determined from Western blot analysis 
are shown for each of the different E. coli growth conditions.  
Numerical values 0.05, 0.1, 0.2 and 0.5 refer to the chemostat dilution rates (1/h), 
which correspond to the E. coli MG1655 growth rates.  For each of the chemostat 
samples, two biological replicates were taken with an average quantified intensity 
plotted on the chart.  The quantified level of variation between the replicates is 
shown by error bars.  
The numbers above each bar indicate the relative intensities of FlhDC detected in 
each condition.  
  Wild-type     ΔflhDC          0.05              0.1                0.2               0.5 
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rate caused the concentration of FlhDC to be up-regulated (Figure 5.16).  An approximately 
equal transition was present between the 0.1 and 0.2 /h dilution samples, signifying even 
higher levels of FlhDC at the 0.2 /h dilution rate.  However, the protein levels peaked at this 
dilution rate, with a decrease in protein quantities in the 0.5 /h dilution rate sample.  In real 
terms, the quantity of FlhD in the maximal growth conditions has been calculated at ~5 ng 
per 0.22 OD600 units, using the intensity of the known concentration FlhDC sample as a 
reference.   If 1 unit of cells at OD600  is equivalent to 5 x10
8 - 1 x109 cells, this equates to 
~0.03 fg of FlhDC per cell.  
 
Therefore, these data demonstrate that the optimal growth rate for FlhDC production is 
equivalent to a dilution rate of 0.2 /h, equivalent to a 3.5 h doubling time.  Future work 
could investigate the mechanism by which this maximal FlhDC production is produced; 
whether gene transcription or translation are maximally activated or whether protein 
degradation rates are maximally decreased.  
 
5.7   DNA-binding capacity of FlhDC in the presence of YdiV   
 
Electromobility shift assays (Section 2.9.2) were carried out to investigate the binding of 
the transcription factor FlhDC to flagellar type II genes in the presence and absence of the 
anti-FlhDC factor YdiV.   
 
The entire promoter region of the fliD gene (PfliD) was chosen as an example of a class II 
gene and contained two FlhDC recognition sites or ‘binding boxes’ that constitute the FlhDC 
binding site.  This promoter region was amplified from E. coli MG1655 genomic DNA using 
primers NSW27 and NSW28 (Table 5.2) by PCR (Section 2.3.3).  
 
Table 5.2: Primers for amplification of PfliD for EMSA assays 
 
 
Primer Sequence Function 
NSW27 TTTTTCTAGAGATTCGTTATCCTATATT
GCAAGT 
Forward primer for PfliD amplification 
NSW28 TTTTGCGATTTCCTTTTATCTTTCG Reverse primer for PfliD amplification 
The sequence shaded in grey indicates an XbaI site.  
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The amplified DNA was purified, digested using XbaI enzyme and subsequently purified and 
quantified (Sections 2.3.10; 2.3.6 and 2.3.8).  The DNA fragment (150 ng) was radiolabelled 
using [α32P]-dCTP and purified once more prior to use in EMSAs (Section 2.9.1).  Reaction 
samples were produced containing radiolabelled PfliD with increasing quantities of FlhDC 
and subsequently YdiV (Section 2.9.2).  Both proteins were purified with C-terminal His6-
tags and were used directly in sodium phosphate elution buffers (Sections 4.2.3 and 5.2.3). 
The proteins (of specified concentrations) were incubated with ~ 2 nM radioactively 
labelled PfliD, before being incubated at 37⁰C for 30 min.  Following this, the samples were 
mixed with EMSA loading dye (Table 2.14) and electrophoresed to separate the free PfliD 
DNA from the protein-DNA complexes.   
 
The EMSA showed that FlhDC (at concentrations from 9 µM) bound at PfliD, but in the 
presence of YdiV (at 7.5 µM and above) was no longer able to bind PfliD (Figure 5.17).  This 
indicates that the formation of the FlhDC:YdiV complex inhibits the formation of the 
FlhDC:PfliD complex, with YdiV causing the dissociation of PfliD DNA.  This switch in FlhDC 
binding partners (from PfliD DNA to YdiV), revealed that the interactions are competitive to 
some extent, possibly via the DNA and YdiV interacting at the same site in the FlhDC 
complex, or inducing a change to FlhDC which prevents both partners binding 
simultaneously.  
 
This analysis confirms that the E. coli YdiV:FlhDC interaction has the same DNA-binding 
properties as in S. enterica (Wada et al., 2011).  Whilst undertaking this study, the same 
conclusion was reached by competing groups, who also found YdiV to be an anti-FlhDC 
factor (Wada et al., 2012; Li et al., 2012).  
 
Calculating the stoichiometry, the initial addition of YdiV at 4 µM yields an ~ 1:4 ratio 
between YdiV:FlhDC and at this molar ratio, the DNA remained shifted (Figure 5.17). 
Addition of 7.5 µM YdiV to samples (producing a 1:2 molar ratio of YdiV:FlhDC) however 
caused a complete lack of DNA shifting, confirming complete DNA dissociation.  Competing 
groups such as Wada et al. (2012) and Li et al. (2012) also calculated the YdiV:FlhDC molar 
ratios necessary for DNA dissociation from FlhDC.  Wada et al. (2012) found that DNA 
remained shifted in a 1:1 ratio between YdiV:FlhDC, but increasing the ratio to 2.5:1 caused 
DNA dissociation from the FlhDC complex.  A similar stoichiometry was found by Li et al. 
(2012) who found that below a 2.5:1 molar ratio of YdiV:FlhDC, DNA binding remained but  
208 
 
                                  
 
 
 
 
 
 
 
 
 
 
  
Figure 5.17: EMSA of radiolabelled PfliD DNA with varying quantities of FlhDC and 
YdiV proteins  
Exposed autoradiography film, showing the labelled DNA in the presence of purified 
FlhDC and YdiV, with protein concentrations as stated.  
Free PfliD DNA and bound protein:PfliD species are indicated, as well as the multiple 
protein:PfliD species.  
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a 3:1 ratio of YdiV:FlhDC protein prevented the DNA shift entirely.  These stoichiometry 
variations could feasibly be a result of different reaction buffer conditions as well as 
different affinities of FlhDC for the various promoter regions.  The data here are for the 
PfliD region, whilst the PflhB and PfliA regions were used in the Li et al. (2012) and Wada et 
al. (2012) studies respectively.  
 
Noteably, the EMSA showed three distinct species of protein:PfliD complexes in the shifted 
region indicating that FlhDC and PfliD formed three different interactions (Figure 5.17).  
The PfliD DNA region contains both ‘FlhDC-binding boxes’ which are characteristically 
present in all Class II flagella gene promoters for FlhDC recognition (Claret & Hughes, 2002; 
Wang et al., 2006).  It is believed that the promoter motifs act as one single binding site, 
consisting of two FlhDC binding boxes and the interlinking region, all of which is necessary 
to bind a single FlhD4C2 (Claret & Hughes, 2002).  Both FlhC and FlhD are necessary to 
produce a stable DNA-binding complex, with much higher concentrations of FlhC singularly 
required to bind to DNA (Claret & Hughes, 2002).  Therefore a single FlhDC functional 
species is the most likely protein interacting with the PfliD rather than singular FlhD or FlhC.   
One possible reason for the multiple shifted species could be a heterogeneous mixture of 
FlhDC complexes in solution, producing a mixture of FlhD2C2-DNA and FlhD4C2-DNA 
interactions which would potentially account for two of the three species.  Equally, it is 
unknown whether essentially ‘half’ of the FlhDC complex binds to one of the FlhDC-binding 
boxes, and the other ‘half’ to the other box.  If this were the case, then there is a possibility 
of one FlhDC-binding box being occupied whilst the other is unoccupied, which would again 
produce different EMSA shifted species.  To clarify this result, techniques such as gel 
filtration or analytical centrifugation could be used to determine the identity of the three 
distinct shifted species and determine precisely which proteins are involved in each case.  
Additionally, segmenting the PfliD DNA into multiple fragments would provide useful 
information, identifying whether any form of FlhDC could bind to just one of the binding 
boxes or whether both were essential.  
 
An alternative and perhaps more likely explanation, is the presence of low homology 
binding sequences in the PfliD DNA fragment which also interact with the FlhDC protein. 
Obviously the ‘FlhDC-binding box’ is the prefential site for FlhDC binding, and would 
produce the lower shifted species which is produced initially.  Once the protein 
concentration increases, the less mobile species are produced, as a result of binding at 
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alternative lower affinity sites.  In order for this to be true, there would need to be two 
lower affinity FlhDC-binding sites in the PfliD region.  
 
5.8   Characterisation of binding kinetics of DNA:FlhDC interaction 
 
BLItz analysis was utilised once more to kinetically analyse the binding of FlhDC to PfliD 
DNA (Section 2.9.5), as shown previously by EMSA analysis (Figure 5.17).   
 
The interactions between purified FlhDC and the “target” DNA region of PfliD were tested 
alongside the interactions between FlhDC and “control” DNA, which lacked the ‘FlhDC-
binding box motifs’.  In addition purified YdiV was tested against both DNA fragments, 
acting as a protein control predicted to have no interaction with the DNA.  
 
Both target and control DNA fragments were synthesised to produce 5’ biotinylated dsDNA 
fragment of 160 bp long.  The target DNA corresponded to a region in the fliD promoter 
(PfliD) including both FlhDC binding boxes, whilst the control DNA corresponded to a region 
further upstream of the PfliD sequence lacking the FlhDC binding boxes.  The regions were 
amplified from E. coli MG1655 genomic DNA by PCR (Section 2.3.3) using primer pairs 
NSW84 and NSW28 (target) and primers NSW85 and NSW86 (control DNA) (Table 5.3).   
 
Table 5.3: Primers for synthesis of target and control dsDNA for BLItz analysis 
 
 
The amplified DNA was then purified using a QIAgen Gel Extraction kit (Section 2.3.7) and 
concentrated using a heat-vacuum system.  The DNA concentration was determined, 
Primer Sequence Function 
NSW84 Biotin-AGCCATTTTTTGTTAGTCGCCG
AAATACTCTTTTCTCTGCCCCTTATTCC
CGCTATTAAAAAAAACAATT 
Forward primer for target PfliD 160 bp 
DNA (including FlhDC binding boxes) 
NSW28 TTTTGCGATTTCCTTTTATCTTTCG Reverse primer for target PfliD 160 bp 
DNA (including FlhDC binding boxes) 
NSW85 Biotin- TGCGTCATCCTTCGCGCTGT    Forward primer for control 160 bp 
DNA 
NSW86 TTTTGACTTGCAATATAGGATAACG Reverse primer for control 160 bp 
DNA 
The sequences highlighted in grey indicate FlhDC binding boxes in the PfliD region.  
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reverting back to further concentrating of DNA, if the concentration was not deemed 
sufficiently high (Section 2.3.8). 
 
Using the synthesized biotinylated DNA fragments, the “target” or “control” DNA were 
immobilised to streptavidin (SA) biosensors at fixed concentrations of 35 µg/ml.  The FlhDC 
and YdiV proteins were subsequently added to the biosensor systems at multiple 
concentrations, to detect any binding interactions.  Both proteins were produced as His6-
tagged fusion proteins and were purified and dialysed in sodium phosphate buffers 
(Sections 4.2.3; 5.2.3 and 2.6.7).  
 
5.8.1   Control experiments  
 
To assess the binding affinity of DNA and FlhDC, the DNA was attached to a biosensor (step 
2) with FlhDC added at the association stage (step 4).  Prior to this, control experiments 
were carried out, to ensure that the equipment was capable of immobilising this particular 
DNA and differentiating between non-interacting and interacting proteins (Figure 5.18).  
The first control (run 1) was an entire buffer assay, with stages 1-5 all consisting of buffer 
only (Figure 5.18).  As expected this gave a completely flat trace, with no buffer loading 
onto the biosensor, and no association curve.  Secondly, a DNA immobilisation control (run 
2) was carried out, loading the target dsDNA to the biosensor and adding buffer at step 4. 
Here, a loading curve was clearly visible, confirming that DNA was immobilised to the chip. 
Upon addition of buffer at step 4, no association was indicated, which confirmed that the 
buffer components did not bind to the DNA.  
 
The equipment was then tested for its ability to detect DNA and protein interactions, using 
both positive and negative controls.  The target dsDNA was immobilised to the biosensor 
and a protein (100 µg/ml concentration) added in step 4.  The positive control protein was 
FlhDC (run 3) and clearly showed immobilisation of DNA prior to a clear association curve 
upon protein addition, indicating an interaction between DNA and protein.  Finally target 
DNA was tested against a negative control protein (run 4) mH0579 which is a protein found 
in Mannheimia haemolytica of ~130 amino acids length.  The function of this protein is 
currently unknown, but has no predicted DNA binding ability.  In this case the association 
step produced a flat trace, indicative of a lack of protein:DNA binding.  
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Figure 5.18: BLItz binding spectra for DNA-protein control experiments 
Binding spectra for a series of control experiments in which target biotinylated DNA was 
immobilised to a streptavidin biosensor and positive and negative control proteins were 
added.  The binding reaction was composed of 5 discrete steps; 1: initial baseline, 2: 
DNA immobilisation, 3: baseline, 4: association and 5: dissociation. 
A) Biosensor binding (nm) for entire duration of the experiments, as the reactions 
proceeded (sec).  
B) Biosensor binding (nm) trace for the final three steps, focused on the 
association and dissociation data.   
For both traces, the steps are specified, with each vertical line indicating the start of a 
new step.  
Each of the four runs had different immobilisation and association components to act as 
various controls, with all DNA added at 35 µg/ml and proteins added at 100 µg/ml.  The 
components of each run were as follows; 1: Buffer throughout, 2: Target DNA 
immobilisation and buffer association, 3: Target DNA immobilisation and FlhDC 
association, 4: Target DNA immobilisation and mH0579 association.  
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These four control reactions confirmed that the assay worked as expected, with DNA 
successfully immobilised to the streptavidin chip.  Of importance, the buffer-DNA control 
indicated absolutely no signs of any association interaction, meaning that any protein-DNA 
interaction would be a direct result of the protein rather than any buffer component.  In 
addition, the system was able to detect the interaction between FlhDC and DNA, but did 
not detect any interaction with mH0579, therefore confirming the ability of the equipment 
to differentiate between interacting and non-interacting experiments.  
 
Following this, the kinetic analysis of the FlhDC: DNA interaction could commence.  
 
5.8.2   Kinetics of the FlhDC:DNA interaction 
 
The interaction between target DNA and FlhDC was measured by BLItz analysis (Section 
2.9.5) to determine the binding affinities of the PfliD and FlhDC interaction.  Alongside this, 
the interaction between the control DNA and FlhDC was measured.  This enabled the 
binding kinetics of both reactions to be compared, to assess whether the FlhDC and PfliD 
interaction was genuine and sequence specific.  
 
The target DNA and FlhDC experiment series was carried out by immobilising target DNA to 
a streptavidin (SA) biosensor at a concentration of 35 µg/ml. FlhDC was then added at 5 
different concentrations ranging from 11 µM to 44 nM, almost a 1000-fold range (Figure 
5.19).  The resultant traces showed an increase in biosensor thickness (step 2) upon 
addition and immobilisation of target DNA to the streptavidin chip.  FlhDC was 
subsequently added (step 4) and an upward association curve was produced, indicating the 
binding interaction of DNA and FlhDC, before the dissociation step (step 5) which showed a 
gradual loss of binding (Figure 5.19B).  Of note, the association step is of varying gradients 
dependent on the protein concentrations used.  The almost flat dissociation step indicates 
that the interaction is kinetically stable and plateaus at a higher biosensor thickness than 
the baseline, showing that even after the 10 min dissociation step some of the protein 
remained bound to DNA.  This is in contrast to the control DNA and FlhDC experiment, 
which shows a steep dissociation curve (Figure 5.20), thereby indicating the genuity of the 
target DNA and FlhDC interaction.  
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Figure 5.19: BLItz binding spectra for “target” DNA immobilisation and FlhDC addition  
See p215 for details.  
 
 
Figure 5.20: BLItz binding spectra for “control” DNA immobilisation and FlhDC addition  
See p215 for details.   
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Figure 5.20: BLItz binding spectra for “control” DNA immobilisation and FlhDC 
addition  
Binding spectra for a series of control experiments in which control biotinylated DNA 
was immobilised to a streptavidin biosensor and FlhDC protein added.  The binding 
reaction was composed of 5 discrete steps; 1: initial baseline, 2: DNA immobilisation, 3: 
baseline, 4: association and 5: dissociation. 
A) Biosensor binding (nm) trace for entire duration of the experiments, as the 
reactions proceeded over time (sec).  
B) Biosensor binding (nm) trace for the final three steps, enlarging the association 
and dissociation curve data.  
 
For both traces, the steps are specified, with each vertical line indicating the start of a 
new step.  
The concentration of dsDNA was fixed at 35 µg/ml, with FlhDC concentrations varying 
for each of the five runs.  The concentration of FlhDC tested was as follows; run 1: 22 
µM, run 2: 4.4 µM, run 3:  11 µM, run 4: 2.2 µM and run 5: 440 nM.  
Figure 5.19: BLItz binding spectra for “target” DNA immobilisation and FlhDC addition  
Binding spectra for a series of control experiments in which target biotinylated DNA was 
immobilised to a streptavidin biosensor and FlhDC protein added.  The binding reaction 
was composed of 5 discrete steps; 1: initial baseline, 2: DNA immobilisation, 3: baseline, 
4: association and 5: dissociation. 
A) Biosensor binding (nm) trace for entire duration of the experiments, as the 
reactions proceeded over time (sec).  
B) Biosensor binding (nm) trace for the final three steps, enlarging the association 
and dissociation curve data.  
 
For both traces, the steps are specified, with each vertical line indicating the start of a 
new step.  
The concentration of dsDNA was fixed at 35 µg/ml, with FlhDC concentrations varying 
for each of the five runs.  The concentration of FlhDC tested was as follows; run 1: 4.4 
µM, run 2: 2.2 µM, run 3:  11 µM, run 4: 440 nM and run 5: 44 nM.  
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The global kinetics suggested a KD of 158 nM, which is indicative of tight binding and a 
strong affinity between the DNA and FlhDC.  The association rate constant ka was 
calculated at 1.88x 102 ± 3.8x101 1/Ms and the dissociation rate constant kd was 2.98 x10-5 
± 2.5x10-5 1/s.  These values indicate a reasonable rate of association but an extremely low  
off-rate, which may suggest that YdiV is necessary for the efficient removal of DNA from 
FlhDC.  
 
The KD was calculated for the interaction between FlhDC with four other flagella class II 
promoters, giving binding values between 12-43 nM (Stafford et al., 2005).  Comparing 
these binding affinities with that of FlhDC to PfliD reveals a weaker binding constant to 
PfliD.  The major hypothesis to account for this difference is due to the large calculated 
errors of this analysis.  Taking these factors into account, the calculated affinity constant of 
FlhDC for the fliD promoter is consistent with other class II promoter regions (Stafford et 
al., 2005).  
 
The control DNA series utilised control dsDNA (35 µg/ml) immobilised to a biosensor to test 
whether the FlhDC:target DNA interactions were specific or not (Figure 5.20).  Once more, 
a range of FlhDC concentrations were tested, between 22 µM and 440 nM.  The resultant 
traces again confirmed DNA immobilisation (step 2), this time the control DNA to the 
biosensor.   Upon FlhDC addition, an association curve was seen, representing some 
interaction between the protein and DNA (Figure 5.20B).  However, the traces of the 
association curve run parallel to one another, indicating that the interaction is not protein 
concentration dependent and is purely a result of the protein and DNA being in the same 
area for a given time.  Once the biosensor is removed from the protein sample (step 5), 
there is a clear rapid drop in the biosensor thickness signifying that any interaction 
between the protein and control DNA is quickly dissociated and therefore non-specific.  
The calculated kinetic values yield a much higher global KD value, indicating much weaker 
binding, of 4 mM.  For completeness, the ka value was measured as 3.22 x10-1 ± 2.1 x102 
1/Ms and kd calculated to be 1.3 x10-3 ± 9.12 x10-5 1/s.  
 
This mM KD constant is indicative of non-specific binding interactions, with this interaction 
likely to only occur in these artificial conditions rather than in vivo.  Of note, this control KD 
is dramatically different from the KD of 158 nM measured for the target DNA binding, 
confirming that the initial FlhDC: PfliD interaction was sequence specific.    
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5.8.3   Kinetics of the YdiV:DNA interaction 
 
For completeness, the YdiV and PfliD binding interaction was analysed, predicting no 
affinity at all, as shown by EMSA analysis (Figure 5.21).  Both the target PfliD and control 
dsDNA were tested, to determine whether YdiV interacted more favourably with the PfliD 
DNA than a random sequence control DNA.  
 
Both types of DNA were immobilised to a streptavidin chip at a fixed 35 µg/ml 
concentration.  Two concentrations of YdiV were then added (5355 nM and 1500 nM), to 
the reactions and were tested against both types of DNA.   
 
Both the target and control DNA were clearly immobilised to the streptavidin chip, with 
clear upwards traces visible (Figure 5.21A).  Upon YdiV addition to the test dsDNA (run 1 
and 2), the association curves were flat, with the dissociation trace level with the baseline. 
This indicated that any association between YdiV and PfliD is temporary, with no or little 
interaction remaining following the dissociation step (Figure 5.21B).  Upon addition of YdiV 
to the immobilised control dsDNA (run 3 and 4) a marked increase in the association 
gradient was seen, compared to the much flatter response to the target DNA.  However the 
dissociation step shows a quick drop in the biosensor thickness before forming a plateau at 
a baseline level.  This indicates that any binding that occurred in these reactions was non-
specific, and therefore were quickly dissociated.  
 
The kinetics were then calculated for these experiments, and consistently showed a high KD 
in the range of 0.8 mM and 14.4 mM for YdiV with both types of DNA.  The ka values for all 
assays were between 1.36  and 7.73 x10-1 1/Ms (errors of ~4 x102 1/Ms) and kd values 
calculated ranging between 1.03 x10-2 and 6.5 x10-4 (errors of ~1.5x10-4).  
 
This demonstrates that YdiV has no preferential binding for the PfliD region than the 
further upstream control region, and indicates that this affinity range shows non-specific 
background interaction.  In addition, the interactions between FlhDC and the control DNA 
were of the same KD range, again convincing evidence that these are simply background 
interactions rather than anything significant.  
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Figure 5.21: BLItz binding spectra for “control” and “target” DNA immobilisation and 
YdiV addition  
Binding spectra for a series of control experiments in which both control and target 
biotinylated DNA were immobilised to streptavidin biosensors and YdiV protein added. 
The binding reaction was composed of 5 discrete steps; 1: initial baseline, 2: DNA 
immobilisation, 3: baseline, 4: association and 5: dissociation. 
A) Biosensor binding (nm) trace for entire duration of the experiments, as the 
reactions proceeded over time (sec).  
B) Biosensor binding (nm) trace for the final three steps, enlarging the association 
and dissociation curve data.  
 
For both traces, the steps are specified, with each vertical line indicating the start of a 
new step.  
Target dsDNA was immobilised in run 1 and 2 and control DNA immobilised in run 
number 3 and 4 (both at 35 µg/ml).  YdiV was added at the association step in all four 
experiments, at 5355 nM in run 1 and 3, and 1500 nM in run 2 and 4.   
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5.9   Effect of YdiV concentration on in vitro transcription of fliD  
 
Following the observation that YdiV inhibited FlhDC:PfliD interactions, transcription of fliD 
was studied using in vitro transcription assays (Section 2.9.3).  Radio-labelled RNA 
corresponding to the fliD DNA was synthesised during the experiment, with regulatory 
proteins such as FlhDC and YdiV included in the reactions, enabling the impact of these 
proteins on transcription to be determined.  The extent of fliD transcription could then be 
analysed by electrophoresis of the samples on an IVT gel and detection by autoradiography 
(Section 2.9.4).  
 
DNA was synthesised to cover the entire promoter region and 200 bp of the fliD gene by 
amplifying the region from E. coli MG1655 genomic DNA using primers NSW39 and NSW40 
(Table 5.4) (Section 2.3.3).  
 
Table 5.4: Primers for IVT PfliD- fliD DNA synthesis 
 
The amplified DNA was then purified and quantified, prior to storage at -20⁰C until required 
(Section 2.3.8 and 2.3.10).  Reaction mixtures were made, consisting of 1 pmole RNA 
polymerase (specifically as a holoenzyme with σ70), 0.1 pmole fliD DNA and varying 
concentrations of the purified proteins FlhDC and YdiV in an IVT Tris-HCl buffer, pH 8 
(Section 2.9.3).  Both proteins were purified as His6-tagged fusion proteins and were used 
in these assays directly in sodium phosphate elution buffer (Sections 4.2.3 and 5.2.3).  
 
A control reaction containing neither FlhDC nor YdiV was analysed, alongside various 
samples containing 12 µM (seen previously to be the minimum concentration of FlhDC to 
cause DNA-binding in the EMSA assays; Figure 5.17), with increasing quantities of the anti-
FlhDC factor YdiV.  These samples were incubated at 37⁰C for 15 min prior to transcription 
initiation by addition of a nucleotide mix, containing [α-32P]-labelled UTP.  Once again 
samples were incubated for 15 min at 37⁰C to enable transcription to proceed.  The 
Primer Sequence Function 
NSW39 TTTTGGATCCGATTCGTTATCCTATATTG
CAAGT 
Forward primer for PfliD (leading to 
fliD gene) 
NSW40 TTTTGAATTCGCGCGCTTTTCAGCGTACC Reverse primer for fliD gene and 
PfliD 
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reactions were stopped by addition of stop/loading dye (Table 2.15).  The samples were 
then electrophoresed on a 6% IVT gel alongside a 0.1-1 Kb RNA marker (Section 2.9.3).  
 
In the absence of FlhDC, no fliD transcript was detected, indicating that PfliD transcription 
was completely dependent on FlhDC (Figure 5.22, lane 1).  In the presence of FlhDC, two 
transcripts were detected, suggesting two FlhDC-dependent transcript starts (Figure 5.22, 
lane 2).  Interestingly, concentrations of YdiV caused an initial increase in the abundance of 
both transcripts (Figure 5.22, lanes 3-5) followed by a decrease (Figure 5.22, lanes 6-10).  Of 
note, equimolar concentrations of FlhDC and YdiV caused repression of PfliD transcription 
(Figure 5.22, lane 8).   
 
This data suggests that maximal transcription occurred when a small quantity of YdiV was 
present, perhaps by inhibiting the formation of the minor alternate PfliD:FlhDC complexes 
observed in EMSAs (Figure 5.17).  Alternatively, YdiV could be part of the FlhDC:PfliD 
binding complex, directly aiding transcription in some manner, possibly by altering the DNA 
conformation.  The possibility that YdiV might act to aid FlhDC:PfliD transcription under 
some conditions is in contrast to the previous hypothesis in which YdiV was reported solely 
as an anti-FlhDC factor, with no evidence of YdiV having any positive effect on the 
FlhDC:DNA complex (Wada et al., 2011; Wada et al., 2012).  However, a theoretical model 
of the YdiV:FlhDC interaction has been hypothesised, in which a transitional 
YdiV2:FlhD4C2:DNA complex was proposed (Li et al., 2012).  Therefore attempting to 
understand the manner in which YdiV increased fliD transcription was of interest. 
 
5.9.1   Deciphering the role of YdiV in the FlhDC:DNA complex 
 
Following the IVT assays, the role of YdiV in the FlhDC, PfliD and YdiV reaction mix was 
analysed, carrying out EMSAs in the presence of YdiV and FlhDC antibodies.  It was 
hypothesised that a supershift would occur in the EMSA if an antibody bound to a DNA-
binding complex protein, and therefore would identify which proteins were present in this 
DNA complex.  
 
Electromobility shift assays (Section 2.9.2) were carried out using radiolabelled PfliD DNA 
(Section 5.7).  Reaction mixes of 12 µM FlhDC and 1.5 µM YdiV were incubated with 2 nM 
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Figure 5.22: In vitro transcription of fliD in the presence of the transcription factor 
FlhDC and anti-FlhDC factor YdiV 
Autoradiograph showing the extent of radiolabelled fliD transcript formed under 
various conditions.  
IVT reactions containing RNA polymerase, fliD DNA, a radiolabelled NTP mix and varying 
concentrations of the purified proteins FlhDC and YdiV as specified.  Following the initial 
control reaction (containing no FlhDC or YdiV), the remaining samples contained 12 µM 
FlhDC as this was the minimum concentration required for a PfliD:protein shift in an 
EMSA (Figure 5.17). The YdiV protein was then titrated in to the samples, with molar 
ratios of FlhDC: YdiV progressing from 16:1 right to 1:4.  
The location of the fliD transcript is indicated.  
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radiolabelled PfliD (Section 2.9.1) for 30 min at 37⁰C (as these protein concentrations 
caused maximum transcription in the IVT assays).  Following this, YdiV and FlhDC antibodies 
(Section 5.5) were added to the relevant samples (at an antiserum dilution of 1/10), just 
prior to addition of EMSA loading dye (Table 2.14) and electrophoresis of the samples.  
The EMSA showed the free PfliD DNA (lane 1) being shifted to indicate a protein:PfliD 
complex upon FlhDC and YdiV addition (lanes 2 and 3) (Figure 5.23).  Upon addition of both 
the YdiV antibody (lane 4) and the FlhDC antibody (lane 5), the protein:PfliD species was 
itself shifted, giving two supershifted species.  This indicated that both the FlhDC and YdiV 
proteins were present in the DNA binding complex. To confirm this result, control reactions 
of PfliD and the YdiV and FlhDC antibodies (lanes 6 and 7 respectively) were carried out and 
caused no DNA shifting, thereby authenticating the supershifts seen in lanes 4 and 5.  
 
An additional control was carried out to ensure that the YdiV antibody had no affinity for 
the FlhDC protein (Figure 5.24).  Here, as expected, FlhDC addition produced a shifted 
species upon binding to the PfliD DNA.  However, upon addition of the anti-YdiV serum to 
the protein:PfliD species, no supershift was produced indicating no cross-affinity of the 
anti-YdiV for the FlhDC complex.  This confirms that the supershift seen in Figure 5.23 was 
directly due to the presence of YdiV in the DNA:protein complex.  
 
These assays clarify the IVT result, suggesting that the YdiV protein has a direct effect on 
the FlhDC:DNA interaction, and is part of the DNA-binding complex, forming a 
YdiV:FlhDC:PfliD complex.  This conclusion is in agreement with that of Takaya et al. (2012) 
who identified the existence of the same DNA:YdiV:FlhDC complex.  Whilst the formation of 
this complex is conclusive, identifying the mechanism of the interaction and the possible 
upregulation ability of YdiV is a crucial area for investigation.  
 
5.10   Investigation of ligand interaction to the YdiV:FlhDC complex  
 
At present, there is no known trigger for the FlhDC:YdiV interaction. Analysis of YdiV 
tentatively suggested a possible interaction with c-di-GMP (Section 4.5) which provided a 
reason to investigate nucleotide binding.  Therefore, a number of assays were carried out, 
each with its own limitations, and hence the data were interpreted as a collective.  
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Figure 5.23: EMSA to determine the role of YdiV in the PfliD , FlhDC and YdiV reaction 
mix 
Autoradiograph, showing labelled DNA in the presence of purified FlhDC and YdiV, as 
well as YdiV or FlhDC antibodies.  
Lanes 1-7 all contain 2 nM radiolabelled PfliD DNA, with the additional constituents 
detailed below:  
Lane 1: DNA only 
Lane 2: DNA + 12 µM FlhDC 
Lane 3: DNA, 12 µM FlhDC +1.5 µM YdiV  
Lane 4: DNA, 12 µM FlhDC, 1.5 µM YdiV + anti-YdiV 
Lane 5: DNA, 12 µM FlhDC, 1.5 µM YdiV + anti-FlhDC 
Lane 6: DNA + anti-YdiV 
Lane 7: DNA + anti-FlhDC 
 
The free PfliD, PfliD:protein and PfliD:protein:Ig species are indicated.  
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Figure 5.24: Control EMSA for FlhDC and anti-YdiV   
Autoradiograph, showing labelled DNA in the presence of purified FlhDC and 
YdiV antibodies.  
Lanes 1-5 all contain 2 nM radiolabelled PfliD DNA, with the additional 
constituents detailed below:  
Lane 1: DNA only 
Lane 2: DNA + 12.6 µM FlhDC 
Lane 3: DNA + 38 µM FlhDC  
Lane 4: DNA + 50 µM FlhDC 
Lane 5: DNA, 50 µM FlhDC + anti-YdiV 
 
The free PfliD and PfliD:protein species are indicated.  
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5.10.1   Protein and nucleotide pull-down assays  
 
Pull-down assays were carried out to determine whether the addition of a nucleotide 
altered the YdiV:FlhDC interaction (Section 2.7.5).  The YdiV:FlhDC complex was formed 
prior to the addition of nucleotides, therefore enabling analysis of whether specific 
nucleotides disrupted this complex.  However, feasibly a ligand could also enhance the 
YdiV:FlhDC complex formation, in which case the quantity of the complex or speed of its 
formation may increase.  Whilst any changes in the quantity of complex could be detected, 
any changes in the speed of formation are undetectable, thereby highlighting the 
limitations of this technique.  
 
Pull-down assays were carried out using small aliquots (100 µl) of pre-washed Ni-NTA resin 
(Section 2.7.5).  Soluble crude YdiV-His6 (Section 4.2.2) was immobilised to the resin, before 
addition of crude (FLAG)3-FlhDC (Section 5.2.2) to form the YdiV:FlhDC complex.  Various 
individual nucleotides (30 µl of 50 mM concentration) were then added.  Samples were 
taken from the unbound fraction and the resin was thoroughly washed.  Following this, 
addition of an imidazole-rich elution buffer eluted the His-tagged YdiV protein from the 
resin.  Hypothetically if a nucleotide were to interact and disrupt the FlhDC:YdiV complex, it 
was predicted that the FlhDC component would be lost from the pull-down assay in the 
wash step following ligand addition, whilst the His-tagged YdiV would remain bound until 
imidazole elution.   
 
Samples were collected at each stage and analysed by SDS-PAGE (Section 2.6.9) to identify 
which proteins were eluted at the various stages of the protocol (Figure 5.25).  In all cases, 
there was no obvious indication of YdiV:FlhDC disruption upon nucleotide addition (lane 5), 
with the two proteins clearly eluted together in lanes 6 and 7.  In some cases, such as upon 
GMP or ATP addition, protein species were present in the excess nucleotide sample (lane 
5).  However both YdiV and FlhDC were detected indicating that this could simply be a 
technical error i.e. due to uptake of a small volume of resin along with the supernatant.  
 
Whilst this assay did not indicate FlhDC dissociation upon nucleotide addition, there was a 
noticeable variation in the proportion of YdiV and FlhDC proteins eluted (lane 6) and resin-
bound (lane 7) (Figure 5.25). This difference appeared to be nucleotide dependent and the 
relative amounts of both proteins were quantified by Image-J analysis (Section 2.10.1) of  
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the SDS-PAGE gels (Figure 5.26).  Quantification of these proteins indicated variation 
amongst samples, with the proportion of YdiV fluctuating from 0.5 to 0.65.  Reactions 
containing pGpG, ppGpp and c-di-GMP to the FlhDC:YdiV complex were quantified and 
indicated a 50/50 elution mix of FlhDC and YdiV, possibly indicating a 1:1 stoichiometry of 
the proteins.  Contrastingly, the no ligand sample or the addition of cAMP yielded a 65/35% 
elution mix of YdiV:FlhDC, possible indicating a 2:1 stoichiometry of the eluted proteins.  
 
These stoichiometry changes could be highly significant, with models hypothesising that 
four distinct YdiV:FlhDC complexes (specifically YdiV1:FlhD4C2, YdiV2:FlhD4C2, YdiV3:FlhD4C2 
and YdiV4:FlhD4C2) could form (Li et al., 2012).  Therefore the 1:1 stoichiometry of 
YdiV:FlhDC seen upon pGpG, ppGpp and c-di-GMP addition could feasibly indicate the 
formation of a YdiV1-FlhD4C2 complex whilst the 2:1 stoichiometry could therefore indicate 
the formation of an YdiV2-FlhD4C2 complex.  If the oligomeric state was genuinely altered 
upon nucleotide addition, this would indicate that nucleotide-protein interactions were 
occurring and presumably reduced the ability of the proteins to interact, either by inducing 
a conformational change or by shielding an interaction interface.  
 
Whilst this is one theory, the significance of these protein fluctuations is unknown, 
requiring assay repetitions in order to increase confidence in these data.  Equally, one of 
the limitations of this assay was the fixed order in which the pull-down assay was carried 
out, with the FlhDC-YdiV complex forming before the nucleotide addition.  This complex 
formation could therefore prevent nucleotide binding which might have previously 
occurred to the independent proteins.  Equally, as discussed previously, nucleotide-
dependent enhancement of YdiV:FlhDC complex formation may not be detected by this 
method.  A further experiment would therefore be to investigate the YdiV-FlhDC complex 
formation with nucleotide addition throughout the entire assay.  
 
5.10.2   Fluorescence spectroscopy  
 
Intrinsic tryptophan fluorescence (Section 2.7.4) was measured for the FlhDC:YdiV complex 
before and after nucleotide addition, as a means to determine nucleotide binding.  In 
principal the technique can detect nucleotide binding, providing that this causes a 
conformational change within the FlhDC:YdiV complex that altered the fluorescent 
properties of the tryptophan residues.  Thus the major limitation is that any nucleotide  
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Figure 5.26:  Quantification of the relative amounts of eluted FlhDC and YdiV 
proteins resulting from nucleotide pull-down assays  
Image-J quantification of the FlhDC and YdiV proteins eluted from pull-down assays 
and analysed by SDS-PAGE (Figure 5.25).  
Following quantification of the relative amounts of each protein, a bar chart was 
produced visually indicating each proteins proportion of the total elution mix.  
Nucleotides were added to the pull-down assays, as specified.   
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binding which did not affect the tryptophan residues of the FlhDC:YdiV complex would not 
be detected. 
 
Samples containing the protein complex alone or equimolar mixtures of the protein 
complex and nucleotide were tested, to analyse fluorescence changes upon nucleotide 
addition.  The  samples consisted of  50 µM FlhDC:YdiV complex (sodium phosphate 
buffer),  30-fold molar excess of Mg2+ in a 20 mM sodium phosphate pH 7.5 buffer, with 
nucleotides also added at 50 µM (Section 2.7.4).  
 
The FlhDC:YdiV complex was formed, by carrying out a pull-down assay, to produce a 
native stoichiometry of complex, rather than adding a fixed amount of each (Section 2.8.1).  
Complex formation and purification was confirmed by SDS-PAGE (Section 2.6.9) prior to 
protein quantification by BioRad protein assay (Section 2.6.8).  
 
Samples were made, added to a 3 ml cuvette and fluorescence readings taken at 30⁰C, with 
an excitation wavelength of 280 nm, and emission readings recorded between 300-400 nm. 
The fluorescence spectrum for each sample was recorded and enabled comparisons 
between the complex in the presence and absence of various nucleotides.  Generally the 
resultant traces have overlying protein only (blue) and protein and nucleotide (red) traces 
indicating no fluorescence differences upon nucleotide addition (Figure 5.27).  For example, 
the ATP, AMP, pGpG and GMP traces showed almost no differences in the presence of 
these nucleotides.  Other spectra showed greater differences, such as the cAMP, GTP and 
GDP traces, in which the blue protein only trace showed slightly more fluorescent emission 
than the red protein and nucleotide trace.  The most dramatic difference was for the c-di-
GMP sample, in which the YdiV:FlhDC complex fluorescence seemed to be enhanced upon 
nucleotide addition, which could indicate a tryptophan residue becoming more exposed 
following a nucleotide induced protein conformational change.  However upon triplicate 
repetition of the c-di-GMP samples, the experimental variation was clear which meant 
these results should be treated with caution (Figure 5.28).  
 
From these data, no firm indication of nucleotide binding was detected, however due to 
the limitations of this technique this did not rule out nucleotide binding.   
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Figure 5.27: Fluorescence spectroscopic analysis of the YdiV:FlhDC complex in the 
presence of various nucleotides 
All graphs show the fluorescence spectra at 30 ⁰C.  
In all cases, the blue traces show the protein complex (50 µM) only sample, whilst the 
red traces show the same complex (50 µM) with the addition of a specified nucleotide 
(50 µM).  For all spectra, the fluorescence intensity in mAU (y axis) is shown against 
wavelength (x axis) in nm.  
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Figure 5.28: Fluorescence spectroscopic analysis of the YdiV:FlhDC complex and          
c-di-GMP addition for three biological replicates 
The three traces show three independent c-di-GMP assays, once again with the protein 
complex only trace being the blue trace and the red trace showing the complex plus 
nucleotide sample.  In all cases, nucleotides were added at a fixed concentration, from 
a single stock solution and a single protein preparation was used, with all readings 
taken at 30⁰C.  
For all spectra, the fluorescent intensity in mAU (y axis) is shown against the 
wavelength in nm (x axis).   
232 
 
5.10.3   Determination of the DNA-binding capacity of FlhDC in the 
presence of nucleotides 
 
Electromobility shift assays (Section 2.9.2) were used to analyse what effect, if any, the 
nucleotides c-di-GMP, c-di-GMP and pGpG had on the DNA-binding capacity of FlhDC.  
 
Previous EMSA assays showed that FlhDC bound to the PfliD DNA at a concentration of 12 
µM but binding was repressed fully at equimolar concentrations of YdiV (Figure 5.17). 
Conditions were therefore chosen of 12 µM FlhDC (intended to bind DNA) and 12 µM 
FlhDC plus 12 µM YdiV (expected to inhibit DNA binding).  Both proteins were purified in 
their His6 fusion forms (Sections 4.2.3 and 5.2.3) and used along with a control sample 
containing no protein, incubating all samples with 2 nM radioactively labelled PfliD (Section 
5.7) and excess nucleotide (100 µM) at 37⁰C for 30 min (Section 2.9.2).  Following this, the 
samples were mixed with EMSA loading dye (Table 2.14) and electrophoresed.  
 
The exposed film (Section 2.9.4) showed the expected DNA shift when FlhDC was present, 
whilst only free unbound DNA was present in samples containing both FlhDC and YdiV 
(Figure 5.29).  Once again, three distinct shifted species were present, indicating differing 
protein-DNA species.  The abundance of each shifted species appeared to be nucleotide 
dependent, with the no ligand control producing the two largest shifted species, c-di-AMP 
producing approximately equal quantities of each species and both pGpG and c-di-GMP 
producing only the smallest shifted species.  
 
The identity of these species and their significance is currently unknown, but they are likely 
to represent binding of the FlhDC complex to the high affinity ‘FlhDC-binding box’ as well as 
additional lower affinity regions in the PfliD DNA, producing multiple shifted species.  It 
appears that c-di-GMP and pGpG resolve the multiple complexes into the single high-
affinity complex, but do not inhibit YdiV-mediated dissociation of the PfliD:FlhDC complex.  
 
The highest priority is therefore to understand the significance of these three shifted 
species and to determine the exact components of each.  Following this, the role of 
nucleotides in altering the proportions of the species can be studied.  If a nucleotide were 
to bind to the FlhDC complex, this could potentially alter or limit which oligomeric complex 
could be formed and in this manner could influence DNA binding.  Equally, another  
233 
 
      
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5.29: EMSA to show the PfliD:FlhDC binding capacity in the presence of various 
nucleotides  
EMSA gel consisting of radiolabelled PfliD DNA, in the presence or absence of FlhDC, 
YdiV and nucleotides.  Concentrations of the two proteins and nucleotide additions (100 
µM) are stated.  
The location of the free PfliD and PfliD:protein species are indicated.  
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possibility would be that nucleotide interactions with FlhDC caused a DNA:FlhDC 
interaction site to be shielded, therefore altering how many binding regions in the PfliD 
region could be occupied by FlhDC.  
 
Clearly at this stage the mechanism in which nucleotides alter FlhDC:DNA binding is only 
speculation,  however the presence of nucleotides does appear to affect the FlhDC:DNA 
interaction.  
 
5.10.4   Analysis of the effect, if any, of nucleotides upon FlhDC 
mediated in vitro transcription 
 
The previous EMSA analysis revealed that the presence of nucleotides (specifically               
c-di-GMP, c-di-AMP and pGpG) appeared to alter FlhDC:DNA binding, specifically by 
affecting the proportion of the three PfliD:FlhDC species being produced (Figure 5.29).  
These three nucleotides were further investigated, to identify whether the various 
FlhDC:DNA species (and the proportion of each) had any effect on FlhDC-mediated 
transcription from PfliD.  
 
In vitro transcription assays (Section 2.9.3) were carried out, assessing the level of fliD 
transcription promoted by FlhDC in the presence and absence of nucleotides.  DNA 
corresponding to the entire promoter region and 200 bp of the fliD gene was synthesised 
as previously described (Section 5.9).  This DNA (0.1 pmole) was then incubated with 1 
pmole RNA polymerase and 12 µM purified FlhDC-His6 as described in Section 5.2.3 
(directly in sodium phosphate elution buffer) in an IVT Tris-HCl buffer, pH 8.  A no ligand 
reaction was carried out, as well as samples containing FlhDC and c-di-AMP, c-di-GMP and 
pGpG, with ligands at 1 mM.  These four reactions were incubated at 37⁰C for 15 min and 
analysed on an IVT gel.  
 
The exposed film (Section 2.9.4) showed the level of fliD RNA produced under the various 
conditions (Figure 5.30).  It appeared that the no ligand, c-di-AMP and pGpG samples (lanes 
1, 2 and 4) produced very similar RNA intensity species, indicating similar fliD transcription.  
In contrast to the IVT experiments shown in Figure 5.22, only one transcript was detected.  
Interestingly, c-di-GMP addition (lane 3) appeared to result in a decreased level of 
transcription.  The intensities of the transcripts in the IVT were quantified using Image-J  
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Figure 5.30: In vitro transcription levels of fliD in the presence of FlhDC 
and excess nucleotides 
A) Exposed in vitro transcription film, showing the extent of fliD 
transcription in vitro.  
Lanes 1-4 contain 12 µM FlhDC, with lane 1: no nucleotide 
addition, lane 2: excess pGpG, lane 3: excess c-di-GMP, lane 4: 
excess c-di-AMP.  
B) Quantification of bands on IVT film, as quantified by Image J 
software.  
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(Section 2.10.1; Figure 5.30A).  Image-J quantified the intensity of lane 3 to be ~11,000, 
compared to ~15-17,000 for the remaining three samples (Figure 5.30B).  Therefore 
quantitative analysis showed that the transcriptional differences are significant, indicating a 
possible role of c-di-GMP in fliD transcriptional repression.  
 
5.10.5   Concluding remarks regarding nucleotide binding to the FlhDC 
or FlhDC:YdiV complex 
 
Taking into account the four assay methods utilised here, the results are ambiguous.  
Intrinsic fluorescence spectroscopy suggested that c-di-GMP interacted with the FlhDC:YdiV 
complex, but this was not always observed (Figures 5.27; 5.28).  NMR experiments 
suggested YdiV binds c-di-GMP (Figure 4.14), EMSAs showed that c-di-GMP altered the 
interaction of FlhDC with PfliD (Figure 5.29) and c-di-GMP inhibited fliD transcription in 
vitro (Figure 5.30).  Although there are several caveats associated with these data, there is 
a body of evidence to suggest that c-di-GMP interacts with YdiV and FlhDC, perhaps as the 
FlhDC:YdiV complex, resulting in conformational changes in the complex that alter DNA-
binding/transcriptional activation.  Further experimentation would therefore be essential 
to fully understand the role, if any, of nucleotides in the FlhDC:YdiV complex.   
 
5.11   Competition assays with FliT/FliZ 
 
FliT and FliZ were chosen as potential competitors of the YdiV:FlhDC interaction, due to the 
confirmed direct interaction between FliT and FlhDC and the fact that the potential FlhDC 
interactor FliZ has been shown to increase the stability of FlhDC (Imada et al., 2010; Saini et 
al., 2008). 
 
5.11.1   Cloning of FliT and FliZ overproduction plasmids 
The E. coli genes fliT and fliZ were cloned into the overproduction plasmid pGEX-KG to give 
N-terminal GST-tag fusion constructs (Figure 5.31).  
 
Primers NSW59-62 were designed to amplify the fliT and fliZ genes from genomic DNA 
(Table 5.5).  These primers were designed to contain BamHI and HindIII restriction sites at  
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Figure 5.31: Schematic plasmid maps for the insertion of fliT and fliZ into pGEX-KG 
vectors 
Maps for the constructed pGS2467 and pGS2472 plasmids, indicating the position of 
the GST tag, the antibiotic resistant cassette and the fusion constructs produced. 
The origin of replication is indicated and labelled as ori.  
Each fusion construct encodes the relevant fusion protein of expected molecular 
weights 39 KDa (GST-FliT) and 47 KDa (GST-FliZ).  
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either end of the PCR fragment respectively (Table 5.5).  A start codon was absent in the 
forward primers to enable fusion with the N-terminal plasmid-derived GST tag. 
 
Table 5.5: Primers used for amplification of the fliT and fliZ genes for insertion into the 
pGEX-KG plasmid  
 
 
PCR reactions were carried out using high fidelity polymerase, E. coli MG1655 genomic DNA 
and primers in pairs NSW59 and 60 (fliT) and NSW61 and 62 (fliZ) to amplify the respective 
genes (Sections 2.3.1 and 2.3.3).  The resultant PCR products were cleaned by PCR 
purification and digested using the BamHI and HindIII restriction enzymes (Sections 2.3.10 
and 2.3.6).  The pGEX-KG plasmid (Lab stock) was purified and digested with the same 
restriction enzymes (BamHI and HindIII) (Sections 2.3.4 and 2.3.6).  The fliT and fliZ 
fragments and the linearised pGEX-KG vector were ligated (Section 2.3.9) via their sticky 
ends and used to transform electrically competent E. coli DH5α cells (Section 2.2.7). 
Transformants were selected on ampicillin supplemented agar and screened by colony PCR 
using primers NSW65 and NSW66 (Table 5.6) to assess which plasmids contained the 
correctly sized inserts (Section 2.3.11).  Plasmids containing appropriate length inserts were 
checked by DNA sequencing (Source Bioscience) using the same pGEX-KG sequencing 
primers (Table 5.6).  
Table 5.6: Sequencing primers for pGEX-KG 
Primer Sequence Function 
NSW59 TTTTGGATCCAACCATGCACCGCATTTATATTTC Forward primer for fliT 
gene 
NSW60 TTTTAAGCTTTCAAAAGAGGTTATCCTGCGGAG   Reverse primer for fliT 
gene  
NSW61 TTTTGGATCCATGGTGCAGCACCTGAAAAGAC     Forward primer for fliZ 
gene 
NSW62 TTTTAAGCTTTTAATATATATCAGAAGAAGGCA
GGC    
Reverse primer for fliZ 
gene 
Primer Sequence Function 
NSW65 GACCATCCTCCAAAATCGGA Forward sequencing primer for pGEX-KG 
NSW66 GAGGTTTTCACCGTCATCAC 
 
Reverse sequencing primer for pGEX-KG 
The grey shaded sequences indicate BamHI restriction sites and the boxed sequences 
show HindIII restriction sites.  
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Plasmids containing no mutations in the fliT and fliZ sequences were named pGS2467 
(pGEX-KG::fliT) and pGS2472 (pGEX-KG::fliZ) and the plasmids used to transform electrically 
competent E. coli BL21 λ(DE3) cells (Section 2.2.7).  
 
5.11.2   Overproduction of GST-FliT and GST-FliZ 
 
Overproduction of the proteins, GST-fliT and GST-fliZ was carried out in E. coli BL21 (λDE3) 
(Section 2.6.1).  The optimal overproduction conditions were not investigated, instead 
simply inducing cultures for 2.5 h with 100 µg/ml IPTG, which upon SDS-PAGE gel analysis  
(Section 2.6.9) confirmed successful overproduction of the respective proteins at the 
expected molecular weights (data not shown).  
 
When required, the cell pellets of the overproduction strains (E. coli BL21 λ(DE3)/pGS2467 
and BL21 λ(DE3)/pGS2472) were resuspended in sodium phosphate breakage buffer, cells 
broken by sonication and the phases separated (Section 2.6.2), using the soluble fraction 
for the pull-down assays (Section 2.8.2). 
 
5.11.3   Control assays 
 
Control pull-down assays (Section 2.8.2) were carried out to determine whether the FliT 
and FliZ proteins interacted with solely FlhDC, prior to interaction analysis with the 
FlhDC:YdiV complex.  
 
Crude soluble extracts of overproduced FlhDC-His6 protein (Section 5.2.2) were 
immobilized on a 1 ml HiTrap column before crude extracts of GST-FliT or GST-FliZ were 
added (Section 5.11.2).  The columns were thoroughly washed before an imidazole-rich 
elution buffer was added. Fractions from each stage of the assay were analysed by SDS-
PAGE (Section 2.6.9), to identify the point of elution for each of the proteins.  
Both SDS-PAGE gels clearly showed the overproduced FlhDC initially being immobilised 
onto the column (lanes 1-3) with species at approximately the expected sizes for the FlhD-
His6 and FlhC components (Figure 5.32).  Lanes 4-6 then showed the addition of the 
overproduced FliT (Figure 5.32A) and FliZ (Figure 5.32B) to the column, again with GST-FliT 
and GST-FliZ at the expected sizes.  For both Figure 5.32A and 5.32B, lanes 7-11 show the 
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Figure 5.32: Control pull-down assay, testing potential binding partners of the 
transcription factor FlhDC 
Coomassie-stained SDS-PAGE gel analysing fractions of the control pull-down assays.  
In both cases, FlhDC-His6 was immobilised to a 1 ml HiTrap column, prior to addition 
of GST-tagged FliT (A) and FliZ (B).  The columns were then thoroughly washed before 
an imidazole-rich elution buffer was added (Section 2.8.2).  
In both cases, M: Precision plus protein standard (molecular weights indicated in 
KDa), 1: Soluble FlhDC-His, 2: FlhDC flow-through, 3: Wash step, 4: Soluble FliT/Z, 5: 
FliT/Z flow-through, 6: Wash step 2, 7-11: Elution fractions.  
The positions of FlhC-His6 (22), FlhD (13), GST- FliT (39) and GST-FliZ (47) are indicated, 
with their respective expected sizes shown here in KDa.   
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column elution fractions, with clear FlhDC elution in these fractions.  Of note, the GST-FliT 
protein is present in these elution fractions indicating a direct interaction between FliT and 
FlhDC (Figure 5.32A).  However the GST-FliZ protein was not present in the elution 
fractions, instead being eluted in a wash step (lane 6) suggesting it does not have a direct 
interaction with FlhDC (Figure 5.32B).  
 
These results were as expected from literature reports confirming a direct interaction 
between FliT and FlhDC (Saini et al., 2008; Imada et al., 2010).  Following this outcome, it 
was deemed highly unlikely that the FliZ protein would interact with the FlhDC:YdiV 
complex, given that it did not directly interact with FlhDC and there were no reports of any 
interactions between FliZ and YdiV.  However, for completeness the competition assays 
were carried out for both FliT and FliZ.  
 
5.11.4   Competition assays 
 
To determine whether FliT or FliZ interacted or interfered with the known YdiV:FlhDC 
complex, pull-down assays were carried out once more (Section 2.8.2).  Soluble YdiV-His6 
(Section 4.2.2) was firstly immobilized onto a 1 ml HiTrap column before (FLAG)3- FlhDC 
was added (Section 5.2.2), to produce the immobilised complex YdiV:FlhDC.  Following a 
thorough wash of the column, the potential competitor proteins FliT and FliZ were added 
(Section 5.11.2).  Another wash step was carried out, before an imidazole-rich elution 
buffer was added to strip His-tagged proteins from the column.  
 
Fractions were retained from each step in the assay and were analysed by SDS-PAGE 
electrophoresis (Section 2.6.9).  The resulting gels showed the overproduction of each 
protein at the expected sizes in the relevant fractions, with lane 1 showing YdiV-His6, lane 4 
showing the FlhD and FlhC components and lane 7 containing the FliT or FliZ protein (Figure 
5.33).  
 
In the case of FliT, the elution fractions in lanes 11-13, show the presence of all four 
individual proteins, indicating the combined elution of FliT, YdiV and FlhDC (Figure 5.33A). 
This signifies that an interaction has occurred between these three components, forming a 
multispecies complex.  Of note, the FliT:FlhDC interaction did not break the YdiV:FlhDC 
interaction, therefore the binding of FliT and YdiV to the FlhDC probably occurs at  
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Figure 5.33: Competition pull-down assay, testing potential competitors of the 
FlhDC:YdiV interaction 
Coomassie stained SDS-PAGE gel of the competition pull-down assays (Section 
2.8.2), immobilising YdiV-His6 to a 1 ml HiTrap column.  Soluble (FLAG)3-FlhDC was 
subsequently added to the columns, producing the FlhDC:YdiV complex.  Finally 
potential competitors were tested, adding GST- FliT (A) and GST-FliZ (B) to the 
column, to detect whether these out-competeted the FlhDC:YdiV interaction.  
In both cases, M: Precision plus protein standard (molecular weights indicated in 
KDa), 1: Soluble YdiV, 2: YdiV flow-through, 3: Wash step, 4: Soluble FlhDC, 5: FlhDC 
flow-through, 6: Wash step 2, 7: Soluble FliT/Z, 8: FliT/Z flow-through, 9: Wash step 
3, 10-14: elution fractions.  
The positions of YdiV-His6 (28), (FLAG)3 –FlhD (16), FlhC (22), GST-FliT (39) and GST-
FliZ (47) are indicated, with the expected sizes shown here in KDa.  
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independent sites, which do not overlap or shield the other binding site.  Further 
investigations in vivo would reveal whether this complex is formed in the cell, and if so 
functional assays could be carried out, assessing whether the complex altered the DNA 
binding properties of FlhDC.   
 
In contrast, FliZ was present in the wash step in lane 9, indicating the loss of protein from 
the column (Figure 5.33B).  Additionally the protein was absent in the elution fractions in 
lanes 11-13.  This signifies that FliZ neither binds to FlhDC singularly, or to the complex 
YdiV:FlhDC, and therefore does not regulate FlhDC directly, or indirectly via YdiV.  
 
5.12   Discussion  
 
The interactions between the inactive PDE protein YdiV and the transcription factor FlhDC 
in E. coli have been explored.  Successful cloning and overproduction of FlhDC and YdiV 
proteins was achieved which subsequently enabled the interactions and functions of these 
proteins to be studied.   
 
At the outset, complex formation between FlhDC and STM1344 (YdiV) was only known in  
S. enterica (Wada et al., 2011) and therefore it was a priority to analyse the interaction in  
E. coli.  Pull-down assays using overproduced FlhDC and YdiV protein (Figure 5.5) revealed  
complex formation in E. coli, a result which now supports the same conclusion reached by 
Wada et al. (2012) and Li et al. (2012).  Analysis of this FlhDC:YdiV interaction by BLItz 
methods measured the affinity of binding (KD of 286-395 nM) (Figures 5.7 and 5.8).   
Isothermal calorimetry revealed the FlhDC:YdiV interaction to be exothermic, with a KD of 
158 nM, similar to the value determined by BLItz analysis.  The data fitted an independent 
binding model, with a stoichiometry of 1:1, indicating that only a single YdiV was binding to 
the FlhD4C2 complex under these conditions (Figure 5.9).  
 
At this point, attempts were carried out to determine the growth conditions in which this 
FlhDC:YdiV complex would form in vivo.  Polyclonal antibodies were successfully raised 
against both FlhDC and YdiV proteins and enabled Western blot analysis of the FlhDC and 
YdiV expression levels in E. coli.  However, under all conditions tested the levels of YdiV 
were below the detection limit (Figure 4.21).  FlhDC protein expression could be detected, 
with the highest levels produced when E. coli doubled ~ every 3.5 h (Figure 5.15).   
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Following the identification that an FlhDC:YdiV complex was produced in E. coli, and an 
indication of the growth conditions in which it would form, the role of this complex was 
investigated.  It was previously known that FlhDC bound to class 2 promoter regions of 
flagellar genes, controlling the expression and synthesis of flagella in Bacteria (Liu & 
Matsumara, 1994).  Analysis in S. enterica had revealed STM1344 to act as an anti-FlhDC 
factor, inhibiting FlhDC binding to DNA (Wada et al., 2011).  The ability of the protein 
complex FlhDC:YdiV to bind to DNA was therefore investigated, revealing by EMSA analysis 
that YdiV was an anti-FlhDC factor in E. coli (Figure 5.17).  This was in agreement with the 
conclusions determined by Wada et al. (2012) and Li et al. (2012), with approximately 
similar molar ratios of YdiV:FlhDC necessary for DNA dissociation in all three analyses.  
 
Noteably, three distinct species of FlhDC:DNA complexes were observed in the EMSA 
assays, potentially resulting from various oligomeric forms of FlhDC binding to the 
promoter region, or FlhDC binding to multiple regions in the DNA (at the ‘FlhDC-binding 
boxes as well as other low affinity sites).  Further experimentation is therefore essential to 
understand the significance of these three species.   Analytical centrifugation would enable 
the molecular weights of the three species to be determined, whilst promoter fragments 
containing only part of the motif region would reveal exactly which DNA bases were 
required for FlhDC to bind.  Additionally, if cofactors were involved in the DNA:FlhDC 
interactions, these could be identified by mass spectroscopy techniques.  
 
Kinetic analysis of the DNA and FlhDC interaction was undertaken using BLItz methods, 
comparing the affinity of the FlhDC complex to a target piece of DNA (a region of PfliD 
containing two FlhDC-binding boxes) and a control piece of DNA (with no FlhDC-binding 
sites).  A clear sequence-specific interaction between FlhDC and the target DNA was 
detected (KD of 158 nM) (Figures 5.19 and 5.20).  The measured KD value (with errors) for 
FlhDC to PfliD was reasonably consistent with the KD values reported for the binding 
interactions between FlhDC and four other Class II DNA regions (Stafford et al., 2005).  
 
In vitro transcription analysis was subsequently carried out, investigating the effects of YdiV 
on the FlhDC-mediated fliD transcription rate.  Rather surprisingly, the highest level of gene 
transcription occurred in sample conditions of 12 µM FlhDC and 1.5 µM YdiV rather than in 
conditions lacking any YdiV (Figure 5.22).  The role of YdiV in this reaction was clarified by 
EMSA analysis, revealing that YdiV was part of the FlhDC:DNA binding complex and was 
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having a direct effect on DNA transcription (Figure 5.23).  This FlhDC:DNA:YdiV complex 
was subsequently identified by Takaya et al. (2012) too, supporting these findings.  
Additionally, this detection of YdiV binding to the FlhD4C2: DNA complex is in agreement 
with the transitional YdiV:FlhDC:DNA complex proposed in a model by Li et al. (2012). 
Whilst our data does not fully support the Li et al., (2012) model, it does certainly agree 
with the presence of the proposed transitional species.  
 
The mechanism in which YdiV enhances transcription is unknown and therefore open to 
speculation.  One possible explanation is that YdiV binding to the FlhDC:DNA complex 
causes the DNA to increase the degree in which it bends around the FlhDC complex, 
thereby increasing the accessibility of RNA polymerase to the DNA.  From X-ray 
crystallography of the FlhDC:DNA complex, It is known that upon binding to FlhDC, DNA 
bends 111⁰ around the complex (Wang et al., 2006).  Therefore hypothetically, if this angle 
of DNA curvature was to increase, this could increase the exposure of DNA to RNA 
polymerase, thereby increasing transcription.   Alternatively, as discussed previously, three 
shifted species are produced upon FlhDC binding to the PfliD DNA, which may be produced 
by FlhDC binding to lower homology regions of DNA.  YdiV binding to the FlhDC:DNA 
complex, may therefore, prevent the binding of FlhDC to these lower affinity binding sites, 
therefore increasing the proportion of FlhDC complexes binding at the ‘FlhDC-binding box’ 
and therefore initiating gene transcription from this site.  As previously stated, 
investigations into FlhDC binding to short PfliD fragments would reveal whether multiple 
DNA sites were binding to FlhDC, which would subsequently impact the putative role of 
YdiV in restricting the additional species formation.  Analysis of DNA curvature around the 
FlhDC complex in the presence and absence of YdiV could additionally be studied to assess 
the veracity of this hypothesis.  
 
In this work, kinetic and thermodynamic parameters have been determined for various 
interactions.  Bringing all this data together, a model has been proposed for the mechanism 
by which FlhDC and YdiV control DNA transcription in the cell.  The BLItz data for the 
interaction between FlhD4C2 and PfliD DNA yielded a KD value (~158 nM ka = 1.9 x 10
2 M-1 s-
1, kd = 2.9 x 10
-5 s-1) (Figure 5.19).  Isothermal calorimetry (ITC) indicated that the 
stoichiometry of the FlhD4C2:YdiV interaction was 1:1 and the KD value for this interaction 
was ~150 nM (Figure 5.9).  The BLItz analyses showed that the KD values for FlhD4C2 – YdiV 
interactions were similar when either partner protein was immobilized (KD ~280 nM when 
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FlhD4C2 was immobilized, ka = 1.6 x 10
3 M-1 s-1, kd = 4.4 x 10
-4 s-1; KD ~395 nM, ka = 3.2 x 10
3 
M-1 s-1, kd = 13 x 10
-4 s-1 when YdiV was immobilized).  Therefore the KD value when FlhD4C2 
was immobilised was closer to that obtained by ITC and was the mid-range value and hence 
the rate constants obtained from BLItz when FlhD4C2 was immobilised were used in the 
following analysis.  The EMSA experiments (with 2 nM PfliD, 15 M FlhD4C2 and 0-30 M 
YdiV incubated for 30 min before electrophoresis) were used to determine the amount of 
FlhD4C2:PfliD complex formed in the presence of increasing concentrations of YdiV (Figure 
5.17).  A simple model (Model 1) was constructed in Copasi 4.8 Build 35 
(http://www.copasi.org/tiki-index.php?page=Build35Changelog) to simulate competitive 
binding of PfliD and YdiV to FlhD4C2 (Figure 5.34; Table 5.7).  Steady-state simulations were 
unable to match the experimental data (i.e. the amount of free DNA in reactions with 
different ratios of FlhD4C2 and YdiV; Figure 5.35) and hence simple YdiV sequestration of 
FlhD4C2 leading to liberation of free DNA was not sufficient to capture the behaviour of the 
system. 
 
Supershift EMSAs showed that an FlhD4C2:PfliD:YdiV complex was formed (Figure 5.23), 
consistent with published work (Takaya et al., 2012).  Therefore, Model 1 was extended to 
include the formation and breakdown of an FlhD4C2:PfliD:YdiV complex (Figure 5.34; Model 
2).  Analysis of the EMSA data of Takaya et al. (2012) suggested a KD for the 
FlhD4C2:PfliD:YdiV complex of ~200 nM, similar to the KD for the FlhD4C2:YdiV complex 
measured here.  On this basis the ka and kd values for this reaction were assigned as ka = 2 x 
103 M-1 s-1, kd = 4 x 10
-4 s-1.  There are no experimental data for the breakdown of the 
FlhD4C2:PfliD:YdiV complex but the EMSAs show that that this complex degrades more 
readily than the FlhD4C2:PfliD binary complex and so a kd value (1 x 10
-2 s-1) ~300-fold 
greater than that for FlhD4C2:PfliD was assigned.  Steady-state simulations of the extended 
model (Model 2; Figures 5.34; 5.35) were run in Copasi 4.8 Build 35 
(http://www.copasi.org/tiki-index.php?page=Build35Changelog) for comparison with the 
EMSA data shown in Figure 5.17.  The reactions and parameters of Model 2 are 
summarized in Figure 5.34 and Table 5.7.  Plotting the steady-state values of free DNA 
predicted by Model 2 as a function of YdiV concentration matched the experimental data 
much more closely than those of Model 1 (Figure 5.35).  Thus, it was concluded that the 
formation of the FlhD4C2:PfliD:YdiV ternary complex and its subsequent breakdown are 
crucial components for YdiV-mediated inhibition of FlhD4C2-mediated gene expression.   
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Table 5.7: Model reactions and parameter values 
Reaction Parameter value Measurement technique Designation 
in model 
1. F + D = FD ka = 1.9 x 10
2 M-1 s-1  
kd  = 2.9 x 10
-5 s-1 
BLItz k1  
k2 
2. F + Y = FY ka = 1.6 x 10
3 M-1 s-1 
kd = 4.4 x 10
-4 s-1 
ITC (stoichiometry) and BLItz 
(immobilized FlhD4C2) 
k3 
k4 
3. FD + Y = FYD ka = 2 x 10
3 M-1 s-1 
kd = 4 x 10
-4 s-1 
EMSAs (Takaya et al., 2012) 
combined with BLItz data for 
the F + Y = FY reaction 
k5 
k6 
4. FYD  FY + D kd = 1 x 10
-2 s-1 Assigned k7 
 
Abbreviations: D, PfliD DNA (2 nM); F, FlhD4C2; FD, FlhD4C2:DNA complex; FY, 
FlhD4C2:DNA:YdiV complex; Y, YdiV. 
 
 
     
                       
 
 
 
 
 
Figure 5.34: The structure of models developed to simulate inhibition of FlhD4C2-
mediated gene expression by YdiV 
Components of Model 1 are shown against a pale background; Model 2 incorporates 
all the components shown.  The corresponding reactions and parameters are listed 
in Table 5.7. 
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Figure 5.35: Graphical representation of the effect of YdiV on DNA:FlhDC dissociation  
The amount of free PfliD in reactions containing a fixed concentration of FlhD4C2 and 
variable concentrations of YdiV measured in EMSAs compared the output from Model 
1 and Model 2.  The relative amounts of free DNA (% of total, 2 nM) in the EMSA 
shown in Figure 5.17 were determined by analysis with ImageJ (Section 2.10.1) and 
plotted against the concentration of YdiV in each reaction (open squares).  The 
predicted steady-state concentrations of free DNA from simulations of the EMSA 
reactions using Model 1 (filled squares) and Model 2 (filled triangles) were converted 
to % values and plotted against YdiV concentration. 
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Previous studies had revealed a possible YdiV binding interaction with c-di-GMP, thereby 
giving a reason to investigate the role of nucleotides in the YdiV:FlhDC complex.  
Ambiguious results were produced, finding no indication of nucleotide binding at all from 
fluorescence analysis.  Pull-down assays revealed varying stoichiometries of FlhDC and YdiV 
in elution fractions, which may be nucleotide-induced (Figure 5.26).  However, there are 
several experimental limitations which would need to be overcome before any conclusions 
could be made about this stoichiometry difference.  EMSA analysis indicated that the 
presence of nucleotides (specifically pGpG, c-di-GMP and c-di-AMP) altered the proportion 
of the three FlhDC:DNA species produced (Figure 5.29).  Hypothetically nucleotides binding 
to the FlhDC complex could feasibly shield DNA binding sites, and therefore influence FlhDC 
binding to the PfliD DNA.  The primary concern is therefore determining the identity of 
each species, which will subsequently put these proportional changes into context.  Finally 
IVT analysis indicated a decrease in fliD transcription in the presence of c-di-GMP rather 
than in the presence of alternative tested nucleotides or in the absence of nucleotides 
(Figure 5.30).  Whilst there are many limitations to these assays, there are small indications 
that suggest c-di-GMP may interact with FlhDC and YdiV.  There was a body of evidence to 
previously suggest that YdiV may be interacting with c-di-GMP (Section 4.5).  This data 
further supports this notion, indicating a possible interaction of c-di-GMP with YdiV and 
FlhDC, either individually or as the FlhDC:YdiV complex.  Therefore given this data, there is 
significant reason to further investigate the role of c-di-GMP in the FlhDC and YdiV system.  
 
Competition assays were carried out, using the known FlhDC binding protein FliT, to 
determine which protein (FliT or YdiV) had the stronger affinity for FlhDC.  FliZ was 
additionally investigated as this is known to indirectly increase the stability of FlhDC, and 
therefore could be imparting its function via YdiV.  Whilst no binding was detected for FliZ 
with the FlhDC:YdiV complex, an interaction between FliT and FlhDC:YdiV was produced. 
Rather than FliT outcompeting YdiV to bind to FlhDC, a larger complex was formed 
consisting of YdiV:FlhDC:FliT (Figure 5.33).  This indicates that FliT and YdiV bind to FlhDC at 
independent sites (FlhC and FlhD respectively), and clearly binding at one site does not 
impair binding at the other site.  Of interest would be to determine whether this complex 
was formed in vivo and if so, to determine the role of this complex.  It has been suggested 
that FliT weakens the FlhD-FlhC interactions within the FlhDC complex and therefore 
analysis as to whether YdiV reduces this destabilisation would be a logical progression 
(Imada et al., 2010).        
250 
 
 
Chapter 6: Discussion 
 
Work in this thesis has investigated the roles of the putative ‘degenerate’ DGC and PDE 
proteins in E. coli K-12, specifically YeaI and YdiV.  Both proteins were chosen because of 
their non-conserved active site (GGDEF and EAL) motifs, which suggested that they were 
probably catalytically inactive and possible regulatory or effector proteins. The aims were 
therefore to characterise both proteins, aiming to determine whether they had regulatory 
roles in the cell or even if they were c-di-GMP effector proteins (as some degenerate 
GGDEF/EAL proteins are).  
 
YeaI was shown to be a catalytically inactive DGC protein, in agreement with Sommerfeldt 
et al. (2009) and contradicting Sanchez-Torres et al. (2011).  It was therefore hypothesised 
that the protein could have a regulatory role in the cell, however a role for YeaI was not 
identified.  One of the major limitations was the amount of soluble, purified YeaI that could 
be produced using His-tagged protein constructs of YeaIGGDEF (both with C- and N-terminal 
His tags).  The solubility of YeaIGGDEF was significantly increased upon fusion with a trigger 
factor chaperone using a pCOLD TF vector, however purification of the protein was still 
problematic. Thrombin was used to cleave the large TF tag from the YeaIGGDEF domain at a 
thrombin cleavage site. Whilst cleavage was successful, separation of the TF tag and 
YeaIGGDEF domain was not achieved, suggesting that the two proteins were interacting. A 
possible mechanism to disrupt this TF:YeaIGGDEF interaction could be the use of detergents 
or urea which may enable the isolation of YeaIGGDEF.  If detergent addition was not 
successful, it may be necessary to study YeaI intact, including the N-terminal membrane 
bound domain. Whilst isolation of membrane proteins is difficult, this domain may provide 
structural stability required for the native folding of the GGDEF domain. The longstanding 
purification problems identified have clearly limited progress in characterising the protein, 
however major improvements have been made in YeaI solubility which should advance 
further analysis of the protein.  Comparisons of wild-type E. coli and an E. coli strain in 
which the yeaI gene is upregulated, could reveal genome-wide phenotypic changes upon 
yeaI upregulation.  
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Investigations into the degenerate PDE protein, YdiV, were more productive, identifying a 
cellular role for this protein. The scientific interest in this protein has noticeably grown 
since the initiation of this project, with many competing research groups becoming active 
and the protein becoming increasingly well characterised.  
 
The YdiV protein was shown to be catalytically inactive as a c-di-GMP PDE, in agreement 
with the data from Tchigvintsev et al. (2010) and Wada et al. (2011), but in contrast to 
Hisert et al. (2005).  Nucleotide binding assays were not entirely consistent but the balance 
of the evidence suggested that c-di-GMP was a putative interacting nucleotide.  Both the 
NMR spectrum of the protein and the partial proteolysis cleavage pattern of YdiV were 
altered upon c-di-GMP addition.  It is therefore tempting to speculate that c-di-GMP binds 
to YdiV and regulates the activity of this protein in some manner.  This possible c-di-GMP 
binding has not been reported previously, however the X-ray crystallographic structure of 
the protein did identify a surface groove, which in other EAL domains is the active-site for 
c-di-GMP hydrolysis (Li et al., 2012).  Taken together, the c-di-GMP binding of YdiV and the 
FlhDC:YdiV complex is certainly a focus point for further investigation. High sensitivity 
methods such as Isothermal Titration Calorimetry or BLItz techniques could be used to 
further study this possible interaction.  
 
One concern, which may put the validity of nucleotide-binding assays into doubt, is that the 
YdiV protein may have been purified in complex with a ligand. All overproduced proteins 
(including YdiV, Clp and YeaIGGDEF) were produced using the E. coli BL21 λ(DE3) strain, the  
genome of which encodes all DGCs and PDEs encoded by E. coli MG1655 K-12 except the 
DGC YedQ (Figure 1.6) (http://www.genome.jp/kegg/kegg2.html). Therefore, there is a 
high probability that the E. coli BL21 λ(DE3) cells will contain c-di-GMP, given the presence 
of many DGCs and PDEs. This is a major concern when studying the nucleotide-binding 
character of a protein, as there is a strong likelihood that c-di-GMP binding proteins would 
be purified already in complex with the ligand, thereby potentially shielding all detection of 
nucleotide-binding in the assays. Several of the nucleotide-binding assays yielded results 
which indicated possible c-di-GMP binding but were slightly ambiguous (NMR and partial 
proteolysis in particular), which could be due to the heterogeneity of the protein (partly 
bound to c-di-GMP). Additionally, some proteins bind 2 c-di-GMP molecules such as PilZ 
domains, thereby questioning whether any c-di-GMP binding detected was a single c-di-
GMP binding to the protein or whether it was the 2nd c-di-GMP binding to an already c-di-
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GMP-YdiV complex. Furthermore, the NMR control protein Clp exists as a dimer, so whilst 
the NMR spectra showed differences between the Clp sample and the Clp + c-di-GMP 
sample, this could have been due to a 2nd c-di-GMP binding and may therefore produce a 
different signal to a single c-di-GMP binding to YdiV (Section 4.5).  Whilst this is clearly a 
concern, all overproduced proteins were produced in E. coli BL21 λ(DE3) so therefore the 
protein assays were at least consistent with one another. There is no doubt that partial 
proteolysis and NMR assays produced differing results upon YdiV and YdiV + c-di-GMP, 
however a greater confidence would be achieved by ensuring no c-di-GMP was pre-bound 
to the protein before these assays were carried out. Futhermore, if all ligand was removed 
from the protein before the assays were carried out, the stoichiometry of any nucleotide-
protein binding could be determined accurately.  
 
One way to overcome this problem in future, would be to incubate the overproduced 
protein with a known active PDE, such as YfgF, to sequester any c-di-GMP present in the 
sample and degrade it to pGpG. The proteins could subsequently be separated by gel 
filtration and the pre-treated overproduced protein used for all nucleotide-binding assays.  
 
Oligomerisation assays of YdiV revealed a monomeric species by gel filtration and 
glutaraldehyde assays.  This was consistent with the conclusions made by Li et al. (2012), 
who independently identified a monomeric species by gel filtration.  Based on both 
sequence and structural analysis this native monomeric species is not at all surprising; YdiV 
has only 4/7 conserved residues necessary for protein dimerisation, and a much reduced 
‘dimerisation interface’ was observed by X-ray crystallography (Li et al., 2012; Tchigvintsev 
et al., 2010).  Further analysis of the oligomeric state of YdiV could therefore include site-
directed mutagenesis of the three non-conserved amino acid residues in YdiV which are 
required for dimerisation, to analyse whether native dimerisation occurs. 
 
At the beginning of this project, one of the few known characteristics of YdiV was that over-
expression of the ydiV gene resulted in a marked decrease in cell motility (Dr. M. Lacey, 
unpublished).  Upon ydiV over-expression, there was a complete lack of FliC detection and 
an 80% decrease in flagella numbers.  The slight disparity between the results from both 
assays is likely to be simply due to timescales and therefore not significant, with fliC 
expression presumably repressed more quickly than pre-formed flagella are degraded. 
Hence, these data are in agreement with the motility effects seen by Dr. M. Lacey. 
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Additionally, the data (showing that ydiV over-expression reduces motility and flagella 
production) supports the same conclusions made by other groups during the course of this 
work (Li et al., 2012; Wada, et al., 2012).   
 
Bacterial culture conditions have been a continuing issue throughout this work, with 
several assays carried out at non-optimal conditions, thereby requiring repetition at 
optimal conditions.  Bacteria induce flagellar expression when they sense environments 
where motility might give them a fitness advantage, which in E. coli is in nutrient starvation 
conditions and at ~30⁰C  (Wada et al., 2012; Adler & Templeton, 1967).  
 
In this work, motility assays (specifically Western blot and TEM assays) were carried out at 
37⁰C, which in hindsight is a too high temperature for flagellar studies (Section 4.6). It has 
previously been identified that flagellar synthesis is downregulated above 37⁰C, with 30⁰C 
reported as the optimal temperature for bacterial flagellation (Adler & Templeton, 1967).  
Additionally, the cultures were grown in 2 L conical flasks, whereas in hindsight round-
bottom flasks would be preferential as they would provide a more gentle culture vessel to 
limit flagellar shearing. Chemostat samples were later used in a bid to determine YdiV and 
FlhDC expression conditions (Sections 4.7; 5.6), in which bacterial samples were produced 
at 37⁰C, in aerobic conditions in a stirred chemostat (Section 2.2.2).  Western blot assays 
were carried out with these samples, however whilst the chemostat samples were readily 
available, they were not a suitable source for this work and have not generated usable 
data. When E. coli resides in the gut, it respires anaerobically and thereby the bacterial 
growth conditions should have been anaerobic and without stirring in order to mimic these 
conditions. Additionally, as discussed previously, flagellar gene expression is maximal at 
30⁰C and therefore samples should have been cultured at 30⁰C rather than 37⁰C. Given 
these significant differences between ideal growth conditions and the chemostat 
conditions used, the Western blot data should not be used for future work and YdiV and 
FlhDC protein analysis should be repeated using bacterial samples grown in more optimal 
conditions.   
 
The S. enterica YdiV homolog STM1344 had previously been shown to bind to the 
transcription factor FlhDC and cause repression of flagellar genes (Wada et al., 2011).  Pull-
down analysis proved that this interaction did occur in E. coli, again in agreement with 
competing research groups (Wada et al., 2012; Li et al., 2012).  Going a step further, kinetic 
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and thermodynamic analyses showed the proteins to interact specifically and strongly in a 
1:1 stoichiometry (KD value of 286-395 nM from BLItz analysis, 158 nM by ITC).  
 
The stoichiometry of the YdiV:FlhDC complex is a topic of much dispute.  Li et al. (2012) 
have reported YdiV to bind to FlhD4C2, creating four complexes (YdiV:FlhD4C2, 
YdiV2:FlhD4C2, YdiV3:FlhD4C2 and YdiV4:FlhD4C2).  These species have been identified by size-
exclusion chromatography however the physiological relevance of these complexes may be 
debatable given the low levels of YdiV in the cell.  Takaya et al. (2012) identified a stable 
YdiV2:FlhD4C2 complex upon incubation of the proteins and gel filtration.  The ITC analysis 
performed in this work identified a 1:1 molar ratio of YdiV and FlhD4C2, indicating that only 
one YdiV molecule was binding to the complex.  Notably, whilst structures have been 
elucidated for YdiV, FlhD4C2 and YdiV2-FlhD2, no crystal structure has been produced for 
YdiV:FlhD4C2, presumably indicating the long-term instability or transient nature of the 
various YdiV1-4:FlhD4C2 complexes (Li et al., 2012; Wang et al., 2006).  Clearly there are 
discrepancies in the reported YdiV:FlhDC complex stoichiometries, indicating an area for 
future investigation and one which would have significant impact on the proposed models 
for this interaction.  
 
After determining that YdiV and FlhDC interacted, the DNA-binding capacity of the complex 
was analysed.  S. enterica studies had shown STM1344 to induce DNA dissociation from 
FlhDC, producing free DNA upon formation of the STM1334:FlhDC complex (Wada et al., 
2011).  EMSA assays revealed that the E. coli YdiV acted in a similar manner to STM1344, 
causing DNA (specifically PfliD) dissociation, which was also shown by competing research 
groups during this work (Wada et al., 2012; Li et al., 2012; Takaya et al., 2012).  Kinetic 
analysis of this FlhDC:DNA interaction revealed a strong and sequence specific interaction, 
KD of ~158 nM.  
 
EMSA analysis revealed three FlhDC:DNA species.  In this case, the chosen DNA was the fliD 
promoter region, a class II promoter of ~250 bases long.  Given that this trio of shifted 
species was novel, this may be a DNA-specific effect rather than a general FlhDC-effect.  
The most likely hypotheses for the multiple shifted species is the presence of low-
specificity weaker binding sites in the DNA (Section 5.7).  To clarify this hypothesis, further 
EMSA assays could be carried out using fragmented DNA, with regions spanning the FlhDC-
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binding box region only, and regions other sides of this to visualise whether the pattern of 
shifted species was altered.  
 
In vitro transcription assays revealed a maximal transcription rate in the presence of FlhDC 
and substoichiometric YdiV.  Control assays confirmed both proteins were part of a DNA-
binding complex, indicating the presence of a novel FlhDC:YdiV:DNA complex.  Whilst this 
was previously not identified, the same complex was later identified by Takaya et al. 
(2012).  The manner in which this complex causes increased gene transcription is currently 
unknown.  Again, further assays using various different fragments of DNA would enable 
clarification here.  
 
Given the putative YdiV:c-di-GMP interaction, the FlhDC:YdiV complex was studied in the 
presence of nucleotides to analyse whether c-di-GMP (or other nucleotides) were involved 
in the complex formation/dissociation or regulated activity.  EMSA and IVT assays provided 
the most useful data.  In both cases, the presence of c-di-GMP had an effect on FlhDC 
activity, with c-di-GMP altering the proportion of the three FlhDC:DNA species produced 
compared to a no ligand control sample (Figure 5.29).  The in vitro transcription levels of 
fliD were decreased in the presence of c-di-GMP (Figure 5.30).  Taken together, in addition 
to the experimental data suggesting YdiV may interact with c-di-GMP and the X-ray 
structure of YdiV, this provides multiple pieces of evidence to suggest that the proteins 
YdiV and FlhDC, possibly as a YdiV:FlhDC complex, are interacting with c-di-GMP (Li et al., 
2012).  Thereby, there is significant reason to further investigate the role of c-di-GMP, and 
nucleotide analogues, with the complex to determine the role of this putative nucleotide 
interaction. As discussed previously, pre-treatment of the overproduced protein with an 
active PDE protein would ensure that the protein was not already bound to c-di-GMP, and 
therefore yield more conclusive data of the nucleotide-binding character of YdiV and FlhDC.  
In order to understand the significance of the data characterising YdiV and the YdiV:FlhDC 
interaction, both YdiV and FlhDC expression levels were investigated to identify growth 
conditions in which YdiV:FlhDC would likely be produced. The optimal conditions for YdiV 
production could not be determined, with YdiV protein levels below the detection limit. 
Whilst this is a concern, as discussed previously, the chemostat bacterial culture conditions 
were far from optimal and therefore these assays should be repeated in different 
conditions.  Promoter alignment revealed the presence of both the -35 and -10 consensus 
sites in the PydiV region but weak -35 sequence conservation, possibly explaining the low 
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level of ydiV transcription due to poor promoter recognition.  The low protein 
concentrations of YdiV were also noted by Wada et al. (2012), who identified efficient gene 
transcription but poor translation in cells.  FlhDC expression levels were also analysed but 
again using sub-optimal bacterial growth conditions and therefore any results produced 
using this work are far from conclusive.  
 
In order to understand the cellular mechanism in which YdiV affects FlhDC transcriptional 
activity, various models have been produced.  The Li et al. (2012) group, identified four 
YdiV and FlhDC complexes (YdiV1-4:FlhD4C2) which led to the hypothesis of a sequential 
binding model (Figure 5.10).  Based on the structural data known, the group hypothesised 
that 2 YdiV molecules would bind to the ring-like FlhD4C2 complex without disrupting the 
DNA-binding regions of the complex.  Therefore a YdiV:FlhDC:DNA complex would be 
formed.  Upon addition of the third and fourth YdiV molecules, the ring-structure of FlhDC 
would be altered and the DNA-binding regions of the protein would become less exposed, 
thereby releasing the DNA.  This model thereby accounts for the YdiV:FlhDC:DNA complex 
which has been identified and the DNA dissociation seen by EMSAs.  However, the basis of 
this model is on a sequential binding model with no known trigger for YdiV binding or 
understanding how YdiV has bias for certain FlhD subunits.  Furthermore, this model 
assumes that YdiV would be in enough of an excess to FlhDC that four molecules could bind 
to the complex, requiring a 3:1 ratio of YdiV:FlhDC before YdiV-mediated gene repression 
was produced.  
 
A contrasting model has been produced by Takaya et al. (2012) who identified that YdiV 
not only caused DNA dissociation of FlhDC, but targeted FlhDC for ClpXP-mediated 
proteolysis.  This paper reported that YdiV bound to free- and DNA-bound FlhDC and 
delivered FlhDC to ClpXP for proteolysis.  The half-life of FlhDC was vastly increased in the 
absence of both YdiV and ClpXP.  This model indicates that at low levels of YdiV, the ClpXP 
machinery causes slow proteolysis of FlhDC, thereby activating flagellar gene expression. 
Upon an increase in YdiV concentration, YdiV binds to FlhDC (indicated to form an YdiV4-
FlhD4C2 complex), which both prevents FlhDC binding to DNA (and dissociates the DNA 
already bound) and targets FlhDC for ClpXP proteolysis (Takaya et al., 2012).  Whilst this 
model accounts for the DNA-dissociation of FlhDC:YdiV complexes, it does not indicate in 
any way the manner in which YdiV binds to the complex.  
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In this work, a model has been proposed to account for the experimental data obtained 
(Figure 5.34; 5.35).  Using the calculated rate constants of various reactions (FlhDC and 
YdiV; FlhDC and DNA), a steady-state model was determined and matched to the 
experimental data.  An FlhDC:PfliD:YdiV complex was identified by supershift EMSA assays 
(Figure 5.23), however it was unknown whether this complex was a key component of the 
molecular system.  The model proposes that the FlhDC:PfliD:YdiV complex is a crucial step 
in the YdiV-mediated inhibition of FlhDC-mediated DNA transcription, binding to 
FlhDC:PfliD and promoting the dissociation of DNA from FlhDC.  
 
All three models clearly require further experimentation for verification.  The Li et al. 
(2012) model depends on sequential YdiV binding inducing an FlhDC conformational 
change.  Crystallographic studies of an FlhDC complex bound to YdiV at low and high 
concentrations would therefore be a useful next step, potentially supporting this 
hypothesis if an FlhDC conformational change was induced.  Equally binding studies would 
be helpful, if the order in which FlhD subunits being occupied could be determined.  
Further analysis into the ClpXP proteolysis of FlhDC would be useful. Whilst Takaya et al. 
(2012) report on the increased degradation of FlhDC upon YdiV binding to the complex, the 
exact stoichiometry of this complex is not known, thereby questioning whether there is any 
difference in the rate of adaptor-mediated proteolysis when YdiV2-FlhD4C2 is produced 
rather than YdiV4-FlhD4C2.  Equally, the biochemical manner in which YdiV delivers FlhD4C2 
to the ClpXP protein is another unknown, requiring further analysis for a complete 
understanding.  The model proposed in this work was based on experimentally-derived 
reaction constants, which provided the basis for the modelling of a steady-state system. 
Whilst the majority of reaction constants were known, one value was assigned (for the 
FlhDC:PfliD:YdiV dissociation).  Kinetic analysis of the rate of FlhDC:PfliD:YdiV dissociation is 
therefore a crucial step to advancing this model.  Additionally, this model does not take 
into account the role of ClpXP, or the rate at which this ClpXP-mediated FlhDC degradation 
occurs.   
 
Clearly there are several key questions which need to be answered in order to advance our 
understanding of YdiV; the mechanism of regulation of YdiV binding to FlhDC, the manner 
in which YdiV binds to FlhDC (whether it is sequential or random and the range of possible 
stoichiometries), the in vivo levels of YdiV and conditions in which high levels of YdiV are 
produced and a clear understanding of exactly which complexes are formed.  Additionally, 
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investigations into the possible nucleotide binding of YdiV, and whether the FliT:FlhDC:YdiV 
complex (identified by pull-down analysis) is produced in vivo, would add to our 
understanding of the YdiV and FlhDC cellular roles.  Kinetic analysis of the FlhDC 
interactions with both DNA and YdiV revealed strong high affinity interactions.  Of interest 
however, would be to analyse the binding affinity of YdiV to the FlhDC:DNA complex, and 
of the FlhDC:YdiV complex to DNA, to determine whether the affinity’s were altered. 
Additionally, given the strong affinity interactions of FlhDC to DNA, it can be assumed that 
an energy input is required to break apart this interaction.  The question then is whether 
the FlhDC:YdiV interaction alone provides this energy or whether a nucleotide or trigger of 
some form is involved as well.  
 
To summarise, the work in this thesis has increased our knowledge of the putative 
‘degenerate’ EAL domain protein YdiV, and has revealed this protein to have an important 
role in flagellar gene expression and motility.  In this manner, YdiV is acting as a regulatory 
protein, as predicted upon its identification as a non-consensus EAL protein (Sommerfeldt 
et al., 2009).  The YdiV protein has been shown to act as an anti-FlhDC factor, causing DNA 
dissociation from FlhDC at certain concentrations.  Upon addition of YdiV at lower 
concentrations to the FlhDC:DNA system, a large FlhDC:YdiV:DNA complex was produced, 
which is proposed to have a crucial role in FlhDC:DNA dissociation.  Methods in this thesis 
have produced a reliable system in which to study the YdiV and FlhDC proteins.  One area 
in which to develop may be the buffer components in which to purify and dialyse FlhDC, as 
currently the stability of this protein is relatively poor, only able to be stored for a few days. 
Improvements in this would reduce the workload necessary to purify the protein, thereby 
increasing the ease in which experiments could be carried out.  Several suggestions for 
future experiments have been detailed, however key foci may be the putative YdiV:c-di-
GMP interaction, clarification of the EMSA shifted species and investigations into the ydiV 
expression conditions and in vivo protein levels.  
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